| Sunao Tanaka, Tomoko Ishii, Fumiaki Sato, Masakazu Toi, Junji Itou |
Sunao Tanaka, Tomoko Ishii, Fumiaki Sato, Masakazu Toi, Junji Itou |
Sunao Tanaka, Tomoko Ishii, Fumiaki Sato, Masakazu Toi, Junji Itou |
Eribulin mesylate-induced c-Fos upregulation enhances cell survival in breast cancer cell lines |
Eribulin mesylate-induced c-Fos upregulation enhances cell survival in breast cancer cell lines |
Eribulin mesylate-induced c-Fos upregulation enhances cell survival in breast cancer cell lines |
Biochemical and Biophysical Research Communications, 526, 1, 154-157 |
Biochemical and Biophysical Research Communications, 526, 1, 154-157 |
Biochemical and Biophysical Research Communications, 526, 1, 154-157 |
2020/05 |
有 |
|
研究論文(学術雑誌) |
公開 |
| Ayami Ohno Kishimoto, Masako Kataoka, Mami Iima, Maya Honda, Kanae Kawai Miyake, Akane Ohashi, Rie Ota, Tatsuki Kataoka, Takaki Sakurai, Masakazu Toi, Kaori Togashi |
Ayami Ohno Kishimoto, Masako Kataoka, Mami Iima, Maya Honda, Kanae Kawai Miyake, Akane Ohashi, Rie Ota, Tatsuki Kataoka, Takaki Sakurai, Masakazu Toi, Kaori Togashi |
Ayami Ohno Kishimoto, Masako Kataoka, Mami Iima, Maya Honda, Kanae Kawai Miyake, Akane Ohashi, Rie Ota, Tatsuki Kataoka, Takaki Sakurai, Masakazu Toi, Kaori Togashi |
The comparison of high-resolution diffusion weighted imaging (DWI) with high-resolution contrast-enhanced MRI in the evaluation of breast cancers. |
The comparison of high-resolution diffusion weighted imaging (DWI) with high-resolution contrast-enhanced MRI in the evaluation of breast cancers. |
The comparison of high-resolution diffusion weighted imaging (DWI) with high-resolution contrast-enhanced MRI in the evaluation of breast cancers. |
Magnetic resonance imaging |
Magnetic resonance imaging |
Magnetic resonance imaging |
2020/04/19 |
有 |
英語 |
|
公開 |
| Akane Ohashi, Masako Kataoka, Mami Iima, Shotaro Kanao, Maya Honda, Yuta Urushibata, Marcel Dominik Nickel, Ayami Ohno Kishimoto, Rie Ota, Masakazu Toi, Kaori Togashi |
Akane Ohashi, Masako Kataoka, Mami Iima, Shotaro Kanao, Maya Honda, Yuta Urushibata, Marcel Dominik Nickel, Ayami Ohno Kishimoto, Rie Ota, Masakazu Toi, Kaori Togashi |
Akane Ohashi, Masako Kataoka, Mami Iima, Shotaro Kanao, Maya Honda, Yuta Urushibata, Marcel Dominik Nickel, Ayami Ohno Kishimoto, Rie Ota, Masakazu Toi, Kaori Togashi |
A multiparametric approach to diagnosing breast lesions using diffusion-weighted imaging and ultrafast dynamic contrast-enhanced MRI. |
A multiparametric approach to diagnosing breast lesions using diffusion-weighted imaging and ultrafast dynamic contrast-enhanced MRI. |
A multiparametric approach to diagnosing breast lesions using diffusion-weighted imaging and ultrafast dynamic contrast-enhanced MRI. |
Magnetic resonance imaging |
Magnetic resonance imaging |
Magnetic resonance imaging |
2020/04/14 |
有 |
英語 |
|
公開 |
| Saseem Poudel, Satoshi Hirano, Yo Kurashima, Dimitrios Stefanidis, Hirotoshi Akiyama, Susumu Eguchi, Toshihiro Fukui, Masaru Hagiwara, Daisuke Hashimoto, Koya Hida, Tomoko Izaki, Hirotaka Iwase, Shunsuke Kawamoto, Yasuhiro Otomo, Eishi Nagai, Mitsue Saito, Hideki Takami, Yuko Takeda, Masakazu Toi, Hiroki Yamaue, Motofumi Yoshida, Shigetoshi Yoshida, Yasuhiro Kodera |
Saseem Poudel, Satoshi Hirano, Yo Kurashima, Dimitrios Stefanidis, Hirotoshi Akiyama, Susumu Eguchi, Toshihiro Fukui, Masaru Hagiwara, Daisuke Hashimoto, Koya Hida, Tomoko Izaki, Hirotaka Iwase, Shunsuke Kawamoto, Yasuhiro Otomo, Eishi Nagai, Mitsue Saito, Hideki Takami, Yuko Takeda, Masakazu Toi, Hiroki Yamaue, Motofumi Yoshida, Shigetoshi Yoshida, Yasuhiro Kodera |
Saseem Poudel, Satoshi Hirano, Yo Kurashima, Dimitrios Stefanidis, Hirotoshi Akiyama, Susumu Eguchi, Toshihiro Fukui, Masaru Hagiwara, Daisuke Hashimoto, Koya Hida, Tomoko Izaki, Hirotaka Iwase, Shunsuke Kawamoto, Yasuhiro Otomo, Eishi Nagai, Mitsue Saito, Hideki Takami, Yuko Takeda, Masakazu Toi, Hiroki Yamaue, Motofumi Yoshida, Shigetoshi Yoshida, Yasuhiro Kodera |
Are graduating residents sufficiently competent? Results of a national gap analysis survey of program directors and graduating residents in Japan |
Are graduating residents sufficiently competent? Results of a national gap analysis survey of program directors and graduating residents in Japan |
Are graduating residents sufficiently competent? Results of a national gap analysis survey of program directors and graduating residents in Japan |
SURGERY TODAY |
SURGERY TODAY |
SURGERY TODAY |
2020/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Md. Rasel Al Mahmud,, Kenichiro Ishii,, Cristina Bernal-Lozano,, Irene Delgado-Sainz,, Masakazu Toi,, Shusuke Akamatsu,, Manabu Fukumoto,, Masatoshi Watanabe,, Shunichi Takeda,, Felipe Cortés-Ledesma,, Hiroyuki Sasanuma |
Md. Rasel Al Mahmud,, Kenichiro Ishii,, Cristina Bernal-Lozano,, Irene Delgado-Sainz,, Masakazu Toi,, Shusuke Akamatsu,, Manabu Fukumoto,, Masatoshi Watanabe,, Shunichi Takeda,, Felipe Cortés-Ledesma,, Hiroyuki Sasanuma |
Md. Rasel Al Mahmud, Kenichiro Ishii, Cristina Bernal-Lozano, Irene Delgado-Sainz, Masakazu Toi, Shusuke Akamatsu, Manabu Fukumoto, Masatoshi Watanabe, Shunichi Takeda, Felipe Cortés-Ledesma, Hiroyuki Sasanuma |
TDP2 suppresses genomic instability induced by androgens in the epithelial cells of prostate glands |
TDP2 suppresses genomic instability induced by androgens in the epithelial cells of prostate glands |
TDP2 suppresses genomic instability induced by androgens in the epithelial cells of prostate glands |
Genes to Cells, in press |
Genes to Cells, in press |
Genes to Cells, in press |
2020/03 |
有 |
|
|
公開 |
| Ishiguro H, Masuda N, Sato N, Higaki K, Morimoto T, Yanagita Y, Mizutani M, Ohtani S, Kaneko k, Fujisawa T, Takahashi M, Kadoya T, Matsunami M, Yamamoto Y, Ohno S, Takano T, Morita S, , Tanaka-Mizuno S, Toi M |
Ishiguro H, Masuda N, Sato N, Higaki K, Morimoto T, Yanagita Y, Mizutani M, Ohtani S, Kaneko k, Fujisawa T, Takahashi M, Kadoya T, Matsunami M, Yamamoto Y, Ohno S, Takano T, Morita S, , Tanaka-Mizuno S, Toi M |
Ishiguro H, Masuda N, Sato N, Higaki K, Morimoto T, Yanagita Y, Mizutani M, Ohtani S, Kaneko k, Fujisawa T, Takahashi M, Kadoya T, Matsunami M, Yamamoto Y, Ohno S, Takano T, Morita S, , Tanaka-Mizuno S, Toi M |
A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer |
A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer |
A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer |
Breast Cancer Res and Treat |
Breast Cancer Res and Treat |
Breast Cancer Res and Treat |
2020/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Junji Itou, Rei Takahashi, Hiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, Yoshiaki Matsumoto, Tomoko Ishii, Fumiaki Sato, Shunichi Takeda, Masakazu Toi |
Junji Itou, Rei Takahashi, Hiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, Yoshiaki Matsumoto, Tomoko Ishii, Fumiaki Sato, Shunichi Takeda, Masakazu Toi |
Junji Itou, Rei Takahashi, Hiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, Yoshiaki Matsumoto, Tomoko Ishii, Fumiaki Sato, Shunichi Takeda, Masakazu Toi |
Estrogen Induces Mammary Ductal Dysplasia via the Upregulation of Myc Expression in a DNA-Repair-Deficient Condition.  |
Estrogen Induces Mammary Ductal Dysplasia via the Upregulation of Myc Expression in a DNA-Repair-Deficient Condition. |
Estrogen Induces Mammary Ductal Dysplasia via the Upregulation of Myc Expression in a DNA-Repair-Deficient Condition. |
iScience, 23, 2, 100821-100821 |
iScience, 23, 2, 100821-100821 |
iScience, 23, 2, 100821-100821 |
2020/02/21 |
有 |
英語 |
|
公開 |
| Noriko Senda, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Yukiko Inagaki-Kawata, Kenichi Yoshida, Tomomi Nishimura, Masahiro Takada, Eiji Suzuki, Yuki Kataoka, Fumiaki Sato, Yoshiaki Matsumoto, Masae Torii, Hiroshi Yoshibayashi, Kazuhiro Yamagami, Shigeru Tsuyuki, Akira Yamauchi, Nobuhiko Shinkura, Hironori Kato, Yoshio Moriguchi, Ryuji Okamura, Norimichi Kan, Hirofumi Suwa, Shingo Sakata, Susumu Mashima, Fumiaki Yotsumoto, Tsuyoshi Tachibana, Mitsuru Tanaka, Takashi Inamoto, Masahiro Sugimoto, Seishi Ogawa, Masakazu Toi |
Noriko Senda, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Yukiko Inagaki-Kawata, Kenichi Yoshida, Tomomi Nishimura, Masahiro Takada, Eiji Suzuki, Yuki Kataoka, Fumiaki Sato, Yoshiaki Matsumoto, Masae Torii, Hiroshi Yoshibayashi, Kazuhiro Yamagami, Shigeru Tsuyuki, Akira Yamauchi, Nobuhiko Shinkura, Hironori Kato, Yoshio Moriguchi, Ryuji Okamura, Norimichi Kan, Hirofumi Suwa, Shingo Sakata, Susumu Mashima, Fumiaki Yotsumoto, Tsuyoshi Tachibana, Mitsuru Tanaka, Takashi Inamoto, Masahiro Sugimoto, Seishi Ogawa, Masakazu Toi |
Noriko Senda, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Yukiko Inagaki-Kawata, Kenichi Yoshida, Tomomi Nishimura, Masahiro Takada, Eiji Suzuki, Yuki Kataoka, Fumiaki Sato, Yoshiaki Matsumoto, Masae Torii, Hiroshi Yoshibayashi, Kazuhiro Yamagami, Shigeru Tsuyuki, Akira Yamauchi, Nobuhiko Shinkura, Hironori Kato, Yoshio Moriguchi, Ryuji Okamura, Norimichi Kan, Hirofumi Suwa, Shingo Sakata, Susumu Mashima, Fumiaki Yotsumoto, Tsuyoshi Tachibana, Mitsuru Tanaka, Takashi Inamoto, Masahiro Sugimoto, Seishi Ogawa, Masakazu Toi |
Abstract P2-10-12: Relationship between predicted risks of carrying breast cancer susceptibility genes and the presence of germline variants in Japanese patients with primary breast cancer |
Abstract P2-10-12: Relationship between predicted risks of carrying breast cancer susceptibility genes and the presence of germline variants in Japanese patients with primary breast cancer |
Abstract P2-10-12: Relationship between predicted risks of carrying breast cancer susceptibility genes and the presence of germline variants in Japanese patients with primary breast cancer |
Poster Session Abstracts |
Poster Session Abstracts |
Poster Session Abstracts |
2020/02/15 |
有 |
|
研究論文(国際会議プロシーディングス) |
公開 |
| Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S |
Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S |
Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S |
Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study. |
Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study. |
Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study. |
Breast Cancer |
Breast Cancer |
Breast Cancer |
2019/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Saseem Poudel, Satoshi Hirano, Yo Kurashima, Dimitrios Stefanidis, Hirotoshi Akiyama, Susumu Eguchi, Toshihiro Fukui, Masaru Hagiwara, Daisuke Hashimoto, Koya Hida, Tomoko Izaki, Hirotaka Iwase, Shunsuke Kawamoto, Yasuhiro Otomo, Eishi Nagai, Mitsue Saito, Hideki Takami, Yuko Takeda, Masakazu Toi, Hiroki Yamaue, Motofumi Yoshida, Shigetoshi Yoshida, Yasuhiro Kodera |
Saseem Poudel, Satoshi Hirano, Yo Kurashima, Dimitrios Stefanidis, Hirotoshi Akiyama, Susumu Eguchi, Toshihiro Fukui, Masaru Hagiwara, Daisuke Hashimoto, Koya Hida, Tomoko Izaki, Hirotaka Iwase, Shunsuke Kawamoto, Yasuhiro Otomo, Eishi Nagai, Mitsue Saito, Hideki Takami, Yuko Takeda, Masakazu Toi, Hiroki Yamaue, Motofumi Yoshida, Shigetoshi Yoshida, Yasuhiro Kodera |
Saseem Poudel, Satoshi Hirano, Yo Kurashima, Dimitrios Stefanidis, Hirotoshi Akiyama, Susumu Eguchi, Toshihiro Fukui, Masaru Hagiwara, Daisuke Hashimoto, Koya Hida, Tomoko Izaki, Hirotaka Iwase, Shunsuke Kawamoto, Yasuhiro Otomo, Eishi Nagai, Mitsue Saito, Hideki Takami, Yuko Takeda, Masakazu Toi, Hiroki Yamaue, Motofumi Yoshida, Shigetoshi Yoshida, Yasuhiro Kodera |
A snapshot of surgical resident training in Japan: results of a national-level needs assessment survey. |
A snapshot of surgical resident training in Japan: results of a national-level needs assessment survey. |
A snapshot of surgical resident training in Japan: results of a national-level needs assessment survey. |
Surgery today, 49, 10, 870-876 |
Surgery today, 49, 10, 870-876 |
Surgery today, 49, 10, 870-876 |
2019/10 |
有 |
英語 |
|
公開 |
| Ishiguro H, Ohno S, Yamamoto Y, Takao S, Sato N, Fujisawa T, Kadoya T, Kuroi K, Bando H, Teramura Y, Iwata H, Tanaka S, Toi M |
Ishiguro H, Ohno S, Yamamoto Y, Takao S, Sato N, Fujisawa T, Kadoya T, Kuroi K, Bando H, Teramura Y, Iwata H, Tanaka S, Toi M |
Ishiguro H, Ohno S, Yamamoto Y, Takao S, Sato N, Fujisawa T, Kadoya T, Kuroi K, Bando H, Teramura Y, Iwata H, Tanaka S, Toi M |
Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer. |
Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer. |
Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer. |
Breast Cancer, 26, 5, 535-543 |
Breast Cancer, 26, 5, 535-543 |
Breast Cancer, 26, 5, 535-543 |
2019/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M |
Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M |
Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M |
Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study. |
Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study. |
Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study. |
Cancer medicine, 8, 12, 5468-5481 |
Cancer medicine, 8, 12, 5468-5481 |
Cancer medicine, 8, 12, 5468-5481 |
2019/09 |
有 |
|
|
公開 |
| Kinoshita T, Nakayama T, Fukuma E, Inokuchi M, Ishiguro H, Ogo E, Kikuchi M, Jinno H, Yamazaki N, Toi M |
Kinoshita T, Nakayama T, Fukuma E, Inokuchi M, Ishiguro H, Ogo E, Kikuchi M, Jinno H, Yamazaki N, Toi M |
Kinoshita T, Nakayama T, Fukuma E, Inokuchi M, Ishiguro H, Ogo E, Kikuchi M, Jinno H, Yamazaki N, Toi M |
The Efficacy of Scalp Cooling in Preventing and Recovering from Chemotherapy-induced alopecia in Breast Cancer Patients: The HOPE study |
The Efficacy of Scalp Cooling in Preventing and Recovering from Chemotherapy-induced alopecia in Breast Cancer Patients: The HOPE study |
The Efficacy of Scalp Cooling in Preventing and Recovering from Chemotherapy-induced alopecia in Breast Cancer Patients: The HOPE study |
Frontiers in Oncology, 1-9 |
Frontiers in Oncology, 1-9 |
Frontiers in Oncology, 1-9 |
2019/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Ohashi A, Kataoka M, Kanao S, Iima M, Murata K, Weiland E, Onishi N, Kawai M, Toi M, Togashi K |
Ohashi A, Kataoka M, Kanao S, Iima M, Murata K, Weiland E, Onishi N, Kawai M, Toi M, Togashi K |
Ohashi A, Kataoka M, Kanao S, Iima M, Murata K, Weiland E, Onishi N, Kawai M, Toi M, Togashi K |
Diagnostic performance of maximum slope: A kinetic parameter obtained from ultrafast dynamic contrast-enhanced magnetic resonance imaging of the breast using k-space weighted image contrast (KWIC). |
Diagnostic performance of maximum slope: A kinetic parameter obtained from ultrafast dynamic contrast-enhanced magnetic resonance imaging of the breast using k-space weighted image contrast (KWIC). |
Diagnostic performance of maximum slope: A kinetic parameter obtained from ultrafast dynamic contrast-enhanced magnetic resonance imaging of the breast using k-space weighted image contrast (KWIC). |
European journal of radiology, 118, 285-292 |
European journal of radiology, 118, 285-292 |
European journal of radiology, 118, 285-292 |
2019/06 |
有 |
|
|
公開 |
| Honda M, Kataoka M, Onishi N, Iima M, Ohashi A, Kanao S, Nickel MD, Toi M, Togashi K |
Honda M, Kataoka M, Onishi N, Iima M, Ohashi A, Kanao S, Nickel MD, Toi M, Togashi K |
Honda M, Kataoka M, Onishi N, Iima M, Ohashi A, Kanao S, Nickel MD, Toi M, Togashi K |
New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing. |
New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing. |
New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing. |
Journal of magnetic resonance imaging : JMRI |
Journal of magnetic resonance imaging : JMRI |
Journal of magnetic resonance imaging : JMRI |
2019/06 |
有 |
|
|
公開 |
| Takada M, Toi M |
Takada M, Toi M |
Takada M, Toi M |
Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes. |
Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes. |
Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes. |
International Journal of Clinical Oncology, 24, 6, 608-613 |
International Journal of Clinical Oncology, 24, 6, 608-613 |
International Journal of Clinical Oncology, 24, 6, 608-613 |
2019/06 |
有 |
|
|
公開 |
| Masuda N, Mukai H, Inoue K, Rai Y, Ohno S, Mori Y, Hashigaki S, Muramatsu Y, Umeyama Y, Iwata H, Toi M |
Masuda N, Mukai H, Inoue K, Rai Y, Ohno S, Mori Y, Hashigaki S, Muramatsu Y, Umeyama Y, Iwata H, Toi M |
Masuda N, Mukai H, Inoue K, Rai Y, Ohno S, Mori Y, Hashigaki S, Muramatsu Y, Umeyama Y, Iwata H, Toi M |
Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer. |
Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer. |
Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer. |
Breast Cancer (Tokyo, Japan) |
Breast Cancer (Tokyo, Japan) |
Breast Cancer (Tokyo, Japan) |
2019/06 |
有 |
|
|
公開 |
| Yap YS, Lu YS, Tamura K, Lee JE, Ko EY, Park YH, Cao AY, Lin CH, Toi M, Wu J, Lee SC |
Yap YS, Lu YS, Tamura K, Lee JE, Ko EY, Park YH, Cao AY, Lin CH, Toi M, Wu J, Lee SC |
Yap YS, Lu YS, Tamura K, Lee JE, Ko EY, Park YH, Cao AY, Lin CH, Toi M, Wu J, Lee SC |
Insights Into Breast Cancer in the East vs the West: A Review. |
Insights Into Breast Cancer in the East vs the West: A Review. |
Insights Into Breast Cancer in the East vs the West: A Review. |
JAMA oncology |
JAMA oncology |
JAMA oncology |
2019/05 |
有 |
|
|
公開 |
| Sakaguchi R, Kataoka M, Kanao S, Miyake KK, Nakamoto Y, Sugie T, Toi M, Mikami Y, Togashi K |
Sakaguchi R, Kataoka M, Kanao S, Miyake KK, Nakamoto Y, Sugie T, Toi M, Mikami Y, Togashi K |
Sakaguchi R, Kataoka M, Kanao S, Miyake KK, Nakamoto Y, Sugie T, Toi M, Mikami Y, Togashi K |
Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer. |
Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer. |
Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer. |
Annals of Nuclear Medicine |
Annals of Nuclear Medicine |
Annals of Nuclear Medicine |
2019/05 |
有 |
|
|
公開 |
| Im SA, Mukai H, Park IH, Masuda N, Shimizu C, Kim SB, Im YH, Ohtani S, Huang Bartlett C, Lu DR, Iyer S, Mori Y, Mori A, Gauthier E, Finn RS, Toi M |
Im SA, Mukai H, Park IH, Masuda N, Shimizu C, Kim SB, Im YH, Ohtani S, Huang Bartlett C, Lu DR, Iyer S, Mori Y, Mori A, Gauthier E, Finn RS, Toi M |
Im SA, Mukai H, Park IH, Masuda N, Shimizu C, Kim SB, Im YH, Ohtani S, Huang Bartlett C, Lu DR, Iyer S, Mori Y, Mori A, Gauthier E, Finn RS, Toi M |
Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study. |
Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study. |
Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study. |
Journal of Global Oncology, 5, 1-19 |
Journal of Global Oncology, 5, 1-19 |
Journal of Global Oncology, 5, 1-19 |
2019/05 |
有 |
|
|
公開 |
| Perez EA, de Haas SL, Eiermann W, Barrios CH, Toi M, Im YH, Conte PF, Martin M, Pienkowski T, Pivot XB, Burris HA, Stanzel S, Patre M, Ellis PA |
Perez EA, de Haas SL, Eiermann W, Barrios CH, Toi M, Im YH, Conte PF, Martin M, Pienkowski T, Pivot XB, Burris HA, Stanzel S, Patre M, Ellis PA |
Perez EA, de Haas SL, Eiermann W, Barrios CH, Toi M, Im YH, Conte PF, Martin M, Pienkowski T, Pivot XB, Burris HA, Stanzel S, Patre M, Ellis PA |
Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer. |
Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer. |
Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer. |
BMC cancer, 19, 1, 517 |
BMC cancer, 19, 1, 517 |
BMC cancer, 19, 1, 517 |
2019/05 |
有 |
|
|
公開 |
| Benson JR, Jatoi I, Toi M |
Benson JR, Jatoi I, Toi M |
Benson JR, Jatoi I, Toi M |
Surgical management of multiple ipsilateral breast cancers. |
Surgical management of multiple ipsilateral breast cancers. |
Surgical management of multiple ipsilateral breast cancers. |
Future oncology (London, England), 15, 11, 1185-1191 |
Future oncology (London, England), 15, 11, 1185-1191 |
Future oncology (London, England), 15, 11, 1185-1191 |
2019/04 |
有 |
|
|
公開 |
| Ueno T, Masuda N, Kamigaki S, Morimoto T, Saji S, Imoto S, Sasano H, Toi M |
Ueno T, Masuda N, Kamigaki S, Morimoto T, Saji S, Imoto S, Sasano H, Toi M |
Ueno T, Masuda N, Kamigaki S, Morimoto T, Saji S, Imoto S, Sasano H, Toi M |
Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR. |
Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR. |
Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR. |
International journal of molecular sciences, 20, 4 |
International journal of molecular sciences, 20, 4 |
International journal of molecular sciences, 20, 4 |
2019/02 |
有 |
|
|
公開 |
| Kawaguchi K, Sakurai M, Yamamoto Y, Suzuki E, Tsuda M, Kataoka TR, Hirata M, Nishie M, Nojiri T, Kumazoe M, Saito K, Toi M |
Kawaguchi K, Sakurai M, Yamamoto Y, Suzuki E, Tsuda M, Kataoka TR, Hirata M, Nishie M, Nojiri T, Kumazoe M, Saito K, Toi M |
Kawaguchi K, Sakurai M, Yamamoto Y, Suzuki E, Tsuda M, Kataoka TR, Hirata M, Nishie M, Nojiri T, Kumazoe M, Saito K, Toi M |
Alteration of specific cytokine expression patterns in patients with breast cancer. |
Alteration of specific cytokine expression patterns in patients with breast cancer. |
Alteration of specific cytokine expression patterns in patients with breast cancer. |
Scientific reports, 9, 1, 2924 |
Scientific reports, 9, 1, 2924 |
Scientific reports, 9, 1, 2924 |
2019/02 |
有 |
|
|
公開 |
| Kawashima M, Tokiwa M, Nishimura T, Kawata Y, Sugimoto M, Kataoka T, Sakurai T, Iwaisako K, Suzuki E, Hagiwara M, Harris A, Toi M |
Kawashima M, Tokiwa M, Nishimura T, Kawata Y, Sugimoto M, Kataoka T, Sakurai T, Iwaisako K, Suzuki E, Hagiwara M, Harris A, Toi M |
Eizi Suzuki |
High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer |
High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer |
High-resolution imaging mass spectrometry combined with transcriptomic analysis identified a link between fatty acid composition of phosphatidylinositols and the immune checkpoint pathway at the primary tumour site of breast cancer |
British Journal of Cancer |
British Journal of Cancer |
British Journal of Cancer |
2019 |
有 |
|
|
公開 |
| Ono Y, Yoshimura M, Hirata K, Yamauchi C, Toi M, Suzuki E, Takada M, Hiraoka M, Mizowaki T |
Ono Y, Yoshimura M, Hirata K, Yamauchi C, Toi M, Suzuki E, Takada M, Hiraoka M, Mizowaki T |
Eizi Suzuki |
The impact of age on the risk of ipsilateral breast tumor recurrence after breastconserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation |
The impact of age on the risk of ipsilateral breast tumor recurrence after breastconserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation |
The impact of age on the risk of ipsilateral breast tumor recurrence after breastconserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation |
Radiation Oncology |
Radiation Oncology |
Radiation Oncology |
2019 |
有 |
|
|
公開 |
| Tanaka S, Senda N, Iida A, Sehara-Fujisawa A, Ishii T, Sato F, Toi M, Itou J |
Tanaka S, Senda N, Iida A, Sehara-Fujisawa A, Ishii T, Sato F, Toi M, Itou J |
Tanaka S, Senda N, Iida A, Sehara-Fujisawa A, Ishii T, Sato F, Toi M, Itou J |
In silico analysis-based identification of the target residue of integrin α6 for metastasis inhibition of basal-like breast cancer. |
In silico analysis-based identification of the target residue of integrin α6 for metastasis inhibition of basal-like breast cancer. |
In silico analysis-based identification of the target residue of integrin α6 for metastasis inhibition of basal-like breast cancer. |
Genes to Cells, 24, 596-607 |
Genes to Cells, 24, 596-607 |
Genes to Cells, 24, 596-607 |
2019 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Ueno T, Saji S, Masuda N, Iwata H, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Sasano H, Toi M |
Ueno T, Saji S, Masuda N, Iwata H, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Sasano H, Toi M |
Ueno T, Saji S, Masuda N, Iwata H, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Sasano H, Toi M |
Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication. |
Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication. |
Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication. |
ESMO open, 4, 1, e000476 |
ESMO open, 4, 1, e000476 |
ESMO open, 4, 1, e000476 |
2019 |
有 |
|
|
公開 |
| Kiso M, Tanaka S, Saji S, Toi M, Sato F |
Kiso M, Tanaka S, Saji S, Toi M, Sato F |
Kiso M, Tanaka S, Saji S, Toi M, Sato F |
Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network. |
Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network. |
Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network. |
Int J Cancer, 1;143, 11, 2905-2918 |
Int J Cancer, 1;143, 11, 2905-2918 |
Int J Cancer, 1;143, 11, 2905-2918 |
2018/12 |
有 |
|
|
公開 |
| Masahiro Takada, Masahiro Sugimoto, Norikazu Masuda, Hiroji Iwata, Katsumasa Kuroi, Hiroyasu Yamashiro, Shinji Ohno, Hiroshi Ishiguro, Takashi Inamoto, Masakazu Toi |
Masahiro Takada, Masahiro Sugimoto, Norikazu Masuda, Hiroji Iwata, Katsumasa Kuroi, Hiroyasu Yamashiro, Shinji Ohno, Hiroshi Ishiguro, Takashi Inamoto, Masakazu Toi |
Masahiro Takada, Masahiro Sugimoto, Norikazu Masuda, Hiroji Iwata, Katsumasa Kuroi, Hiroyasu Yamashiro, Shinji Ohno, Hiroshi Ishiguro, Takashi Inamoto, Masakazu Toi |
Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm |
Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm |
Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm |
Breast Cancer Research and Treatment, 172, 3, 611-618 |
Breast Cancer Research and Treatment, 172, 3, 611-618 |
Breast Cancer Research and Treatment, 172, 3, 611-618 |
2018/12 |
有 |
|
研究論文(学術雑誌) |
公開 |
| Hiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, Liton Kumar Saha, Md Maminur Rahman, Yusuke Kiyooka, Haruna Fujiike, Andrew D Cherniack, Junji Itou, Elsa Callen Moreu, Masakazu Toi, Shinichiro Nakada, Hisashi Tanaka, Ken Tsutsui, Shintaro Yamada, Andre Nussenzweig, Shunichi Takeda |
Hiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, Liton Kumar Saha, Md Maminur Rahman, Yusuke Kiyooka, Haruna Fujiike, Andrew D Cherniack, Junji Itou, Elsa Callen Moreu, Masakazu Toi, Shinichiro Nakada, Hisashi Tanaka, Ken Tsutsui, Shintaro Yamada, Andre Nussenzweig, Shunichi Takeda |
Hiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, Liton Kumar Saha, Md Maminur Rahman, Yusuke Kiyooka, Haruna Fujiike, Andrew D Cherniack, Junji Itou, Elsa Callen Moreu, Masakazu Toi, Shinichiro Nakada, Hisashi Tanaka, Ken Tsutsui, Shintaro Yamada, Andre Nussenzweig, Shunichi Takeda |
BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes. |
BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes. |
BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes. |
Proceedings of the National Academy of Sciences of the United States of America, 115, 45, E10642-E10651-E10651 |
Proceedings of the National Academy of Sciences of the United States of America, 115, 45, E10642-E10651-E10651 |
Proceedings of the National Academy of Sciences of the United States of America, 115, 45, E10642-E10651-E10651 |
2018/11/06 |
有 |
英語 |
|
公開 |
| Ueno T, Saji S, Chiba T, Kamma H, Isaka H, Itoh H, Imi K, Miyamoto K, Tada M, Sasano H, Toi M, Imoto S |
Ueno T, Saji S, Chiba T, Kamma H, Isaka H, Itoh H, Imi K, Miyamoto K, Tada M, Sasano H, Toi M, Imoto S |
Ueno T, Saji S, Chiba T, Kamma H, Isaka H, Itoh H, Imi K, Miyamoto K, Tada M, Sasano H, Toi M, Imoto S |
Progesterone receptor expression in proliferating cancer cells of hormone-receptor-positive breast cancer. |
Progesterone receptor expression in proliferating cancer cells of hormone-receptor-positive breast cancer. |
Progesterone receptor expression in proliferating cancer cells of hormone-receptor-positive breast cancer. |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 40, 10, 1010428318811025 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 40, 10, 1010428318811025 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 40, 10, 1010428318811025 |
2018/11 |
有 |
|
|
公開 |
| Sagawa H, Kataoka M, Kanao S, Onishi N, Nickel MD, Toi M, Togashi K |
Sagawa H, Kataoka M, Kanao S, Onishi N, Nickel MD, Toi M, Togashi K |
Sagawa H, Kataoka M, Kanao S, Onishi N, Nickel MD, Toi M, Togashi K |
Impact of the Number of Iterations in Compressed Sensing Reconstruction on Ultrafast Dynamic Contrast-enhanced Breast MR Imaging. |
Impact of the Number of Iterations in Compressed Sensing Reconstruction on Ultrafast Dynamic Contrast-enhanced Breast MR Imaging. |
Impact of the Number of Iterations in Compressed Sensing Reconstruction on Ultrafast Dynamic Contrast-enhanced Breast MR Imaging. |
Magn Reson Med Sci, 9, doi: 10.2463/mrms.mp.2018-0015 |
Magn Reson Med Sci, 9, doi: 10.2463/mrms.mp.2018-0015 |
Magn Reson Med Sci, 9, doi: 10.2463/mrms.mp.2018-0015 |
2018/11 |
有 |
|
|
公開 |
| Sagara Y, Takada M, Ohi Y, Ohtani S, Kurozumi S, Inoue K, Kosaka Y, Hattori M, Yamashita T, Takao S, Sato N, Iwata H, Kurosumi M, Toi M |
Sagara Y, Takada M, Ohi Y, Ohtani S, Kurozumi S, Inoue K, Kosaka Y, Hattori M, Yamashita T, Takao S, Sato N, Iwata H, Kurosumi M, Toi M |
Sagara Y, Takada M, Ohi Y, Ohtani S, Kurozumi S, Inoue K, Kosaka Y, Hattori M, Yamashita T, Takao S, Sato N, Iwata H, Kurosumi M, Toi M |
Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03. |
Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03. |
Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03. |
Breast Cancer Res Treat, 171, 3, 675-683 |
Breast Cancer Res Treat, 171, 3, 675-683 |
Breast Cancer Res Treat, 171, 3, 675-683 |
2018/10 |
有 |
|
|
公開 |
| Matsumoto Y, Asao Y, Sekiguchi H, Yoshikawa A, Ishii T, Nagae KI, Kobayashi S, Tsuge I, Saito S, Takada M, Ishida Y, Kataoka M, Sakurai T, Yagi T, Kabashima K, Suzuki S, Togashi K, Shiina T, Toi M |
Matsumoto Y, Asao Y, Sekiguchi H, Yoshikawa A, Ishii T, Nagae KI, Kobayashi S, Tsuge I, Saito S, Takada M, Ishida Y, Kataoka M, Sakurai T, Yagi T, Kabashima K, Suzuki S, Togashi K, Shiina T, Toi M |
Matsumoto Y, Asao Y, Sekiguchi H, Yoshikawa A, Ishii T, Nagae KI, Kobayashi S, Tsuge I, Saito S, Takada M, Ishida Y, Kataoka M, Sakurai T, Yagi T, Kabashima K, Suzuki S, Togashi K, Shiina T, Toi M |
Visualising peripheral arterioles and venules through high-resolution and large-area photoacoustic imaging. |
Visualising peripheral arterioles and venules through high-resolution and large-area photoacoustic imaging. |
Visualising peripheral arterioles and venules through high-resolution and large-area photoacoustic imaging. |
Sci Rep, 8;8, 1, 14930-doi: 10.1038/s41598-018-33255- |
Sci Rep, 8;8, 1, 14930-doi: 10.1038/s41598-018-33255- |
Sci Rep, 8;8, 1, 14930-doi: 10.1038/s41598-018-33255- |
2018/10 |
有 |
|
|
公開 |
| Suzuki E, Sugimoto M, Kawaguchi K, Pu F, Uozumi R, Yamaguchi A, Nishie M, Tsuda M, Kotake T, Morita S, Toi M |
Suzuki E, Sugimoto M, Kawaguchi K, Pu F, Uozumi R, Yamaguchi A, Nishie M, Tsuda M, Kotake T, Morita S, Toi M |
Suzuki E, Sugimoto M, Kawaguchi K, Pu F, Uozumi R, Yamaguchi A, Nishie M, Tsuda M, Kotake T, Morita S, Toi M |
Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients. |
Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients. |
Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients. |
Breast Cancer, 13, doi: 10.1007/s12282-018-0920-2 |
Breast Cancer, 13, doi: 10.1007/s12282-018-0920-2 |
Breast Cancer, 13, doi: 10.1007/s12282-018-0920-2 |
2018/10 |
有 |
|
|
公開 |
| Saito S, Bise R, Yoshikawa A, Sekiguchi H, Tsuge I, Toi M |
Saito S, Bise R, Yoshikawa A, Sekiguchi H, Tsuge I, Toi M |
Saito S, Bise R, Yoshikawa A, Sekiguchi H, Tsuge I, Toi M |
Digital artery deformation on movement of the proximal interphalangeal joint |
Digital artery deformation on movement of the proximal interphalangeal joint |
Digital artery deformation on movement of the proximal interphalangeal joint |
J Hand Surg Eur, 18:1753193418807833, doi: 10.1177/1753193418807833. |
J Hand Surg Eur, 18:1753193418807833, doi: 10.1177/1753193418807833. |
J Hand Surg Eur, 18:1753193418807833, doi: 10.1177/1753193418807833. |
2018/10 |
有 |
|
|
公開 |
| Yamamoto Y, Iwata H, Ueno T, Taira N, Kashiwaba M, Takahashi M, Tada H, Tsugawa K, Toyama T, Niikura N, Hara F, Fujisawa T, Yoshinami T, Saji S, Takano T, Masuda N, Morita S, Toi M, Ohno S |
Yamamoto Y, Iwata H, Ueno T, Taira N, Kashiwaba M, Takahashi M, Tada H, Tsugawa K, Toyama T, Niikura N, Hara F, Fujisawa T, Yoshinami T, Saji S, Takano T, Masuda N, Morita S, Toi M, Ohno S |
Yamamoto Y, Iwata H, Ueno T, Taira N, Kashiwaba M, Takahashi M, Tada H, Tsugawa K, Toyama T, Niikura N, Hara F, Fujisawa T, Yoshinami T, Saji S, Takano T, Masuda N, Morita S, Toi M, Ohno S |
A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS s |
A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS s |
A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS s |
Jpn J Clin Oncol, 1;48, 9, 855-859 |
Jpn J Clin Oncol, 1;48, 9, 855-859 |
Jpn J Clin Oncol, 1;48, 9, 855-859 |
2018/09 |
有 |
|
|
公開 |
| Fukui Y, Kawashima M, Kawaguchi K, Takeuchi M, Hirata M, Kataoka TR, Sakurai T, Kataoka M, Kanao S, Nakamoto Y, Hirata K, Yoshimura M, Yoshikawa K, Ishiguro H, Toi M |
Fukui Y, Kawashima M, Kawaguchi K, Takeuchi M, Hirata M, Kataoka TR, Sakurai T, Kataoka M, Kanao S, Nakamoto Y, Hirata K, Yoshimura M, Yoshikawa K, Ishiguro H, Toi M |
Fukui Y, Kawashima M, Kawaguchi K, Takeuchi M, Hirata M, Kataoka TR, Sakurai T, Kataoka M, Kanao S, Nakamoto Y, Hirata K, Yoshimura M, Yoshikawa K, Ishiguro H, Toi M |
Granulocyte-colony-stimulating factor-producing metaplastic carcinoma of the breast with significant elevation of serum interleukin-17 and vascular endothelial growth factor levels. |
Granulocyte-colony-stimulating factor-producing metaplastic carcinoma of the breast with significant elevation of serum interleukin-17 and vascular endothelial growth factor levels. |
Granulocyte-colony-stimulating factor-producing metaplastic carcinoma of the breast with significant elevation of serum interleukin-17 and vascular endothelial growth factor levels. |
International cancer conference journal, 7, 3, 107-113 |
International cancer conference journal, 7, 3, 107-113 |
International cancer conference journal, 7, 3, 107-113 |
2018/07 |
有 |
|
|
公開 |
| Mackenzie LJ, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D'Este C, Yoshimura M, Toi M |
Mackenzie LJ, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D'Este C, Yoshimura M, Toi M |
Mackenzie LJ, Carey ML, Suzuki E, Sanson-Fisher RW, Asada H, Ogura M, D'Este C, Yoshimura M, Toi M |
Agreement between patients' and radiation oncologists' cancer diagnosis and prognosis perceptions: A cross sectional study in Japan. |
Agreement between patients' and radiation oncologists' cancer diagnosis and prognosis perceptions: A cross sectional study in Japan. |
Agreement between patients' and radiation oncologists' cancer diagnosis and prognosis perceptions: A cross sectional study in Japan. |
PLoS One, 8;13, 6, :e0198437. doi: 10.1371/journa |
PLoS One, 8;13, 6, :e0198437. doi: 10.1371/journa |
PLoS One, 8;13, 6, :e0198437. doi: 10.1371/journa |
2018/06 |
有 |
|
|
公開 |
| Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M |
Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M |
Sato N, Masuda N, Morimoto T, Ueno T, Kanbayashi C, Kaneko K, Yasojima H, Saji S, Sasano H, Morita S, Ohno S, Toi M |
Neoadjuvant endocrine therapy with exemestane followed by response-guided combination therapy with low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study. |
Neoadjuvant endocrine therapy with exemestane followed by response-guided combination therapy with low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study. |
Neoadjuvant endocrine therapy with exemestane followed by response-guided combination therapy with low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study. |
Cancer Med, 14, 1002/cam4.1600. [Epub ahead of |
Cancer Med, 14, 1002/cam4.1600. [Epub ahead of |
Cancer Med, 14, 1002/cam4.1600. [Epub ahead of |
2018/06 |
有 |
|
|
公開 |
| Yamaga I, Kawaguchi-Sakita N, Asao Y, Matsumoto Y, Yoshikawa A, Fukui T, Takada M, Kataoka M, Kawashima M, Fakhrejahani E, Kanao S, Nakayama Y, Tokiwa M, Torii M, Yagi T, Sakurai T, Haga H, Togashi K, Shiina T, Toi M |
Yamaga I, Kawaguchi-Sakita N, Asao Y, Matsumoto Y, Yoshikawa A, Fukui T, Takada M, Kataoka M, Kawashima M, Fakhrejahani E, Kanao S, Nakayama Y, Tokiwa M, Torii M, Yagi T, Sakurai T, Haga H, Togashi K, Shiina T, Toi M |
Yamaga I, Kawaguchi-Sakita N, Asao Y, Matsumoto Y, Yoshikawa A, Fukui T, Takada M, Kataoka M, Kawashima M, Fakhrejahani E, Kanao S, Nakayama Y, Tokiwa M, Torii M, Yagi T, Sakurai T, Haga H, Togashi K, Shiina T, Toi M |
Vascular branching point counts using photoacoustic imaging in the superficial layer of the breast: A potential biomarker for breast cancer. |
Vascular branching point counts using photoacoustic imaging in the superficial layer of the breast: A potential biomarker for breast cancer. |
Vascular branching point counts using photoacoustic imaging in the superficial layer of the breast: A potential biomarker for breast cancer. |
Photoacoustics, 20;11, 6-13 |
Photoacoustics, 20;11, 6-13 |
Photoacoustics, 20;11, 6-13 |
2018/06 |
有 |
|
|
公開 |
| Iima M, Kataoka M, Kanao S, Onishi N, Kawai M, Ohashi A, Sakaguchi R, Toi M, Togashi K |
Iima M, Kataoka M, Kanao S, Onishi N, Kawai M, Ohashi A, Sakaguchi R, Toi M, Togashi K |
Iima M, Kataoka M, Kanao S, Onishi N, Kawai M, Ohashi A, Sakaguchi R, Toi M, Togashi K |
Intravoxel Incoherent Motion and Quantitative Non-Gaussian Diffusion MR Imaging: Evaluation of the Diagnostic and Prognostic Value of Several Markers of Malignant and Benign Breast Lesions. |
Intravoxel Incoherent Motion and Quantitative Non-Gaussian Diffusion MR Imaging: Evaluation of the Diagnostic and Prognostic Value of Several Markers of Malignant and Benign Breast Lesions. |
Intravoxel Incoherent Motion and Quantitative Non-Gaussian Diffusion MR Imaging: Evaluation of the Diagnostic and Prognostic Value of Several Markers of Malignant and Benign Breast Lesions. |
Radiology, 287, 2, 432-441 |
Radiology, 287, 2, 432-441 |
Radiology, 287, 2, 432-441 |
2018/05 |
有 |
|
|
公開 |
| Miyake O, Murata K, Tanaka S, Ishiguro H, Toi M, Tamura K, Kawakami K |
Miyake O, Murata K, Tanaka S, Ishiguro H, Toi M, Tamura K, Kawakami K |
Miyake O, Murata K, Tanaka S, Ishiguro H, Toi M, Tamura K, Kawakami K |
Costs associated with febrile neutropenia in Japanese patients with primary breast cancer: post-hoc analysis of a randomized clinical trial. |
Costs associated with febrile neutropenia in Japanese patients with primary breast cancer: post-hoc analysis of a randomized clinical trial. |
Costs associated with febrile neutropenia in Japanese patients with primary breast cancer: post-hoc analysis of a randomized clinical trial. |
Jpn J Clin Oncol, 1;48, 5, 410-416 |
Jpn J Clin Oncol, 1;48, 5, 410-416 |
Jpn J Clin Oncol, 1;48, 5, 410-416 |
2018/05 |
有 |
|
|
公開 |
| Tsuge I, Saito S, Sekiguchi H, Yoshikawa A, Matsumoto Y, Toi M, Suzuki S |
Tsuge I, Saito S, Sekiguchi H, Yoshikawa A, Matsumoto Y, Toi M, Suzuki S |
Tsuge I, Saito S, Sekiguchi H, Yoshikawa A, Matsumoto Y, Toi M, Suzuki S |
Photoacoustic Tomography Shows the Branching Pattern of Anterolateral Thigh Perforators In Vivo. |
Photoacoustic Tomography Shows the Branching Pattern of Anterolateral Thigh Perforators In Vivo. |
Photoacoustic Tomography Shows the Branching Pattern of Anterolateral Thigh Perforators In Vivo. |
Plast Reconstr Surg, 141, 5, 1288-1292 |
Plast Reconstr Surg, 141, 5, 1288-1292 |
Plast Reconstr Surg, 141, 5, 1288-1292 |
2018/05 |
有 |
|
|
公開 |
| Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, Panel Members of the, St. Gallen International Expert, Consensus on the, Primary Therapy of Early Breast Cancer |
Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, Panel Members of the, St. Gallen International Expert, Consensus on the, Primary Therapy of Early Breast Cancer |
Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, Panel Members of the, St. Gallen International Expert, Consensus on the, Primary Therapy of Early Breast Cancer |
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. |
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. |
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. |
Ann Oncol, 3, doi: 10.1093/annonc/mdx806. [E |
Ann Oncol, 3, doi: 10.1093/annonc/mdx806. [E |
Ann Oncol, 3, doi: 10.1093/annonc/mdx806. [E |
2018/05 |
有 |
|
|
公開 |
| Ueno T, Masuda N, Kamigaki S, Morimoto T, Akiyama F, Kurosumi M, Tsuda H, Mikami Y, Tanaka S, Morita S, Toi M |
Ueno T, Masuda N, Kamigaki S, Morimoto T, Akiyama F, Kurosumi M, Tsuda H, Mikami Y, Tanaka S, Morita S, Toi M |
Ueno T, Masuda N, Kamigaki S, Morimoto T, Akiyama F, Kurosumi M, Tsuda H, Mikami Y, Tanaka S, Morita S, Toi M |
A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cells. |
A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cells. |
A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cells. |
Cancer Med, 7, . doi: 10.1002/cam4.1516. [Epu |
Cancer Med, 7, . doi: 10.1002/cam4.1516. [Epu |
Cancer Med, 7, . doi: 10.1002/cam4.1516. [Epu |
2018/05 |
有 |
|
|
公開 |
| Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M |
Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M |
Takada M, Takeuchi M, Suzuki E, Sato F, Matsumoto Y, Torii M, Kawaguchi-Sakita N, Nishino H, Seo S, Hatano E, Toi M |
Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence. |
Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence. |
Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence. |
Breast Cancer, 9, doi: 10.1007/s12282-018-0868-2 |
Breast Cancer, 9, doi: 10.1007/s12282-018-0868-2 |
Breast Cancer, 9, doi: 10.1007/s12282-018-0868-2 |
2018/05 |
有 |
|
|
公開 |
| Shiina T, Toi M, Yagi T |
Shiina T, Toi M, Yagi T |
Shiina T, Toi M, Yagi T |
Development and clinical translation of photoacoustic mammography. |
Development and clinical translation of photoacoustic mammography. |
Development and clinical translation of photoacoustic mammography. |
Biomed Eng Lett., 7;8, 2, 157-165 |
Biomed Eng Lett., 7;8, 2, 157-165 |
Biomed Eng Lett., 7;8, 2, 157-165 |
2018/05 |
有 |
|
|
公開 |
| Tomoharu Sugie, Eiji Suzuki, Akira Yamauchi, Kazuhiko Yamagami, Norikazu Masuda, Naomi Gondo, Eriko Sumi, Takafumi Ikeda, Harue Tada, Ryuji Uozumi, Shotaro Kanao, Yoshimasa Tanaka, Yoko Hamazaki, Nagahiro Minato, Masakazu Toi |
Tomoharu Sugie, Eiji Suzuki, Akira Yamauchi, Kazuhiko Yamagami, Norikazu Masuda, Naomi Gondo, Eriko Sumi, Takafumi Ikeda, Harue Tada, Ryuji Uozumi, Shotaro Kanao, Yoshimasa Tanaka, Yoko Hamazaki, Nagahiro Minato, Masakazu Toi |
Tomoharu Sugie, Eiji Suzuki, Akira Yamauchi, Kazuhiko Yamagami, Norikazu Masuda, Naomi Gondo, Eriko Sumi, Takafumi Ikeda, Harue Tada, Ryuji Uozumi, Shotaro Kanao, Yoshimasa Tanaka, Yoko Hamazaki, Nagahiro Minato, Masakazu Toi |
Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer |
Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer |
Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer |
Breast, 38, 114-119 |
Breast, 38, 114-119 |
Breast, 38, 114-119 |
2018/04/01 |
|
|
|
公開 |
| Itou J, Li W, Ito S, Tanaka S, Matsumoto Y, Sato F, Toi M |
Itou J, Li W, Ito S, Tanaka S, Matsumoto Y, Sato F, Toi M |
Itou J, Li W, Ito S, Tanaka S, Matsumoto Y, Sato F, Toi M |
Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif-containing 21. |
Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif-containing 21. |
Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif-containing 21. |
J Biological Chemostry, 27;293, 17, 6556-6564 |
J Biological Chemostry, 27;293, 17, 6556-6564 |
J Biological Chemostry, 27;293, 17, 6556-6564 |
2018/04 |
有 |
|
|
公開 |
| Kotake T, Toi M |
Kotake T, Toi M |
Kotake T, Toi M |
Abemaciclib for the treatment of breast cancer. |
Abemaciclib for the treatment of breast cancer. |
Abemaciclib for the treatment of breast cancer. |
Expert Opin Pharmacother., 19, 5, 517-524 |
Expert Opin Pharmacother., 19, 5, 517-524 |
Expert Opin Pharmacother., 19, 5, 517-524 |
2018/04 |
有 |
|
|
公開 |
| Bidard FC, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, Naume B, Horiguchi J, Gisbert-Criado R, Sleijfer S, Toi M, Garcia-Saenz JA, Hartkopf A, Generali D, Rothé F, Smerage J, Muinelo-Romay L, Stebbing J, Viens P, Magbanua MJM, Hall CS, Engebraaten O, Takata D, Vidal-Martínez J, Onstenk W, Fujisawa N, Diaz-Rubio E, Taran FA, Cappelletti MR, Ignatiadis M, Proudhon C, Wolf DM, Bauldry JB, Borgen E, Nagaoka R, Carañana V, Kraan J, Maestro M, Brucker SY, Weber K, Reyal F, Amara D, Karhade MG, Mathiesen RR, Tokiniwa H, Llombart-Cussac A, Meddis A, Blanche P, d'Hollander K, Cottu P, Park JW, Loibl S, Latouche A, Pierga JY, Pantel K |
Bidard FC, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, Naume B, Horiguchi J, Gisbert-Criado R, Sleijfer S, Toi M, Garcia-Saenz JA, Hartkopf A, Generali D, Rothé F, Smerage J, Muinelo-Romay L, Stebbing J, Viens P, Magbanua MJM, Hall CS, Engebraaten O, Takata D, Vidal-Martínez J, Onstenk W, Fujisawa N, Diaz-Rubio E, Taran FA, Cappelletti MR, Ignatiadis M, Proudhon C, Wolf DM, Bauldry JB, Borgen E, Nagaoka R, Carañana V, Kraan J, Maestro M, Brucker SY, Weber K, Reyal F, Amara D, Karhade MG, Mathiesen RR, Tokiniwa H, Llombart-Cussac A, Meddis A, Blanche P, d'Hollander K, Cottu P, Park JW, Loibl S, Latouche A, Pierga JY, Pantel K |
Bidard FC, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, Naume B, Horiguchi J, Gisbert-Criado R, Sleijfer S, Toi M, Garcia-Saenz JA, Hartkopf A, Generali D, Rothé F, Smerage J, Muinelo-Romay L, Stebbing J, Viens P, Magbanua MJM, Hall CS, Engebraaten O, Takata D, Vidal-Martínez J, Onstenk W, Fujisawa N, Diaz-Rubio E, Taran FA, Cappelletti MR, Ignatiadis M, Proudhon C, Wolf DM, Bauldry JB, Borgen E, Nagaoka R, Carañana V, Kraan J, Maestro M, Brucker SY, Weber K, Reyal F, Amara D, Karhade MG, Mathiesen RR, Tokiniwa H, Llombart-Cussac A, Meddis A, Blanche P, d'Hollander K, Cottu P, Park JW, Loibl S, Latouche A, Pierga JY, Pantel K |
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. |
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. |
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. |
J Natl Cancer Inst, 12, doi: 10.1093/jnci/djy018. [Ep |
J Natl Cancer Inst, 12, doi: 10.1093/jnci/djy018. [Ep |
J Natl Cancer Inst, 12, doi: 10.1093/jnci/djy018. [Ep |
2018/04 |
有 |
|
|
公開 |
| Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R |
Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R |
Mackenzie L, Carey M, Suzuki E, Yoshimura M, Toi M, D'Este C, Sanson-Fisher R |
A cross-sectional study of agreement between the Hospital Anxiety and Depression Scale and patient- and radiation oncologist-reported single-item assessment of depression and anxiety. |
A cross-sectional study of agreement between the Hospital Anxiety and Depression Scale and patient- and radiation oncologist-reported single-item assessment of depression and anxiety. |
A cross-sectional study of agreement between the Hospital Anxiety and Depression Scale and patient- and radiation oncologist-reported single-item assessment of depression and anxiety. |
Psychooncology, 16, doi: 10.1002/pon.4736. [Epub |
Psychooncology, 16, doi: 10.1002/pon.4736. [Epub |
Psychooncology, 16, doi: 10.1002/pon.4736. [Epub |
2018/04 |
有 |
|
|
公開 |
| Mukai H, Shimizu C, Masuda N, Ohtani S, Ohno S, Takahashi M, Yamamoto Y, Nishimura R, Sato N, Ohsumi S, Iwata H, Mori Y, Hashigaki S, Muramatsu Y, Nagasawa T, Umeyama Y, Lu DR, Toi M |
Mukai H, Shimizu C, Masuda N, Ohtani S, Ohno S, Takahashi M, Yamamoto Y, Nishimura R, Sato N, Ohsumi S, Iwata H, Mori Y, Hashigaki S, Muramatsu Y, Nagasawa T, Umeyama Y, Lu DR, Toi M |
Mukai H, Shimizu C, Masuda N, Ohtani S, Ohno S, Takahashi M, Yamamoto Y, Nishimura R, Sato N, Ohsumi S, Iwata H, Mori Y, Hashigaki S, Muramatsu Y, Nagasawa T, Umeyama Y, Lu DR, Toi M |
Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients. |
Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients. |
Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients. |
Int J Clin Oncol, doi: 10.1007/s10147-018-1353-9 |
Int J Clin Oncol, doi: 10.1007/s10147-018-1353-9 |
Int J Clin Oncol, doi: 10.1007/s10147-018-1353-9 |
2018/04 |
有 |
|
|
公開 |
| Yoshimasa Tanaka, Kaoru Murata-Hirai, Masashi Iwasaki, Kenji Matsumoto, Kosuke Hayashi, Asuka Kumagai, Mohanad, H. Nada, Hong Wang, Hirohito Kobayashi, Hiroshi Kamitakahara, Haruki Okamura, Tomoharu Sugie, Nagahiro Minato, Masakazu Toi, Craig T. Morita |
Yoshimasa Tanaka, Kaoru Murata-Hirai, Masashi Iwasaki, Kenji Matsumoto, Kosuke Hayashi, Asuka Kumagai, Mohanad, H. Nada, Hong Wang, Hirohito Kobayashi, Hiroshi Kamitakahara, Haruki Okamura, Tomoharu Sugie, Nagahiro Minato, Masakazu Toi, Craig T. Morita |
Yoshimasa Tanaka, Kaoru Murata-Hirai, Masashi Iwasaki, Kenji Matsumoto, Kosuke Hayashi, Asuka Kumagai, Mohanad, H. Nada, Hong Wang, Hirohito Kobayashi, Hiroshi Kamitakahara, Haruki Okamura, Tomoharu Sugie, Nagahiro Minato, Masakazu Toi, Craig T. Morita |
Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug |
Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug |
Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug |
Cancer Science, 109, 587-599 |
Cancer Science, 109, 587-599 |
Cancer Science, 109, 587-599 |
2018/03/01 |
|
|
|
公開 |
| Filipits M, Dafni U, Gnant M, Polydoropoulou V, Hills M, Kiermaier A, de Azambuja E, Larsimont D, Rojo F, Viale G, Toi M, Harbeck N, Prichard KI, Gelber RD, Dinh P, Zardavas D, Leyla, Jones B, Piccart-Gebhart MJ, Dowsett M, TransHERA investigators |
Filipits M, Dafni U, Gnant M, Polydoropoulou V, Hills M, Kiermaier A, de Azambuja E, Larsimont D, Rojo F, Viale G, Toi M, Harbeck N, Prichard KI, Gelber RD, Dinh P, Zardavas D, Leyla, Jones B, Piccart-Gebhart MJ, Dowsett M, TransHERA investigators |
Filipits M, Dafni U, Gnant M, Polydoropoulou V, Hills M, Kiermaier A, de Azambuja E, Larsimont D, Rojo F, Viale G, Toi M, Harbeck N, Prichard KI, Gelber RD, Dinh P, Zardavas D, Leyla, Jones B, Piccart-Gebhart MJ, Dowsett M, TransHERA investigators |
Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study. |
Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study. |
Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study. |
Clin Cancer Res, 12, doi: 10.1158/1078-0432.CCR-17- |
Clin Cancer Res, 12, doi: 10.1158/1078-0432.CCR-17- |
Clin Cancer Res, 12, doi: 10.1158/1078-0432.CCR-17- |
2018/03 |
有 |
|
|
公開 |
| Kanao S, Kataoka M, Iima M, Ikeda DM, Toi M, Togashi K |
Kanao S, Kataoka M, Iima M, Ikeda DM, Toi M, Togashi K |
Kanao S, Kataoka M, Iima M, Ikeda DM, Toi M, Togashi K |
Differentiating benign and malignant inflammatory breast lesions: Value of T2 weighted and diffusion weighted MR images. |
Differentiating benign and malignant inflammatory breast lesions: Value of T2 weighted and diffusion weighted MR images. |
Differentiating benign and malignant inflammatory breast lesions: Value of T2 weighted and diffusion weighted MR images. |
Magn Reson Imaging, 12;50, 38-44 doi: 10.1016/j.mri.2018.03. |
Magn Reson Imaging, 12;50, 38-44 doi: 10.1016/j.mri.2018.03. |
Magn Reson Imaging, 12;50, 38-44 doi: 10.1016/j.mri.2018.03. |
2018/03 |
有 |
|
|
公開 |
| Tada, Hiroshi, Miyashita, Minoru, Gonda, Kohsuke, Watanabe, Mika, Suzuki, Akihiko, Watanabe, Go, Harada, Narumi, Sato, Akiko, Hamanaka, Yohei, Masuda, Norikazu, Toi, Masakazu, Ohno, Shinji, Bando, Hiroko, Ishiguro, Hiroshi, Inoue, Kenichi, Yamamoto, Naohito, Kuroi, Katsumasa, Ohuchi, Noriaki, Ishida, Takanori |
Tada, Hiroshi, Miyashita, Minoru, Gonda, Kohsuke, Watanabe, Mika, Suzuki, Akihiko, Watanabe, Go, Harada, Narumi, Sato, Akiko, Hamanaka, Yohei, Masuda, Norikazu, Toi, Masakazu, Ohno, Shinji, Bando, Hiroko, Ishiguro, Hiroshi, Inoue, Kenichi, Yamamoto, Naohito, Kuroi, Katsumasa, Ohuchi, Noriaki, Ishida, Takanori |
Tada, Hiroshi, Miyashita, Minoru, Gonda, Kohsuke, Watanabe, Mika, Suzuki, Akihiko, Watanabe, Go, Harada, Narumi, Sato, Akiko, Hamanaka, Yohei, Masuda, Norikazu, Toi, Masakazu, Ohno, Shinji, Bando, Hiroko, Ishiguro, Hiroshi, Inoue, Kenichi, Yamamoto, Naohito, Kuroi, Katsumasa, Ohuchi, Noriaki, Ishida, Takanori |
New quantitative diagnostic method by fluorescence nanoparticle for HER2 positive breast cancer treated with neoadjuvant lapatinib and trastuzumab: The Neo LaTH study (JBCRG-16TR) |
New quantitative diagnostic method by fluorescence nanoparticle for HER2 positive breast cancer treated with neoadjuvant lapatinib and trastuzumab: The Neo LaTH study (JBCRG-16TR) |
New quantitative diagnostic method by fluorescence nanoparticle for HER2 positive breast cancer treated with neoadjuvant lapatinib and trastuzumab: The Neo LaTH study (JBCRG-16TR) |
CANCER RESEARCH, 78, 4::S |
CANCER RESEARCH, 78, 4::S |
CANCER RESEARCH, 78, 4::S |
2018/02 |
|
英語 |
研究論文(学術雑誌) |
公開 |
| Kawaguchi, Hidetoshi, Yamashita, Toshinari, Masuda, Norikazu, Kitada, Masahiro, Narui, Kazutaka, Hattori, Masaya, Yoshinami, Tetsuhiro, Matsunami, Nobuki, Yanagihara, Kazuhiro, Kawasoe, Teru, Nagashima, Takeshi, Bando, Hiroko, Yano, Hiroshi, Hasegawa, Yoshie, Nakamura, Rikiya, Kashiwaba, Masahiro, Morita, Satoshi, Ohno, Shinji, Toi, Masakazu |
Kawaguchi, Hidetoshi, Yamashita, Toshinari, Masuda, Norikazu, Kitada, Masahiro, Narui, Kazutaka, Hattori, Masaya, Yoshinami, Tetsuhiro, Matsunami, Nobuki, Yanagihara, Kazuhiro, Kawasoe, Teru, Nagashima, Takeshi, Bando, Hiroko, Yano, Hiroshi, Hasegawa, Yoshie, Nakamura, Rikiya, Kashiwaba, Masahiro, Morita, Satoshi, Ohno, Shinji, Toi, Masakazu |
Kawaguchi, Hidetoshi, Yamashita, Toshinari, Masuda, Norikazu, Kitada, Masahiro, Narui, Kazutaka, Hattori, Masaya, Yoshinami, Tetsuhiro, Matsunami, Nobuki, Yanagihara, Kazuhiro, Kawasoe, Teru, Nagashima, Takeshi, Bando, Hiroko, Yano, Hiroshi, Hasegawa, Yoshie, Nakamura, Rikiya, Kashiwaba, Masahiro, Morita, Satoshi, Ohno, Shinji, Toi, Masakazu |
Phase II study of eribulin in combination with pertuzumab plus trastuzumab for human epidermal growth factor receptor 2 (HER2)-positive advanced or metastatic breast cancer |
Phase II study of eribulin in combination with pertuzumab plus trastuzumab for human epidermal growth factor receptor 2 (HER2)-positive advanced or metastatic breast cancer |
Phase II study of eribulin in combination with pertuzumab plus trastuzumab for human epidermal growth factor receptor 2 (HER2)-positive advanced or metastatic breast cancer |
CANCER RESEARCH, 78, 4::S |
CANCER RESEARCH, 78, 4::S |
CANCER RESEARCH, 78, 4::S |
2018/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| 戸井 雅和 |
戸井 雅和 |
Masuda N, Nishimura R, Takahashi M, Inoue K, Ohno S, Iwata H, Mori Y, Hashigaki S, Muramatsu Y, Nagasawa T, Umeyama Y, Toi M |
Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study. |
Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study. |
Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study. |
Cancer Sci, 109(3), 803-813 |
Cancer Sci, 109(3), 803-813 |
Cancer Sci, 109(3), 803-813 |
2018/02 |
有 |
|
|
公開 |
| Förnvik D, Kataoka M, Iima M, Ohashi A, Kanao S, Toi M, Togashi K |
Förnvik D, Kataoka M, Iima M, Ohashi A, Kanao S, Toi M, Togashi K |
Förnvik D, Kataoka M, Iima M, Ohashi A, Kanao S, Toi M, Togashi K |
The role of breast tomosynthesis in a predominantly dense breast population at a tertiary breast centre: breast density assessment and diagnostic performance in comparison with MRI. |
The role of breast tomosynthesis in a predominantly dense breast population at a tertiary breast centre: breast density assessment and diagnostic performance in comparison with MRI. |
The role of breast tomosynthesis in a predominantly dense breast population at a tertiary breast centre: breast density assessment and diagnostic performance in comparison with MRI. |
Eur Radiol, 19, doi: 10.1007/s00330-017-52-1846 |
Eur Radiol, 19, doi: 10.1007/s00330-017-52-1846 |
Eur Radiol, 19, doi: 10.1007/s00330-017-52-1846 |
2018/02 |
有 |
|
|
公開 |
| Ueno T, Saji S, Masuda N, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Iwata H, Yamanaka T, Sasano H, Toi M |
Ueno T, Saji S, Masuda N, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Iwata H, Yamanaka T, Sasano H, Toi M |
Ueno T, Saji S, Masuda N, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Iwata H, Yamanaka T, Sasano H, Toi M |
Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial. |
Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial. |
Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial. |
ESMO Open, 14;3, 2, e000314. doi: 10.1136/esmoopen |
ESMO Open, 14;3, 2, e000314. doi: 10.1136/esmoopen |
ESMO Open, 14;3, 2, e000314. doi: 10.1136/esmoopen |
2018/02 |
有 |
|
|
公開 |
| Akiko Hanai, Hiroshi Ishiguro, Takashi Sozu, Moe Tsuda, Ikuko Yano, Takayuki Nakagawa, Satoshi Imai, Yoko Hamabe, Masakazu Toi, Hidenori Arai, Tadao Tsuboyama |
Akiko Hanai, Hiroshi Ishiguro, Takashi Sozu, Moe Tsuda, Ikuko Yano, Takayuki Nakagawa, Satoshi Imai, Yoko Hamabe, Masakazu Toi, Hidenori Arai, Tadao Tsuboyama |
Akiko Hanai, Hiroshi Ishiguro, Takashi Sozu, Moe Tsuda, Ikuko Yano, Takayuki Nakagawa, Satoshi Imai, Yoko Hamabe, Masakazu Toi, Hidenori Arai, Tadao Tsuboyama |
Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial |
Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial |
Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial |
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 110, 2, 141-148 |
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 110, 2, 141-148 |
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 110, 2, 141-148 |
2018/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Osamu Miyake, Kyoko Murata, Shiro Tanaka, Hiroshi Ishiguro, Masakazu Toi, Kazuo Tamura, Koji Kawakami |
Osamu Miyake, Kyoko Murata, Shiro Tanaka, Hiroshi Ishiguro, Masakazu Toi, Kazuo Tamura, Koji Kawakami |
Osamu Miyake, Kyoko Murata, Shiro Tanaka, Hiroshi Ishiguro, Masakazu Toi, Kazuo Tamura, Koji Kawakami |
Cost analysis with febrile neutropenia in Japanese patients with primary breast cancer: retrospective analysis of a randomized clinical trial. |
Cost analysis with febrile neutropenia in Japanese patients with primary breast cancer: retrospective analysis of a randomized clinical trial. |
Cost analysis with febrile neutropenia in Japanese patients with primary breast cancer: retrospective analysis of a randomized clinical trial. |
Japanese Journal of Clinical Oncology, 48, 5, 410-416 |
Japanese Journal of Clinical Oncology, 48, 5, 410-416 |
Japanese Journal of Clinical Oncology, 48, 5, 410-416 |
2018 |
有 |
|
|
公開 |
| Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S |
Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S |
Kawaguchi H, Masuda N, Nakayama T, Aogi K, Anan K, Ito Y, Ohtani S, Sato N, Saji S, Takano T, Tokunaga E, Nakamura S, Hasegawa Y, Hattori M, Fujisawa T, Morita S, Yamaguchi M, Yamashita H, Yamashita T, Yamamoto Y, Yotsumoto D, Toi M, Ohno S |
Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study. |
Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study. |
Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study. |
Current medical research and opinion, 34, 1, 49-54 |
Current medical research and opinion, 34, 1, 49-54 |
Current medical research and opinion, 34, 1, 49-54 |
2018/01 |
有 |
|
|
公開 |
| Nagae K, Asao Y, Sudo Y, Murayama N, Tanaka Y, Ohira K, Ishida Y, Otsuka A, Matsumoto Y, Saito S, Furu M, Murata K, Sekiguchi H, Kataoka M, Yoshikawa A, Ishii T, Togashi K, Shiina T, Kabashima K, Toi M, Yagi T |
Nagae K, Asao Y, Sudo Y, Murayama N, Tanaka Y, Ohira K, Ishida Y, Otsuka A, Matsumoto Y, Saito S, Furu M, Murata K, Sekiguchi H, Kataoka M, Yoshikawa A, Ishii T, Togashi K, Shiina T, Kabashima K, Toi M, Yagi T |
Nagae K, Asao Y, Sudo Y, Murayama N, Tanaka Y, Ohira K, Ishida Y, Otsuka A, Matsumoto Y, Saito S, Furu M, Murata K, Sekiguchi H, Kataoka M, Yoshikawa A, Ishii T, Togashi K, Shiina T, Kabashima K, Toi M, Yagi T |
Real-time 3D Photoacoustic Visualization System with a Wide Field of View for Imaging Human Limbs. |
Real-time 3D Photoacoustic Visualization System with a Wide Field of View for Imaging Human Limbs. |
Real-time 3D Photoacoustic Visualization System with a Wide Field of View for Imaging Human Limbs. |
F1000Research, 7, 1813 |
F1000Research, 7, 1813 |
F1000Research, 7, 1813 |
2018 |
有 |
|
|
公開 |
| Tomohiro Shibata, Eriko Tokunaga, Satoshi Hattori, Kosuke Watari, Yuichi Murakami, Nami Yamashita, Eiji Oki, Junji Itou, Masakazu Toi, Yoshihiko Maehara, Michihiko Kuwano, Mayumi Ono |
Tomohiro Shibata, Eriko Tokunaga, Satoshi Hattori, Kosuke Watari, Yuichi Murakami, Nami Yamashita, Eiji Oki, Junji Itou, Masakazu Toi, Yoshihiko Maehara, Michihiko Kuwano, Mayumi Ono |
|
Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer. |
Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer. |
|
Oncotarget, 9, 98, 37216-37228 |
Oncotarget, 9, 98, 37216-37228 |
, 9, 98, 37216-37228 |
2018 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Hiroyasu Yamashiro, Masataka Sawaki, Norikazu Masuda, Yasuhiro Okumura, Toshimi Takano, Eriko Tokunaga, Tsuyoshi Saito, Yasuaki Sagara, Kosuke Yamazaki, Yoshihiro Kawaguchi, Tecchuu Lee, Shinji Ozaki, Kazuhiko Yamagami, Naohito Yamamoto, Katsumasa Kuroi, Hirofumi Suwa, Shoichiro Ohtani, Toshikazu Ito, Shinji Yasuno, Satoshi Morita, Shinji Ohno, Masakazu Toi |
Hiroyasu Yamashiro, Masataka Sawaki, Norikazu Masuda, Yasuhiro Okumura, Toshimi Takano, Eriko Tokunaga, Tsuyoshi Saito, Yasuaki Sagara, Kosuke Yamazaki, Yoshihiro Kawaguchi, Tecchuu Lee, Shinji Ozaki, Kazuhiko Yamagami, Naohito Yamamoto, Katsumasa Kuroi, Hirofumi Suwa, Shoichiro Ohtani, Toshikazu Ito, Shinji Yasuno, Satoshi Morita, Shinji Ohno, Masakazu Toi |
Hiroyasu Yamashiro, Masataka Sawaki, Norikazu Masuda, Yasuhiro Okumura, Toshimi Takano, Eriko Tokunaga, Tsuyoshi Saito, Yasuaki Sagara, Kosuke Yamazaki, Yoshihiro Kawaguchi, Tecchuu Lee, Shinji Ozaki, Kazuhiko Yamagami, Naohito Yamamoto, Katsumasa Kuroi, Hirofumi Suwa, Shoichiro Ohtani, Toshikazu Ito, Shinji Yasuno, Satoshi Morita, Shinji Ohno, Masakazu Toi |
Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study. |
Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study. |
Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study. |
Breast cancer : basic and clinical research, 12, 1178223418786243-1178223418786243 |
Breast cancer : basic and clinical research, 12, 1178223418786243-1178223418786243 |
Breast cancer : basic and clinical research, 12, 1178223418786243-1178223418786243 |
2018 |
有 |
英語 |
|
公開 |
| Hiroshi Ishiguro, Shigehira Saji, Shogo Nomura, Sunao Tanaka, Takayuki Ueno, Masahide Onoue, Hiroji Iwata, Takeharu Yamanaka, Yasutsuna Sasaki, Masakazu Toi |
Hiroshi Ishiguro, Shigehira Saji, Shogo Nomura, Sunao Tanaka, Takayuki Ueno, Masahide Onoue, Hiroji Iwata, Takeharu Yamanaka, Yasutsuna Sasaki, Masakazu Toi |
Hiroshi Ishiguro, Shigehira Saji, Shogo Nomura, Sunao Tanaka, Takayuki Ueno, Masahide Onoue, Hiroji Iwata, Takeharu Yamanaka, Yasutsuna Sasaki, Masakazu Toi |
A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S-1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG-M01 study) |
A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S-1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG-M01 study) |
A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S-1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG-M01 study) |
CANCER MEDICINE, 6, 12, 2909-2917 |
CANCER MEDICINE, 6, 12, 2909-2917 |
CANCER MEDICINE, 6, 12, 2909-2917 |
2017/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Kawai M, Kataoka M, Kanao S, Iima M, Onishi N, Ohashi A, Sakaguchi R, Toi M, Togashi K |
Kawai M, Kataoka M, Kanao S, Iima M, Onishi N, Ohashi A, Sakaguchi R, Toi M, Togashi K |
Kawai M, Kataoka M, Kanao S, Iima M, Onishi N, Ohashi A, Sakaguchi R, Toi M, Togashi K |
The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses. |
The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses. |
The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses. |
Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine |
Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine |
Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine |
2017/12 |
有 |
|
|
公開 |
| Toi M, Masuda N, Lee SJ |
Toi M, Masuda N, Lee SJ |
Toi M, Masuda N, Lee SJ |
Capecitabine for primary breast cancer. |
Capecitabine for primary breast cancer. |
Capecitabine for primary breast cancer. |
Oncotarget, 6;8, 67, 110739-110740 |
Oncotarget, 6;8, 67, 110739-110740 |
Oncotarget, 6;8, 67, 110739-110740 |
2017/12 |
有 |
|
|
公開 |
| Matthew P. Goetz, Masakazu Toi, Mario Campone, Joohyuk Sohn, Shani Paluch-Shimon, Jens Huober, In Hae Park, Olivier Tredan, Shin-Cheh Chen, Luis Manso, Orit C. Freedman, Georgina Garnica Jaliffe, Tammy Forrester, Martin Frenzel, Susana Barriga, Ian C. Smith, Nawel Bourayou, Angelo Di Leo |
Matthew P. Goetz, Masakazu Toi, Mario Campone, Joohyuk Sohn, Shani Paluch-Shimon, Jens Huober, In Hae Park, Olivier Tredan, Shin-Cheh Chen, Luis Manso, Orit C. Freedman, Georgina Garnica Jaliffe, Tammy Forrester, Martin Frenzel, Susana Barriga, Ian C. Smith, Nawel Bourayou, Angelo Di Leo |
Matthew P. Goetz, Masakazu Toi, Mario Campone, Joohyuk Sohn, Shani Paluch-Shimon, Jens Huober, In Hae Park, Olivier Tredan, Shin-Cheh Chen, Luis Manso, Orit C. Freedman, Georgina Garnica Jaliffe, Tammy Forrester, Martin Frenzel, Susana Barriga, Ian C. Smith, Nawel Bourayou, Angelo Di Leo |
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer |
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer |
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer |
JOURNAL OF CLINICAL ONCOLOGY, 35, 32, 3638-+ |
JOURNAL OF CLINICAL ONCOLOGY, 35, 32, 3638-+ |
JOURNAL OF CLINICAL ONCOLOGY, 35, 32, 3638-+ |
2017/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Ohgami M, Bando H, Ishiguro H, Tsuda M, Toriguchi N, Aogi K, Toi M, Masuda N, Mitsuhashi S, Kurosawa A, Homma M |
Ohgami M, Bando H, Ishiguro H, Tsuda M, Toriguchi N, Aogi K, Toi M, Masuda N, Mitsuhashi S, Kurosawa A, Homma M |
Ohgami M, Bando H, Ishiguro H, Tsuda M, Toriguchi N, Aogi K, Toi M, Masuda N, Mitsuhashi S, Kurosawa A, Homma M |
Effect of dose timing on the blood concentration of lapatinib in patients with breast cancer |
Effect of dose timing on the blood concentration of lapatinib in patients with breast cancer |
Effect of dose timing on the blood concentration of lapatinib in patients with breast cancer |
Ann Oncol, 28, 11, 2888-2889 |
Ann Oncol, 28, 11, 2888-2889 |
Ann Oncol, 28, 11, 2888-2889 |
2017/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman, Han Koh, Eva-Maria Grischke, Martin Frenzel, Yong Lin, Susana Barriga, Ian C. Smith, Nawel Bourayou, Antonio Llombart-Cussac |
George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman, Han Koh, Eva-Maria Grischke, Martin Frenzel, Yong Lin, Susana Barriga, Ian C. Smith, Nawel Bourayou, Antonio Llombart-Cussac |
George W. Sledge, Masakazu Toi, Patrick Neven, Joohyuk Sohn, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda, Peter A. Kaufman, Han Koh, Eva-Maria Grischke, Martin Frenzel, Yong Lin, Susana Barriga, Ian C. Smith, Nawel Bourayou, Antonio Llombart-Cussac |
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy |
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy |
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2-Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy |
JOURNAL OF CLINICAL ONCOLOGY, 35, 25, 2875-+ |
JOURNAL OF CLINICAL ONCOLOGY, 35, 25, 2875-+ |
JOURNAL OF CLINICAL ONCOLOGY, 35, 25, 2875-+ |
2017/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Torii M, Fukui T, Inoue M, Kanao S, Umetani K, Shirai M, Inagaki T, Tsuchimochi H, Pearson JT, Toi M |
Torii M, Fukui T, Inoue M, Kanao S, Umetani K, Shirai M, Inagaki T, Tsuchimochi H, Pearson JT, Toi M |
Torii M, Fukui T, Inoue M, Kanao S, Umetani K, Shirai M, Inagaki T, Tsuchimochi H, Pearson JT, Toi M |
Analysis of the microvascular morphology and hemodynamics of breast cancer in mice using SPring-8 synchrotron radiation microangiography. |
Analysis of the microvascular morphology and hemodynamics of breast cancer in mice using SPring-8 synchrotron radiation microangiography. |
Analysis of the microvascular morphology and hemodynamics of breast cancer in mice using SPring-8 synchrotron radiation microangiography. |
Journal of synchrotron radiation, 24, Pt 5, 1039-1047 |
Journal of synchrotron radiation, 24, Pt 5, 1039-1047 |
Journal of synchrotron radiation, 24, Pt 5, 1039-1047 |
2017/09 |
有 |
|
|
公開 |
| 三宅 可奈江, 中本 裕士, 西松 佳代, 金尾 昌太郎, 片岡 正子, 石守 崇好, 戸井 雅和, 富樫 かおり |
三宅 可奈江, 中本 裕士, 西松 佳代, 金尾 昌太郎, 片岡 正子, 石守 崇好, 戸井 雅和, 富樫 かおり |
三宅 可奈江, 中本 裕士, 西松 佳代, 金尾 昌太郎, 片岡 正子, 石守 崇好, 戸井 雅和, 富樫 かおり |
全身用PETと乳房専用PETにおける定量値の比較 |
全身用PETと乳房専用PETにおける定量値の比較 |
全身用PETと乳房専用PETにおける定量値の比較 |
核医学, 54, Suppl., S195-S195 |
核医学, 54, Suppl., S195-S195 |
核医学, 54, Suppl., S195-S195 |
2017/09 |
|
日本語 |
|
公開 |
| Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Masashi Inoue, Fengling Pu, Keiko Iwaisako, Moe Tsuda, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi |
Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Masashi Inoue, Fengling Pu, Keiko Iwaisako, Moe Tsuda, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi |
Kosuke Kawaguchi, Eiji Suzuki, Mariko Nishie, Isao Kii, Tatsuki R. Kataoka, Masahiro Hirata, Masashi Inoue, Fengling Pu, Keiko Iwaisako, Moe Tsuda, Ayane Yamaguchi, Hironori Haga, Masatoshi Hagiwara, Masakazu Toi |
Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity |
Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity |
Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity |
CANCER IMMUNOLOGY IMMUNOTHERAPY, 66, 9, 1131-1142 |
CANCER IMMUNOLOGY IMMUNOTHERAPY, 66, 9, 1131-1142 |
CANCER IMMUNOLOGY IMMUNOTHERAPY, 66, 9, 1131-1142 |
2017/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Yoshimasa Tanaka, Masashi Iwasaki, Kaoru Murata-Hirai, Kenji Matsumoto, Kosuke Hayashi, Haruki Okamura, Tomoharu Sugie, Nagahiro Minato, Craig T. Morita, Masakazu Toi |
Yoshimasa Tanaka, Masashi Iwasaki, Kaoru Murata-Hirai, Kenji Matsumoto, Kosuke Hayashi, Haruki Okamura, Tomoharu Sugie, Nagahiro Minato, Craig T. Morita, Masakazu Toi |
Yoshimasa Tanaka, Masashi Iwasaki, Kaoru Murata-Hirai, Kenji Matsumoto, Kosuke Hayashi, Haruki Okamura, Tomoharu Sugie, Nagahiro Minato, Craig T. Morita, Masakazu Toi |
Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug |
Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug |
Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug |
SCIENTIFIC REPORTS, 7 |
SCIENTIFIC REPORTS, 7 |
SCIENTIFIC REPORTS, 7 |
2017/07 |
|
英語 |
研究論文(学術雑誌) |
公開 |
| H. Kawaguchi, N. Masuda, T. Nakayama, K. Aogi, K. Anan, Y. Ito, S. Ohtani, N. Sato, S. Saji, E. Tokunaga, S. Nakamura, Y. Hasegawa, M. Hattori, T. Fujisawa, S. Morita, M. Yamaguchi, T. Yamashita, Y. Yamamoto, S. Ohno, M. Toi |
H. Kawaguchi, N. Masuda, T. Nakayama, K. Aogi, K. Anan, Y. Ito, S. Ohtani, N. Sato, S. Saji, E. Tokunaga, S. Nakamura, Y. Hasegawa, M. Hattori, T. Fujisawa, S. Morita, M. Yamaguchi, T. Yamashita, Y. Yamamoto, S. Ohno, M. Toi |
H. Kawaguchi, N. Masuda, T. Nakayama, K. Aogi, K. Anan, Y. Ito, S. Ohtani, N. Sato, S. Saji, E. Tokunaga, S. Nakamura, Y. Hasegawa, M. Hattori, T. Fujisawa, S. Morita, M. Yamaguchi, T. Yamashita, Y. Yamamoto, S. Ohno, M. Toi |
Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari) |
Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari) |
Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari) |
BREAST CANCER RESEARCH AND TREATMENT, 163, 3, 545-554 |
BREAST CANCER RESEARCH AND TREATMENT, 163, 3, 545-554 |
BREAST CANCER RESEARCH AND TREATMENT, 163, 3, 545-554 |
2017/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Amir Sonnenblick, Dominique Agbor-Tarh, Ian Bradbury, Serena Di Cosimo, Hatem A. Azim, Debora Fumagalli, Severine Sarp, Antonio C. Wolff, Michael Andersson, Judith Kroep, Tanja Cufer, Sergio D. Simon, Pamela Salman, Masakazu Toi, Lyndsay Harris, Julie Gralow, Maccon Keane, Alvaro Moreno-Aspitia, Martine Piccart-Gebhart, Evandro de Azambuja |
Amir Sonnenblick, Dominique Agbor-Tarh, Ian Bradbury, Serena Di Cosimo, Hatem A. Azim, Debora Fumagalli, Severine Sarp, Antonio C. Wolff, Michael Andersson, Judith Kroep, Tanja Cufer, Sergio D. Simon, Pamela Salman, Masakazu Toi, Lyndsay Harris, Julie Gralow, Maccon Keane, Alvaro Moreno-Aspitia, Martine Piccart-Gebhart, Evandro de Azambuja |
Amir Sonnenblick, Dominique Agbor-Tarh, Ian Bradbury, Serena Di Cosimo, Hatem A. Azim, Debora Fumagalli, Severine Sarp, Antonio C. Wolff, Michael Andersson, Judith Kroep, Tanja Cufer, Sergio D. Simon, Pamela Salman, Masakazu Toi, Lyndsay Harris, Julie Gralow, Maccon Keane, Alvaro Moreno-Aspitia, Martine Piccart-Gebhart, Evandro de Azambuja |
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial |
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial |
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial |
JOURNAL OF CLINICAL ONCOLOGY, 35, 13, 1421-+ |
JOURNAL OF CLINICAL ONCOLOGY, 35, 13, 1421-+ |
JOURNAL OF CLINICAL ONCOLOGY, 35, 13, 1421-+ |
2017/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Kayo Nishimatsu, Yuji Nakamoto, Kanae K. Miyake, Takayoshi Ishimori, Shotaro Kanao, Masakazu Toi, Kaori Togashi |
Kayo Nishimatsu, Yuji Nakamoto, Kanae K. Miyake, Takayoshi Ishimori, Shotaro Kanao, Masakazu Toi, Kaori Togashi |
Kayo Nishimatsu, Yuji Nakamoto, Kanae K. Miyake, Takayoshi Ishimori, Shotaro Kanao, Masakazu Toi, Kaori Togashi |
Higher breast cancer conspicuity on dbPET compared to WB-PET/CT |
Higher breast cancer conspicuity on dbPET compared to WB-PET/CT |
Higher breast cancer conspicuity on dbPET compared to WB-PET/CT |
EUROPEAN JOURNAL OF RADIOLOGY, 90, 138-145 |
EUROPEAN JOURNAL OF RADIOLOGY, 90, 138-145 |
EUROPEAN JOURNAL OF RADIOLOGY, 90, 138-145 |
2017/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori, Kayo Nishimatsu, Kanae K. Miyake, Shotaro Kanao, Mami Iima, Masakazu Toi, Kaori Togashi |
Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori, Kayo Nishimatsu, Kanae K. Miyake, Shotaro Kanao, Mami Iima, Masakazu Toi, Kaori Togashi |
Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori, Kayo Nishimatsu, Kanae K. Miyake, Shotaro Kanao, Mami Iima, Masakazu Toi, Kaori Togashi |
Diagnostic performance of a novel dedicated breast PET scanner with C-shaped ring detectors |
Diagnostic performance of a novel dedicated breast PET scanner with C-shaped ring detectors |
Diagnostic performance of a novel dedicated breast PET scanner with C-shaped ring detectors |
NUCLEAR MEDICINE COMMUNICATIONS, 38, 5, 388-395 |
NUCLEAR MEDICINE COMMUNICATIONS, 38, 5, 388-395 |
NUCLEAR MEDICINE COMMUNICATIONS, 38, 5, 388-395 |
2017/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Onishi N, Kataoka M, Kanao S, Sagawa H, Iima M, Nickel MD, Toi M, Togashi K |
Onishi N, Kataoka M, Kanao S, Sagawa H, Iima M, Nickel MD, Toi M, Togashi K |
Onishi N, Kataoka M, Kanao S, Sagawa H, Iima M, Nickel MD, Toi M, Togashi K |
Ultrafast dynamic contrast-enhanced mri of the breast using compressed sensing: breast cancer diagnosis based on separate visualization of breast arteries and veins. |
Ultrafast dynamic contrast-enhanced mri of the breast using compressed sensing: breast cancer diagnosis based on separate visualization of breast arteries and veins. |
Ultrafast dynamic contrast-enhanced mri of the breast using compressed sensing: breast cancer diagnosis based on separate visualization of breast arteries and veins. |
Journal of magnetic resonance imaging : JMRI, 47, 1, 97-104 |
Journal of magnetic resonance imaging : JMRI, 47, 1, 97-104 |
Journal of magnetic resonance imaging : JMRI, 47, 1, 97-104 |
2017/05 |
有 |
|
|
公開 |
| Tanaka S, Ueno T, Ishiguro H, Morita S, Toi M |
Tanaka S, Ueno T, Ishiguro H, Morita S, Toi M |
Tanaka S, Ueno T, Ishiguro H, Morita S, Toi M |
The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients |
The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients |
The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients |
NPJ Precis Oncol, 1, 6 |
NPJ Precis Oncol, 1, 6 |
NPJ Precis Oncol, 1, 6 |
2017/04 |
有 |
英語 |
|
公開 |
| R. Bell, J. Brown, M. Parmar, M. Toi, T. Suter, G. G. Steger, X. Pivot, J. Mackey, C. Jackisch, R. Dent, P. Hall, N. Xu, L. Morales, L. Provencher, R. Hegg, L. Vanlemmens, A. Kirsch, A. Schneeweiss, N. Masuda, F. Overkamp, D. Cameron |
R. Bell, J. Brown, M. Parmar, M. Toi, T. Suter, G. G. Steger, X. Pivot, J. Mackey, C. Jackisch, R. Dent, P. Hall, N. Xu, L. Morales, L. Provencher, R. Hegg, L. Vanlemmens, A. Kirsch, A. Schneeweiss, N. Masuda, F. Overkamp, D. Cameron |
R. Bell, J. Brown, M. Parmar, M. Toi, T. Suter, G. G. Steger, X. Pivot, J. Mackey, C. Jackisch, R. Dent, P. Hall, N. Xu, L. Morales, L. Provencher, R. Hegg, L. Vanlemmens, A. Kirsch, A. Schneeweiss, N. Masuda, F. Overkamp, D. Cameron |
Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer |
Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer |
Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer |
ANNALS OF ONCOLOGY, 28, 4, 754-760 |
ANNALS OF ONCOLOGY, 28, 4, 754-760 |
ANNALS OF ONCOLOGY, 28, 4, 754-760 |
2017/04 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Takafumi Ikeda, Tomoharu Sugie, Akira Shimizu, Masakazu Toi |
Takafumi Ikeda, Tomoharu Sugie, Akira Shimizu, Masakazu Toi |
Takafumi Ikeda, Tomoharu Sugie, Akira Shimizu, Masakazu Toi |
Patterns of clinical practice for sentinel lymph node biopsy in women with node-negative breast cancer: the results of a national survey in Japan |
Patterns of clinical practice for sentinel lymph node biopsy in women with node-negative breast cancer: the results of a national survey in Japan |
Patterns of clinical practice for sentinel lymph node biopsy in women with node-negative breast cancer: the results of a national survey in Japan |
BREAST CANCER, 24, 2, 341-344 |
BREAST CANCER, 24, 2, 341-344 |
BREAST CANCER, 24, 2, 341-344 |
2017/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Tomoharu Sugie, Takafumi Ikeda, Atsushi Kawaguchi, Akira Shimizu, Masakazu Toi |
Tomoharu Sugie, Takafumi Ikeda, Atsushi Kawaguchi, Akira Shimizu, Masakazu Toi |
Tomoharu Sugie, Takafumi Ikeda, Atsushi Kawaguchi, Akira Shimizu, Masakazu Toi |
Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis |
Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis |
Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 1, 11-17 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 1, 11-17 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 1, 11-17 |
2017/02 |
有 |
英語 |
|
公開 |
| M. Toi, Y. Asao, Y. Matsumoto, H. Sekiguchi, A. Yoshikawa, M. Takada, M. Kataoka, T. Endo, N. Kawaguchi-Sakita, M. Kawashima, E. Fakhrejahani, S. Kanao, I. Yamaga, Y. Nakayama, M. Tokiwa, M. Torii, T. Yagi, T. Sakurai, K. Togashi, T. Shiina |
M. Toi, Y. Asao, Y. Matsumoto, H. Sekiguchi, A. Yoshikawa, M. Takada, M. Kataoka, T. Endo, N. Kawaguchi-Sakita, M. Kawashima, E. Fakhrejahani, S. Kanao, I. Yamaga, Y. Nakayama, M. Tokiwa, M. Torii, T. Yagi, T. Sakurai, K. Togashi, T. Shiina |
M. Toi, Y. Asao, Y. Matsumoto, H. Sekiguchi, A. Yoshikawa, M. Takada, M. Kataoka, T. Endo, N. Kawaguchi-Sakita, M. Kawashima, E. Fakhrejahani, S. Kanao, I. Yamaga, Y. Nakayama, M. Tokiwa, M. Torii, T. Yagi, T. Sakurai, K. Togashi, T. Shiina |
Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector array |
Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector array |
Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector array |
SCIENTIFIC REPORTS, 7, 7;7:41970. doi: 10.1038/srep41 |
SCIENTIFIC REPORTS, 7, 7;7:41970. doi: 10.1038/srep41 |
SCIENTIFIC REPORTS, 7, 7;7:41970. doi: 10.1038/srep41 |
2017/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Sagara Y, Julia W, Golshan M, Toi M |
Sagara Y, Julia W, Golshan M, Toi M |
Sagara Y, Julia W, Golshan M, Toi M |
Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma <i>In Situ</i> of Breast. |
Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma <i>In Situ</i> of Breast. |
Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma <i>In Situ</i> of Breast. |
Frontiers in oncology, 7, 192 |
Frontiers in oncology, 7, 192 |
Frontiers in oncology, 7, 192 |
2017 |
有 |
|
|
公開 |
| N. Masuda, S.-J. Lee, S. Ohtani, Y.-H. Im, E.-S. Lee, I. Yokota, K. Kuroi, S.-A. Im, B.-W. Park, S.-B. Kim, Y. Yanagita, S. Ohno, S. Takao, K. Aogi, H. Iwata, J. Jeong, A. Kim, K.-H. Park, H. Sasano, Y. Ohashi, M. Toi |
N. Masuda, S.-J. Lee, S. Ohtani, Y.-H. Im, E.-S. Lee, I. Yokota, K. Kuroi, S.-A. Im, B.-W. Park, S.-B. Kim, Y. Yanagita, S. Ohno, S. Takao, K. Aogi, H. Iwata, J. Jeong, A. Kim, K.-H. Park, H. Sasano, Y. Ohashi, M. Toi |
N. Masuda, S.-J. Lee, S. Ohtani, Y.-H. Im, E.-S. Lee, I. Yokota, K. Kuroi, S.-A. Im, B.-W. Park, S.-B. Kim, Y. Yanagita, S. Ohno, S. Takao, K. Aogi, H. Iwata, J. Jeong, A. Kim, K.-H. Park, H. Sasano, Y. Ohashi, M. Toi |
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy |
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy |
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy |
N Engl J Med, 1;376, 22, 2147-2159 |
N Engl J Med, 1;376, 22, 2147-2159 |
N Engl J Med, 1;376, 22, 2147-2159 |
2017/01 |
有 |
|
|
公開 |
| Edith A. Perez, Carlos Barrios, Wolfgang Eiermann, Masakazu Toi, Young-Hyuck Im, Pierfranco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier Pivot, Howard Burris, Jennifer A. Petersen, Sven Stanzel, Alexander Strasak, Monika Patre, Paul Ellis |
Edith A. Perez, Carlos Barrios, Wolfgang Eiermann, Masakazu Toi, Young-Hyuck Im, Pierfranco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier Pivot, Howard Burris, Jennifer A. Petersen, Sven Stanzel, Alexander Strasak, Monika Patre, Paul Ellis |
Edith A. Perez, Carlos Barrios, Wolfgang Eiermann, Masakazu Toi, Young-Hyuck Im, Pierfranco Conte, Miguel Martin, Tadeusz Pienkowski, Xavier Pivot, Howard Burris, Jennifer A. Petersen, Sven Stanzel, Alexander Strasak, Monika Patre, Paul Ellis |
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study |
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study |
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study |
JOURNAL OF CLINICAL ONCOLOGY, 35, 2, 141-+ |
JOURNAL OF CLINICAL ONCOLOGY, 35, 2, 141-+ |
JOURNAL OF CLINICAL ONCOLOGY, 35, 2, 141-+ |
2017/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Natsuko Onishi, Masako Kataoka, Shotaro Kanao, Makiko Kawai, Mami Iima, Akane Ohashi, Masakazu Toi, Kaori Togashi |
Natsuko Onishi, Masako Kataoka, Shotaro Kanao, Makiko Kawai, Mami Iima, Akane Ohashi, Masakazu Toi, Kaori Togashi |
Natsuko Onishi, Masako Kataoka, Shotaro Kanao, Makiko Kawai, Mami Iima, Akane Ohashi, Masakazu Toi, Kaori Togashi |
A pilot study to determine the diagnostic criteria of spiculated masses for BI-RADS MRI category 5: when to perform re-biopsy after discordant pathologic result? |
A pilot study to determine the diagnostic criteria of spiculated masses for BI-RADS MRI category 5: when to perform re-biopsy after discordant pathologic result? |
A pilot study to determine the diagnostic criteria of spiculated masses for BI-RADS MRI category 5: when to perform re-biopsy after discordant pathologic result? |
BREAST CANCER, 24, 1, 69-78 |
BREAST CANCER, 24, 1, 69-78 |
BREAST CANCER, 24, 1, 69-78 |
2017/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Michio Yamamoto, Satoshi Morita, Masakazu Toi |
Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Michio Yamamoto, Satoshi Morita, Masakazu Toi |
Kosuke Kawaguchi, Eiji Suzuki, Ayane Yamaguchi, Michio Yamamoto, Satoshi Morita, Masakazu Toi |
Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer |
Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer |
Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer |
BREAST CANCER, 24, 1, 111-120 |
BREAST CANCER, 24, 1, 111-120 |
BREAST CANCER, 24, 1, 111-120 |
2017/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Kimiko Hirata, Michio Yoshimura, Minoru Inoue, Chikako Yamauchi, Masakazu Ogura, Masakazu Toi, Eiji Suzuki, Megumi Takeuchi, Masahiro Takada, Masahiro Hiraoka |
Kimiko Hirata, Michio Yoshimura, Minoru Inoue, Chikako Yamauchi, Masakazu Ogura, Masakazu Toi, Eiji Suzuki, Megumi Takeuchi, Masahiro Takada, Masahiro Hiraoka |
Kimiko Hirata, Michio Yoshimura, Minoru Inoue, Chikako Yamauchi, Masakazu Ogura, Masakazu Toi, Eiji Suzuki, Megumi Takeuchi, Masahiro Takada, Masahiro Hiraoka |
Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation |
Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation |
Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation |
JOURNAL OF RADIATION RESEARCH, 58, 1, 79-85 |
JOURNAL OF RADIATION RESEARCH, 58, 1, 79-85 |
JOURNAL OF RADIATION RESEARCH, 58, 1, 79-85 |
2017/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Itou J, Tanaka S, Li W, Iida A, Sehara-Fujisawa A, Sato F, Toi M |
Itou J, Tanaka S, Li W, Iida A, Sehara-Fujisawa A, Sato F, Toi M |
Junji Itou, Sunao Tanaka, Wenzhao Li, Atsuo Iida, Atsuko Sehara-Fujisawa, Fumiaki Sato, Masakazu Toi |
The Sal-like 4 - integrin α6β1 network promotes cell migration for metastasis via activation of focal adhesion dynamics in basal-like breast cancer cells. |
The Sal-like 4 - integrin α6β1 network promotes cell migration for metastasis via activation of focal adhesion dynamics in basal-like breast cancer cells. |
The Sal-like 4-integrin alpha 6 beta 1 network promotes cell migration for metastasis via activation of focal adhesion dynamics in basal-like breast cancer cells |
Biochim Biophys Acta., 1864, 1, 76-88 |
Biochim Biophys Acta., 1864, 1, 76-88 |
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1864, 1, 76-88 |
2017/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Gongping Shi, Yoko Yoshida, Kanako Yuki, Tomomi Nishimura, Yukiko Kawata, Masahiro Kawashima, Keiko Iwaisako, Kiyotsugu Yoshikawa, Junichi Kurebayashi, Masakazu Toi, Makoto Noda |
Gongping Shi, Yoko Yoshida, Kanako Yuki, Tomomi Nishimura, Yukiko Kawata, Masahiro Kawashima, Keiko Iwaisako, Kiyotsugu Yoshikawa, Junichi Kurebayashi, Masakazu Toi, Makoto Noda |
Gongping Shi, Yoko Yoshida, Kanako Yuki, Tomomi Nishimura, Yukiko Kawata, Masahiro Kawashima, Keiko Iwaisako, Kiyotsugu Yoshikawa, Junichi Kurebayashi, Masakazu Toi, Makoto Noda |
Pattern of RECK CpG methylation as a potential marker for predicting breast cancer prognosis and drug-sensitivity |
Pattern of RECK CpG methylation as a potential marker for predicting breast cancer prognosis and drug-sensitivity |
Pattern of RECK CpG methylation as a potential marker for predicting breast cancer prognosis and drug-sensitivity |
ONCOTARGET, 7, 50, 82158-82169 |
ONCOTARGET, 7, 50, 82158-82169 |
ONCOTARGET, 7, 50, 82158-82169 |
2016/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Natsue Uehiro, Fumiaki Sato, Fengling Pu, Sunao Tanaka, Masahiro Kawashima, Kosuke Kawaguchi, Masahiro Sugimoto, Shigehira Saji, Masakazu Toi |
Natsue Uehiro, Fumiaki Sato, Fengling Pu, Sunao Tanaka, Masahiro Kawashima, Kosuke Kawaguchi, Masahiro Sugimoto, Shigehira Saji, Masakazu Toi |
Natsue Uehiro, Fumiaki Sato, Fengling Pu, Sunao Tanaka, Masahiro Kawashima, Kosuke Kawaguchi, Masahiro Sugimoto, Shigehira Saji, Masakazu Toi |
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer |
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer |
Circulating cell-free DNA-based epigenetic assay can detect early breast cancer |
BREAST CANCER RESEARCH, 18, 1, 129 |
BREAST CANCER RESEARCH, 18, 1, 129 |
BREAST CANCER RESEARCH, 18, 1, 129 |
2016/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Ismail Jatoi, John R. Benson, Masakazu Toi |
Ismail Jatoi, John R. Benson, Masakazu Toi |
Ismail Jatoi, John R. Benson, Masakazu Toi |
De-escalation of axillary surgery in early breast cancer |
De-escalation of axillary surgery in early breast cancer |
De-escalation of axillary surgery in early breast cancer |
LANCET ONCOLOGY, 17, 10, E430-E441 |
LANCET ONCOLOGY, 17, 10, E430-E441 |
LANCET ONCOLOGY, 17, 10, E430-E441 |
2016/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| John R. Benson, Ismail Jatoi, Masakazu Toi |
John R. Benson, Ismail Jatoi, Masakazu Toi |
John R. Benson, Ismail Jatoi, Masakazu Toi |
Treatment of low-risk ductal carcinoma in situ: is nothing better than something? |
Treatment of low-risk ductal carcinoma in situ: is nothing better than something? |
Treatment of low-risk ductal carcinoma in situ: is nothing better than something? |
LANCET ONCOLOGY, 17, 10, E442-E451 |
LANCET ONCOLOGY, 17, 10, E442-E451 |
LANCET ONCOLOGY, 17, 10, E442-E451 |
2016/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| E. -S. Lee, W. Han, H. -C. Shin, M. Takada, H. S. Ryu, N. Cho, M. K. Kim, J. Kim, T. -k. Yoo, H. -G. Moon, M. Toi, W. K. Moon, I. -A. Park, D. -Y. Noh |
E. -S. Lee, W. Han, H. -C. Shin, M. Takada, H. S. Ryu, N. Cho, M. K. Kim, J. Kim, T. -k. Yoo, H. -G. Moon, M. Toi, W. K. Moon, I. -A. Park, D. -Y. Noh |
E. -S. Lee, W. Han, H. -C. Shin, M. Takada, H. S. Ryu, N. Cho, M. K. Kim, J. Kim, T. -k. Yoo, H. -G. Moon, M. Toi, W. K. Moon, I. -A. Park, D. -Y. Noh |
Clinical benefit of nomogram for predicting positive resection margins in breast conserving surgery |
Clinical benefit of nomogram for predicting positive resection margins in breast conserving surgery |
Clinical benefit of nomogram for predicting positive resection margins in breast conserving surgery |
EJSO, 42, 8, 1169-1175 |
EJSO, 42, 8, 1169-1175 |
EJSO, 42, 8, 1169-1175 |
2016/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi |
Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi |
Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi |
Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan |
Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan |
Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan |
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 |
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 |
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 |
2016/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi |
Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi |
Eiji Suzuki, Lisa Mackenzie, Robert Sanson-Fisher, Mariko Carey, Catherine D'Este, Hiromi Asada, Masakazu Toi |
Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan |
Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan |
Acceptability of a Touch Screen Tablet Psychosocial Survey Administered to Radiation Therapy Patients in Japan |
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 |
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 |
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 23, 4, 485-491 |
2016/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| 大神 正宏, 坂東 裕子, 石黒 洋, 鳥口 尚子, 津田 萌, 戸井 雅和, 増田 慎三, 武井 敬司, Homma, Masato |
大神 正宏, 坂東 裕子, 石黒 洋, 鳥口 尚子, 津田 萌, 戸井 雅和, 増田 慎三, 武井 敬司, Homma, Masato |
大神 正宏, 坂東 裕子, 石黒 洋, 鳥口 尚子, 津田 萌, 戸井 雅和, 増田 慎三, 武井 敬司, Homma, Masato |
ラパチニブの血中濃度に及ぼす服用タイミングとタモキシフェン併用の影響(会議録) |
ラパチニブの血中濃度に及ぼす服用タイミングとタモキシフェン併用の影響(会議録) |
ラパチニブの血中濃度に及ぼす服用タイミングとタモキシフェン併用の影響(会議録) |
TDM研究, 33, 2, 192 |
TDM研究, 33, 2, 192 |
TDM研究, 33, 2, 192 |
2016/05 |
|
日本語 |
研究論文(研究会、シンポジウム資料等) |
公開 |
| Buyse M, Hurvitz SA, Andre F, Jiang Z, Burris HA, Toi M, Eiermann W, Lindsay MA, Slamon D |
Buyse M, Hurvitz SA, Andre F, Jiang Z, Burris HA, Toi M, Eiermann W, Lindsay MA, Slamon D |
M. Buyse, S. A. Hurvitz, F. Andre, Z. Jiang, H. A. Burris, M. Toi, W. Eiermann, M. -A. Lindsay, D. Slamon |
Statistical controversies in clinical research: statistical significance-too much of a good thing …. |
Statistical controversies in clinical research: statistical significance-too much of a good thing …. |
Statistical controversies in clinical research: statistical significance-too much of a good thing ... |
Ann Oncol, 27, 5, 760-762 |
Ann Oncol, 27, 5, 760-762 |
ANNALS OF ONCOLOGY, 27, 5, 760-762 |
2016/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Wenzhao Li, Junji Itou, Sunao Tanaka, Tomomi Nishimura, Fumiaki Sato, Masakazu Toi |
Wenzhao Li, Junji Itou, Sunao Tanaka, Tomomi Nishimura, Fumiaki Sato, Masakazu Toi |
Wenzhao Li, Junji Itou, Sunao Tanaka, Tomomi Nishimura, Fumiaki Sato, Masakazu Toi |
A homeobox protein, NKX6.1, up-regulates interleukin-6 expression for cell growth in basal-like breast cancer cells |
A homeobox protein, NKX6.1, up-regulates interleukin-6 expression for cell growth in basal-like breast cancer cells |
A homeobox protein, NKX6.1, up-regulates interleukin-6 expression for cell growth in basal-like breast cancer cells |
EXPERIMENTAL CELL RESEARCH, 343, 2, 177-189 |
EXPERIMENTAL CELL RESEARCH, 343, 2, 177-189 |
EXPERIMENTAL CELL RESEARCH, 343, 2, 177-189 |
2016/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| 松本純明, 浅尾恭史, 浅尾恭史, 金尾昌太郎, 片岡正子, 椎名隆, 戸井雅和 |
松本純明, 浅尾恭史, 浅尾恭史, 金尾昌太郎, 片岡正子, 椎名隆, 戸井雅和 |
松本 純明, 浅尾 恭史, 金尾 昌太郎, 片岡 正子, 椎名 毅, 戸井 雅和 |
新しい分子・光イメージング技術の開発と乳癌診断領域への応用 光超音波技術の乳癌診断への応用 |
新しい分子・光イメージング技術の開発と乳癌診断領域への応用 光超音波技術の乳癌診断への応用 |
【新しい分子・光イメージング技術の開発と乳癌診断領域への応用】 光超音波技術の乳癌診断への応用 |
乳癌の臨床, 31, 1, 7‐17-17 |
乳癌の臨床, 31, 1, 7‐17-17 |
乳癌の臨床, 31, 1, 7‐17-17 |
2016/03/25 |
|
日本語 |
|
公開 |
| Masakazu Toi, Shinji Ohno, Toshiaki Saeki, Seigo Nakamura, Beat Thurlimann |
Masakazu Toi, Shinji Ohno, Toshiaki Saeki, Seigo Nakamura, Beat Thurlimann |
Masakazu Toi, Shinji Ohno, Toshiaki Saeki, Seigo Nakamura, Beat Thurlimann |
For choosing axillary treatment, and adjuvant hormonal treatment |
For choosing axillary treatment, and adjuvant hormonal treatment |
For choosing axillary treatment, and adjuvant hormonal treatment |
BREAST CANCER, 23, 2, 167-169 |
BREAST CANCER, 23, 2, 167-169 |
BREAST CANCER, 23, 2, 167-169 |
2016/03 |
有 |
英語 |
|
公開 |
| Hayakawa Yoshihiro, Kawada Manabu, Nishikawa Hiroyoshi, Ochiya Takahiro, Saya Hideyuki, Seimiya Hiroyuki, Yao Ryoji, Hayashi Masahiro, Kai Chieko, Matsuda Akira, Naoe Tomoki, Ohtsu Atsushi, Okazaki Taku, Saji Hideo, Sata Masataka, Sugimura Haruhiko, Sugiyama Yuichi, Toi Masakazu, Irimura Tatsuro |
Hayakawa Yoshihiro, Kawada Manabu, Nishikawa Hiroyoshi, Ochiya Takahiro, Saya Hideyuki, Seimiya Hiroyuki, Yao Ryoji, Hayashi Masahiro, Kai Chieko, Matsuda Akira, Naoe Tomoki, Ohtsu Atsushi, Okazaki Taku, Saji Hideo, Sata Masataka, Sugimura Haruhiko, Sugiyama Yuichi, Toi Masakazu, Irimura Tatsuro |
Hayakawa Yoshihiro, Kawada Manabu, Nishikawa Hiroyoshi, Ochiya Takahiro, Saya Hideyuki, Seimiya Hiroyuki, Yao Ryoji, Hayashi Masahiro, Kai Chieko, Matsuda Akira, Naoe Tomoki, Ohtsu Atsushi, Okazaki Taku, Saji Hideo, Sata Masataka, Sugimura Haruhiko, Sugiyama Yuichi, Toi Masakazu, Irimura Tatsuro |
Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs |
Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs |
Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs |
Cancer Science, 107, 2, 189-202 |
Cancer Science, 107, 2, 189-202 |
Cancer Science, 107, 2, 189-202 |
2016/02/01 |
|
英語 |
|
公開 |
| Ohno,S, Ishiguro,H, Yamamoto,Y, Takao,S, Sato,N, Fujisawa,T, Kadoya,T, Kuroi,K, Bando,H, Teramura,Y, Iwata,H, Tanaka,S, Toi,M |
Ohno,S, Ishiguro,H, Yamamoto,Y, Takao,S, Sato,N, Fujisawa,T, Kadoya,T, Kuroi,K, Bando,H, Teramura,Y, Iwata,H, Tanaka,S, Toi,M |
Ohno,S, Ishiguro,H, Yamamoto,Y, Takao,S, Sato,N, Fujisawa,T, Kadoya,T, Kuroi,K, Bando,H, Teramura,Y, Iwata,H, Tanaka,S, Toi,M |
Pharmacogenomics-pharmacokinetics study of selective estrogen receptor modulators with intra-patient dose-escalation for Japanese breast cancer patients |
Pharmacogenomics-pharmacokinetics study of selective estrogen receptor modulators with intra-patient dose-escalation for Japanese breast cancer patients |
Pharmacogenomics-pharmacokinetics study of selective estrogen receptor modulators with intra-patient dose-escalation for Japanese breast cancer patients |
CANCER RESEARCH, 76, 4 |
CANCER RESEARCH, 76, 4 |
CANCER RESEARCH, 76, 4 |
2016/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Yoshihiro Hayakawa, Manabu Kawada, Hiroyoshi Nishikawa, Takahiro Ochiya, Hideyuki Saya, Hiroyuki Seimiya, Ryoji Yao, Masahiro Hayashi, Chieko Kai, Akira Matsuda, Tomoki Naoe, Atsushi Ohtsu, Taku Okazaki, Hideo Saji, Masataka Sata, Haruhiko Sugimura, Yuichi Sugiyama, Masakazu Toi, Tatsuro Irimura |
Yoshihiro Hayakawa, Manabu Kawada, Hiroyoshi Nishikawa, Takahiro Ochiya, Hideyuki Saya, Hiroyuki Seimiya, Ryoji Yao, Masahiro Hayashi, Chieko Kai, Akira Matsuda, Tomoki Naoe, Atsushi Ohtsu, Taku Okazaki, Hideo Saji, Masataka Sata, Haruhiko Sugimura, Yuichi Sugiyama, Masakazu Toi, Tatsuro Irimura |
Yoshihiro Hayakawa, Manabu Kawada, Hiroyoshi Nishikawa, Takahiro Ochiya, Hideyuki Saya, Hiroyuki Seimiya, Ryoji Yao, Masahiro Hayashi, Chieko Kai, Akira Matsuda, Tomoki Naoe, Atsushi Ohtsu, Taku Okazaki, Hideo Saji, Masataka Sata, Haruhiko Sugimura, Yuichi Sugiyama, Masakazu Toi, Tatsuro Irimura |
Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs |
Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs |
Report on the use of non-clinical studies in the regulatory evaluation of oncology drugs |
CANCER SCIENCE, 107, 2, 189-202 |
CANCER SCIENCE, 107, 2, 189-202 |
CANCER SCIENCE, 107, 2, 189-202 |
2016/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Fumiaki Sato, Shigehira Saji, Masakazu Toi |
Fumiaki Sato, Shigehira Saji, Masakazu Toi |
Fumiaki Sato, Shigehira Saji, Masakazu Toi |
Genomic tumor evolution of breast cancer |
Genomic tumor evolution of breast cancer |
Genomic tumor evolution of breast cancer |
BREAST CANCER, 23, 1, 4-11 |
BREAST CANCER, 23, 1, 4-11 |
BREAST CANCER, 23, 1, 4-11 |
2016/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Tomoharu Sugie, Takayuki Kinoshita, Norikazu Masuda, Terumasa Sawada, Akira Yamauchi, Katsumasa Kuroi, Tetsuya Taguchi, Hiroko Bando, Hiroyasu Yamashiro, Tecchuu Lee, Nobuhiko Shinkura, Hironori Kato, Takafumi Ikeda, Kenichi Yoshimura, Hanae Ueyama, Masakazu Toi |
Tomoharu Sugie, Takayuki Kinoshita, Norikazu Masuda, Terumasa Sawada, Akira Yamauchi, Katsumasa Kuroi, Tetsuya Taguchi, Hiroko Bando, Hiroyasu Yamashiro, Tecchuu Lee, Nobuhiko Shinkura, Hironori Kato, Takafumi Ikeda, Kenichi Yoshimura, Hanae Ueyama, Masakazu Toi |
Tomoharu Sugie, Takayuki Kinoshita, Norikazu Masuda, Terumasa Sawada, Akira Yamauchi, Katsumasa Kuroi, Tetsuya Taguchi, Hiroko Bando, Hiroyasu Yamashiro, Tecchuu Lee, Nobuhiko Shinkura, Hironori Kato, Takafumi Ikeda, Kenichi Yoshimura, Hanae Ueyama, Masakazu Toi |
Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer |
Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer |
Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer |
ANNALS OF SURGICAL ONCOLOGY, 23, 1, 44-50 |
ANNALS OF SURGICAL ONCOLOGY, 23, 1, 44-50 |
ANNALS OF SURGICAL ONCOLOGY, 23, 1, 44-50 |
2016/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Nobuko Kawaguchi-Sakita, Kaoru Kaneshiro-Nakagawa, Masahiro Kawashima, Masahiro Sugimoto, Mariko Tokiwa, Eiji Suzuki, Shigeki Kajihara, Yuichiro Fujita, Shinichi Iwamoto, Koichi Tanaka, Masakazu Toi |
Nobuko Kawaguchi-Sakita, Kaoru Kaneshiro-Nakagawa, Masahiro Kawashima, Masahiro Sugimoto, Mariko Tokiwa, Eiji Suzuki, Shigeki Kajihara, Yuichiro Fujita, Shinichi Iwamoto, Koichi Tanaka, Masakazu Toi |
Nobuko Kawaguchi-Sakita, Kaoru Kaneshiro-Nakagawa, Masahiro Kawashima, Masahiro Sugimoto, Mariko Tokiwa, Eiji Suzuki, Shigeki Kajihara, Yuichiro Fujita, Shinichi Iwamoto, Koichi Tanaka, Masakazu Toi |
Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls |
Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls |
Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 469, 4, 1140-1145 |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 469, 4, 1140-1145 |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 469, 4, 1140-1145 |
2016/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Fumiaki Sato, Shigehira Saji, Masakazu Toi |
Fumiaki Sato, Shigehira Saji, Masakazu Toi |
Fumiaki Sato, Shigehira Saji, Masakazu Toi |
Genomic tumor evolution of breast cancer |
Genomic tumor evolution of breast cancer |
Genomic tumor evolution of breast cancer |
BREAST CANCER, 23, 1, 4-11 |
BREAST CANCER, 23, 1, 4-11 |
BREAST CANCER, 23, 1, 4-11 |
2016/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama |
Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama |
Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama |
Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG |
Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG |
Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG |
BREAST CANCER, 22, 6, 586-595 |
BREAST CANCER, 22, 6, 586-595 |
BREAST CANCER, 22, 6, 586-595 |
2015/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama |
Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama |
Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama |
Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG |
Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG |
Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG |
BREAST CANCER, 22, 6, 586-595 |
BREAST CANCER, 22, 6, 586-595 |
BREAST CANCER, 22, 6, 586-595 |
2015/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Hirofumi Mukai, Norikazu Masuda, Hiroshi Ishiguro, Ayako Mitsuma, Takashi Shibata, Jun Yamamura, Masakazu Toi, Aiko Watabe, Akiko Sarashina, Martina Uttenreuther-Fischer, Yuichi Ando |
Hirofumi Mukai, Norikazu Masuda, Hiroshi Ishiguro, Ayako Mitsuma, Takashi Shibata, Jun Yamamura, Masakazu Toi, Aiko Watabe, Akiko Sarashina, Martina Uttenreuther-Fischer, Yuichi Ando |
Hirofumi Mukai, Norikazu Masuda, Hiroshi Ishiguro, Ayako Mitsuma, Takashi Shibata, Jun Yamamura, Masakazu Toi, Aiko Watabe, Akiko Sarashina, Martina Uttenreuther-Fischer, Yuichi Ando |
Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer |
Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer |
Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 4, 739-750 |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 4, 739-750 |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 76, 4, 739-750 |
2015/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| R. Coleman, T. Powles, A. Paterson, M. Gnant, S. Anderson, I. Diel, J. Gralow, G. von Minckwitz, V. Moebus, J. Bergh, K. I. Pritchard, J. Bliss, D. Cameron, V. Evans, H. Pan, R. Peto, R. Bradley, R. Gray, R. Bartsch, P. Dubsky, C. Fesl, H. Fohler, M. Gnant, R. Greil, R. Jakesz, A. Lang, G. Luschin-Ebengreuth, C. Marth, B. Mlineritsch, H. Samonigg, C. F. Singer, G. G. Steger, H. Stoeger, I. Olivotto, J. Ragaz, P. Christiansen, B. Ejlertsen, M. Ewertz, M-B Jensen, S. Moller, H. T. Mouridsen, W. Eiermann, J. Hilfrich, W. Jonat, M. Kaufmann, R. Kreienberg, M. Schumacher, J. U. Blohmer, S. D. Costa, H. Eidtmann, B. Gerber, C. Jackisch, S. Loibl, G. von Minckwitz, U. Dafni, C. Markopoulos, C. Blomqvist, T. Saarto, J-H Ahn, K. H. Jung, F. Perrone, S. Anderson, G. Bass, A. Brown, J. Bryant, J. Costantino, J. Dignam, B. Fisher, C. Geyer, E. P. Mamounas, S. Paik, C. Redmond, S. Swain, L. Wickerham, N. Wolmark, E. Perez, J. N. Ingle, V. J. Suman, P. Hadji, R. A'Hern, M. Dowsett, A. Makris, M. Parton, K. Pennert, T. J. Powles, I. E. Smith, J. R. Yarnold, G. Clack, C. Van Poznak, T. Safra, R. Bell, D. Cameron, R. E. Coleman, D. Dodwell, S. Hinsley, H. C. Marshall, E. Solomayer, T. Fehm, R. E. Coleman, J. Lester, M. C. Winter, J. M. Horsman, R. Aft, A. M. Brufsky, R. Coleman, H. A. Llombart |
R. Coleman, T. Powles, A. Paterson, M. Gnant, S. Anderson, I. Diel, J. Gralow, G. von Minckwitz, V. Moebus, J. Bergh, K. I. Pritchard, J. Bliss, D. Cameron, V. Evans, H. Pan, R. Peto, R. Bradley, R. Gray, R. Bartsch, P. Dubsky, C. Fesl, H. Fohler, M. Gnant, R. Greil, R. Jakesz, A. Lang, G. Luschin-Ebengreuth, C. Marth, B. Mlineritsch, H. Samonigg, C. F. Singer, G. G. Steger, H. Stoeger, I. Olivotto, J. Ragaz, P. Christiansen, B. Ejlertsen, M. Ewertz, M-B Jensen, S. Moller, H. T. Mouridsen, W. Eiermann, J. Hilfrich, W. Jonat, M. Kaufmann, R. Kreienberg, M. Schumacher, J. U. Blohmer, S. D. Costa, H. Eidtmann, B. Gerber, C. Jackisch, S. Loibl, G. von Minckwitz, U. Dafni, C. Markopoulos, C. Blomqvist, T. Saarto, J-H Ahn, K. H. Jung, F. Perrone, S. Anderson, G. Bass, A. Brown, J. Bryant, J. Costantino, J. Dignam, B. Fisher, C. Geyer, E. P. Mamounas, S. Paik, C. Redmond, S. Swain, L. Wickerham, N. Wolmark, E. Perez, J. N. Ingle, V. J. Suman, P. Hadji, R. A'Hern, M. Dowsett, A. Makris, M. Parton, K. Pennert, T. J. Powles, I. E. Smith, J. R. Yarnold, G. Clack, C. Van Poznak, T. Safra, R. Bell, D. Cameron, R. E. Coleman, D. Dodwell, S. Hinsley, H. C. Marshall, E. Solomayer, T. Fehm, R. E. Coleman, J. Lester, M. C. Winter, J. M. Horsman, R. Aft, A. M. Brufsky, R. Coleman, H. A. Llombart |
R. Coleman, T. Powles, A. Paterson, M. Gnant, S. Anderson, I. Diel, J. Gralow, G. von Minckwitz, V. Moebus, J. Bergh, K. I. Pritchard, J. Bliss, D. Cameron, V. Evans, H. Pan, R. Peto, R. Bradley, R. Gray, R. Bartsch, P. Dubsky, C. Fesl, H. Fohler, M. Gnant, R. Greil, R. Jakesz, A. Lang, G. Luschin-Ebengreuth, C. Marth, B. Mlineritsch, H. Samonigg, C. F. Singer, G. G. Steger, H. Stoeger, I. Olivotto, J. Ragaz, P. Christiansen, B. Ejlertsen, M. Ewertz, M-B Jensen, S. Moller, H. T. Mouridsen, W. Eiermann, J. Hilfrich, W. Jonat, M. Kaufmann, R. Kreienberg, M. Schumacher, J. U. Blohmer, S. D. Costa, H. Eidtmann, B. Gerber, C. Jackisch, S. Loibl, G. von Minckwitz, U. Dafni, C. Markopoulos, C. Blomqvist, T. Saarto, J-H Ahn, K. H. Jung, F. Perrone, S. Anderson, G. Bass, A. Brown, J. Bryant, J. Costantino, J. Dignam, B. Fisher, C. Geyer, E. P. Mamounas, S. Paik, C. Redmond, S. Swain, L. Wickerham, N. Wolmark, E. Perez, J. N. Ingle, V. J. Suman, P. Hadji, R. A'Hern, M. Dowsett, A. Makris, M. Parton, K. Pennert, T. J. Powles, I. E. Smith, J. R. Yarnold, G. Clack, C. Van Poznak, T. Safra, R. Bell, D. Cameron, R. E. Coleman, D. Dodwell, S. Hinsley, H. C. Marshall, E. Solomayer, T. Fehm, R. E. Coleman, J. Lester, M. C. Winter, J. M. Horsman, R. Aft, A. M. Brufsky, R. Coleman, H. A. Llombart |
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials |
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials |
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials |
LANCET, 386, 10001, 1353-1361 |
LANCET, 386, 10001, 1353-1361 |
LANCET, 386, 10001, 1353-1361 |
2015/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Dowsett, J. F. Forbes, R. Bradley, J. Ingle, T. Aihara, J. Bliss, F. Boccardo, A. Coates, R. C. Coombes, J. Cuzick, P. Dubsky, M. Gnant, M. Kaufmann, L. Kilburn, F. Perrone, D. Rea, B. Thuerlimann, C. van de Velde, H. Pan, R. Peto, C. Davies, R. Gray, M. Baum, A. Buzdar, J. Cuzick, M. Dowsett, J. F. Forbes, I. Sestak, C. Markopoulos, P. Dubsky, C. Fesl, M. Gnant, R. Jakesz, A. Coates, M. Colleoni, J. F. Forbes, R. Gelber, M. Regan, M. Kaufmann, G. von Minckwitz, J. Bliss, A. Coates, R. C. Coombes, J. F. Forbes, L. Kilburn, C. Snowdon, F. Boccardo, F. Perrone, P. Goss, J. Ingle, K. Pritchard, S. Anderson, J. Costantino, E. Mamounas, T. Aihara, Y. Ohashi, T. Watanabe, E. Bastiaannet, C. van de Velde, D. Rea |
M. Dowsett, J. F. Forbes, R. Bradley, J. Ingle, T. Aihara, J. Bliss, F. Boccardo, A. Coates, R. C. Coombes, J. Cuzick, P. Dubsky, M. Gnant, M. Kaufmann, L. Kilburn, F. Perrone, D. Rea, B. Thuerlimann, C. van de Velde, H. Pan, R. Peto, C. Davies, R. Gray, M. Baum, A. Buzdar, J. Cuzick, M. Dowsett, J. F. Forbes, I. Sestak, C. Markopoulos, P. Dubsky, C. Fesl, M. Gnant, R. Jakesz, A. Coates, M. Colleoni, J. F. Forbes, R. Gelber, M. Regan, M. Kaufmann, G. von Minckwitz, J. Bliss, A. Coates, R. C. Coombes, J. F. Forbes, L. Kilburn, C. Snowdon, F. Boccardo, F. Perrone, P. Goss, J. Ingle, K. Pritchard, S. Anderson, J. Costantino, E. Mamounas, T. Aihara, Y. Ohashi, T. Watanabe, E. Bastiaannet, C. van de Velde, D. Rea |
M. Dowsett, J. F. Forbes, R. Bradley, J. Ingle, T. Aihara, J. Bliss, F. Boccardo, A. Coates, R. C. Coombes, J. Cuzick, P. Dubsky, M. Gnant, M. Kaufmann, L. Kilburn, F. Perrone, D. Rea, B. Thuerlimann, C. van de Velde, H. Pan, R. Peto, C. Davies, R. Gray, M. Baum, A. Buzdar, J. Cuzick, M. Dowsett, J. F. Forbes, I. Sestak, C. Markopoulos, P. Dubsky, C. Fesl, M. Gnant, R. Jakesz, A. Coates, M. Colleoni, J. F. Forbes, R. Gelber, M. Regan, M. Kaufmann, G. von Minckwitz, J. Bliss, A. Coates, R. C. Coombes, J. F. Forbes, L. Kilburn, C. Snowdon, F. Boccardo, F. Perrone, P. Goss, J. Ingle, K. Pritchard, S. Anderson, J. Costantino, E. Mamounas, T. Aihara, Y. Ohashi, T. Watanabe, E. Bastiaannet, C. van de Velde, D. Rea |
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials |
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials |
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials |
LANCET, 386, 10001, 1341-1352 |
LANCET, 386, 10001, 1341-1352 |
LANCET, 386, 10001, 1341-1352 |
2015/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Elham Fakhrejahani, Masae Toii, Toshiyuki Kitai, Shotaro Kanao, Yasufumi Asao, Yohei Hashizume, Yoshiki Mikami, Iku Yamaga, Masako Kataoka, Tomoharu Sugie, Masahiro Takada, Hironori Haga, Kaori Togashi, Tsuyoshi Shiina, Masakazu Toi |
Elham Fakhrejahani, Masae Toii, Toshiyuki Kitai, Shotaro Kanao, Yasufumi Asao, Yohei Hashizume, Yoshiki Mikami, Iku Yamaga, Masako Kataoka, Tomoharu Sugie, Masahiro Takada, Hironori Haga, Kaori Togashi, Tsuyoshi Shiina, Masakazu Toi |
Elham Fakhrejahani, Masae Toii, Toshiyuki Kitai, Shotaro Kanao, Yasufumi Asao, Yohei Hashizume, Yoshiki Mikami, Iku Yamaga, Masako Kataoka, Tomoharu Sugie, Masahiro Takada, Hironori Haga, Kaori Togashi, Tsuyoshi Shiina, Masakazu Toi |
Clinical Report on the First Prototype of a Photoacoustic Tomography System with Dual Illumination for Breast Cancer Imaging |
Clinical Report on the First Prototype of a Photoacoustic Tomography System with Dual Illumination for Breast Cancer Imaging |
Clinical Report on the First Prototype of a Photoacoustic Tomography System with Dual Illumination for Breast Cancer Imaging |
PLOS ONE, 10, 10, e0139113 |
PLOS ONE, 10, 10, e0139113 |
PLOS ONE, 10, 10, e0139113 |
2015/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Bando,H, Masuda,N, Nakamura,R, Kondo,N, Kuroi,K, Akiyoshi,S, Ohtani,S, Toshimi,T, Inoue,K, Yanagida,Y, Ishiguro,H, Shimizu,S, Aogi,K, Amano,S, Ozaki,S, Iguchi-Manaka,A, Kasai,H, Morita,S, Kataoka,T. R, Toi,M |
Bando,H, Masuda,N, Nakamura,R, Kondo,N, Kuroi,K, Akiyoshi,S, Ohtani,S, Toshimi,T, Inoue,K, Yanagida,Y, Ishiguro,H, Shimizu,S, Aogi,K, Amano,S, Ozaki,S, Iguchi-Manaka,A, Kasai,H, Morita,S, Kataoka,T. R, Toi,M |
Bando,H, Masuda,N, Nakamura,R, Kondo,N, Kuroi,K, Akiyoshi,S, Ohtani,S, Toshimi,T, Inoue,K, Yanagida,Y, Ishiguro,H, Shimizu,S, Aogi,K, Amano,S, Ozaki,S, Iguchi-Manaka,A, Kasai,H, Morita,S, Kataoka,T. R, Toi,M |
Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+breast cancer (BC) patients |
Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+breast cancer (BC) patients |
Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+breast cancer (BC) patients |
EUROPEAN JOURNAL OF CANCER, 51, 3, S316-S316 |
EUROPEAN JOURNAL OF CANCER, 51, 3, S316-S316 |
EUROPEAN JOURNAL OF CANCER, 51, 3, S316-S316 |
2015/09 |
有 |
英語 |
研究論文(国際会議プロシーディングス) |
公開 |
| Yamashita,T, Masuda,N, Yamamoto,N, Kondo,N, Bando,H, Akiyoshi,S, Ohtani,S, Takano,T, Inoue,K, Fujisawa,T, Ishiguro,H, Nakayama,H, Aogi,K, Amano,S, Ozaki,H, Yasojima,H, Kasai,H, Kataoka,T. R, Morita,S, Toi,M |
Yamashita,T, Masuda,N, Yamamoto,N, Kondo,N, Bando,H, Akiyoshi,S, Ohtani,S, Takano,T, Inoue,K, Fujisawa,T, Ishiguro,H, Nakayama,H, Aogi,K, Amano,S, Ozaki,H, Yasojima,H, Kasai,H, Kataoka,T. R, Morita,S, Toi,M |
Yamashita,T, Masuda,N, Yamamoto,N, Kondo,N, Bando,H, Akiyoshi,S, Ohtani,S, Takano,T, Inoue,K, Fujisawa,T, Ishiguro,H, Nakayama,H, Aogi,K, Amano,S, Ozaki,H, Yasojima,H, Kasai,H, Kataoka,T. R, Morita,S, Toi,M |
Primary systemic therapy by dual HER2 blockage with lapatinib (La) plus trastuzumab (T) for Japanese patients (pts) with HER2+breast cancer (BC): Association of La toxicity and dose with treatment efficacy |
Primary systemic therapy by dual HER2 blockage with lapatinib (La) plus trastuzumab (T) for Japanese patients (pts) with HER2+breast cancer (BC): Association of La toxicity and dose with treatment efficacy |
Primary systemic therapy by dual HER2 blockage with lapatinib (La) plus trastuzumab (T) for Japanese patients (pts) with HER2+breast cancer (BC): Association of La toxicity and dose with treatment efficacy |
EUROPEAN JOURNAL OF CANCER, 51, 3, S317-S318 |
EUROPEAN JOURNAL OF CANCER, 51, 3, S317-S318 |
EUROPEAN JOURNAL OF CANCER, 51, 3, S317-S318 |
2015/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama |
Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama |
Katsumasa Kuroi, Masakazu Toi, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Nobuaki Sato, Hitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama |
Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG |
Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG |
Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG |
BREAST CANCER, 22, 5, 486-495 |
BREAST CANCER, 22, 5, 486-495 |
BREAST CANCER, 22, 5, 486-495 |
2015/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H |
Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H |
Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H |
The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion. |
The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion. |
The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion. |
Cancer immunology research, 3, 8, 871-880 |
Cancer immunology research, 3, 8, 871-880 |
Cancer immunology research, 3, 8, 871-880 |
2015/08 |
有 |
|
|
公開 |
| Hiroyasu Yamshiro, Hiroji Iwata, Norikazu Masuda, Naohito Yamamoto, Reiki Nishimura, Shoichiro Ohtani, Nobuki Sato, Masato Takahashi, Takako Kamio, Kosuke Yamazaki, Tsuyoshi Saito, Makoto Kato, Tecchuu Lee, Shinji Ohno, Katsumasa Kuroi, Toshimi Takano, Masahiro Takada, Shinji Yasuno, Satoshi Morita, Masakazu Toi |
Hiroyasu Yamshiro, Hiroji Iwata, Norikazu Masuda, Naohito Yamamoto, Reiki Nishimura, Shoichiro Ohtani, Nobuki Sato, Masato Takahashi, Takako Kamio, Kosuke Yamazaki, Tsuyoshi Saito, Makoto Kato, Tecchuu Lee, Shinji Ohno, Katsumasa Kuroi, Toshimi Takano, Masahiro Takada, Shinji Yasuno, Satoshi Morita, Masakazu Toi |
Hiroyasu Yamshiro, Hiroji Iwata, Norikazu Masuda, Naohito Yamamoto, Reiki Nishimura, Shoichiro Ohtani, Nobuki Sato, Masato Takahashi, Takako Kamio, Kosuke Yamazaki, Tsuyoshi Saito, Makoto Kato, Tecchuu Lee, Shinji Ohno, Katsumasa Kuroi, Toshimi Takano, Masahiro Takada, Shinji Yasuno, Satoshi Morita, Masakazu Toi |
Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients |
Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients |
Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 4, 709-722 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 4, 709-722 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 20, 4, 709-722 |
2015/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| A. S. Coates, E. P. Winer, A. Goldhirsch, R. D. Gelber, M. Gnant, M. Piccart-Gebhart, B. Thuerlimann, H. -J. Senn |
A. S. Coates, E. P. Winer, A. Goldhirsch, R. D. Gelber, M. Gnant, M. Piccart-Gebhart, B. Thuerlimann, H. -J. Senn |
A. S. Coates, E. P. Winer, A. Goldhirsch, R. D. Gelber, M. Gnant, M. Piccart-Gebhart, B. Thuerlimann, H. -J. Senn |
Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 |
Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 |
Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 |
ANNALS OF ONCOLOGY, 26, 8, 1533-1546 |
ANNALS OF ONCOLOGY, 26, 8, 1533-1546 |
ANNALS OF ONCOLOGY, 26, 8, 1533-1546 |
2015/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Sara A. Hurvitz, Fabrice Andre, Zefei Jiang, Zhimin Shao, Max S. Mano, Silvia P. Neciosup, Ling-Min Tseng, Qingyuan Zhang, Kunwei Shen, Donggeng Liu, Lydia M. Dreosti, Howard A. Burris, Masakazu Toi, Marc E. Buyse, David Cabaribere, Mary-Ann Lindsay, Shantha Rao, Lida Bubuteishvili Pacaud, Tetiana Taran, Dennis Slamon |
Sara A. Hurvitz, Fabrice Andre, Zefei Jiang, Zhimin Shao, Max S. Mano, Silvia P. Neciosup, Ling-Min Tseng, Qingyuan Zhang, Kunwei Shen, Donggeng Liu, Lydia M. Dreosti, Howard A. Burris, Masakazu Toi, Marc E. Buyse, David Cabaribere, Mary-Ann Lindsay, Shantha Rao, Lida Bubuteishvili Pacaud, Tetiana Taran, Dennis Slamon |
Sara A. Hurvitz, Fabrice Andre, Zefei Jiang, Zhimin Shao, Max S. Mano, Silvia P. Neciosup, Ling-Min Tseng, Qingyuan Zhang, Kunwei Shen, Donggeng Liu, Lydia M. Dreosti, Howard A. Burris, Masakazu Toi, Marc E. Buyse, David Cabaribere, Mary-Ann Lindsay, Shantha Rao, Lida Bubuteishvili Pacaud, Tetiana Taran, Dennis Slamon |
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial |
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial |
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial |
LANCET ONCOLOGY, 16, 7, 816-829 |
LANCET ONCOLOGY, 16, 7, 816-829 |
LANCET ONCOLOGY, 16, 7, 816-829 |
2015/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Kawashima Masahiro, Yamaga Iku, Torii Masae, Tokiwa Mariko, Elham Fakhrejahani, Kataoka Masako, Kanao Shotaro, Takada Masahiro, Asao Yasufumi, Shiina Tsuyoshi, Toi Masakazu |
Kawashima Masahiro, Yamaga Iku, Torii Masae, Tokiwa Mariko, Elham Fakhrejahani, Kataoka Masako, Kanao Shotaro, Takada Masahiro, Asao Yasufumi, Shiina Tsuyoshi, Toi Masakazu |
Kawashima Masahiro, Yamaga Iku, Torii Masae, Tokiwa Mariko, Elham Fakhrejahani, Kataoka Masako, Kanao Shotaro, Takada Masahiro, Asao Yasufumi, Shiina Tsuyoshi, Toi Masakazu |
Evaluation of second-generation photoacoustic mammography in detecting the breast cancer vasculature and hypoxic status; a preliminary study |
Evaluation of second-generation photoacoustic mammography in detecting the breast cancer vasculature and hypoxic status; a preliminary study |
Evaluation of second-generation photoacoustic mammography in detecting the breast cancer vasculature and hypoxic status; a preliminary study |
CANCER RESEARCH, 75 |
CANCER RESEARCH, 75 |
CANCER RESEARCH, 75 |
2015/05/01 |
有 |
|
|
公開 |
| Fakhrejahani Elham, Torii Masae, Asao Yasufumi, Yamaga Iku, Kitai Toshiyuki, Kataoka Masako, Kanao Shotaro, Takada Masahiro, Shiina Tsuyoshi, Toi Masakazu |
Fakhrejahani Elham, Torii Masae, Asao Yasufumi, Yamaga Iku, Kitai Toshiyuki, Kataoka Masako, Kanao Shotaro, Takada Masahiro, Shiina Tsuyoshi, Toi Masakazu |
Fakhrejahani Elham, Torii Masae, Asao Yasufumi, Yamaga Iku, Kitai Toshiyuki, Kataoka Masako, Kanao Shotaro, Takada Masahiro, Shiina Tsuyoshi, Toi Masakazu |
Clinical, anatomical and histological characteristics of breast lesions visualized by photoacoustic mammography; first clinical study in CK project |
Clinical, anatomical and histological characteristics of breast lesions visualized by photoacoustic mammography; first clinical study in CK project |
Clinical, anatomical and histological characteristics of breast lesions visualized by photoacoustic mammography; first clinical study in CK project |
CANCER RESEARCH, 75 |
CANCER RESEARCH, 75 |
CANCER RESEARCH, 75 |
2015/05/01 |
有 |
|
|
公開 |
| Masakazu Toi, Norikazu Masuda, Hiroshi Ishiguro, Shigehira Saji, Shinji Ohno, Louis W. C. Chow |
Masakazu Toi, Norikazu Masuda, Hiroshi Ishiguro, Shigehira Saji, Shinji Ohno, Louis W. C. Chow |
Masakazu Toi, Norikazu Masuda, Hiroshi Ishiguro, Shigehira Saji, Shinji Ohno, Louis W. C. Chow |
Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant setting |
Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant setting |
Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant setting |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 30, 2, E252-E253 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 30, 2, E252-E253 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 30, 2, E252-E253 |
2015/04 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Iwata,H, Yamamoto,N, Masuda,N, Bando,H, Kuroi,K, Ohno,S, Kasai,H, Morita,S, Sakurai,T, Toi,M |
Iwata,H, Yamamoto,N, Masuda,N, Bando,H, Kuroi,K, Ohno,S, Kasai,H, Morita,S, Sakurai,T, Toi,M |
Iwata,H, Yamamoto,N, Masuda,N, Bando,H, Kuroi,K, Ohno,S, Kasai,H, Morita,S, Sakurai,T, Toi,M |
Dual HER2 blockage with lapatinib and trastuzumab for Japanese patients with HER2+breast cancer |
Dual HER2 blockage with lapatinib and trastuzumab for Japanese patients with HER2+breast cancer |
Dual HER2 blockage with lapatinib and trastuzumab for Japanese patients with HER2+breast cancer |
BREAST, 24, 1, S95-S95 |
BREAST, 24, 1, S95-S95 |
BREAST, 24, 1, S95-S95 |
2015/03 |
|
英語 |
研究論文(学術雑誌) |
公開 |
| Natsuko Onishi, Shotaro Kanao, Masako Kataoka, Mami Iima, Rena Sakaguchi, Makiko Kawai, Tatsuki R. Kataoka, Yoshiki Mikami, Masakazu Toi, Kaori Togashi |
Natsuko Onishi, Shotaro Kanao, Masako Kataoka, Mami Iima, Rena Sakaguchi, Makiko Kawai, Tatsuki R. Kataoka, Yoshiki Mikami, Masakazu Toi, Kaori Togashi |
Natsuko Onishi, Shotaro Kanao, Masako Kataoka, Mami Iima, Rena Sakaguchi, Makiko Kawai, Tatsuki R. Kataoka, Yoshiki Mikami, Masakazu Toi, Kaori Togashi |
Apparent Diffusion Coefficient as a Potential Surrogate Marker for Ki-67 Index in Mucinous Breast Carcinoma |
Apparent Diffusion Coefficient as a Potential Surrogate Marker for Ki-67 Index in Mucinous Breast Carcinoma |
Apparent Diffusion Coefficient as a Potential Surrogate Marker for Ki-67 Index in Mucinous Breast Carcinoma |
JOURNAL OF MAGNETIC RESONANCE IMAGING, 41, 3, 610-615 |
JOURNAL OF MAGNETIC RESONANCE IMAGING, 41, 3, 610-615 |
JOURNAL OF MAGNETIC RESONANCE IMAGING, 41, 3, 610-615 |
2015/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi |
Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi |
Eiji Suzuki, Tatsuki R. Kataoka, Masahiro Hirata, Kosuke Kawaguchi, Mariko Nishie, Hironori Haga, Masakazu Toi |
Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients |
Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients |
Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients |
BMC CANCER, 15, 1, 39 |
BMC CANCER, 15, 1, 39 |
BMC CANCER, 15, 1, 39 |
2015/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Junji Itou, Sunao Tanaka, Wenzhao Li, Yoshiaki Matsumoto, Fumiaki Sato, Masakazu Toi, ual, contribution, corresponding author |
Junji Itou, Sunao Tanaka, Wenzhao Li, Yoshiaki Matsumoto, Fumiaki Sato, Masakazu Toi, ual, contribution, corresponding author |
|
Data of a fluorescent imaging-based analysis of anti-cancer drug effects on three-dimensional cultures of breast cancer cells |
Data of a fluorescent imaging-based analysis of anti-cancer drug effects on three-dimensional cultures of breast cancer cells |
|
Data in Brief, 5, 429-433 |
Data in Brief, 5, 429-433 |
, 5, 429-433 |
2015 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Yoko Goto, Lihua Zeng, Chan Joo Yeom, Yuxi Zhu, Akiyo Morinibu, Kazumi Shinomiya, Minoru Kobayashi, Kiichi Hirota, Satoshi Itasaka, Michio Yoshimura, Keiji Tanimoto, Masae Torii, Terumasa Sowa, Toshi Menju, Makoto Sonobe, Hideaki Kakeya, Masakazu Toi, Hiroshi Date, Ester M. Hammond, Masahiro Hiraoka, Hiroshi Harada |
|
Yoko Goto, Lihua Zeng, Chan Joo Yeom, Yuxi Zhu, Akiyo Morinibu, Kazumi Shinomiya, Minoru Kobayashi, Kiichi Hirota, Satoshi Itasaka, Michio Yoshimura, Keiji Tanimoto, Masae Torii, Terumasa Sowa, Toshi Menju, Makoto Sonobe, Hideaki Kakeya, Masakazu Toi, Hiroshi Date, Ester M. Hammond, Masahiro Hiraoka, Hiroshi Harada |
UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α. Nat Commun. |
UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α. Nat Commun. |
UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1 alpha |
Nature Communications, 6, 6, 6153 |
Nature Communications, 6, 6, 6153 |
Nature Communications, 6, 6, 6153 |
2015/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Takayuki Ueno, Jun Utsumi, Masakazu Toi, Kazuharu Shimizu |
Takayuki Ueno, Jun Utsumi, Masakazu Toi, Kazuharu Shimizu |
Takayuki Ueno, Jun Utsumi, Masakazu Toi, Kazuharu Shimizu |
Characteristic Gene Expression Profiles of Human Fibroblasts and Breast Cancer Cells in a Newly Developed Bilateral Coculture System |
Characteristic Gene Expression Profiles of Human Fibroblasts and Breast Cancer Cells in a Newly Developed Bilateral Coculture System |
Characteristic Gene Expression Profiles of Human Fibroblasts and Breast Cancer Cells in a Newly Developed Bilateral Coculture System |
BIOMED RESEARCH INTERNATIONAL, 11 |
BIOMED RESEARCH INTERNATIONAL, 11 |
BIOMED RESEARCH INTERNATIONAL, 11 |
2015 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masakazu Toi, Eric P. Winer, John R. Benson, Takashi Inamoto, John F. Forbes, Gunter von Minckwitz, John F. R. Robertson, Stephen R. Grobmyer, Ismail Jatoi, Hironobu Sasano, Ian Kunkler, Alice Y. Ho, Chikako Yamauchi, Louis W. C. Chow, Chiun-Sheng Huang, Wonshik Han, Shinzaburo Noguchi, Mark D. Pegram, Hideko Yamauchi, Eun-Sook Lee, Alexey A. Larionov, Jose L. B. Bevilacqua, Michio Yoshimura, Tomoharu Sugie, Akira Yamauchi, Ian E. Krop, Dong Young Noh, V. Suzanne Klimberg |
Masakazu Toi, Eric P. Winer, John R. Benson, Takashi Inamoto, John F. Forbes, Gunter von Minckwitz, John F. R. Robertson, Stephen R. Grobmyer, Ismail Jatoi, Hironobu Sasano, Ian Kunkler, Alice Y. Ho, Chikako Yamauchi, Louis W. C. Chow, Chiun-Sheng Huang, Wonshik Han, Shinzaburo Noguchi, Mark D. Pegram, Hideko Yamauchi, Eun-Sook Lee, Alexey A. Larionov, Jose L. B. Bevilacqua, Michio Yoshimura, Tomoharu Sugie, Akira Yamauchi, Ian E. Krop, Dong Young Noh, V. Suzanne Klimberg |
Masakazu Toi, Eric P. Winer, John R. Benson, Takashi Inamoto, John F. Forbes, Gunter von Minckwitz, John F. R. Robertson, Stephen R. Grobmyer, Ismail Jatoi, Hironobu Sasano, Ian Kunkler, Alice Y. Ho, Chikako Yamauchi, Louis W. C. Chow, Chiun-Sheng Huang, Wonshik Han, Shinzaburo Noguchi, Mark D. Pegram, Hideko Yamauchi, Eun-Sook Lee, Alexey A. Larionov, Jose L. B. Bevilacqua, Michio Yoshimura, Tomoharu Sugie, Akira Yamauchi, Ian E. Krop, Dong Young Noh, V. Suzanne Klimberg |
Personalization of loco-regional care for primary breast cancer patients (part 1) |
Personalization of loco-regional care for primary breast cancer patients (part 1) |
Personalization of loco-regional care for primary breast cancer patients (part 1) |
FUTURE ONCOLOGY, 11, 9, 1297-1300 |
FUTURE ONCOLOGY, 11, 9, 1297-1300 |
FUTURE ONCOLOGY, 11, 9, 1297-1300 |
2015 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masakazu Toi, Eric P. Winer, John R. Benson, Takashi Inamoto, John F. Forbes, Gunter von Minckwitz, John F. R. Robertson, Stephen R. Grobmyer, Ismail Jatoi, Hironobu Sasano, Ian Kunkler, Alice Y. Ho, Chikako Yamauchi, Louis W. C. Chow, Chiun-Sheng Huang, Wonshik Han, Shinzaburo Noguchi, Mark D. Pegram, Hideko Yamauchi, Eun-Sook Lee, Alexey A. Larionov, Jose L. B. Bevilacqua, Michio Yoshimura, Tomoharu Sugie, Akira Yamauchi, Ian E. Krop, Dong Young Noh, V. Suzanne Klimberg |
Masakazu Toi, Eric P. Winer, John R. Benson, Takashi Inamoto, John F. Forbes, Gunter von Minckwitz, John F. R. Robertson, Stephen R. Grobmyer, Ismail Jatoi, Hironobu Sasano, Ian Kunkler, Alice Y. Ho, Chikako Yamauchi, Louis W. C. Chow, Chiun-Sheng Huang, Wonshik Han, Shinzaburo Noguchi, Mark D. Pegram, Hideko Yamauchi, Eun-Sook Lee, Alexey A. Larionov, Jose L. B. Bevilacqua, Michio Yoshimura, Tomoharu Sugie, Akira Yamauchi, Ian E. Krop, Dong Young Noh, V. Suzanne Klimberg |
Masakazu Toi, Eric P. Winer, John R. Benson, Takashi Inamoto, John F. Forbes, Gunter von Minckwitz, John F. R. Robertson, Stephen R. Grobmyer, Ismail Jatoi, Hironobu Sasano, Ian Kunkler, Alice Y. Ho, Chikako Yamauchi, Louis W. C. Chow, Chiun-Sheng Huang, Wonshik Han, Shinzaburo Noguchi, Mark D. Pegram, Hideko Yamauchi, Eun-Sook Lee, Alexey A. Larionov, Jose L. B. Bevilacqua, Michio Yoshimura, Tomoharu Sugie, Akira Yamauchi, Ian E. Krop, Dong Young Noh, V. Suzanne Klimberg |
Personalization of loco-regional care for primary breast cancer patients (part 2) |
Personalization of loco-regional care for primary breast cancer patients (part 2) |
Personalization of loco-regional care for primary breast cancer patients (part 2) |
FUTURE ONCOLOGY, 11, 9, 1301-1305 |
FUTURE ONCOLOGY, 11, 9, 1301-1305 |
FUTURE ONCOLOGY, 11, 9, 1301-1305 |
2015 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Hirofumi Mukai, Shinzaburo Noguchi, Futoshi Akiyama, Hideo Inaji, Hirotaka Iwase, Jun Horiguchi, Junichi Kurebayashi, Koichi Hirata, Masakazu Toi, Masafumi Kurosumi, Norio Kohno, Reiki Nishimura, Seigo Nakamura, Shigeru Imoto, Takuji Iwase, Tokiko Endo, Toshiaki Saeki, Yasuhiro Ogawa, Yoshinori Ito, Yutaka Tokuda, Tadashi Ikeda |
Hirofumi Mukai, Shinzaburo Noguchi, Futoshi Akiyama, Hideo Inaji, Hirotaka Iwase, Jun Horiguchi, Junichi Kurebayashi, Koichi Hirata, Masakazu Toi, Masafumi Kurosumi, Norio Kohno, Reiki Nishimura, Seigo Nakamura, Shigeru Imoto, Takuji Iwase, Tokiko Endo, Toshiaki Saeki, Yasuhiro Ogawa, Yoshinori Ito, Yutaka Tokuda, Tadashi Ikeda |
Hirofumi Mukai, Shinzaburo Noguchi, Futoshi Akiyama, Hideo Inaji, Hirotaka Iwase, Jun Horiguchi, Junichi Kurebayashi, Koichi Hirata, Masakazu Toi, Masafumi Kurosumi, Norio Kohno, Reiki Nishimura, Seigo Nakamura, Shigeru Imoto, Takuji Iwase, Tokiko Endo, Toshiaki Saeki, Yasuhiro Ogawa, Yoshinori Ito, Yutaka Tokuda, Tadashi Ikeda |
2013 clinical practice guidelines (The Japanese Breast Cancer Society): history, policy and mission |
2013 clinical practice guidelines (The Japanese Breast Cancer Society): history, policy and mission |
2013 clinical practice guidelines (The Japanese Breast Cancer Society): history, policy and mission |
BREAST CANCER, 22, 1, 1-4 |
BREAST CANCER, 22, 1, 1-4 |
BREAST CANCER, 22, 1, 1-4 |
2015/01 |
有 |
英語 |
|
公開 |
| Junji Itou, Sunao Tanaka, Fumiaki Sato, Ryutaro Akiyama, Yasuhiko Kawakami, Masakazu Toi |
Junji Itou, Sunao Tanaka, Fumiaki Sato, Ryutaro Akiyama, Yasuhiko Kawakami, Masakazu Toi |
Junji Itou, Sunao Tanaka, Fumiaki Sato, Ryutaro Akiyama, Yasuhiko Kawakami, Masakazu Toi |
An optical labeling-based proliferation assay system reveals the paracrine effect of interleukin-6 in breast cancer |
An optical labeling-based proliferation assay system reveals the paracrine effect of interleukin-6 in breast cancer |
An optical labeling-based proliferation assay system reveals the paracrine effect of interleukin-6 in breast cancer |
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1853, 1, 27-40 |
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1853, 1, 27-40 |
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1853, 1, 27-40 |
2015/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Ran Ito, Naoki Morimoto, Pham Hieu Liem, Yoko Nakamura, Katsuya Kawai, Tsuguyoshi Taira, Wakako Tsuji, Masakazu Toi, Shigehiko Suzuki |
Ran Ito, Naoki Morimoto, Pham Hieu Liem, Yoko Nakamura, Katsuya Kawai, Tsuguyoshi Taira, Wakako Tsuji, Masakazu Toi, Shigehiko Suzuki |
Ran Ito, Naoki Morimoto, Pham Hieu Liem, Yoko Nakamura, Katsuya Kawai, Tsuguyoshi Taira, Wakako Tsuji, Masakazu Toi, Shigehiko Suzuki |
Adipogenesis using human adipose tissue-derived stromal cells combined with a collagen/gelatin sponge sustaining release of basic fibroblast growth factor |
Adipogenesis using human adipose tissue-derived stromal cells combined with a collagen/gelatin sponge sustaining release of basic fibroblast growth factor |
Adipogenesis using human adipose tissue-derived stromal cells combined with a collagen/gelatin sponge sustaining release of basic fibroblast growth factor |
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 8, 12, 1000-1008 |
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 8, 12, 1000-1008 |
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 8, 12, 1000-1008 |
2014/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Eriko Sumi, Tomoharu Sugie, Kenichi Yoshimura, Harue Tada, Takafumi Ikeda, Eiji Suzuki, Yoshimasa Tanaka, Satoshi Teramukai, Akira Shimizu, Masakazu Toi, Nagahiro Minato |
|
Eriko Sumi, Tomoharu Sugie, Kenichi Yoshimura, Harue Tada, Takafumi Ikeda, Eiji Suzuki, Yoshimasa Tanaka, Satoshi Teramukai, Akira Shimizu, Masakazu Toi, Nagahiro Minato |
Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol. |
Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol. |
Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol. |
J Transl Med, 12, 12, 310-310 |
J Transl Med, 12, 12, 310-310 |
Journal of translational medicine, 12, 12, 310-310 |
2014/11/25 |
有 |
英語 |
|
公開 |
| Nishimura T, Ishiguro H, Kawaguchi K, Sigie T, Tokiwa M, Takeuchi M, Toi M |
Nishimura T, Ishiguro H, Kawaguchi K, Sigie T, Tokiwa M, Takeuchi M, Toi M |
Nishimura T, Ishiguro H, Kawaguchi K, Sigie T, Tokiwa M, Takeuchi M, Toi M |
Prevention of Chemotherapy-Induced Nausea and Vomiting by Olanzapine in Japanese Female patients with Early Breast Cancer who had Poor Control with the Standard Antiemetic Regimen |
Prevention of Chemotherapy-Induced Nausea and Vomiting by Olanzapine in Japanese Female patients with Early Breast Cancer who had Poor Control with the Standard Antiemetic Regimen |
Prevention of Chemotherapy-Induced Nausea and Vomiting by Olanzapine in Japanese Female patients with Early Breast Cancer who had Poor Control with the Standard Antiemetic Regimen |
Cancer Stud Open Access, 1, 2, 2014 |
Cancer Stud Open Access, 1, 2, 2014 |
Cancer Stud Open Access, 1, 2, 2014 |
2014/10 |
有 |
英語 |
|
公開 |
| Masahiro Sugimoto, Masahiro Takada, Masakazu Toi |
Masahiro Sugimoto, Masahiro Takada, Masakazu Toi |
Masahiro Sugimoto, Masahiro Takada, Masakazu Toi |
Development of Web tools to predict axillary lymph node metastasis and pathological response to neoadjuvant chemotherapy in breast cancer patients |
Development of Web tools to predict axillary lymph node metastasis and pathological response to neoadjuvant chemotherapy in breast cancer patients |
Development of Web tools to predict axillary lymph node metastasis and pathological response to neoadjuvant chemotherapy in breast cancer patients |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 4, E372-E379 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 4, E372-E379 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 4, E372-E379 |
2014/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masahiro Sugimoto, Masahiro Takada, Masakazu Toi |
Masahiro Sugimoto, Masahiro Takada, Masakazu Toi |
Masahiro Sugimoto, Masahiro Takada, Masakazu Toi |
Development of Web tools to predict axillary lymph node metastasis and pathological response to neoadjuvant chemotherapy in breast cancer patients |
Development of Web tools to predict axillary lymph node metastasis and pathological response to neoadjuvant chemotherapy in breast cancer patients |
Development of Web tools to predict axillary lymph node metastasis and pathological response to neoadjuvant chemotherapy in breast cancer patients |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 4, E372-E379 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 4, E372-E379 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 4, E372-E379 |
2014/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Hiroyasu Yamashiro, Masahiro Takada, Eiji Nakatani, Shiro Imai, Akira Yamauchi, Shigeru Tsuyuki, Yasuo Matsutani, Shingo Sakata, Yasuo Wada, Ryuji Okamura, Tomika Harada, Fumie Tanaka, Yoshio Moriguchi, Hironori Kato, Shunichi Higashide, Norimichi Kan, Hiroshi Yoshibayashi, Hirofumi Suwa, Takashi Okino, Ichiro Nakayama, You Ichinose, Kazuhiko Yamagami, Takashi Hashimoto, Takashi Inamoto, Masakazu Toi |
Hiroyasu Yamashiro, Masahiro Takada, Eiji Nakatani, Shiro Imai, Akira Yamauchi, Shigeru Tsuyuki, Yasuo Matsutani, Shingo Sakata, Yasuo Wada, Ryuji Okamura, Tomika Harada, Fumie Tanaka, Yoshio Moriguchi, Hironori Kato, Shunichi Higashide, Norimichi Kan, Hiroshi Yoshibayashi, Hirofumi Suwa, Takashi Okino, Ichiro Nakayama, You Ichinose, Kazuhiko Yamagami, Takashi Hashimoto, Takashi Inamoto, Masakazu Toi |
Hiroyasu Yamashiro, Masahiro Takada, Eiji Nakatani, Shiro Imai, Akira Yamauchi, Shigeru Tsuyuki, Yasuo Matsutani, Shingo Sakata, Yasuo Wada, Ryuji Okamura, Tomika Harada, Fumie Tanaka, Yoshio Moriguchi, Hironori Kato, Shunichi Higashide, Norimichi Kan, Hiroshi Yoshibayashi, Hirofumi Suwa, Takashi Okino, Ichiro Nakayama, You Ichinose, Kazuhiko Yamagami, Takashi Hashimoto, Takashi Inamoto, Masakazu Toi |
Prevalence and risk factors of bone metastasis and skeletal related events in patients with primary breast cancer in Japan |
Prevalence and risk factors of bone metastasis and skeletal related events in patients with primary breast cancer in Japan |
Prevalence and risk factors of bone metastasis and skeletal related events in patients with primary breast cancer in Japan |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 5, 852-862 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 5, 852-862 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 5, 852-862 |
2014/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| N. Masuda, K. Higaki, T. Takano, N. Matsunami, T. Morimoto, S. Ohtani, M. Mizutani, T. Miyamoto, K. Kuroi, S. Ohno, S. Morita, M. Toi |
N. Masuda, K. Higaki, T. Takano, N. Matsunami, T. Morimoto, S. Ohtani, M. Mizutani, T. Miyamoto, K. Kuroi, S. Ohno, S. Morita, M. Toi |
N. Masuda, K. Higaki, T. Takano, N. Matsunami, T. Morimoto, S. Ohtani, M. Mizutani, T. Miyamoto, K. Kuroi, S. Ohno, S. Morita, M. Toi |
A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer |
A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer |
A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 74, 2, 229-238 |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 74, 2, 229-238 |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 74, 2, 229-238 |
2014/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Kanae Kawai Miyake, Yuji Nakamoto, Shotaro Kanao, Shiro Tanaka, Tomoharu Sugie, Yoshiki Mikami, Masakazu Toi, Kaori Togashi |
Kanae Kawai Miyake, Yuji Nakamoto, Shotaro Kanao, Shiro Tanaka, Tomoharu Sugie, Yoshiki Mikami, Masakazu Toi, Kaori Togashi |
Kanae Kawai Miyake, Yuji Nakamoto, Shotaro Kanao, Shiro Tanaka, Tomoharu Sugie, Yoshiki Mikami, Masakazu Toi, Kaori Togashi |
Diagnostic Value of F-18-FDG PET/CT and MRI in Predicting the Clinicopathologic Subtypes of Invasive Breast Cancer |
Diagnostic Value of F-18-FDG PET/CT and MRI in Predicting the Clinicopathologic Subtypes of Invasive Breast Cancer |
Diagnostic Value of F-18-FDG PET/CT and MRI in Predicting the Clinicopathologic Subtypes of Invasive Breast Cancer |
AMERICAN JOURNAL OF ROENTGENOLOGY, 203, 2, 272-279 |
AMERICAN JOURNAL OF ROENTGENOLOGY, 203, 2, 272-279 |
AMERICAN JOURNAL OF ROENTGENOLOGY, 203, 2, 272-279 |
2014/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Ueno, Takayuki, Masuda, Norikazu, Yamanaka, Takeharu, Saji, Shigehira, Kuroi, Katsumasa, Sato, Nobuaki, Takei, Hiroyuki, Yamamoto, Yutaka, Ohno, Shinji, Yamashita, Hiroko, Hisamatsu, Kazufumi, Aogi, Kenjiro, Iwata, Hiroji, Sasano, Hironobu, Toi, Masakazu |
Ueno, Takayuki, Masuda, Norikazu, Yamanaka, Takeharu, Saji, Shigehira, Kuroi, Katsumasa, Sato, Nobuaki, Takei, Hiroyuki, Yamamoto, Yutaka, Ohno, Shinji, Yamashita, Hiroko, Hisamatsu, Kazufumi, Aogi, Kenjiro, Iwata, Hiroji, Sasano, Hironobu, Toi, Masakazu |
Takayuki Ueno, Norikazu Masuda, Takeharu Yamanaka, Shigehira Saji, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Hironobu Sasano, Masakazu Toi |
Evaluating the 21-gene assay Recurrence Score(®) as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer. |
Evaluating the 21-gene assay Recurrence Score(®) as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer. |
Evaluating the 21-gene assay Recurrence Score(A (R)) as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer |
International journal of clinical oncology, 19, 4, 607-613 |
International journal of clinical oncology, 19, 4, 607-613 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 4, 607-613 |
2014/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Takuwa H, Ueno T, Ishiguro H, Mikami Y, Kanao S, Takada M, Sugie T, Toi M |
Takuwa H, Ueno T, Ishiguro H, Mikami Y, Kanao S, Takada M, Sugie T, Toi M |
Takuwa H, Ueno T, Ishiguro H, Mikami Y, Kanao S, Takada M, Sugie T, Toi M |
A case of metaplastic breast cancer that showed a good response to platinum-based preoperative chemotherapy |
A case of metaplastic breast cancer that showed a good response to platinum-based preoperative chemotherapy |
A case of metaplastic breast cancer that showed a good response to platinum-based preoperative chemotherapy |
Breast Cancer, 21, 4, 504-507 |
Breast Cancer, 21, 4, 504-507 |
Breast Cancer, 21, 4, 504-507 |
2014/07 |
有 |
英語 |
|
公開 |
| Moe Tsuda, Hiroshi Ishiguro, Ikuko Yano, Masakazu Toi |
Moe Tsuda, Hiroshi Ishiguro, Ikuko Yano, Masakazu Toi |
Moe Tsuda, Hiroshi Ishiguro, Ikuko Yano, Masakazu Toi |
RE: Denosumab for Patients With Persistent or Relapsed Hypercalcemia of Malignancy Despite Recent Bisphosphonate Treatment |
RE: Denosumab for Patients With Persistent or Relapsed Hypercalcemia of Malignancy Despite Recent Bisphosphonate Treatment |
RE: Denosumab for Patients With Persistent or Relapsed Hypercalcemia of Malignancy Despite Recent Bisphosphonate Treatment |
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 106, 7 |
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 106, 7 |
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 106, 7 |
2014/07 |
有 |
英語 |
|
公開 |
| Elham Fakhrejahani, Yasufumi Asao, Masakazu Toi |
Elham Fakhrejahani, Yasufumi Asao, Masakazu Toi |
Elham Fakhrejahani, Yasufumi Asao, Masakazu Toi |
Tumor microvasculature characteristics studied by image analysis: Histologically-driven angiogenic profile |
Tumor microvasculature characteristics studied by image analysis: Histologically-driven angiogenic profile |
Tumor microvasculature characteristics studied by image analysis: Histologically-driven angiogenic profile |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 3, E204-E207 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 3, E204-E207 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 29, 3, E204-E207 |
2014/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Wakako Tsuji, Hiroshi Ishiguro, Sunao Tanaka, Megumi Takeuchi, Takayuki Ueno, Masakazu Toi |
Wakako Tsuji, Hiroshi Ishiguro, Sunao Tanaka, Megumi Takeuchi, Takayuki Ueno, Masakazu Toi |
Wakako Tsuji, Hiroshi Ishiguro, Sunao Tanaka, Megumi Takeuchi, Takayuki Ueno, Masakazu Toi |
Orally administered S-1 suppresses circulating endothelial cell counts in metastatic breast cancer patients |
Orally administered S-1 suppresses circulating endothelial cell counts in metastatic breast cancer patients |
Orally administered S-1 suppresses circulating endothelial cell counts in metastatic breast cancer patients |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 3, 452-459 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 3, 452-459 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 19, 3, 452-459 |
2014/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Saji Shigehira, Toi Masakazu, Ishikawa Takashi, Ishida Takanori, Ohtani Shoichiro, Kashiwaba Masahiro, Sagara Yasuaki, Nagai Shigenori E, Hasegawa Yoshie, Fujisawa Tomomi, Masuda Norikazu, Matsumoto Koji, Yamamoto Yutaka, Yoshibayashi Hiroshi, Taira Naruto, Morita Satoshi, Ohno Shinji |
Saji Shigehira, Toi Masakazu, Ishikawa Takashi, Ishida Takanori, Ohtani Shoichiro, Kashiwaba Masahiro, Sagara Yasuaki, Nagai Shigenori E, Hasegawa Yoshie, Fujisawa Tomomi, Masuda Norikazu, Matsumoto Koji, Yamamoto Yutaka, Yoshibayashi Hiroshi, Taira Naruto, Morita Satoshi, Ohno Shinji |
Saji Shigehira, Toi Masakazu, Ishikawa Takashi, Ishida Takanori, Ohtani Shoichiro, Kashiwaba Masahiro, Sagara Yasuaki, Nagai Shigenori E, Hasegawa Yoshie, Fujisawa Tomomi, Masuda Norikazu, Matsumoto Koji, Yamamoto Yutaka, Yoshibayashi Hiroshi, Taira Naruto, Morita Satoshi, Ohno Shinji |
Bevacizumah plus paclitaxel optimization study with interventional maintenance endocrine therapy in advanced or metastatic ER-positive HER2-negative breast cancer: JBCRG-M04 (BOOSTER) trial |
Bevacizumah plus paclitaxel optimization study with interventional maintenance endocrine therapy in advanced or metastatic ER-positive HER2-negative breast cancer: JBCRG-M04 (BOOSTER) trial |
Bevacizumah plus paclitaxel optimization study with interventional maintenance endocrine therapy in advanced or metastatic ER-positive HER2-negative breast cancer: JBCRG-M04 (BOOSTER) trial |
JOURNAL OF CLINICAL ONCOLOGY, 32, 15 |
JOURNAL OF CLINICAL ONCOLOGY, 32, 15 |
JOURNAL OF CLINICAL ONCOLOGY, 32, 15 |
2014/05/20 |
有 |
|
|
公開 |
| Fabrice Andre, Ruth O'Regan, Mustafa Ozguroglu, Masakazu Toi, Binghe Xu, Guy Jerusalem, Norikazu Masuda, Sharon Wilks, Francis Arena, Claudine Isaacs, Yoon-Sim Yap, Zsuzsanna Papai, Istvan Lang, Anne Armstrong, Guillermo Lerzo, Michelle White, Kunwei Shen, Jennifer Litton, David Chen, Yufen Zhang, Shyanne Ali, Tetiana Taran, Luca Gianni |
Fabrice Andre, Ruth O'Regan, Mustafa Ozguroglu, Masakazu Toi, Binghe Xu, Guy Jerusalem, Norikazu Masuda, Sharon Wilks, Francis Arena, Claudine Isaacs, Yoon-Sim Yap, Zsuzsanna Papai, Istvan Lang, Anne Armstrong, Guillermo Lerzo, Michelle White, Kunwei Shen, Jennifer Litton, David Chen, Yufen Zhang, Shyanne Ali, Tetiana Taran, Luca Gianni |
Fabrice Andre, Ruth O'Regan, Mustafa Ozguroglu, Masakazu Toi, Binghe Xu, Guy Jerusalem, Norikazu Masuda, Sharon Wilks, Francis Arena, Claudine Isaacs, Yoon-Sim Yap, Zsuzsanna Papai, Istvan Lang, Anne Armstrong, Guillermo Lerzo, Michelle White, Kunwei Shen, Jennifer Litton, David Chen, Yufen Zhang, Shyanne Ali, Tetiana Taran, Luca Gianni |
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial |
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial |
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial |
LANCET ONCOLOGY, 15, 6, 580-591 |
LANCET ONCOLOGY, 15, 6, 580-591 |
LANCET ONCOLOGY, 15, 6, 580-591 |
2014/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Takada, H. Ishiguro, S. Nagai, S. Ohtani, H. Kawabata, Y. Yanagita, Y. Hozumi, C. Shimizu, S. Takao, N. Sato, Y. Kosaka, Y. Sagara, H. Iwata, S. Ohno, K. Kuroi, N. Masuda, H. Yamashiro, M. Sugimoto, M. Kondo, Y. Naito, H. Sasano, T. Inamoto, S. Morita, M. Toi |
M. Takada, H. Ishiguro, S. Nagai, S. Ohtani, H. Kawabata, Y. Yanagita, Y. Hozumi, C. Shimizu, S. Takao, N. Sato, Y. Kosaka, Y. Sagara, H. Iwata, S. Ohno, K. Kuroi, N. Masuda, H. Yamashiro, M. Sugimoto, M. Kondo, Y. Naito, H. Sasano, T. Inamoto, S. Morita, M. Toi |
M. Takada, H. Ishiguro, S. Nagai, S. Ohtani, H. Kawabata, Y. Yanagita, Y. Hozumi, C. Shimizu, S. Takao, N. Sato, Y. Kosaka, Y. Sagara, H. Iwata, S. Ohno, K. Kuroi, N. Masuda, H. Yamashiro, M. Sugimoto, M. Kondo, Y. Naito, H. Sasano, T. Inamoto, S. Morita, M. Toi |
Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study) |
Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study) |
Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study) |
BREAST CANCER RESEARCH AND TREATMENT, 145, 1, 143-153 |
BREAST CANCER RESEARCH AND TREATMENT, 145, 1, 143-153 |
BREAST CANCER RESEARCH AND TREATMENT, 145, 1, 143-153 |
2014/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Elham Fakhrejahani, Masakazu Toi |
Elham Fakhrejahani, Masakazu Toi |
Elham Fakhrejahani, Masakazu Toi |
Antiangiogenesis Therapy for Breast Cancer: An Update and Perspectives from Clinical Trials |
Antiangiogenesis Therapy for Breast Cancer: An Update and Perspectives from Clinical Trials |
Antiangiogenesis Therapy for Breast Cancer: An Update and Perspectives from Clinical Trials |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 3, 197-207 |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 3, 197-207 |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44, 3, 197-207 |
2014/03 |
有 |
英語 |
|
公開 |
| Toshiyuki Kitai, Masae Torii, Tomoharu Sugie, Shotaro Kanao, Yoshiki Mikami, Tsuyoshi Shiina, Masakazu Toi |
Toshiyuki Kitai, Masae Torii, Tomoharu Sugie, Shotaro Kanao, Yoshiki Mikami, Tsuyoshi Shiina, Masakazu Toi |
Toshiyuki Kitai, Masae Torii, Tomoharu Sugie, Shotaro Kanao, Yoshiki Mikami, Tsuyoshi Shiina, Masakazu Toi |
Photoacoustic mammography: initial clinical results |
Photoacoustic mammography: initial clinical results |
Photoacoustic mammography: initial clinical results |
BREAST CANCER, 21, 2, 146-153 |
BREAST CANCER, 21, 2, 146-153 |
BREAST CANCER, 21, 2, 146-153 |
2014/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Wakako Tsuji, Satoshi Teramukai, Masaya Ueno, Masakazu Toi, Takashi Inamoto |
Wakako Tsuji, Satoshi Teramukai, Masaya Ueno, Masakazu Toi, Takashi Inamoto |
Wakako Tsuji, Satoshi Teramukai, Masaya Ueno, Masakazu Toi, Takashi Inamoto |
Prognostic factors for survival after first recurrence in breast cancer: a retrospective analysis of 252 recurrent cases at a single institution |
Prognostic factors for survival after first recurrence in breast cancer: a retrospective analysis of 252 recurrent cases at a single institution |
Prognostic factors for survival after first recurrence in breast cancer: a retrospective analysis of 252 recurrent cases at a single institution |
BREAST CANCER, 21, 1, 86-95 |
BREAST CANCER, 21, 1, 86-95 |
BREAST CANCER, 21, 1, 86-95 |
2014/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masakazu Toi, Toshiaki Saeki, Hiroji Iwata, Kenichi Inoue, Yutaka Tokuda, Yasuyuki Sato, Yoshinori Ito, Kenjiro Aogi, Yuichi Takatsuka, Hitoshi Arioka |
Masakazu Toi, Toshiaki Saeki, Hiroji Iwata, Kenichi Inoue, Yutaka Tokuda, Yasuyuki Sato, Yoshinori Ito, Kenjiro Aogi, Yuichi Takatsuka, Hitoshi Arioka |
Masakazu Toi, Toshiaki Saeki, Hiroji Iwata, Kenichi Inoue, Yutaka Tokuda, Yasuyuki Sato, Yoshinori Ito, Kenjiro Aogi, Yuichi Takatsuka, Hitoshi Arioka |
A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance |
A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance |
A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance |
BREAST CANCER, 21, 1, 20-27 |
BREAST CANCER, 21, 1, 20-27 |
BREAST CANCER, 21, 1, 20-27 |
2014/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Mikami Y, Ueno T, Yoshimura K, Tsuda H, Kurosumi M, Masuda S, Horii R, Toi M, Sasano H |
Mikami Y, Ueno T, Yoshimura K, Tsuda H, Kurosumi M, Masuda S, Horii R, Toi M, Sasano H |
Mikami Y, Ueno T, Yoshimura K, Tsuda H, Kurosumi M, Masuda S, Horii R, Toi M, Sasano H |
Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study. |
Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study. |
Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study. |
Cancer science, 104, 11, 1539-1543 |
Cancer science, 104, 11, 1539-1543 |
Cancer science, 104, 11, 1539-1543 |
2013/11 |
有 |
|
|
公開 |
| S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi |
S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi |
S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi |
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil-epirubicin-cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy |
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil-epirubicin-cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy |
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil-epirubicin-cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy |
BREAST CANCER RESEARCH AND TREATMENT, 142, 1, 69-80 |
BREAST CANCER RESEARCH AND TREATMENT, 142, 1, 69-80 |
BREAST CANCER RESEARCH AND TREATMENT, 142, 1, 69-80 |
2013/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Arb-Aroon Lertkhachonsuk, Cheng Har Yip, Thiravud Khuhaprema, Ding-Shinn Chen, Martyn Plummer, Sun Ha Jee, Masakazu Toi, Sarikapan Wilailak |
Arb-Aroon Lertkhachonsuk, Cheng Har Yip, Thiravud Khuhaprema, Ding-Shinn Chen, Martyn Plummer, Sun Ha Jee, Masakazu Toi, Sarikapan Wilailak |
Arb-Aroon Lertkhachonsuk, Cheng Har Yip, Thiravud Khuhaprema, Ding-Shinn Chen, Martyn Plummer, Sun Ha Jee, Masakazu Toi, Sarikapan Wilailak |
Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013 |
Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013 |
Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013 |
LANCET ONCOLOGY, 14, 12, E497-E507 |
LANCET ONCOLOGY, 14, 12, E497-E507 |
LANCET ONCOLOGY, 14, 12, E497-E507 |
2013/11 |
有 |
英語 |
|
公開 |
| S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi |
S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi |
S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi |
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil-epirubicin-cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy |
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil-epirubicin-cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy |
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil-epirubicin-cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy |
BREAST CANCER RESEARCH AND TREATMENT, 142, 1, 69-80 |
BREAST CANCER RESEARCH AND TREATMENT, 142, 1, 69-80 |
BREAST CANCER RESEARCH AND TREATMENT, 142, 1, 69-80 |
2013/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Chiaki Kaga, Akimitsu Takagi, Mitsuyoshi Kano, Shoichi Kado, Ikuo Kato, Masashi Sakai, Kouji Miyazaki, Masanobu Nanno, Fumiyasu Ishikawa, Yasuo Ohashi, Masakazu Toi |
Chiaki Kaga, Akimitsu Takagi, Mitsuyoshi Kano, Shoichi Kado, Ikuo Kato, Masashi Sakai, Kouji Miyazaki, Masanobu Nanno, Fumiyasu Ishikawa, Yasuo Ohashi, Masakazu Toi |
Chiaki Kaga, Akimitsu Takagi, Mitsuyoshi Kano, Shoichi Kado, Ikuo Kato, Masashi Sakai, Kouji Miyazaki, Masanobu Nanno, Fumiyasu Ishikawa, Yasuo Ohashi, Masakazu Toi |
Lactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancer |
Lactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancer |
Lactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancer |
CANCER SCIENCE, 104, 11, 1508-1514 |
CANCER SCIENCE, 104, 11, 1508-1514 |
CANCER SCIENCE, 104, 11, 1508-1514 |
2013/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Yoshiki Mikami, Takayuki Ueno, Kenichi Yoshimura, Hitoshi Tsuda, Masafumi Kurosumi, Shinobu Masuda, Rie Horii, Masakazu Toi, Hironobu Sasano |
Yoshiki Mikami, Takayuki Ueno, Kenichi Yoshimura, Hitoshi Tsuda, Masafumi Kurosumi, Shinobu Masuda, Rie Horii, Masakazu Toi, Hironobu Sasano |
Yoshiki Mikami, Takayuki Ueno, Kenichi Yoshimura, Hitoshi Tsuda, Masafumi Kurosumi, Shinobu Masuda, Rie Horii, Masakazu Toi, Hironobu Sasano |
Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study |
Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study |
Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study |
CANCER SCIENCE, 104, 11, 1539-1543 |
CANCER SCIENCE, 104, 11, 1539-1543 |
CANCER SCIENCE, 104, 11, 1539-1543 |
2013/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masahiro Kawashima, Noriko Iwamoto, Nobuko Kawaguchi-Sakita, Masahiro Sugimoto, Takayuki Ueno, Yoshiki Mikami, Kazuya Terasawa, Taka-Aki Sato, Koichi Tanaka, Kazuharu Shimizu, Masakazu Toi |
Masahiro Kawashima, Noriko Iwamoto, Nobuko Kawaguchi-Sakita, Masahiro Sugimoto, Takayuki Ueno, Yoshiki Mikami, Kazuya Terasawa, Taka-Aki Sato, Koichi Tanaka, Kazuharu Shimizu, Masakazu Toi |
Masahiro Kawashima, Noriko Iwamoto, Nobuko Kawaguchi-Sakita, Masahiro Sugimoto, Takayuki Ueno, Yoshiki Mikami, Kazuya Terasawa, Taka-Aki Sato, Koichi Tanaka, Kazuharu Shimizu, Masakazu Toi |
High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer |
High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer |
High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer |
CANCER SCIENCE, 104, 10, 1372-1379 |
CANCER SCIENCE, 104, 10, 1372-1379 |
CANCER SCIENCE, 104, 10, 1372-1379 |
2013/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Shinji Ohno, Katsumasa Kuroi, Masakazu Toi |
Shinji Ohno, Katsumasa Kuroi, Masakazu Toi |
Shinji Ohno, Katsumasa Kuroi, Masakazu Toi |
An overview of the Japan Breast Cancer Research Group (JBCRG) activities |
An overview of the Japan Breast Cancer Research Group (JBCRG) activities |
An overview of the Japan Breast Cancer Research Group (JBCRG) activities |
BREAST CANCER, 20, 4, 291-295 |
BREAST CANCER, 20, 4, 291-295 |
BREAST CANCER, 20, 4, 291-295 |
2013/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Junji Itou, Yoshiaki Matsumoto, Kiyotsugu Yoshikawa, Masakazu Toi |
Junji Itou, Yoshiaki Matsumoto, Kiyotsugu Yoshikawa, Masakazu Toi |
Junji Itou, Yoshiaki Matsumoto, Kiyotsugu Yoshikawa, Masakazu Toi |
Sal-like 4 (SALL4) suppresses CDH1 expression and maintains cell dispersion in basal-like breast cancer |
Sal-like 4 (SALL4) suppresses CDH1 expression and maintains cell dispersion in basal-like breast cancer |
Sal-like 4 (SALL4) suppresses CDH1 expression and maintains cell dispersion in basal-like breast cancer |
FEBS LETTERS, 587, 18, 3115-3121 |
FEBS LETTERS, 587, 18, 3115-3121 |
FEBS LETTERS, 587, 18, 3115-3121 |
2013/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| A. Goldhirsch, E. P. Winer, A. S. Coates, R. D. Gelber, M. Piccart-Gebhart, B. Thuerlimann, H. -J. Senn |
A. Goldhirsch, E. P. Winer, A. S. Coates, R. D. Gelber, M. Piccart-Gebhart, B. Thuerlimann, H. -J. Senn |
A. Goldhirsch, E. P. Winer, A. S. Coates, R. D. Gelber, M. Piccart-Gebhart, B. Thuerlimann, H. -J. Senn |
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 |
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 |
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 |
ANNALS OF ONCOLOGY, 24, 9, 2206-2223 |
ANNALS OF ONCOLOGY, 24, 9, 2206-2223 |
ANNALS OF ONCOLOGY, 24, 9, 2206-2223 |
2013/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Yasuhiro Suzuki, Toshiaki Saeki, Kenjiro Aogi, Masakazu Toi, Hirofumi Fujii, Kenichi Inoue, Toru Watanabe, Yasuhiro Fujiwara, Yoshinori Ito, Yuichi Takatsuka, Hiroji Iwata, Hitoshi Arioka, Yutaka Tokuda |
Yasuhiro Suzuki, Toshiaki Saeki, Kenjiro Aogi, Masakazu Toi, Hirofumi Fujii, Kenichi Inoue, Toru Watanabe, Yasuhiro Fujiwara, Yoshinori Ito, Yuichi Takatsuka, Hiroji Iwata, Hitoshi Arioka, Yutaka Tokuda |
Yasuhiro Suzuki, Toshiaki Saeki, Kenjiro Aogi, Masakazu Toi, Hirofumi Fujii, Kenichi Inoue, Toru Watanabe, Yasuhiro Fujiwara, Yoshinori Ito, Yuichi Takatsuka, Hiroji Iwata, Hitoshi Arioka, Yutaka Tokuda |
A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane |
A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane |
A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 18, 4, 590-597 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 18, 4, 590-597 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 18, 4, 590-597 |
2013/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Hiroshi Ishiguro, Masakazu Toi |
Hiroshi Ishiguro, Masakazu Toi |
Hiroshi Ishiguro, Masakazu Toi |
Colony-Stimulating Factors for Febrile Neutropenia |
Colony-Stimulating Factors for Febrile Neutropenia |
Colony-Stimulating Factors for Febrile Neutropenia |
NEW ENGLAND JOURNAL OF MEDICINE, 369, 3, 284-284 |
NEW ENGLAND JOURNAL OF MEDICINE, 369, 3, 284-284 |
NEW ENGLAND JOURNAL OF MEDICINE, 369, 3, 284-284 |
2013/07 |
|
英語 |
|
公開 |
| Tomoharu Sugie, Terumasa Sawada, Nobumi Tagaya, Takayuki Kinoshita, Kazuhiko Yamagami, Hirofumi Suwa, Takafumi Ikeda, Kenichi Yoshimura, Miyuki Niimi, Akira Shimizu, Masakazu Toi |
Tomoharu Sugie, Terumasa Sawada, Nobumi Tagaya, Takayuki Kinoshita, Kazuhiko Yamagami, Hirofumi Suwa, Takafumi Ikeda, Kenichi Yoshimura, Miyuki Niimi, Akira Shimizu, Masakazu Toi |
Tomoharu Sugie, Terumasa Sawada, Nobumi Tagaya, Takayuki Kinoshita, Kazuhiko Yamagami, Hirofumi Suwa, Takafumi Ikeda, Kenichi Yoshimura, Miyuki Niimi, Akira Shimizu, Masakazu Toi |
Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer |
Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer |
Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer |
ANNALS OF SURGICAL ONCOLOGY, 20, 7, 2213-2218 |
ANNALS OF SURGICAL ONCOLOGY, 20, 7, 2213-2218 |
ANNALS OF SURGICAL ONCOLOGY, 20, 7, 2213-2218 |
2013/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Anelia Horvath, Suresh Babu Pakala, Prakriti Mudvari, Sirigiri Divijendra Natha Reddy, Kazufumi Ohshiro, Sandra Casimiro, Ricardo Pires, Suzanne A. W. Fuqua, Masakazu Toi, Luis Costa, Sujit S. Nair, Saraswati Sukumar, Rakesh Kumar |
Anelia Horvath, Suresh Babu Pakala, Prakriti Mudvari, Sirigiri Divijendra Natha Reddy, Kazufumi Ohshiro, Sandra Casimiro, Ricardo Pires, Suzanne A. W. Fuqua, Masakazu Toi, Luis Costa, Sujit S. Nair, Saraswati Sukumar, Rakesh Kumar |
Anelia Horvath, Suresh Babu Pakala, Prakriti Mudvari, Sirigiri Divijendra Natha Reddy, Kazufumi Ohshiro, Sandra Casimiro, Ricardo Pires, Suzanne A. W. Fuqua, Masakazu Toi, Luis Costa, Sujit S. Nair, Saraswati Sukumar, Rakesh Kumar |
Novel Insights into Breast Cancer Genetic Variance through RNA Sequencing |
Novel Insights into Breast Cancer Genetic Variance through RNA Sequencing |
Novel Insights into Breast Cancer Genetic Variance through RNA Sequencing |
SCIENTIFIC REPORTS, 3 |
SCIENTIFIC REPORTS, 3 |
SCIENTIFIC REPORTS, 3 |
2013/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masahito Komuro, Kenichi Suzuki, Makoto Kanebako, Takashi Kawahara, Takeshige Otoi, Kenji Kitazato, Toshio Inagi, Kimiko Makino, Masakazu Toi, Hiroshi Terada |
Masahito Komuro, Kenichi Suzuki, Makoto Kanebako, Takashi Kawahara, Takeshige Otoi, Kenji Kitazato, Toshio Inagi, Kimiko Makino, Masakazu Toi, Hiroshi Terada |
Masahito Komuro, Kenichi Suzuki, Makoto Kanebako, Takashi Kawahara, Takeshige Otoi, Kenji Kitazato, Toshio Inagi, Kimiko Makino, Masakazu Toi, Hiroshi Terada |
Novel iontophoretic administration method for local therapy of breast cancer |
Novel iontophoretic administration method for local therapy of breast cancer |
Novel iontophoretic administration method for local therapy of breast cancer |
JOURNAL OF CONTROLLED RELEASE, 168, 3, 298-306 |
JOURNAL OF CONTROLLED RELEASE, 168, 3, 298-306 |
JOURNAL OF CONTROLLED RELEASE, 168, 3, 298-306 |
2013/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| A.S.M. Idrees, T. Sugie, C. Inoue, K. Murata-Hirai, H. Okamura, C.T. Morita, N. Minato, M. Toi, Y. Tanaka |
A.S.M. Idrees, T. Sugie, C. Inoue, K. Murata-Hirai, H. Okamura, C.T. Morita, N. Minato, M. Toi, Y. Tanaka |
|
Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid |
Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid |
|
Cancer Science, 104, 5, 536-542 |
Cancer Science, 104, 5, 536-542 |
, 104, 5, 536-542 |
2013/05 |
有 |
日本語 |
|
公開 |
| Hiroshi Ishiguro, Kosuke Kawaguchi, Tomomi Nishimura, Masakazu Toi |
Hiroshi Ishiguro, Kosuke Kawaguchi, Tomomi Nishimura, Masakazu Toi |
Hiroshi Ishiguro, Kosuke Kawaguchi, Tomomi Nishimura, Masakazu Toi |
Antipsychotics-Containing Regimen As an Alternative to Standard Antiemetics for Delayed Nausea Induced by Highly Emetogenic Chemotherapy |
Antipsychotics-Containing Regimen As an Alternative to Standard Antiemetics for Delayed Nausea Induced by Highly Emetogenic Chemotherapy |
Antipsychotics-Containing Regimen As an Alternative to Standard Antiemetics for Delayed Nausea Induced by Highly Emetogenic Chemotherapy |
JOURNAL OF CLINICAL ONCOLOGY, 31, 10, 1377-1378 |
JOURNAL OF CLINICAL ONCOLOGY, 31, 10, 1377-1378 |
JOURNAL OF CLINICAL ONCOLOGY, 31, 10, 1377-1378 |
2013/04 |
|
英語 |
|
公開 |
| Wenzhao Li, Shigehira Saji, Fumiaki Sato, Makoto Noda, Masakazu Toi |
Wenzhao Li, Shigehira Saji, Fumiaki Sato, Makoto Noda, Masakazu Toi |
Wenzhao Li, Shigehira Saji, Fumiaki Sato, Makoto Noda, Masakazu Toi |
Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects |
Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects |
Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 28, 2, 117-130 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 28, 2, 117-130 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 28, 2, 117-130 |
2013/04 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T. Sugie, K. Murata-Hirai, M. Iwasaki, C.T. Morita, W. Li, H. Okamura, N. Minato, M. Toi, Y. Tanaka |
T. Sugie, K. Murata-Hirai, M. Iwasaki, C.T. Morita, W. Li, H. Okamura, N. Minato, M. Toi, Y. Tanaka |
Tomoharu Sugie, Kaoru Murata-Hirai, Masashi Iwasaki, Craig T. Morita, Wen Li, Haruki Okamura, Nagahiro Minato, Masakazu Toi, Yoshimasa Tanaka |
Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: Effect of IL-18 on helper NK cells |
Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: Effect of IL-18 on helper NK cells |
Zoledronic acid-induced expansion of gamma delta T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells |
Cancer Immunology, Immunotherapy, 62, 4, 677-687 |
Cancer Immunology, Immunotherapy, 62, 4, 677-687 |
CANCER IMMUNOLOGY IMMUNOTHERAPY, 62, 4, 677-687 |
2013/04 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Wakako Tsuji, Takashi Inamoto, Ran Ito, Naoki Morimoto, Yasuhiko Tabata, Masakazu Toi |
Wakako Tsuji, Takashi Inamoto, Ran Ito, Naoki Morimoto, Yasuhiko Tabata, Masakazu Toi |
Wakako Tsuji, Takashi Inamoto, Ran Ito, Naoki Morimoto, Yasuhiko Tabata, Masakazu Toi |
Simple and longstanding adipose tissue engineering in rabbits |
Simple and longstanding adipose tissue engineering in rabbits |
Simple and longstanding adipose tissue engineering in rabbits |
JOURNAL OF ARTIFICIAL ORGANS, 16, 1, 110-114 |
JOURNAL OF ARTIFICIAL ORGANS, 16, 1, 110-114 |
JOURNAL OF ARTIFICIAL ORGANS, 16, 1, 110-114 |
2013/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Louis W. C. Chow, Stewart Y. Tung, Ting-Ying Ng, Seock-Ah Im, Min-Hyuk Lee, Adrian Y. S. Yip, Masakazu Toi, Stefan Glueck |
Louis W. C. Chow, Stewart Y. Tung, Ting-Ying Ng, Seock-Ah Im, Min-Hyuk Lee, Adrian Y. S. Yip, Masakazu Toi, Stefan Glueck |
Louis W. C. Chow, Stewart Y. Tung, Ting-Ying Ng, Seock-Ah Im, Min-Hyuk Lee, Adrian Y. S. Yip, Masakazu Toi, Stefan Glueck |
Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II-III invasive breast cancer: the OOTR-N001 study |
Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II-III invasive breast cancer: the OOTR-N001 study |
Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II-III invasive breast cancer: the OOTR-N001 study |
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 22, 3, 299-307 |
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 22, 3, 299-307 |
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 22, 3, 299-307 |
2013/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| 河口 浩介, 石黒 洋, 戸井 雅和 |
河口 浩介, 石黒 洋, 戸井 雅和 |
|
【キナーゼ阻害薬の新しい展開】 乳癌治療におけるキナーゼ阻害薬の新しい展開 |
【キナーゼ阻害薬の新しい展開】 乳癌治療におけるキナーゼ阻害薬の新しい展開 |
|
BIO Clinica, 28, 1, 28-32 |
BIO Clinica, 28, 1, 28-32 |
, 28, 1, 28-32 |
2013/01 |
|
|
|
公開 |
| Masahiro Sugimoto, Masahiro Takada, Masakazu Toi |
Masahiro Sugimoto, Masahiro Takada, Masakazu Toi |
Masahiro Sugimoto, Masahiro Takada, Masakazu Toi |
Comparison of robustness against missing values of alternative decision tree and multiple logistic regression for predicting clinical data in primary breast cancer |
Comparison of robustness against missing values of alternative decision tree and multiple logistic regression for predicting clinical data in primary breast cancer |
Comparison of robustness against missing values of alternative decision tree and multiple logistic regression for predicting clinical data in primary breast cancer |
2013 35TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 3054-3057 |
2013 35TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 3054-3057 |
2013 35TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 3054-3057 |
2013 |
有 |
英語 |
研究論文(国際会議プロシーディングス) |
公開 |
| Shota Hamada, Shiro Hinotsu, Hiroshi Ishiguro, Masakazu Toi, Koji Kawakami |
Shota Hamada, Shiro Hinotsu, Hiroshi Ishiguro, Masakazu Toi, Koji Kawakami |
Shota Hamada, Shiro Hinotsu, Hiroshi Ishiguro, Masakazu Toi, Koji Kawakami |
Cross-National Comparison of Medical Costs Shared by Payers and Patients: A Study of Postmenopausal Women with Early-Stage Breast Cancer Based on Assumption Case Scenarios and Reimbursement Fees |
Cross-National Comparison of Medical Costs Shared by Payers and Patients: A Study of Postmenopausal Women with Early-Stage Breast Cancer Based on Assumption Case Scenarios and Reimbursement Fees |
Cross-National Comparison of Medical Costs Shared by Payers and Patients: A Study of Postmenopausal Women with Early-Stage Breast Cancer Based on Assumption Case Scenarios and Reimbursement Fees |
BREAST CARE, 8, 4, 282-288 |
BREAST CARE, 8, 4, 282-288 |
BREAST CARE, 8, 4, 282-288 |
2013 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Toi, S. Hirota, A. Tomotaki, N. Sato, Y. Hozumi, K. Anan, T. Nagashima, Y. Tokuda, N. Masuda, S. Ohsumi, S. Ohno, M. Takahashi, H. Hayashi, S. Yamamoto, Y. Ohashi |
M. Toi, S. Hirota, A. Tomotaki, N. Sato, Y. Hozumi, K. Anan, T. Nagashima, Y. Tokuda, N. Masuda, S. Ohsumi, S. Ohno, M. Takahashi, H. Hayashi, S. Yamamoto, Y. Ohashi |
M. Toi, S. Hirota, A. Tomotaki, N. Sato, Y. Hozumi, K. Anan, T. Nagashima, Y. Tokuda, N. Masuda, S. Ohsumi, S. Ohno, M. Takahashi, H. Hayashi, S. Yamamoto, Y. Ohashi |
Probiotic beverage with soy isoflavone consumption for breast cancer prevention: A case-control study |
Probiotic beverage with soy isoflavone consumption for breast cancer prevention: A case-control study |
Probiotic beverage with soy isoflavone consumption for breast cancer prevention: A case-control study |
Current Nutrition and Food Science, 9, 3, 194-200 |
Current Nutrition and Food Science, 9, 3, 194-200 |
Current Nutrition and Food Science, 9, 3, 194-200 |
2013 |
有 |
英語 |
|
公開 |
| R. Kumar, A. Horvath, R. Mazumder, M. Toi, F. Sato, M.R. Pillai, L. Costa, M. Carmo-Fonseca, S. Knapp, A. Dutt, S. Gupta, R. Badwe |
R. Kumar, A. Horvath, R. Mazumder, M. Toi, F. Sato, M.R. Pillai, L. Costa, M. Carmo-Fonseca, S. Knapp, A. Dutt, S. Gupta, R. Badwe |
R. Kumar, A. Horvath, R. Mazumder, M. Toi, F. Sato, M.R. Pillai, L. Costa, M. Carmo-Fonseca, S. Knapp, A. Dutt, S. Gupta, R. Badwe |
The Global Cancer Genomics Consortium\\'s Second Annual Symposium: Genomics Medicine in Cancer Research |
The Global Cancer Genomics Consortium\\'s Second Annual Symposium: Genomics Medicine in Cancer Research |
The Global Cancer Genomics Consortium\\'s Second Annual Symposium: Genomics Medicine in Cancer Research |
Genes and Cancer, 4, 5-6, 196-200 |
Genes and Cancer, 4, 5-6, 196-200 |
Genes and Cancer, 4, 5-6, 196-200 |
2013 |
有 |
英語 |
|
公開 |
| D. Cameron, J. Brown, R. Dent, C. Jackisch, J. Mackey, X. Pivot, G.G. Steger, T.M. Suter, M. Toi, M. Parmar, R. Laeufle, Y.-H. Im, G. Romieu, V. Harvey, O. Lipatov, T. Pienkowski, P. Cottu, A. Chan, S.-A. Im, P.S. Hall, L. Bubuteishvili-Pacaud, V. Henschel, R.J. Deurloo, C. Pallaud, R. Bell |
D. Cameron, J. Brown, R. Dent, C. Jackisch, J. Mackey, X. Pivot, G.G. Steger, T.M. Suter, M. Toi, M. Parmar, R. Laeufle, Y.-H. Im, G. Romieu, V. Harvey, O. Lipatov, T. Pienkowski, P. Cottu, A. Chan, S.-A. Im, P.S. Hall, L. Bubuteishvili-Pacaud, V. Henschel, R.J. Deurloo, C. Pallaud, R. Bell |
D. Cameron, J. Brown, R. Dent, C. Jackisch, J. Mackey, X. Pivot, G.G. Steger, T.M. Suter, M. Toi, M. Parmar, R. Laeufle, Y.-H. Im, G. Romieu, V. Harvey, O. Lipatov, T. Pienkowski, P. Cottu, A. Chan, S.-A. Im, P.S. Hall, L. Bubuteishvili-Pacaud, V. Henschel, R.J. Deurloo, C. Pallaud, R. Bell |
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): Primary results of a randomised, phase 3 trial |
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): Primary results of a randomised, phase 3 trial |
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): Primary results of a randomised, phase 3 trial |
The Lancet Oncology, 14, 10, 933-942 |
The Lancet Oncology, 14, 10, 933-942 |
The Lancet Oncology, 14, 10, 933-942 |
2013 |
有 |
英語 |
|
公開 |
| B. Zheng, R. Ishikawa, J. Takamatsu, K. Ikeuchi, T. Endo, K. Sato, T. Ueno, T. Sugie, M. Toi, S. Kanao, K. Togashi |
B. Zheng, R. Ishikawa, J. Takamatsu, K. Ikeuchi, T. Endo, K. Sato, T. Ueno, T. Sugie, M. Toi, S. Kanao, K. Togashi |
B. Zheng, R. Ishikawa, J. Takamatsu, K. Ikeuchi, T. Endo, K. Sato, T. Ueno, T. Sugie, M. Toi, S. Kanao, K. Togashi |
Breast MR Image fusion by deformable implicit polynomial (DIP) |
Breast MR Image fusion by deformable implicit polynomial (DIP) |
Breast MR Image fusion by deformable implicit polynomial (DIP) |
IPSJ Transactions on Computer Vision and Applications, 5, 99-103 |
IPSJ Transactions on Computer Vision and Applications, 5, 99-103 |
IPSJ Transactions on Computer Vision and Applications, 5, 99-103 |
2013 |
有 |
英語 |
|
公開 |
| M. Chan, L. Wang, N. Chanplakorn, K. Tamaki, T. Ueno, M. Toi, W. Loo, L.W.C. Chow, T. Suzuki, H. Sasano |
M. Chan, L. Wang, N. Chanplakorn, K. Tamaki, T. Ueno, M. Toi, W. Loo, L.W.C. Chow, T. Suzuki, H. Sasano |
M. Chan, L. Wang, N. Chanplakorn, K. Tamaki, T. Ueno, M. Toi, W. Loo, L.W.C. Chow, T. Suzuki, H. Sasano |
Author\\'s response |
Author\\'s response |
Author\\'s response |
Expert Opinion on Therapeutic Targets, 17, 1, 106- |
Expert Opinion on Therapeutic Targets, 17, 1, 106- |
Expert Opinion on Therapeutic Targets, 17, 1, 106- |
2013 |
有 |
英語 |
|
公開 |
| 河口 浩介, 石黒 洋, 戸井 雅和 |
河口 浩介, 石黒 洋, 戸井 雅和 |
|
【癌分子標的治療up to date】 乳癌分子標的治療薬の臨床応用 |
【癌分子標的治療up to date】 乳癌分子標的治療薬の臨床応用 |
|
癌の臨床, 58, 6, 321-327 |
癌の臨床, 58, 6, 321-327 |
, 58, 6, 321-327 |
2012/12 |
|
|
|
公開 |
| Koshi Imami, Naoyuki Sugiyama, Haruna Imamura, Masaki Wakabayashi, Masaru Tomita, Masatoshi Taniguchi, Takayuki Ueno, Masakazu Toi, Yasushi Ishihama |
Koshi Imami, Naoyuki Sugiyama, Haruna Imamura, Masaki Wakabayashi, Masaru Tomita, Masatoshi Taniguchi, Takayuki Ueno, Masakazu Toi, Yasushi Ishihama |
Koshi Imami, Naoyuki Sugiyama, Haruna Imamura, Masaki Wakabayashi, Masaru Tomita, Masatoshi Taniguchi, Takayuki Ueno, Masakazu Toi, Yasushi Ishihama |
Temporal Profiling of Lapatinib-suppressed Phosphorylation Signals in EGFR/HER2 Pathways |
Temporal Profiling of Lapatinib-suppressed Phosphorylation Signals in EGFR/HER2 Pathways |
Temporal Profiling of Lapatinib-suppressed Phosphorylation Signals in EGFR/HER2 Pathways |
MOLECULAR & CELLULAR PROTEOMICS, 11, 12, 1741-1757 |
MOLECULAR & CELLULAR PROTEOMICS, 11, 12, 1741-1757 |
MOLECULAR & CELLULAR PROTEOMICS, 11, 12, 1741-1757 |
2012/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masakazu Toi, John R. Benson, Eric P. Winer, John F. Forbes, Gunter von Minckwitz, Mehra Golshan, John F. R. Robertson, Hironobu Sasano, Bernard F. Cole, Louis W. C. Chow, Mark D. Pegram, Wonshik Han, Chiun-Sheng Huang, Tadashi Ikeda, Shotaro Kanao, Eun-Sook Lee, Shinzaburo Noguchi, Shinji Ohno, Ann H. Partridge, Roman Rouzier, Mitsuhiro Tozaki, Tomoharu Sugie, Akira Yamauchi, Takashi Inamoto |
Masakazu Toi, John R. Benson, Eric P. Winer, John F. Forbes, Gunter von Minckwitz, Mehra Golshan, John F. R. Robertson, Hironobu Sasano, Bernard F. Cole, Louis W. C. Chow, Mark D. Pegram, Wonshik Han, Chiun-Sheng Huang, Tadashi Ikeda, Shotaro Kanao, Eun-Sook Lee, Shinzaburo Noguchi, Shinji Ohno, Ann H. Partridge, Roman Rouzier, Mitsuhiro Tozaki, Tomoharu Sugie, Akira Yamauchi, Takashi Inamoto |
Masakazu Toi, John R. Benson, Eric P. Winer, John F. Forbes, Gunter von Minckwitz, Mehra Golshan, John F. R. Robertson, Hironobu Sasano, Bernard F. Cole, Louis W. C. Chow, Mark D. Pegram, Wonshik Han, Chiun-Sheng Huang, Tadashi Ikeda, Shotaro Kanao, Eun-Sook Lee, Shinzaburo Noguchi, Shinji Ohno, Ann H. Partridge, Roman Rouzier, Mitsuhiro Tozaki, Tomoharu Sugie, Akira Yamauchi, Takashi Inamoto |
Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference |
Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference |
Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference |
BREAST CANCER RESEARCH AND TREATMENT, 136, 3, 919-926 |
BREAST CANCER RESEARCH AND TREATMENT, 136, 3, 919-926 |
BREAST CANCER RESEARCH AND TREATMENT, 136, 3, 919-926 |
2012/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Koshi Imami, Naoyuki Sugiyama, Haruna Imamura, Masaki Wakabayashi, Masaru Tomita, Masatoshi Taniguchi, Takayuki Ueno, Masakazu Toi, Yasushi Ishihama |
Koshi Imami, Naoyuki Sugiyama, Haruna Imamura, Masaki Wakabayashi, Masaru Tomita, Masatoshi Taniguchi, Takayuki Ueno, Masakazu Toi, Yasushi Ishihama |
Koshi Imami, Naoyuki Sugiyama, Haruna Imamura, Masaki Wakabayashi, Masaru Tomita, Masatoshi Taniguchi, Takayuki Ueno, Masakazu Toi, Yasushi Ishihama |
Temporal Profiling of Lapatinib-suppressed Phosphorylation Signals in EGFR/HER2 Pathways |
Temporal Profiling of Lapatinib-suppressed Phosphorylation Signals in EGFR/HER2 Pathways |
Temporal Profiling of Lapatinib-suppressed Phosphorylation Signals in EGFR/HER2 Pathways |
MOLECULAR & CELLULAR PROTEOMICS, 11, 12, 1741-1757 |
MOLECULAR & CELLULAR PROTEOMICS, 11, 12, 1741-1757 |
MOLECULAR & CELLULAR PROTEOMICS, 11, 12, 1741-1757 |
2012/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| 石黒 洋, 佐治 重衡, 戸井 雅和 |
石黒 洋, 佐治 重衡, 戸井 雅和 |
|
【分子標的薬-がんから他疾患までの治癒をめざして-】 臨床研究 腫瘍性疾患の分子標的薬 乳がん 分子標的薬の臨床薬理学的特徴 |
【分子標的薬-がんから他疾患までの治癒をめざして-】 臨床研究 腫瘍性疾患の分子標的薬 乳がん 分子標的薬の臨床薬理学的特徴 |
|
日本臨床 (0047-1852)巻刊 Page-, 70, 増刊8, 分子標的薬443-446 |
日本臨床 (0047-1852)巻刊 Page-, 70, 増刊8, 分子標的薬443-446 |
, 70, 増刊8, 分子標的薬443-446 |
2012/11 |
|
|
|
公開 |
| Megumi Takeuchi, Tomoharu Sugie, Kassim Abdelazeem, Hironori Kato, Nobuhiko Shinkura, Masahiro Takada, Hiroyasu Yamashiro, Takayuki Ueno, Masakazu Toi |
Megumi Takeuchi, Tomoharu Sugie, Kassim Abdelazeem, Hironori Kato, Nobuhiko Shinkura, Masahiro Takada, Hiroyasu Yamashiro, Takayuki Ueno, Masakazu Toi |
Megumi Takeuchi, Tomoharu Sugie, Kassim Abdelazeem, Hironori Kato, Nobuhiko Shinkura, Masahiro Takada, Hiroyasu Yamashiro, Takayuki Ueno, Masakazu Toi |
Lymphatic Mapping With Fluorescence Navigation Using Indocyanine Green and Axillary Surgery in Patients With Primary Breast Cancer |
Lymphatic Mapping With Fluorescence Navigation Using Indocyanine Green and Axillary Surgery in Patients With Primary Breast Cancer |
Lymphatic Mapping With Fluorescence Navigation Using Indocyanine Green and Axillary Surgery in Patients With Primary Breast Cancer |
BREAST JOURNAL, 18, 6, 535-541 |
BREAST JOURNAL, 18, 6, 535-541 |
BREAST JOURNAL, 18, 6, 535-541 |
2012/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Sunao Tanaka, Takayuki Ueno, Fumiaki Sato, Yoshitsugu Chigusa, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Noriyoshi Fujisawa, Kenichi Yoshimura, Satoshi Teramukai, Hiroshi Fujiwara, Masatoshi Fujita, Masakazu Toi |
Sunao Tanaka, Takayuki Ueno, Fumiaki Sato, Yoshitsugu Chigusa, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Noriyoshi Fujisawa, Kenichi Yoshimura, Satoshi Teramukai, Hiroshi Fujiwara, Masatoshi Fujita, Masakazu Toi |
Sunao Tanaka, Takayuki Ueno, Fumiaki Sato, Yoshitsugu Chigusa, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Noriyoshi Fujisawa, Kenichi Yoshimura, Satoshi Teramukai, Hiroshi Fujiwara, Masatoshi Fujita, Masakazu Toi |
Alterations of Circulating Endothelial Cell and Endothelial Progenitor Cell Counts around the Ovulation |
Alterations of Circulating Endothelial Cell and Endothelial Progenitor Cell Counts around the Ovulation |
Alterations of Circulating Endothelial Cell and Endothelial Progenitor Cell Counts around the Ovulation |
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 97, 11, 4182-4192 |
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 97, 11, 4182-4192 |
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 97, 11, 4182-4192 |
2012/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Megumi Takeuchi, Tomoharu Sugie, Kassim Abdelazeem, Hironori Kato, Nobuhiko Shinkura, Masahiro Takada, Hiroyasu Yamashiro, Takayuki Ueno, Masakazu Toi |
Megumi Takeuchi, Tomoharu Sugie, Kassim Abdelazeem, Hironori Kato, Nobuhiko Shinkura, Masahiro Takada, Hiroyasu Yamashiro, Takayuki Ueno, Masakazu Toi |
Megumi Takeuchi, Tomoharu Sugie, Kassim Abdelazeem, Hironori Kato, Nobuhiko Shinkura, Masahiro Takada, Hiroyasu Yamashiro, Takayuki Ueno, Masakazu Toi |
Lymphatic Mapping With Fluorescence Navigation Using Indocyanine Green and Axillary Surgery in Patients With Primary Breast Cancer |
Lymphatic Mapping With Fluorescence Navigation Using Indocyanine Green and Axillary Surgery in Patients With Primary Breast Cancer |
Lymphatic Mapping With Fluorescence Navigation Using Indocyanine Green and Axillary Surgery in Patients With Primary Breast Cancer |
BREAST JOURNAL, 18, 6, 535-541 |
BREAST JOURNAL, 18, 6, 535-541 |
BREAST JOURNAL, 18, 6, 535-541 |
2012/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Monica S. M. Chan, Lin Wang, Saulo J. A. Felizola, Takayuki Ueno, Masakazu Toi, W. Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano |
Monica S. M. Chan, Lin Wang, Saulo J. A. Felizola, Takayuki Ueno, Masakazu Toi, W. Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano |
Monica S. M. Chan, Lin Wang, Saulo J. A. Felizola, Takayuki Ueno, Masakazu Toi, W. Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano |
Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients - an immunohistochemical study of cd8+and foxp3+using double immunostaining with correlation to the pathobiological response of the patients |
Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients - an immunohistochemical study of cd8+and foxp3+using double immunostaining with correlation to the pathobiological response of the patients |
Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients - an immunohistochemical study of cd8+and foxp3+using double immunostaining with correlation to the pathobiological response of the patients |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 27, 4, E295-E304 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 27, 4, E295-E304 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 27, 4, E295-E304 |
2012/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Mami Iima, Yuji Nakamoto, Shotaro Kanao, Tomoharu Sugie, Takayuki Ueno, Mayumi Kawada, Yoshiki Mikami, Masakazu Toi, Kaori Togashi |
Mami Iima, Yuji Nakamoto, Shotaro Kanao, Tomoharu Sugie, Takayuki Ueno, Mayumi Kawada, Yoshiki Mikami, Masakazu Toi, Kaori Togashi |
Mami Iima, Yuji Nakamoto, Shotaro Kanao, Tomoharu Sugie, Takayuki Ueno, Mayumi Kawada, Yoshiki Mikami, Masakazu Toi, Kaori Togashi |
Clinical Performance of 2 Dedicated PET Scanners for Breast Imaging: Initial Evaluation |
Clinical Performance of 2 Dedicated PET Scanners for Breast Imaging: Initial Evaluation |
Clinical Performance of 2 Dedicated PET Scanners for Breast Imaging: Initial Evaluation |
JOURNAL OF NUCLEAR MEDICINE, 53, 10, 1534-1542 |
JOURNAL OF NUCLEAR MEDICINE, 53, 10, 1534-1542 |
JOURNAL OF NUCLEAR MEDICINE, 53, 10, 1534-1542 |
2012/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Kazuna Takeda, Shotaro Kanao, Tomohisa Okada, Masako Kataoka, Takayuki Ueno, Masakazu Toi, Hiroshi Ishiguro, Yoshiki Mikami, Kaori Togashi |
Kazuna Takeda, Shotaro Kanao, Tomohisa Okada, Masako Kataoka, Takayuki Ueno, Masakazu Toi, Hiroshi Ishiguro, Yoshiki Mikami, Kaori Togashi |
Kazuna Takeda, Shotaro Kanao, Tomohisa Okada, Masako Kataoka, Takayuki Ueno, Masakazu Toi, Hiroshi Ishiguro, Yoshiki Mikami, Kaori Togashi |
Assessment of CAD-generated tumor volumes measured using MRI in breast cancers before and after neoadjuvant chemotherapy |
Assessment of CAD-generated tumor volumes measured using MRI in breast cancers before and after neoadjuvant chemotherapy |
Assessment of CAD-generated tumor volumes measured using MRI in breast cancers before and after neoadjuvant chemotherapy |
EUROPEAN JOURNAL OF RADIOLOGY, 81, 10, 2627-2631 |
EUROPEAN JOURNAL OF RADIOLOGY, 81, 10, 2627-2631 |
EUROPEAN JOURNAL OF RADIOLOGY, 81, 10, 2627-2631 |
2012/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Louis W. C. Chow, Masakazu Toi |
Louis W. C. Chow, Masakazu Toi |
Louis W. C. Chow, Masakazu Toi |
The clinical trials of the Organisation for Oncology and Translational Research (OOTR) |
The clinical trials of the Organisation for Oncology and Translational Research (OOTR) |
The clinical trials of the Organisation for Oncology and Translational Research (OOTR) |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 27, 4, E353-E356 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 27, 4, E353-E356 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 27, 4, E353-E356 |
2012/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H. Ishiguro, S. Takashima, K. Yoshimura, I. Yano, T. Yamamoto, M. Niimi, H. Yamashiro, T. Ueno, M. Takeuchi, T. Sugie, K. Yanagihara, M. Toi, M. Fukushima |
H. Ishiguro, S. Takashima, K. Yoshimura, I. Yano, T. Yamamoto, M. Niimi, H. Yamashiro, T. Ueno, M. Takeuchi, T. Sugie, K. Yanagihara, M. Toi, M. Fukushima |
H. Ishiguro, S. Takashima, K. Yoshimura, I. Yano, T. Yamamoto, M. Niimi, H. Yamashiro, T. Ueno, M. Takeuchi, T. Sugie, K. Yanagihara, M. Toi, M. Fukushima |
Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients |
Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients |
Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients |
SUPPORTIVE CARE IN CANCER, 20, 9, 2017-2024 |
SUPPORTIVE CARE IN CANCER, 20, 9, 2017-2024 |
SUPPORTIVE CARE IN CANCER, 20, 9, 2017-2024 |
2012/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Kazuna Takeda, Shotaro Kanao, Tomohisa Okada, Takayuki Ueno, Masakazu Toi, Hiroshi Ishiguro, Yoshiki Mikami, Shiro Tanaka, Kaori Togashi |
Kazuna Takeda, Shotaro Kanao, Tomohisa Okada, Takayuki Ueno, Masakazu Toi, Hiroshi Ishiguro, Yoshiki Mikami, Shiro Tanaka, Kaori Togashi |
Kazuna Takeda, Shotaro Kanao, Tomohisa Okada, Takayuki Ueno, Masakazu Toi, Hiroshi Ishiguro, Yoshiki Mikami, Shiro Tanaka, Kaori Togashi |
MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy |
MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy |
MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy |
EUROPEAN JOURNAL OF RADIOLOGY, 81, 9, 2148-2153 |
EUROPEAN JOURNAL OF RADIOLOGY, 81, 9, 2148-2153 |
EUROPEAN JOURNAL OF RADIOLOGY, 81, 9, 2148-2153 |
2012/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H. Ishiguro, S. Takashima, K. Yoshimura, I. Yano, T. Yamamoto, M. Niimi, H. Yamashiro, T. Ueno, M. Takeuchi, T. Sugie, K. Yanagihara, M. Toi, M. Fukushima |
H. Ishiguro, S. Takashima, K. Yoshimura, I. Yano, T. Yamamoto, M. Niimi, H. Yamashiro, T. Ueno, M. Takeuchi, T. Sugie, K. Yanagihara, M. Toi, M. Fukushima |
H. Ishiguro, S. Takashima, K. Yoshimura, I. Yano, T. Yamamoto, M. Niimi, H. Yamashiro, T. Ueno, M. Takeuchi, T. Sugie, K. Yanagihara, M. Toi, M. Fukushima |
Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients |
Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients |
Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients |
SUPPORTIVE CARE IN CANCER, 20, 9, 2017-2024 |
SUPPORTIVE CARE IN CANCER, 20, 9, 2017-2024 |
SUPPORTIVE CARE IN CANCER, 20, 9, 2017-2024 |
2012/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Jeyanthy Eswaran, Sudeep Gupta, Amit Dutt, Masakazu Toi, M. Radhakrishna Pillai, Luis Costa, Stefan Knapp, Rajendra Badwe, Rakesh Kumar |
Jeyanthy Eswaran, Sudeep Gupta, Amit Dutt, Masakazu Toi, M. Radhakrishna Pillai, Luis Costa, Stefan Knapp, Rajendra Badwe, Rakesh Kumar |
Jeyanthy Eswaran, Sudeep Gupta, Amit Dutt, Masakazu Toi, M. Radhakrishna Pillai, Luis Costa, Stefan Knapp, Rajendra Badwe, Rakesh Kumar |
The Global Cancer Genomics Consortium: Interfacing Genomics and Cancer Medicine |
The Global Cancer Genomics Consortium: Interfacing Genomics and Cancer Medicine |
The Global Cancer Genomics Consortium: Interfacing Genomics and Cancer Medicine |
CANCER RESEARCH, 72, 15, 3720-3724 |
CANCER RESEARCH, 72, 15, 3720-3724 |
CANCER RESEARCH, 72, 15, 3720-3724 |
2012/08 |
有 |
英語 |
|
公開 |
| Jeyanthy Eswaran, Sudeep Gupta, Amit Dutt, Masakazu Toi, M. Radhakrishna Pillai, Luis Costa, Stefan Knapp, Rajendra Badwe, Rakesh Kumar |
Jeyanthy Eswaran, Sudeep Gupta, Amit Dutt, Masakazu Toi, M. Radhakrishna Pillai, Luis Costa, Stefan Knapp, Rajendra Badwe, Rakesh Kumar |
Jeyanthy Eswaran, Sudeep Gupta, Amit Dutt, Masakazu Toi, M. Radhakrishna Pillai, Luis Costa, Stefan Knapp, Rajendra Badwe, Rakesh Kumar |
The Global Cancer Genomics Consortium: Interfacing Genomics and Cancer Medicine |
The Global Cancer Genomics Consortium: Interfacing Genomics and Cancer Medicine |
The Global Cancer Genomics Consortium: Interfacing Genomics and Cancer Medicine |
CANCER RESEARCH, 72, 15, 3720-3724 |
CANCER RESEARCH, 72, 15, 3720-3724 |
CANCER RESEARCH, 72, 15, 3720-3724 |
2012/08 |
有 |
英語 |
|
公開 |
| M. Takada, M. Sugimoto, S. Ohno, K. Kuroi, N. Sato, H. Bando, N. Masuda, H. Iwata, M. Kondo, H. Sasano, L. W. C. Chow, T. Inamoto, Y. Naito, M. Tomita, M. Toi |
M. Takada, M. Sugimoto, S. Ohno, K. Kuroi, N. Sato, H. Bando, N. Masuda, H. Iwata, M. Kondo, H. Sasano, L. W. C. Chow, T. Inamoto, Y. Naito, M. Tomita, M. Toi |
M. Takada, M. Sugimoto, S. Ohno, K. Kuroi, N. Sato, H. Bando, N. Masuda, H. Iwata, M. Kondo, H. Sasano, L. W. C. Chow, T. Inamoto, Y. Naito, M. Tomita, M. Toi |
Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique |
Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique |
Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique |
BREAST CANCER RESEARCH AND TREATMENT, 134, 2, 661-670 |
BREAST CANCER RESEARCH AND TREATMENT, 134, 2, 661-670 |
BREAST CANCER RESEARCH AND TREATMENT, 134, 2, 661-670 |
2012/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| 石黒 洋, 戸井雅和 |
石黒 洋, 戸井雅和 |
|
内分泌療法中の日本人乳癌患者において、薬物代謝酵素遺伝子多型が活性薬物血中濃度に及ぼす影響 |
内分泌療法中の日本人乳癌患者において、薬物代謝酵素遺伝子多型が活性薬物血中濃度に及ぼす影響 |
|
臨床薬理の進歩, 33, 9-15 |
臨床薬理の進歩, 33, 9-15 |
, 33, 9-15 |
2012/06 |
|
|
|
公開 |
| Masahiro Takada, Masahiro Sugimoto, Yasuhiro Naito, Hyeong-Gon Moon, Wonshik Han, Dong-Young Noh, Masahide Kondo, Katsumasa Kuroi, Hironobu Sasano, Takashi Inamoto, Masaru Tomita, Masakazu Toi |
Masahiro Takada, Masahiro Sugimoto, Yasuhiro Naito, Hyeong-Gon Moon, Wonshik Han, Dong-Young Noh, Masahide Kondo, Katsumasa Kuroi, Hironobu Sasano, Takashi Inamoto, Masaru Tomita, Masakazu Toi |
Masahiro Takada, Masahiro Sugimoto, Yasuhiro Naito, Hyeong-Gon Moon, Wonshik Han, Dong-Young Noh, Masahide Kondo, Katsumasa Kuroi, Hironobu Sasano, Takashi Inamoto, Masaru Tomita, Masakazu Toi |
Prediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model |
Prediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model |
Prediction of axillary lymph node metastasis in primary breast cancer patients using a decision tree-based model |
BMC MEDICAL INFORMATICS AND DECISION MAKING, 12 |
BMC MEDICAL INFORMATICS AND DECISION MAKING, 12 |
BMC MEDICAL INFORMATICS AND DECISION MAKING, 12 |
2012/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Kondo, S.-L. Hoshi, H. Ishiguro, M. Toi |
M. Kondo, S.-L. Hoshi, H. Ishiguro, M. Toi |
Masahide Kondo, Shu-Ling Hoshi, Hiroshi Ishiguro, Masakazu Toi |
Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan |
Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan |
Economic evaluation of the 70-gene prognosis-signature (MammaPrint(A (R))) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan |
Breast Cancer Research and Treatment, 133, 2, 759-768 |
Breast Cancer Research and Treatment, 133, 2, 759-768 |
BREAST CANCER RESEARCH AND TREATMENT, 133, 2, 759-768 |
2012/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| C. Barrios, J. F. Forbes, W. Jonat, P. Conte, W. Gradishar, A. Buzdar, K. Gelmon, M. Gnant, J. Bonneterre, M. Toi, C. Hudis, J. F. R. Robertson |
C. Barrios, J. F. Forbes, W. Jonat, P. Conte, W. Gradishar, A. Buzdar, K. Gelmon, M. Gnant, J. Bonneterre, M. Toi, C. Hudis, J. F. R. Robertson |
C. Barrios, J. F. Forbes, W. Jonat, P. Conte, W. Gradishar, A. Buzdar, K. Gelmon, M. Gnant, J. Bonneterre, M. Toi, C. Hudis, J. F. R. Robertson |
The sequential use of endocrine treatment for advanced breast cancer: where are we? |
The sequential use of endocrine treatment for advanced breast cancer: where are we? |
The sequential use of endocrine treatment for advanced breast cancer: where are we? |
ANNALS OF ONCOLOGY, 23, 6, 1378-1386 |
ANNALS OF ONCOLOGY, 23, 6, 1378-1386 |
ANNALS OF ONCOLOGY, 23, 6, 1378-1386 |
2012/06 |
有 |
英語 |
|
公開 |
| Yu Tang, Xiangtian Zeng, Fei He, Yonghui Liao, Niansong Qian, Masakazu Toi |
Yu Tang, Xiangtian Zeng, Fei He, Yonghui Liao, Niansong Qian, Masakazu Toi |
Yu Tang, Xiangtian Zeng, Fei He, Yonghui Liao, Niansong Qian, Masakazu Toi |
Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer |
Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer |
Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer |
MEDICAL ONCOLOGY, 29, 2, 977-984 |
MEDICAL ONCOLOGY, 29, 2, 977-984 |
MEDICAL ONCOLOGY, 29, 2, 977-984 |
2012/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| 鈴木 栄治, 佐藤 史顕, 鳥井 雅恵, 藤澤 憲良, 川島 雅央, 川口 展子, 高田 正泰, 辻 和香子, 竹内 恵, 上野 貴之, 杉江 知治, 戸井 雅和 |
鈴木 栄治, 佐藤 史顕, 鳥井 雅恵, 藤澤 憲良, 川島 雅央, 川口 展子, 高田 正泰, 辻 和香子, 竹内 恵, 上野 貴之, 杉江 知治, 戸井 雅和 |
|
Trastuzumabを介した抗体依存性細胞障害活性(ADCC)耐性乳癌細胞株の樹立 |
Trastuzumabを介した抗体依存性細胞障害活性(ADCC)耐性乳癌細胞株の樹立 |
|
日本乳癌学会総会プログラム抄録集, 20回, 255-255 |
日本乳癌学会総会プログラム抄録集, 20回, 255-255 |
, 20回, 255-255 |
2012/05 |
有 |
日本語 |
|
公開 |
| 杉江 知治, 戸井 雅和, 山内 智香子, 石黒 洋, 三上 芳喜, 岡村 隆仁, 加藤 大典, 山内 清明, 稲本 俊 |
杉江 知治, 戸井 雅和, 山内 智香子, 石黒 洋, 三上 芳喜, 岡村 隆仁, 加藤 大典, 山内 清明, 稲本 俊 |
|
【過渡期の家族性腫瘍診療、その現状と展望】 遺伝性・家族性乳がん診療のコンセンサス 多施設アンケート結果から |
【過渡期の家族性腫瘍診療、その現状と展望】 遺伝性・家族性乳がん診療のコンセンサス 多施設アンケート結果から |
|
家族性腫瘍 (1346-1052), 12, 2, 45-49 |
家族性腫瘍 (1346-1052), 12, 2, 45-49 |
, 12, 2, 45-49 |
2012/05 |
|
|
|
公開 |
| Giampietro Gasparini, Francesco Torino, Takayuki Ueno, Stefano Cascinu, Teresa Troiani, Alberto Ballestrero, Rossana Berardi, Junichi Shishido, Akihiko Yoshizawa, Yukiko Mori, Satoshi Nagayama, Paola Morosini, Masakazu Toi |
Giampietro Gasparini, Francesco Torino, Takayuki Ueno, Stefano Cascinu, Teresa Troiani, Alberto Ballestrero, Rossana Berardi, Junichi Shishido, Akihiko Yoshizawa, Yukiko Mori, Satoshi Nagayama, Paola Morosini, Masakazu Toi |
Giampietro Gasparini, Francesco Torino, Takayuki Ueno, Stefano Cascinu, Teresa Troiani, Alberto Ballestrero, Rossana Berardi, Junichi Shishido, Akihiko Yoshizawa, Yukiko Mori, Satoshi Nagayama, Paola Morosini, Masakazu Toi |
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer |
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer |
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer |
ANGIOGENESIS, 15, 1, 141-150 |
ANGIOGENESIS, 15, 1, 141-150 |
ANGIOGENESIS, 15, 1, 141-150 |
2012/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Monica S. M. Chan, Lin Wang, Niramol Chanplakorn, Kentaro Tamaki, Takayuki Ueno, Masakazu Toi, Wings T. Y. Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano |
Monica S. M. Chan, Lin Wang, Niramol Chanplakorn, Kentaro Tamaki, Takayuki Ueno, Masakazu Toi, Wings T. Y. Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano |
Monica S. M. Chan, Lin Wang, Niramol Chanplakorn, Kentaro Tamaki, Takayuki Ueno, Masakazu Toi, Wings T. Y. Loo, Louis W. C. Chow, Takashi Suzuki, Hironobu Sasano |
Effects of estrogen depletion on angiogenesis in estrogen-receptor-positive breast carcinoma - an immunohistochemical study of vasohibin-1 and CD31 with correlation to pathobiological response of the patients in neoadjuvant aromatase inhibitor therapy |
Effects of estrogen depletion on angiogenesis in estrogen-receptor-positive breast carcinoma - an immunohistochemical study of vasohibin-1 and CD31 with correlation to pathobiological response of the patients in neoadjuvant aromatase inhibitor therapy |
Effects of estrogen depletion on angiogenesis in estrogen-receptor-positive breast carcinoma - an immunohistochemical study of vasohibin-1 and CD31 with correlation to pathobiological response of the patients in neoadjuvant aromatase inhibitor therapy |
EXPERT OPINION ON THERAPEUTIC TARGETS, 16, SUPPL. 1, S69-S78 |
EXPERT OPINION ON THERAPEUTIC TARGETS, 16, SUPPL. 1, S69-S78 |
EXPERT OPINION ON THERAPEUTIC TARGETS, 16, SUPPL. 1, S69-S78 |
2012/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Takayuki Ueno, Mitsuru Emi, Hidenori Sato, Noriko Ito, Mariko Muta, Katsumasa Kuroi, Masakazu Toi |
Takayuki Ueno, Mitsuru Emi, Hidenori Sato, Noriko Ito, Mariko Muta, Katsumasa Kuroi, Masakazu Toi |
Takayuki Ueno, Mitsuru Emi, Hidenori Sato, Noriko Ito, Mariko Muta, Katsumasa Kuroi, Masakazu Toi |
Genome-wide copy number analysis in primary breast cancer |
Genome-wide copy number analysis in primary breast cancer |
Genome-wide copy number analysis in primary breast cancer |
EXPERT OPINION ON THERAPEUTIC TARGETS, 16, SUPPL. 1, S31-S35 |
EXPERT OPINION ON THERAPEUTIC TARGETS, 16, SUPPL. 1, S31-S35 |
EXPERT OPINION ON THERAPEUTIC TARGETS, 16, SUPPL. 1, S31-S35 |
2012/03 |
有 |
英語 |
|
公開 |
| 冨田 勝 |
冨田 勝 |
Takada, M, Sugimoto, M, Naito, Y, Moon, H, Han, W, Noh, D, Kondo, M, Kuroi, K, Sasano, H, Inamoto, T, Tomita, M, Toi, M |
Utility of a Prediction Model for Axillary Lymph Node Metastasis in Patients with Primary Breast Cancer using A Decision-tree Algorithm |
Utility of a Prediction Model for Axillary Lymph Node Metastasis in Patients with Primary Breast Cancer using A Decision-tree Algorithm |
Utility of a Prediction Model for Axillary Lymph Node Metastasis in Patients with Primary Breast Cancer using A Decision-tree Algorithm |
ANNALS OF SURGICAL ONCOLOGY, 19, 1, S80-S80 |
ANNALS OF SURGICAL ONCOLOGY, 19, 1, S80-S80 |
ANNALS OF SURGICAL ONCOLOGY, 19, 1, S80-S80 |
2012/02 |
|
英語 |
研究論文(学術雑誌) |
公開 |
| Takehiro Ichikawa, Fumiaki Sato, Kazuya Terasawa, Soken Tsuchiya, Masakazu Toi, Gozoh Tsujimoto, Kazuharu Shimizu |
Takehiro Ichikawa, Fumiaki Sato, Kazuya Terasawa, Soken Tsuchiya, Masakazu Toi, Gozoh Tsujimoto, Kazuharu Shimizu |
Takehiro Ichikawa, Fumiaki Sato, Kazuya Terasawa, Soken Tsuchiya, Masakazu Toi, Gozoh Tsujimoto, Kazuharu Shimizu |
Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells |
Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells |
Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells |
PLOS ONE, 7, 2 |
PLOS ONE, 7, 2 |
PLOS ONE, 7, 2 |
2012/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Yan-Shun Ren, Nian-Song Qian, Yu Tang, Yong-Hui Liao, Yan-Ling Yang, Ke-Feng Dou, Masakazu Toi |
Yan-Shun Ren, Nian-Song Qian, Yu Tang, Yong-Hui Liao, Yan-Ling Yang, Ke-Feng Dou, Masakazu Toi |
Yan-Shun Ren, Nian-Song Qian, Yu Tang, Yong-Hui Liao, Yan-Ling Yang, Ke-Feng Dou, Masakazu Toi |
Sodium channel Nav1.6 is up-regulated in the dorsal root ganglia in a mouse model of type 2 diabetes |
Sodium channel Nav1.6 is up-regulated in the dorsal root ganglia in a mouse model of type 2 diabetes |
Sodium channel Nav1.6 is up-regulated in the dorsal root ganglia in a mouse model of type 2 diabetes |
BRAIN RESEARCH BULLETIN, 87, 2-3, 244-249 |
BRAIN RESEARCH BULLETIN, 87, 2-3, 244-249 |
BRAIN RESEARCH BULLETIN, 87, 2-3, 244-249 |
2012/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masahiro Takada, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takayuki Ueno, Hironobu Sasano, Masakazu Toi |
Masahiro Takada, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takayuki Ueno, Hironobu Sasano, Masakazu Toi |
Masahiro Takada, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Takayuki Ueno, Hironobu Sasano, Masakazu Toi |
Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer |
Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer |
Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer |
BREAST, 21, 1, 40-45 |
BREAST, 21, 1, 40-45 |
BREAST, 21, 1, 40-45 |
2012/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| 冨田 勝 |
冨田 勝 |
Toi, M, Takada, M, Sugimoto, M, Naito, Y, Bando, H, Iwata, H, Kuroi, K, Masuda, N, Ohno, S, Sato, N, Kondo, M, Sasano, H, Inamoto, T, Tomita, M |
Development of a Prediction Model for Treatment Response to Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer Using a Decision-tree Algorithm |
Development of a Prediction Model for Treatment Response to Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer Using a Decision-tree Algorithm |
Development of a Prediction Model for Treatment Response to Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer Using a Decision-tree Algorithm |
ANNALS OF SURGICAL ONCOLOGY, 19, 1, S69-S69 |
ANNALS OF SURGICAL ONCOLOGY, 19, 1, S69-S69 |
ANNALS OF SURGICAL ONCOLOGY, 19, 1, S69-S69 |
2012 |
|
英語 |
研究論文(学術雑誌) |
公開 |
| H. Ishiguro, S. Saji, M. Toi |
H. Ishiguro, S. Saji, M. Toi |
H. Ishiguro, S. Saji, M. Toi |
[Clinical pharmacology of targeted drug for breast cancer]. |
[Clinical pharmacology of targeted drug for breast cancer]. |
[Clinical pharmacology of targeted drug for breast cancer]. |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 8, 443-446 |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 8, 443-446 |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 8, 443-446 |
2012 |
有 |
英語 |
|
公開 |
| H. Ishiguro, M. Toi |
H. Ishiguro, M. Toi |
H. Ishiguro, M. Toi |
How to dose cytotoxic chemotherapeutic drugs |
How to dose cytotoxic chemotherapeutic drugs |
How to dose cytotoxic chemotherapeutic drugs |
Current Topics in Pharmacology, 16, 1, 67-81 |
Current Topics in Pharmacology, 16, 1, 67-81 |
Current Topics in Pharmacology, 16, 1, 67-81 |
2012 |
有 |
英語 |
|
公開 |
| H. Ishiguro, M. Toi |
H. Ishiguro, M. Toi |
H. Ishiguro, M. Toi |
Pharmacokinetics and pharmacogenomics of selective estrogen receptor modulators in breast cancer patients |
Pharmacokinetics and pharmacogenomics of selective estrogen receptor modulators in breast cancer patients |
Pharmacokinetics and pharmacogenomics of selective estrogen receptor modulators in breast cancer patients |
Current Topics in Pharmacology, 16, 1, 53-58 |
Current Topics in Pharmacology, 16, 1, 53-58 |
Current Topics in Pharmacology, 16, 1, 53-58 |
2012 |
有 |
英語 |
|
公開 |
| E. Suzuki, M. Toi |
E. Suzuki, M. Toi |
E. Suzuki, M. Toi |
[Targeting therapy perspectives]. |
[Targeting therapy perspectives]. |
[Targeting therapy perspectives]. |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 620-626 |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 620-626 |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 620-626 |
2012 |
有 |
英語 |
|
公開 |
| Y. Mitsudo, M. Takada, M. Toi |
Y. Mitsudo, M. Takada, M. Toi |
Y. Mitsudo, M. Takada, M. Toi |
[Multidisciplinary treatment of chemotherapy and surgical therapy]. |
[Multidisciplinary treatment of chemotherapy and surgical therapy]. |
[Multidisciplinary treatment of chemotherapy and surgical therapy]. |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 571-575 |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 571-575 |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 571-575 |
2012 |
有 |
英語 |
|
公開 |
| T. Kitai, M. Toi |
T. Kitai, M. Toi |
T. Kitai, M. Toi |
[Photoacoustic mammography for the diagnosis of breast cancer]. |
[Photoacoustic mammography for the diagnosis of breast cancer]. |
[Photoacoustic mammography for the diagnosis of breast cancer]. |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 326-330 |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 326-330 |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 326-330 |
2012 |
有 |
英語 |
|
公開 |
| N. Masuda, M. Toi, K. Kuroi |
N. Masuda, M. Toi, K. Kuroi |
N. Masuda, M. Toi, K. Kuroi |
[Current activities and perspective of JBCRG (Japan Breast Cancer Research Group)]. |
[Current activities and perspective of JBCRG (Japan Breast Cancer Research Group)]. |
[Current activities and perspective of JBCRG (Japan Breast Cancer Research Group)]. |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 763-772 |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 763-772 |
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 7, 763-772 |
2012 |
有 |
英語 |
|
公開 |
| E. Fakhrejahani, M. Toi |
E. Fakhrejahani, M. Toi |
E. Fakhrejahani, M. Toi |
Tumor angiogenesis: Pericytes and maturation are not to be ignored |
Tumor angiogenesis: Pericytes and maturation are not to be ignored |
Tumor angiogenesis: Pericytes and maturation are not to be ignored |
Journal of Oncology |
Journal of Oncology |
Journal of Oncology |
2012 |
有 |
英語 |
|
公開 |
| 西村 友美, 山城 大泰, 清水 華子, 光藤 悠子, 鳥井 雅恵, 辻 和香子, 上野 貴之, 竹内 恵, 杉江 知治, 金尾 昌太郎, 石黒 洋, 三上 芳喜, 戸井 雅和 |
西村 友美, 山城 大泰, 清水 華子, 光藤 悠子, 鳥井 雅恵, 辻 和香子, 上野 貴之, 竹内 恵, 杉江 知治, 金尾 昌太郎, 石黒 洋, 三上 芳喜, 戸井 雅和 |
|
術前高用量トレミフェン療法が著効した閉経後乳癌の1例 |
術前高用量トレミフェン療法が著効した閉経後乳癌の1例 |
|
乳癌の臨床, 26, 6, 711-716 |
乳癌の臨床, 26, 6, 711-716 |
, 26, 6, 711-716 |
2011/12 |
|
|
|
公開 |
| M. Kanai, H. Ishiguro, Y. Mori, T. Kitano, T. Nishimura, S. Matsumoto, K. Yanagihara, T. Chiba, M. Toi |
M. Kanai, H. Ishiguro, Y. Mori, T. Kitano, T. Nishimura, S. Matsumoto, K. Yanagihara, T. Chiba, M. Toi |
M. Kanai, H. Ishiguro, Y. Mori, T. Kitano, T. Nishimura, S. Matsumoto, K. Yanagihara, T. Chiba, M. Toi |
Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancer |
Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancer |
Temporary blood pressure drop after bevacizumab administration is associated with clinical course of advanced colorectal cancer |
BRITISH JOURNAL OF CANCER, 105, 11, 1693-1696 |
BRITISH JOURNAL OF CANCER, 105, 11, 1693-1696 |
BRITISH JOURNAL OF CANCER, 105, 11, 1693-1696 |
2011/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Hyo Sook Han, Isildinha M. Reis, Wei Zhao, Katsumasa Kuroi, Masakazu Toi, Eiji Suzuki, Rachel Syme, Louis Chow, Adrian Y. S. Yip, Stefan Glueck |
Hyo Sook Han, Isildinha M. Reis, Wei Zhao, Katsumasa Kuroi, Masakazu Toi, Eiji Suzuki, Rachel Syme, Louis Chow, Adrian Y. S. Yip, Stefan Glueck |
Hyo Sook Han, Isildinha M. Reis, Wei Zhao, Katsumasa Kuroi, Masakazu Toi, Eiji Suzuki, Rachel Syme, Louis Chow, Adrian Y. S. Yip, Stefan Glueck |
Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer |
Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer |
Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer |
EUROPEAN JOURNAL OF CANCER, 47, 17, 2537-2545 |
EUROPEAN JOURNAL OF CANCER, 47, 17, 2537-2545 |
EUROPEAN JOURNAL OF CANCER, 47, 17, 2537-2545 |
2011/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K. Kawaguchi, H. Ishiguro, S. Morita, S. Nakamura, S. Ohno, N. Masuda, H. Iwata, K. Aogi, K. Kuroi, M. Toi |
K. Kawaguchi, H. Ishiguro, S. Morita, S. Nakamura, S. Ohno, N. Masuda, H. Iwata, K. Aogi, K. Kuroi, M. Toi |
K. Kawaguchi, H. Ishiguro, S. Morita, S. Nakamura, S. Ohno, N. Masuda, H. Iwata, K. Aogi, K. Kuroi, M. Toi |
Correlation between docetaxel-induced skin toxicity and the use of steroids and H-2 blockers: a multi-institution survey |
Correlation between docetaxel-induced skin toxicity and the use of steroids and H-2 blockers: a multi-institution survey |
Correlation between docetaxel-induced skin toxicity and the use of steroids and H-2 blockers: a multi-institution survey |
BREAST CANCER RESEARCH AND TREATMENT, 130, 2, 627-634 |
BREAST CANCER RESEARCH AND TREATMENT, 130, 2, 627-634 |
BREAST CANCER RESEARCH AND TREATMENT, 130, 2, 627-634 |
2011/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masakazu Toi, Eric P. Winer, Takashi Inamoto, John R. Benson, John F. Forbes, Michihide Mitsumori, John F. R. Robertson, Hironobu Sasano, Gunter von Minckwitz, Akira Yamauchi, V. Suzanne Klimberg |
Masakazu Toi, Eric P. Winer, Takashi Inamoto, John R. Benson, John F. Forbes, Michihide Mitsumori, John F. R. Robertson, Hironobu Sasano, Gunter von Minckwitz, Akira Yamauchi, V. Suzanne Klimberg |
Masakazu Toi, Eric P. Winer, Takashi Inamoto, John R. Benson, John F. Forbes, Michihide Mitsumori, John F. R. Robertson, Hironobu Sasano, Gunter von Minckwitz, Akira Yamauchi, V. Suzanne Klimberg |
Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference |
Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference |
Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference |
ANNALS OF SURGICAL ONCOLOGY, 18, 10, 2885-2892 |
ANNALS OF SURGICAL ONCOLOGY, 18, 10, 2885-2892 |
ANNALS OF SURGICAL ONCOLOGY, 18, 10, 2885-2892 |
2011/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Arwa M. Ali, Takayuki Ueno, Sunao Tanaka, Masahiro Takada, Hiroshi Ishiguro, Ashraf Z. Abdellah, Masakazu Toi |
Arwa M. Ali, Takayuki Ueno, Sunao Tanaka, Masahiro Takada, Hiroshi Ishiguro, Ashraf Z. Abdellah, Masakazu Toi |
Arwa M. Ali, Takayuki Ueno, Sunao Tanaka, Masahiro Takada, Hiroshi Ishiguro, Ashraf Z. Abdellah, Masakazu Toi |
Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients |
Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients |
Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients |
EUROPEAN JOURNAL OF CANCER, 47, 15, 2265-2272 |
EUROPEAN JOURNAL OF CANCER, 47, 15, 2265-2272 |
EUROPEAN JOURNAL OF CANCER, 47, 15, 2265-2272 |
2011/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masakazu Toi, Eric P. Winer, Takashi Inamoto, John R. Benson, John F. Forbes, Michihide Mitsumori, John F. R. Robertson, Hironobu Sasano, Gunter von Minckwitz, Akira Yamauchi, V. Suzanne Klimberg |
Masakazu Toi, Eric P. Winer, Takashi Inamoto, John R. Benson, John F. Forbes, Michihide Mitsumori, John F. R. Robertson, Hironobu Sasano, Gunter von Minckwitz, Akira Yamauchi, V. Suzanne Klimberg |
Masakazu Toi, Eric P. Winer, Takashi Inamoto, John R. Benson, John F. Forbes, Michihide Mitsumori, John F. R. Robertson, Hironobu Sasano, Gunter von Minckwitz, Akira Yamauchi, V. Suzanne Klimberg |
Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference |
Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference |
Identifying Gaps in the Locoregional Management of Early Breast Cancer: Highlights from the Kyoto Consensus Conference |
ANNALS OF SURGICAL ONCOLOGY, 18, 10, 2885-2892 |
ANNALS OF SURGICAL ONCOLOGY, 18, 10, 2885-2892 |
ANNALS OF SURGICAL ONCOLOGY, 18, 10, 2885-2892 |
2011/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Niansong Qian, Takayuki Ueno, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Noriyuki Yoshida, Yoshiki Mikami, Tomoko Wakasa, Masayuki Shintaku, Shigeru Tsuyuki, Takashi Inamoto, Masakazu Toi |
Niansong Qian, Takayuki Ueno, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Noriyuki Yoshida, Yoshiki Mikami, Tomoko Wakasa, Masayuki Shintaku, Shigeru Tsuyuki, Takashi Inamoto, Masakazu Toi |
Niansong Qian, Takayuki Ueno, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Noriyuki Yoshida, Yoshiki Mikami, Tomoko Wakasa, Masayuki Shintaku, Shigeru Tsuyuki, Takashi Inamoto, Masakazu Toi |
Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients |
Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients |
Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients |
CANCER SCIENCE, 102, 8, 1590-1596 |
CANCER SCIENCE, 102, 8, 1590-1596 |
CANCER SCIENCE, 102, 8, 1590-1596 |
2011/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| 石黒 洋, 戸井雅和 |
石黒 洋, 戸井雅和 |
|
【乳癌最前線】 腫瘍内科医の考える「乳がん薬物療法」 |
【乳癌最前線】 腫瘍内科医の考える「乳がん薬物療法」 |
|
クリニシアン, 58, 7, 803-808 |
クリニシアン, 58, 7, 803-808 |
, 58, 7, 803-808 |
2011/07 |
|
|
|
公開 |
| Yu Tang, Yonghui Liao, Nobuko Kawaguchi-Sakita, Vikram Raut, Elham Fakhrejahani, Niansong Qian, Masakazu Toi |
Yu Tang, Yonghui Liao, Nobuko Kawaguchi-Sakita, Vikram Raut, Elham Fakhrejahani, Niansong Qian, Masakazu Toi |
Yu Tang, Yonghui Liao, Nobuko Kawaguchi-Sakita, Vikram Raut, Elham Fakhrejahani, Niansong Qian, Masakazu Toi |
Sinisan, a traditional Chinese medicine, attenuates experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats |
Sinisan, a traditional Chinese medicine, attenuates experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats |
Sinisan, a traditional Chinese medicine, attenuates experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 18, 4, 551-558 |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 18, 4, 551-558 |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 18, 4, 551-558 |
2011/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Hiroji Iwata, Nobuaki Sato, Norikazu Masuda, Seigo Nakamura, Naohito Yamamoto, Katsumasa Kuroi, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, Masakazu Toi |
Hiroji Iwata, Nobuaki Sato, Norikazu Masuda, Seigo Nakamura, Naohito Yamamoto, Katsumasa Kuroi, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, Masakazu Toi |
Hiroji Iwata, Nobuaki Sato, Norikazu Masuda, Seigo Nakamura, Naohito Yamamoto, Katsumasa Kuroi, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, Masakazu Toi |
Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer |
Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer |
Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41, 7, 867-875 |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41, 7, 867-875 |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41, 7, 867-875 |
2011/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Kondo, S.-L. Hoshi, T. Yamanaka, H. Ishiguro, M. Toi |
M. Kondo, S.-L. Hoshi, T. Yamanaka, H. Ishiguro, M. Toi |
Masahide Kondo, Shu-Ling Hoshi, Takeharu Yamanaka, Hiroshi Ishiguro, Masakazu Toi |
Economic evaluation of the 21-gene signature (Oncotype DX <sup>®</sup>) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03) |
Economic evaluation of the 21-gene signature (Oncotype DX <sup>®</sup>) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03) |
Economic evaluation of the 21-gene signature (Oncotype DXA (R)) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03) |
Breast Cancer Research and Treatment, 127, 3, 739-749 |
Breast Cancer Research and Treatment, 127, 3, 739-749 |
BREAST CANCER RESEARCH AND TREATMENT, 127, 3, 739-749 |
2011/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Louis W. C. Chow, Adrian Y. S. Yip, W. P. Chu, Wings T. Y. Loo, Masakazu Toi |
Louis W. C. Chow, Adrian Y. S. Yip, W. P. Chu, Wings T. Y. Loo, Masakazu Toi |
Louis W. C. Chow, Adrian Y. S. Yip, W. P. Chu, Wings T. Y. Loo, Masakazu Toi |
Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: Sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial |
Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: Sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial |
Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: Sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial |
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 125, 1-2, 112-119 |
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 125, 1-2, 112-119 |
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 125, 1-2, 112-119 |
2011/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Kenjiro Aogi, Masayuki Yoshida, Yoshiaki Sagara, Shunji Kamigaki, Minoru Okazaki, Jumpei Funai, Toshio Fujimoto, Masakazu Toi, Toshiaki Saeki, Shigemitsu Takashima |
Kenjiro Aogi, Masayuki Yoshida, Yoshiaki Sagara, Shunji Kamigaki, Minoru Okazaki, Jumpei Funai, Toshio Fujimoto, Masakazu Toi, Toshiaki Saeki, Shigemitsu Takashima |
Kenjiro Aogi, Masayuki Yoshida, Yoshiaki Sagara, Shunji Kamigaki, Minoru Okazaki, Jumpei Funai, Toshio Fujimoto, Masakazu Toi, Toshiaki Saeki, Shigemitsu Takashima |
The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype |
The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype |
The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 5, 1007-1015 |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 5, 1007-1015 |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 67, 5, 1007-1015 |
2011/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Yu Tang, Fei Xu, Kaishan Tao, Niansong Qian, Masakazu Toi |
Yu Tang, Fei Xu, Kaishan Tao, Niansong Qian, Masakazu Toi |
Yu Tang, Fei Xu, Kaishan Tao, Niansong Qian, Masakazu Toi |
Clinical Applications of Sentinel Lymph Node Biopsy in Ductal Carcinoma in situ of the Breast: A Dilemma |
Clinical Applications of Sentinel Lymph Node Biopsy in Ductal Carcinoma in situ of the Breast: A Dilemma |
Clinical Applications of Sentinel Lymph Node Biopsy in Ductal Carcinoma in situ of the Breast: A Dilemma |
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 224, 1, 1-5 |
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 224, 1, 1-5 |
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 224, 1, 1-5 |
2011/05 |
有 |
英語 |
|
公開 |
| Masakazu Toi, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Masahiro Takada, Takayuki Ueno, Shigetoyo Saji, Niramol Chanplakorn, Takashi Suzuki, Hironobu Sasano |
Masakazu Toi, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Masahiro Takada, Takayuki Ueno, Shigetoyo Saji, Niramol Chanplakorn, Takashi Suzuki, Hironobu Sasano |
Masakazu Toi, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Masahiro Takada, Takayuki Ueno, Shigetoyo Saji, Niramol Chanplakorn, Takashi Suzuki, Hironobu Sasano |
Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition |
Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition |
Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition |
CANCER SCIENCE, 102, 4, 858-865 |
CANCER SCIENCE, 102, 4, 858-865 |
CANCER SCIENCE, 102, 4, 858-865 |
2011/04 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Michitaka Honda, Shigehira Saji, Shin-ichiro Horiguchi, Eiji Suzuki, Tomoyuki Aruga, Kazumi Horiguchi, Dai Kitagawa, Susumu Sekine, Nobuaki Funata, Masakazu Toi, Katsumasa Kuroi |
Michitaka Honda, Shigehira Saji, Shin-ichiro Horiguchi, Eiji Suzuki, Tomoyuki Aruga, Kazumi Horiguchi, Dai Kitagawa, Susumu Sekine, Nobuaki Funata, Masakazu Toi, Katsumasa Kuroi |
Michitaka Honda, Shigehira Saji, Shin-ichiro Horiguchi, Eiji Suzuki, Tomoyuki Aruga, Kazumi Horiguchi, Dai Kitagawa, Susumu Sekine, Nobuaki Funata, Masakazu Toi, Katsumasa Kuroi |
Clinicopathological Analysis of Ten Patients with Metaplastic Squamous Cell Carcinoma of the Breast |
Clinicopathological Analysis of Ten Patients with Metaplastic Squamous Cell Carcinoma of the Breast |
Clinicopathological Analysis of Ten Patients with Metaplastic Squamous Cell Carcinoma of the Breast |
SURGERY TODAY, 41, 3, 328-332 |
SURGERY TODAY, 41, 3, 328-332 |
SURGERY TODAY, 41, 3, 328-332 |
2011/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Iwasaki, Y. Tanaka, H. Kobayashi, K. Murata-Hirai, H. Miyabe, T. Sugie, M. Toi, N. Minato |
M. Iwasaki, Y. Tanaka, H. Kobayashi, K. Murata-Hirai, H. Miyabe, T. Sugie, M. Toi, N. Minato |
Masashi Iwasaki, Yoshimasa Tanaka, Hirohito Kobayashi, Kaoru Murata-Hirai, Hideto Miyabe, Tomoharu Sugie, Masakazu Toi, Nagahiro Minato |
Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens |
Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens |
Expression and function of PD-1 in human gamma delta T cells that recognize phosphoantigens |
European Journal of Immunology, 41, 2, 345-355 |
European Journal of Immunology, 41, 2, 345-355 |
EUROPEAN JOURNAL OF IMMUNOLOGY, 41, 2, 345-355 |
2011/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Iwasaki, M, Tanaka, Y, Kobayashi, H, Hirai K, Sugie, T, Toi, M, Minato, N |
Iwasaki, M, Tanaka, Y, Kobayashi, H, Hirai K, Sugie, T, Toi, M, Minato, N |
Iwasaki, M, Tanaka, Y, Kobayashi, H, Hirai K, Sugie, T, Toi, M, Minato, N |
Expression and function of PD-1 in human gd T cell responses to tumor cells. Eur. |
Expression and function of PD-1 in human gd T cell responses to tumor cells. Eur. |
Expression and function of PD-1 in human gd T cell responses to tumor cells. Eur. |
J. Immunol. 41(2):345-355. |
J. Immunol. 41(2):345-355. |
J. Immunol. 41(2):345-355. |
2011 |
有 |
英語 |
|
公開 |
| Masahiro Takada, Hiroshi Terunuma, Xuewen Deng, Md. Zahidunnabi Dewan, Shigehira Saji, Katsumasa Kuroi, Naoki Yamamoto, Masakazu Toi |
Masahiro Takada, Hiroshi Terunuma, Xuewen Deng, Md. Zahidunnabi Dewan, Shigehira Saji, Katsumasa Kuroi, Naoki Yamamoto, Masakazu Toi |
Masahiro Takada, Hiroshi Terunuma, Xuewen Deng, Md. Zahidunnabi Dewan, Shigehira Saji, Katsumasa Kuroi, Naoki Yamamoto, Masakazu Toi |
Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach |
Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach |
Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach |
BREAST CANCER, 18, 1, 64-67 |
BREAST CANCER, 18, 1, 64-67 |
BREAST CANCER, 18, 1, 64-67 |
2011/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| A. Tomotaki, S. Hirota, Y. Ohashi, A. Teramoto, M. Yokobori, M. Toi |
A. Tomotaki, S. Hirota, Y. Ohashi, A. Teramoto, M. Yokobori, M. Toi |
A. Tomotaki, S. Hirota, Y. Ohashi, A. Teramoto, M. Yokobori, M. Toi |
Participant proportion of population controls and matching for cases and controls: Lactic acid bacterium and breast cancer in the case-control study |
Participant proportion of population controls and matching for cases and controls: Lactic acid bacterium and breast cancer in the case-control study |
Participant proportion of population controls and matching for cases and controls: Lactic acid bacterium and breast cancer in the case-control study |
Japanese Pharmacology and Therapeutics, 39, SUPPL. 2, S211-SS221 |
Japanese Pharmacology and Therapeutics, 39, SUPPL. 2, S211-SS221 |
Japanese Pharmacology and Therapeutics, 39, SUPPL. 2, S211-SS221 |
2011 |
有 |
英語 |
|
公開 |
| M. Takada, M. Toi |
M. Takada, M. Toi |
|
Surgery for breast cancer - From radical mastectomy to breast-conserving surgery |
Surgery for breast cancer - From radical mastectomy to breast-conserving surgery |
|
Japanese Journal of Cancer and Chemotherapy, 38, 2, 173-178 |
Japanese Journal of Cancer and Chemotherapy, 38, 2, 173-178 |
, 38, 2, 173-178 |
2011 |
有 |
日本語 |
|
公開 |
| 福谷和彦, 染田恭宏, 卓雅一, 浅尾恭史, 小林秀一, 八木隆行, 山川誠, 椎名 毅, 杉江知治, 戸井雅和 |
福谷和彦, 染田恭宏, 卓雅一, 浅尾恭史, 小林秀一, 八木隆行, 山川誠, 椎名 毅, 杉江知治, 戸井雅和 |
|
高深度イメージングを目指した両面照射型光音響イメージングシステムの評価 |
高深度イメージングを目指した両面照射型光音響イメージングシステムの評価 |
|
2011 BIOS(SPIE Photonic West) (2011.1.24) |
2011 BIOS(SPIE Photonic West) (2011.1.24) |
|
2011 |
有 |
日本語 |
|
公開 |
| M. Toi, W. Yasui, H. Ito, E. Tahara |
M. Toi, W. Yasui, H. Ito, E. Tahara |
M. Toi, W. Yasui, H. Ito, E. Tahara |
Recent progress in carcinogenesis, progression and therapy of breast cancer: The 20th Hiroshima Cancer seminar-the 4th three universities\\' Consortium International Symposium, october 2010 |
Recent progress in carcinogenesis, progression and therapy of breast cancer: The 20th Hiroshima Cancer seminar-the 4th three universities\\' Consortium International Symposium, october 2010 |
Recent progress in carcinogenesis, progression and therapy of breast cancer: The 20th Hiroshima Cancer seminar-the 4th three universities\\' Consortium International Symposium, october 2010 |
Japanese Journal of Clinical Oncology, 41, 7, 924-930 |
Japanese Journal of Clinical Oncology, 41, 7, 924-930 |
Japanese Journal of Clinical Oncology, 41, 7, 924-930 |
2011 |
有 |
英語 |
|
公開 |
| H. Takuwa, T. Ueno, H. Ishiguro, Y. Mikami, S. Kanao, M. Takada, T. Sugie, M. Toi |
H. Takuwa, T. Ueno, H. Ishiguro, Y. Mikami, S. Kanao, M. Takada, T. Sugie, M. Toi |
H. Takuwa, T. Ueno, H. Ishiguro, Y. Mikami, S. Kanao, M. Takada, T. Sugie, M. Toi |
A case of metaplastic breast cancer that showed a good response to platinum-based preoperative chemotherapy |
A case of metaplastic breast cancer that showed a good response to platinum-based preoperative chemotherapy |
A case of metaplastic breast cancer that showed a good response to platinum-based preoperative chemotherapy |
Breast Cancer, 1-4 |
Breast Cancer, 1-4 |
Breast Cancer, 1-4 |
2011 |
有 |
英語 |
|
公開 |
| T. Sugie, K. A. Kassim, M. Takeuchi, T. Hashimoto, K. Yamagami, Y. Masai, M. Toi |
T. Sugie, K. A. Kassim, M. Takeuchi, T. Hashimoto, K. Yamagami, Y. Masai, M. Toi |
T. Sugie, K. A. Kassim, M. Takeuchi, T. Hashimoto, K. Yamagami, Y. Masai, M. Toi |
A Novel Method for Sentinel Lymph Node Biopsy by Indocyanine Green Fluorescence Technique in Breast Cancer |
A Novel Method for Sentinel Lymph Node Biopsy by Indocyanine Green Fluorescence Technique in Breast Cancer |
A Novel Method for Sentinel Lymph Node Biopsy by Indocyanine Green Fluorescence Technique in Breast Cancer |
CANCER RESEARCH, 70, 2, 713-720 |
CANCER RESEARCH, 70, 2, 713-720 |
CANCER RESEARCH, 70, 2, 713-720 |
2010/12 |
有 |
英語 |
|
公開 |
| Youichi Kumagai, Masakazu Toi, Kenro Kawada, Tatsuyuki Kawano |
Youichi Kumagai, Masakazu Toi, Kenro Kawada, Tatsuyuki Kawano |
Youichi Kumagai, Masakazu Toi, Kenro Kawada, Tatsuyuki Kawano |
ANGIOGENESIS IN SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA: MAGNIFYING ENDOSCOPIC OBSERVATION AND MOLECULAR ANALYSIS |
ANGIOGENESIS IN SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA: MAGNIFYING ENDOSCOPIC OBSERVATION AND MOLECULAR ANALYSIS |
ANGIOGENESIS IN SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA: MAGNIFYING ENDOSCOPIC OBSERVATION AND MOLECULAR ANALYSIS |
DIGESTIVE ENDOSCOPY, 22, 4, 259-267 |
DIGESTIVE ENDOSCOPY, 22, 4, 259-267 |
DIGESTIVE ENDOSCOPY, 22, 4, 259-267 |
2010/10 |
有 |
英語 |
|
公開 |
| Christopher C. P. Yiu, Niramol Chanplakorn, Monica S. M. Chan, Wings T. Y. Loo, Louis W. C. Chow, Masakazu Toi, Hironobu Sasano |
Christopher C. P. Yiu, Niramol Chanplakorn, Monica S. M. Chan, Wings T. Y. Loo, Louis W. C. Chow, Masakazu Toi, Hironobu Sasano |
Christopher C. P. Yiu, Niramol Chanplakorn, Monica S. M. Chan, Wings T. Y. Loo, Louis W. C. Chow, Masakazu Toi, Hironobu Sasano |
Down-regulation of Heat-shock Protein 70 (HSP-70) Correlated with Responsiveness to Neoadjuvant Aromatase Inhibitor Therapy in Breast Cancer Patients |
Down-regulation of Heat-shock Protein 70 (HSP-70) Correlated with Responsiveness to Neoadjuvant Aromatase Inhibitor Therapy in Breast Cancer Patients |
Down-regulation of Heat-shock Protein 70 (HSP-70) Correlated with Responsiveness to Neoadjuvant Aromatase Inhibitor Therapy in Breast Cancer Patients |
ANTICANCER RESEARCH, 30, 9, 3465-3472 |
ANTICANCER RESEARCH, 30, 9, 3465-3472 |
ANTICANCER RESEARCH, 30, 9, 3465-3472 |
2010/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masakazu Toi, Yasuo Ohashi, Adeline Seow, Takuya Moriya, Gary Tse, Hironobu Sasano, Byeong Woo Park, Louis W. C. Chow, Adriano V. Laudico, Cheng Har Yip, Ei Ueno, Hiroshi Ishiguro, Hiroko Bando |
Masakazu Toi, Yasuo Ohashi, Adeline Seow, Takuya Moriya, Gary Tse, Hironobu Sasano, Byeong Woo Park, Louis W. C. Chow, Adriano V. Laudico, Cheng Har Yip, Ei Ueno, Hiroshi Ishiguro, Hiroko Bando |
Masakazu Toi, Yasuo Ohashi, Adeline Seow, Takuya Moriya, Gary Tse, Hironobu Sasano, Byeong Woo Park, Louis W. C. Chow, Adriano V. Laudico, Cheng Har Yip, Ei Ueno, Hiroshi Ishiguro, Hiroko Bando |
The Breast Cancer Working Group Presentation was Divided into Three Sections: The Epidemiology, Pathology and Treatment of Breast Cancer |
The Breast Cancer Working Group Presentation was Divided into Three Sections: The Epidemiology, Pathology and Treatment of Breast Cancer |
The Breast Cancer Working Group Presentation was Divided into Three Sections: The Epidemiology, Pathology and Treatment of Breast Cancer |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 40, SUPPL. 1, i13-i18 |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 40, SUPPL. 1, i13-i18 |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 40, SUPPL. 1, i13-i18 |
2010/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| L. Chen, A. Endler, K. Uchida, S.-I. Horiguchi, Y. Morizane, O. Iijima, M. Toi, F. Shibasaki |
L. Chen, A. Endler, K. Uchida, S.-I. Horiguchi, Y. Morizane, O. Iijima, M. Toi, F. Shibasaki |
Li Chen, Alexander Endler, Kazuyo Uchida, Shin-ichiro Horiguchi, Yoshihito Morizane, Osamu Iijima, Masakazu Toi, Futoshi Shibasaki |
Int6/eIF3e silencing promotes functional blood vessel outgrowth and enhances wound healing by upregulating hypoxia-induced factor 2α expression |
Int6/eIF3e silencing promotes functional blood vessel outgrowth and enhances wound healing by upregulating hypoxia-induced factor 2α expression |
Int6/eIF3e Silencing Promotes Functional Blood Vessel Outgrowth and Enhances Wound Healing by Upregulating Hypoxia-Induced Factor 2 alpha Expression |
Circulation, 122, 9, 910-919 |
Circulation, 122, 9, 910-919 |
CIRCULATION, 122, 9, 910-919 |
2010/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Marion Procter, Thomas M. Suter, Evandro de Azambuja, Urania Dafni, Veerle van Dooren, Susanne Muehlbauer, Miguel Angel Climent, Ernst Rechberger, Walter Tsang-Wu Liu, Mazakasu Toi, R. Charles Coombes, David Dodwell, Olivia Pagani, Jorge Madrid, Marcia Hall, Shin-Cheh Chen, Christian Focan, Michael Muschol, Dirk J. van Veldhuisen, Martine J. Piccart-Gebhart |
Marion Procter, Thomas M. Suter, Evandro de Azambuja, Urania Dafni, Veerle van Dooren, Susanne Muehlbauer, Miguel Angel Climent, Ernst Rechberger, Walter Tsang-Wu Liu, Mazakasu Toi, R. Charles Coombes, David Dodwell, Olivia Pagani, Jorge Madrid, Marcia Hall, Shin-Cheh Chen, Christian Focan, Michael Muschol, Dirk J. van Veldhuisen, Martine J. Piccart-Gebhart |
Marion Procter, Thomas M. Suter, Evandro de Azambuja, Urania Dafni, Veerle van Dooren, Susanne Muehlbauer, Miguel Angel Climent, Ernst Rechberger, Walter Tsang-Wu Liu, Mazakasu Toi, R. Charles Coombes, David Dodwell, Olivia Pagani, Jorge Madrid, Marcia Hall, Shin-Cheh Chen, Christian Focan, Michael Muschol, Dirk J. van Veldhuisen, Martine J. Piccart-Gebhart |
Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the Herceptin Adjuvant (HERA) Trial |
Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the Herceptin Adjuvant (HERA) Trial |
Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the Herceptin Adjuvant (HERA) Trial |
JOURNAL OF CLINICAL ONCOLOGY, 28, 21, 3422-3428 |
JOURNAL OF CLINICAL ONCOLOGY, 28, 21, 3422-3428 |
JOURNAL OF CLINICAL ONCOLOGY, 28, 21, 3422-3428 |
2010/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masakazu Toi, Hiroji Iwata, Takeharu Yamanaka, Norikazu Masuda, Shinji Ohno, Seigo Nakamura, Takahiro Nakayama, Masahiro Kashiwaba, Shunji Kamigaki, Katsumasa Kuroi |
Masakazu Toi, Hiroji Iwata, Takeharu Yamanaka, Norikazu Masuda, Shinji Ohno, Seigo Nakamura, Takahiro Nakayama, Masahiro Kashiwaba, Shunji Kamigaki, Katsumasa Kuroi |
Masakazu Toi, Hiroji Iwata, Takeharu Yamanaka, Norikazu Masuda, Shinji Ohno, Seigo Nakamura, Takahiro Nakayama, Masahiro Kashiwaba, Shunji Kamigaki, Katsumasa Kuroi |
Clinical Significance of the 21-Gene Signature (Oncotype DX) in Hormone Receptor-Positive Early Stage Primary Breast Cancer in the Japanese Population |
Clinical Significance of the 21-Gene Signature (Oncotype DX) in Hormone Receptor-Positive Early Stage Primary Breast Cancer in the Japanese Population |
Clinical Significance of the 21-Gene Signature (Oncotype DX) in Hormone Receptor-Positive Early Stage Primary Breast Cancer in the Japanese Population |
CANCER, 116, 13, 3112-3118 |
CANCER, 116, 13, 3112-3118 |
CANCER, 116, 13, 3112-3118 |
2010/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Seigo Nakamura, Hiroshi Yagata, Shinji Ohno, Hiroshi Yamaguchi, Hiroji Iwata, Nobuyuki Tsunoda, Yoshinori Ito, Nahomi Tokudome, Masakazu Toi, Katsumasa Kuroi, Eiji Suzuki |
Seigo Nakamura, Hiroshi Yagata, Shinji Ohno, Hiroshi Yamaguchi, Hiroji Iwata, Nobuyuki Tsunoda, Yoshinori Ito, Nahomi Tokudome, Masakazu Toi, Katsumasa Kuroi, Eiji Suzuki |
Seigo Nakamura, Hiroshi Yagata, Shinji Ohno, Hiroshi Yamaguchi, Hiroji Iwata, Nobuyuki Tsunoda, Yoshinori Ito, Nahomi Tokudome, Masakazu Toi, Katsumasa Kuroi, Eiji Suzuki |
Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer |
Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer |
Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer |
BREAST CANCER, 17, 3, 199-204 |
BREAST CANCER, 17, 3, 199-204 |
BREAST CANCER, 17, 3, 199-204 |
2010/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Dai Kitagawa, Shigehira Saji, Shin-ichiro Horiguchi, Yu Satoh, Kazumi Horiguchi, Masakazu Toi, Nobuaki Funata, Katsumasa Kuroi |
Dai Kitagawa, Shigehira Saji, Shin-ichiro Horiguchi, Yu Satoh, Kazumi Horiguchi, Masakazu Toi, Nobuaki Funata, Katsumasa Kuroi |
Dai Kitagawa, Shigehira Saji, Shin-ichiro Horiguchi, Yu Satoh, Kazumi Horiguchi, Masakazu Toi, Nobuaki Funata, Katsumasa Kuroi |
Alternation of Estrogen Receptor and Progesterone Receptor Expression in Primary Breast Cancer Patients Treated with Neoadjuvant Chemotherapy |
Alternation of Estrogen Receptor and Progesterone Receptor Expression in Primary Breast Cancer Patients Treated with Neoadjuvant Chemotherapy |
Alternation of Estrogen Receptor and Progesterone Receptor Expression in Primary Breast Cancer Patients Treated with Neoadjuvant Chemotherapy |
BREAST JOURNAL, 16, 4, 435-436 |
BREAST JOURNAL, 16, 4, 435-436 |
BREAST JOURNAL, 16, 4, 435-436 |
2010/07 |
有 |
英語 |
|
公開 |
| Morihiko Kimura, Takeshi Tominaga, Yuichi Takatsuka, Masakazu Toi, Rikiya Abe, Hiroki Koyama, Shigemitsu Takashima, Yasuo Nomura, Shigeto Miura, Izo Kimijima, Hideya Tashiro, Yasuo Ohashi |
Morihiko Kimura, Takeshi Tominaga, Yuichi Takatsuka, Masakazu Toi, Rikiya Abe, Hiroki Koyama, Shigemitsu Takashima, Yasuo Nomura, Shigeto Miura, Izo Kimijima, Hideya Tashiro, Yasuo Ohashi |
Morihiko Kimura, Takeshi Tominaga, Yuichi Takatsuka, Masakazu Toi, Rikiya Abe, Hiroki Koyama, Shigemitsu Takashima, Yasuo Nomura, Shigeto Miura, Izo Kimijima, Hideya Tashiro, Yasuo Ohashi |
Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan |
Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan |
Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan |
BREAST CANCER, 17, 3, 190-198 |
BREAST CANCER, 17, 3, 190-198 |
BREAST CANCER, 17, 3, 190-198 |
2010/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Takuro Shimbo, Tsuguya Fukui, Chikashi Ishioka, Kohji Okamoto, Takahiro Okamoto, Shingo Kameoka, Atsushi Sato, Masakazu Toi, Kunihiko Matsui, Toshihiko Mayumi, Shigetoyo Saji, Masaru Miyazaki, Yuichi Takatsuka, Koichi Hirata |
Takuro Shimbo, Tsuguya Fukui, Chikashi Ishioka, Kohji Okamoto, Takahiro Okamoto, Shingo Kameoka, Atsushi Sato, Masakazu Toi, Kunihiko Matsui, Toshihiko Mayumi, Shigetoyo Saji, Masaru Miyazaki, Yuichi Takatsuka, Koichi Hirata |
Takuro Shimbo, Tsuguya Fukui, Chikashi Ishioka, Kohji Okamoto, Takahiro Okamoto, Shingo Kameoka, Atsushi Sato, Masakazu Toi, Kunihiko Matsui, Toshihiko Mayumi, Shigetoyo Saji, Masaru Miyazaki, Yuichi Takatsuka, Koichi Hirata |
Quality of guideline development assessed by the Evaluation Committee of the Japan Society of Clinical Oncology |
Quality of guideline development assessed by the Evaluation Committee of the Japan Society of Clinical Oncology |
Quality of guideline development assessed by the Evaluation Committee of the Japan Society of Clinical Oncology |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 15, 3, 227-233 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 15, 3, 227-233 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 15, 3, 227-233 |
2010/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Niramol Chanplakorn, Pongsthorn Chanplakorn, Takashi Suzuki, Katsuhiko Ono, Monica S. M. Chan, Yasuhiro Miki, Shigetoyo Saji, Takayuki Ueno, Masakazu Toi, Hironobu Sasano |
Niramol Chanplakorn, Pongsthorn Chanplakorn, Takashi Suzuki, Katsuhiko Ono, Monica S. M. Chan, Yasuhiro Miki, Shigetoyo Saji, Takayuki Ueno, Masakazu Toi, Hironobu Sasano |
Niramol Chanplakorn, Pongsthorn Chanplakorn, Takashi Suzuki, Katsuhiko Ono, Monica S. M. Chan, Yasuhiro Miki, Shigetoyo Saji, Takayuki Ueno, Masakazu Toi, Hironobu Sasano |
Increased estrogen sulfatase (STS) and 17 beta-hydroxysteroid dehydrogenase type 1(17 beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients |
Increased estrogen sulfatase (STS) and 17 beta-hydroxysteroid dehydrogenase type 1(17 beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients |
Increased estrogen sulfatase (STS) and 17 beta-hydroxysteroid dehydrogenase type 1(17 beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients |
BREAST CANCER RESEARCH AND TREATMENT, 120, 3, 639-648 |
BREAST CANCER RESEARCH AND TREATMENT, 120, 3, 639-648 |
BREAST CANCER RESEARCH AND TREATMENT, 120, 3, 639-648 |
2010/04 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| N. Chanplakorn, P. Chanplakorn, T. Suzuki, K. Ono, M.S.M. Chan, Y. Miki, S. Saji, T. Ueno, M. Toi, H. Sasano |
N. Chanplakorn, P. Chanplakorn, T. Suzuki, K. Ono, M.S.M. Chan, Y. Miki, S. Saji, T. Ueno, M. Toi, H. Sasano |
Niramol Chanplakorn, Pongsthorn Chanplakorn, Takashi Suzuki, Katsuhiko Ono, Monica S. M. Chan, Yasuhiro Miki, Shigetoyo Saji, Takayuki Ueno, Masakazu Toi, Hironobu Sasano |
Increased estrogen sulfatase (STS) and 17βhydroxysteroid dehydrogenase type l(17β-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients |
Increased estrogen sulfatase (STS) and 17βhydroxysteroid dehydrogenase type l(17β-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients |
Increased estrogen sulfatase (STS) and 17 beta-hydroxysteroid dehydrogenase type 1(17 beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients |
Breast Cancer Research and Treatment, 120, 3, 639-648 |
Breast Cancer Research and Treatment, 120, 3, 639-648 |
BREAST CANCER RESEARCH AND TREATMENT, 120, 3, 639-648 |
2010/04 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Louis W. C. Chow, Masakazu Toi |
Louis W. C. Chow, Masakazu Toi |
Louis W. C. Chow, Masakazu Toi |
Combat against cancer with science and medicine |
Combat against cancer with science and medicine |
Combat against cancer with science and medicine |
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 19, SUPPL. 1, S3-S4 |
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 19, SUPPL. 1, S3-S4 |
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 19, SUPPL. 1, S3-S4 |
2010/04 |
有 |
英語 |
|
公開 |
| Hiroshi Ishiguro, Masahide Kondo, Shu-Ling Hoshi, Masahiro Takada, Seigo Nakamura, Satoshi Teramukai, Kazuhiro Yanagihara, Masakazu Toi |
Hiroshi Ishiguro, Masahide Kondo, Shu-Ling Hoshi, Masahiro Takada, Seigo Nakamura, Satoshi Teramukai, Kazuhiro Yanagihara, Masakazu Toi |
Hiroshi Ishiguro, Masahide Kondo, Shu-Ling Hoshi, Masahiro Takada, Seigo Nakamura, Satoshi Teramukai, Kazuhiro Yanagihara, Masakazu Toi |
Economic Evaluation of Intensive Chemotherapy With Prophylactic Granulocyte Colony-Stimulating Factor for Patients With High-Risk Early Breast Cancer in Japan |
Economic Evaluation of Intensive Chemotherapy With Prophylactic Granulocyte Colony-Stimulating Factor for Patients With High-Risk Early Breast Cancer in Japan |
Economic Evaluation of Intensive Chemotherapy With Prophylactic Granulocyte Colony-Stimulating Factor for Patients With High-Risk Early Breast Cancer in Japan |
CLINICAL THERAPEUTICS, 32, 2, 311-326 |
CLINICAL THERAPEUTICS, 32, 2, 311-326 |
CLINICAL THERAPEUTICS, 32, 2, 311-326 |
2010/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masakazu Toi, Jeff Sperinde, Weidong Huang, Shigehira Saji, John Winslow, Xueguang Jin, Yuping Tan, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Kenjiro Aogi, Satoshi Morita, Christos Petropoulos, Michael Bates |
Masakazu Toi, Jeff Sperinde, Weidong Huang, Shigehira Saji, John Winslow, Xueguang Jin, Yuping Tan, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Kenjiro Aogi, Satoshi Morita, Christos Petropoulos, Michael Bates |
Masakazu Toi, Jeff Sperinde, Weidong Huang, Shigehira Saji, John Winslow, Xueguang Jin, Yuping Tan, Shinji Ohno, Seigo Nakamura, Hiroji Iwata, Norikazu Masuda, Kenjiro Aogi, Satoshi Morita, Christos Petropoulos, Michael Bates |
Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer |
Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer |
Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer |
BMC CANCER, 10 |
BMC CANCER, 10 |
BMC CANCER, 10 |
2010/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| 柏葉, 匡寛, 石黒, 洋, 大野, 真司, 川端, 英孝, 中村, 清吾, 坂東, 裕子, 増田, 慎三, 戸井, 雅和 |
柏葉, 匡寛, 石黒, 洋, 大野, 真司, 川端, 英孝, 中村, 清吾, 坂東, 裕子, 増田, 慎三, 戸井, 雅和 |
柏葉, 匡寛, 石黒, 洋, 大野, 真司, 川端, 英孝, 中村, 清吾, 坂東, 裕子, 増田, 慎三, 戸井, 雅和 |
臨床エビデンスからの視点によるTC療法の展開 |
臨床エビデンスからの視点によるTC療法の展開 |
臨床エビデンスからの視点によるTC療法の展開 |
CANCER BOARD 乳癌, 3, 1, 26-38 |
CANCER BOARD 乳癌, 3, 1, 26-38 |
CANCER BOARD 乳癌, 3, 1, 26-38 |
2010/01 |
|
日本語 |
研究論文(学術雑誌) |
公開 |
| M. Toi |
M. Toi |
M. Toi |
[Current organ topics: chemotherapy of breast cancer]. |
[Current organ topics: chemotherapy of breast cancer]. |
[Current organ topics: chemotherapy of breast cancer]. |
Gan to kagaku ryoho. Cancer & chemotherapy, 37, 13, 2844- |
Gan to kagaku ryoho. Cancer & chemotherapy, 37, 13, 2844- |
Gan to kagaku ryoho. Cancer & chemotherapy, 37, 13, 2844- |
2010 |
有 |
英語 |
|
公開 |
| W. Tsuji, H. Yamashiro, M. Toi |
W. Tsuji, H. Yamashiro, M. Toi |
W. Tsuji, H. Yamashiro, M. Toi |
[Basic fibroblast growth factor (FGF-2)]. |
[Basic fibroblast growth factor (FGF-2)]. |
[Basic fibroblast growth factor (FGF-2)]. |
Nippon rinsho. Japanese journal of clinical medicine, 68 Suppl 7, 118-120 |
Nippon rinsho. Japanese journal of clinical medicine, 68 Suppl 7, 118-120 |
Nippon rinsho. Japanese journal of clinical medicine, 68 Suppl 7, 118-120 |
2010 |
有 |
英語 |
|
公開 |
| H. Yamashiro, M. Toi |
H. Yamashiro, M. Toi |
H. Yamashiro, M. Toi |
[Molecular targeted therapy for breast cancer treatment, challenge to cure]. |
[Molecular targeted therapy for breast cancer treatment, challenge to cure]. |
[Molecular targeted therapy for breast cancer treatment, challenge to cure]. |
Nippon rinsho. Japanese journal of clinical medicine, 68, 10, 1854-1858 |
Nippon rinsho. Japanese journal of clinical medicine, 68, 10, 1854-1858 |
Nippon rinsho. Japanese journal of clinical medicine, 68, 10, 1854-1858 |
2010 |
有 |
英語 |
|
公開 |
| S.-I. Horiguchi, T. Hishima, Y. Hayashi, Y. Shiozawa, K. Horiguchi, K. Kuroi, M. Toi, N. Funata, Y. Eishi |
S.-I. Horiguchi, T. Hishima, Y. Hayashi, Y. Shiozawa, K. Horiguchi, K. Kuroi, M. Toi, N. Funata, Y. Eishi |
S.-I. Horiguchi, T. Hishima, Y. Hayashi, Y. Shiozawa, K. Horiguchi, K. Kuroi, M. Toi, N. Funata, Y. Eishi |
HER-2/neu cytoplasmic staining is correlated with neuroendocrine differentiation in breast carcinoma |
HER-2/neu cytoplasmic staining is correlated with neuroendocrine differentiation in breast carcinoma |
HER-2/neu cytoplasmic staining is correlated with neuroendocrine differentiation in breast carcinoma |
Journal of Medical and Dental Sciences, 57, 2, 155-163 |
Journal of Medical and Dental Sciences, 57, 2, 155-163 |
Journal of Medical and Dental Sciences, 57, 2, 155-163 |
2010 |
有 |
英語 |
|
公開 |
| K. Horiguchi, M. Toi, S.-I. Horiguchi, M. Sugimoto, Y. Naito, Y. Hayashi, T. Ueno, S. Ohno, N. Funata, K. Kuroi, M. Tomita, Y. Eishi |
K. Horiguchi, M. Toi, S.-I. Horiguchi, M. Sugimoto, Y. Naito, Y. Hayashi, T. Ueno, S. Ohno, N. Funata, K. Kuroi, M. Tomita, Y. Eishi |
K. Horiguchi, M. Toi, S.-I. Horiguchi, M. Sugimoto, Y. Naito, Y. Hayashi, T. Ueno, S. Ohno, N. Funata, K. Kuroi, M. Tomita, Y. Eishi |
Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients |
Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients |
Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients |
Journal of Medical and Dental Sciences, 57, 2, 165-175 |
Journal of Medical and Dental Sciences, 57, 2, 165-175 |
Journal of Medical and Dental Sciences, 57, 2, 165-175 |
2010 |
有 |
英語 |
|
公開 |
| Y. Matsumura, H. Yamashiro, M. Toi |
Y. Matsumura, H. Yamashiro, M. Toi |
|
Trastuzumab for cancer treatment: Present role and future perspective |
Trastuzumab for cancer treatment: Present role and future perspective |
|
Biotherapy, 24, 2, 178-182 |
Biotherapy, 24, 2, 178-182 |
, 24, 2, 178-182 |
2010 |
有 |
日本語 |
|
公開 |
| Yu Kimura, Wakako Tsuji, Hiroyasu Yamashiro, Masakazu Toi, Takashi Inamoto, Yasuhiko Tabata |
Yu Kimura, Wakako Tsuji, Hiroyasu Yamashiro, Masakazu Toi, Takashi Inamoto, Yasuhiko Tabata |
Yu Kimura, Wakako Tsuji, Hiroyasu Yamashiro, Masakazu Toi, Takashi Inamoto, Yasuhiko Tabata |
In situ adipogenesis in fat tissue augmented by collagen scaffold with gelatin microspheres containing basic fibroblast growth factor |
In situ adipogenesis in fat tissue augmented by collagen scaffold with gelatin microspheres containing basic fibroblast growth factor |
In situ adipogenesis in fat tissue augmented by collagen scaffold with gelatin microspheres containing basic fibroblast growth factor |
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 4, 1, 55-61 |
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 4, 1, 55-61 |
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 4, 1, 55-61 |
2010/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Toi, H. Iwata, Y. Fujiwara, Y. Ito, S. Nakamura, Y. Tokuda, T. Taguchi, Y. Rai, K. Aogi, T. Arai, J. Watanabe, T. Wakamatsu, K. Katsura, C. E. Ellis, R. C. Gagnon, K. E. Allen, Y. Sasaki, S. Takashima |
M. Toi, H. Iwata, Y. Fujiwara, Y. Ito, S. Nakamura, Y. Tokuda, T. Taguchi, Y. Rai, K. Aogi, T. Arai, J. Watanabe, T. Wakamatsu, K. Katsura, C. E. Ellis, R. C. Gagnon, K. E. Allen, Y. Sasaki, S. Takashima |
M. Toi, H. Iwata, Y. Fujiwara, Y. Ito, S. Nakamura, Y. Tokuda, T. Taguchi, Y. Rai, K. Aogi, T. Arai, J. Watanabe, T. Wakamatsu, K. Katsura, C. E. Ellis, R. C. Gagnon, K. E. Allen, Y. Sasaki, S. Takashima |
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies |
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies |
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies |
BRITISH JOURNAL OF CANCER, 101, 10, 1676-1682 |
BRITISH JOURNAL OF CANCER, 101, 10, 1676-1682 |
BRITISH JOURNAL OF CANCER, 101, 10, 1676-1682 |
2009/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Md. Zahidunnabi Dewan, Masahiro Takada, Hiroshi Terunuma, Xuewen Deng, Sunjida Ahmed, Naoki Yamamoto, Masakazu Toi |
Md. Zahidunnabi Dewan, Masahiro Takada, Hiroshi Terunuma, Xuewen Deng, Sunjida Ahmed, Naoki Yamamoto, Masakazu Toi |
Md. Zahidunnabi Dewan, Masahiro Takada, Hiroshi Terunuma, Xuewen Deng, Sunjida Ahmed, Naoki Yamamoto, Masakazu Toi |
Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients |
Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients |
Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients |
BIOMEDICINE & PHARMACOTHERAPY, 63, 9, 703-706 |
BIOMEDICINE & PHARMACOTHERAPY, 63, 9, 703-706 |
BIOMEDICINE & PHARMACOTHERAPY, 63, 9, 703-706 |
2009/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masahide Kondo, Shu-Ling Hoshi, Masakazu Toi |
Masahide Kondo, Shu-Ling Hoshi, Masakazu Toi |
Masahide Kondo, Shu-Ling Hoshi, Masakazu Toi |
Budget Impact Analysis of Chemoprevention of Breast Cancer with Tamoxifen and Raloxifene among High-risk Women in Japan |
Budget Impact Analysis of Chemoprevention of Breast Cancer with Tamoxifen and Raloxifene among High-risk Women in Japan |
Budget Impact Analysis of Chemoprevention of Breast Cancer with Tamoxifen and Raloxifene among High-risk Women in Japan |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39, 11, 767-770 |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39, 11, 767-770 |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39, 11, 767-770 |
2009/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| A. M. Ali, M. Toi, T. Ueno |
A. M. Ali, M. Toi, T. Ueno |
A. M. Ali, M. Toi, T. Ueno |
Anti-Angiogenic Cancer Therapy Updates |
Anti-Angiogenic Cancer Therapy Updates |
Anti-Angiogenic Cancer Therapy Updates |
CURRENT MOLECULAR MEDICINE, 9, 8, 954-966 |
CURRENT MOLECULAR MEDICINE, 9, 8, 954-966 |
CURRENT MOLECULAR MEDICINE, 9, 8, 954-966 |
2009/11 |
有 |
英語 |
|
公開 |
| Shinzaburo Noguchi, Masakazu Toi |
Shinzaburo Noguchi, Masakazu Toi |
Shinzaburo Noguchi, Masakazu Toi |
From standardization to personalization in breast cancer treatment |
From standardization to personalization in breast cancer treatment |
From standardization to personalization in breast cancer treatment |
BREAST CANCER, 16, 4, 241-242 |
BREAST CANCER, 16, 4, 241-242 |
BREAST CANCER, 16, 4, 241-242 |
2009/10 |
有 |
英語 |
|
公開 |
| Tomoyuki Aruga, Eiji Suzuki, Shigehira Saji, Shin-Ichirou Horiguchi, Kazumi Horiguchi, Susumu Sekine, Dai Kitagawa, Nobuaki Funata, Masakazu Toi, Kenichi Sugihara, Katsumasa Kuroi |
Tomoyuki Aruga, Eiji Suzuki, Shigehira Saji, Shin-Ichirou Horiguchi, Kazumi Horiguchi, Susumu Sekine, Dai Kitagawa, Nobuaki Funata, Masakazu Toi, Kenichi Sugihara, Katsumasa Kuroi |
Tomoyuki Aruga, Eiji Suzuki, Shigehira Saji, Shin-Ichirou Horiguchi, Kazumi Horiguchi, Susumu Sekine, Dai Kitagawa, Nobuaki Funata, Masakazu Toi, Kenichi Sugihara, Katsumasa Kuroi |
A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer |
A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer |
A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer |
ONCOLOGY REPORTS, 22, 2, 273-278 |
ONCOLOGY REPORTS, 22, 2, 273-278 |
ONCOLOGY REPORTS, 22, 2, 273-278 |
2009/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masakazu Toi, Hiroyasu Yamashiro, Wakako Tsuji |
Masakazu Toi, Hiroyasu Yamashiro, Wakako Tsuji |
Masakazu Toi, Hiroyasu Yamashiro, Wakako Tsuji |
Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer |
Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer |
Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer |
BREAST CANCER, 16, 3, 207-218 |
BREAST CANCER, 16, 3, 207-218 |
BREAST CANCER, 16, 3, 207-218 |
2009/07 |
有 |
英語 |
|
公開 |
| F. Chen, T. Fujinaga, K. Sato, M. Sonobe, T. Shoji, H. Sakai, R. Miyahara, T. Bando, K. Okubo, T. Hirata, M. Toi, H. Date |
F. Chen, T. Fujinaga, K. Sato, M. Sonobe, T. Shoji, H. Sakai, R. Miyahara, T. Bando, K. Okubo, T. Hirata, M. Toi, H. Date |
F. Chen, T. Fujinaga, K. Sato, M. Sonobe, T. Shoji, H. Sakai, R. Miyahara, T. Bando, K. Okubo, T. Hirata, M. Toi, H. Date |
Clinical features of surgical resection for pulmonary metastasis from breast cancer |
Clinical features of surgical resection for pulmonary metastasis from breast cancer |
Clinical features of surgical resection for pulmonary metastasis from breast cancer |
EJSO, 35, 4, 393-397 |
EJSO, 35, 4, 393-397 |
EJSO, 35, 4, 393-397 |
2009/04 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Kondo, S-L Hoshi, M. Toi |
M. Kondo, S-L Hoshi, M. Toi |
M. Kondo, S-L Hoshi, M. Toi |
Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan |
Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan |
Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan |
BRITISH JOURNAL OF CANCER, 100, 2, 281-290 |
BRITISH JOURNAL OF CANCER, 100, 2, 281-290 |
BRITISH JOURNAL OF CANCER, 100, 2, 281-290 |
2009/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Wakako Tsuji, Takashi Inamoto, Hiroyasu Yamashiro, Takayuki Ueno, Hironori Kato, Yu Kimura, Yasuhiko Tabata, Masakazu Toi |
Wakako Tsuji, Takashi Inamoto, Hiroyasu Yamashiro, Takayuki Ueno, Hironori Kato, Yu Kimura, Yasuhiko Tabata, Masakazu Toi |
Wakako Tsuji, Takashi Inamoto, Hiroyasu Yamashiro, Takayuki Ueno, Hironori Kato, Yu Kimura, Yasuhiko Tabata, Masakazu Toi |
Adipogenesis Induced by Human Adipose Tissue-Derived Stem Cells |
Adipogenesis Induced by Human Adipose Tissue-Derived Stem Cells |
Adipogenesis Induced by Human Adipose Tissue-Derived Stem Cells |
TISSUE ENGINEERING PART A, 15, 1, 83-93 |
TISSUE ENGINEERING PART A, 15, 1, 83-93 |
TISSUE ENGINEERING PART A, 15, 1, 83-93 |
2009/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Kimura Y, Tsuji W, Yamashiro H, Toi M, Inamoto T, Tabata Y |
Kimura Y, Tsuji W, Yamashiro H, Toi M, Inamoto T, Tabata Y |
Kimura Y, Tsuji W, Yamashiro H, Toi M, Inamoto T, Tabata Y |
In Situ adipose tissue regeneration augmented by collagen scaffold combined with gelatin microspheres containing basic fibroblast growth factor. |
In Situ adipose tissue regeneration augmented by collagen scaffold combined with gelatin microspheres containing basic fibroblast growth factor. |
In Situ adipose tissue regeneration augmented by collagen scaffold combined with gelatin microspheres containing basic fibroblast growth factor. |
The 2nd World Congress of the Tissue Engineering and Regenerative Medicine International Society （TERMIS-WC2009） （2009.08.31－09. 03 Seoul, Korea） |
The 2nd World Congress of the Tissue Engineering and Regenerative Medicine International Society （TERMIS-WC2009） （2009.08.31－09. 03 Seoul, Korea） |
The 2nd World Congress of the Tissue Engineering and Regenerative Medicine International Society （TERMIS-WC2009） （2009.08.31－09. 03 Seoul, Korea） |
2009 |
有 |
英語 |
|
公開 |
| H. Ishiguro, I. Yano, M. Toi |
H. Ishiguro, I. Yano, M. Toi |
H. Ishiguro, I. Yano, M. Toi |
Pharmacogenomic considerations in breast cancer management |
Pharmacogenomic considerations in breast cancer management |
Pharmacogenomic considerations in breast cancer management |
Frontiers in Drug Design and Discovery, 4, 1, 122-134 |
Frontiers in Drug Design and Discovery, 4, 1, 122-134 |
Frontiers in Drug Design and Discovery, 4, 1, 122-134 |
2009 |
有 |
英語 |
|
公開 |
| H. Ishiguro, I. Yano, M. Toi |
H. Ishiguro, I. Yano, M. Toi |
H. Ishiguro, I. Yano, M. Toi |
Important drug interactions for clinical oncologists |
Important drug interactions for clinical oncologists |
Important drug interactions for clinical oncologists |
Frontiers in Drug Design and Discovery, 4, 1, 97-121 |
Frontiers in Drug Design and Discovery, 4, 1, 97-121 |
Frontiers in Drug Design and Discovery, 4, 1, 97-121 |
2009 |
有 |
英語 |
|
公開 |
| T. Ueno, M. Toi |
T. Ueno, M. Toi |
T. Ueno, M. Toi |
Biomarker |
Biomarker |
Biomarker |
Japanese Journal of Cancer and Chemotherapy, 36, 1, 15-20 |
Japanese Journal of Cancer and Chemotherapy, 36, 1, 15-20 |
Japanese Journal of Cancer and Chemotherapy, 36, 1, 15-20 |
2009 |
有 |
英語 |
|
公開 |
| H. Yamashiro, M. Toi |
H. Yamashiro, M. Toi |
|
Anti-HER2 antibody and small-molecule tyrosine kinase inhibitor therapy targeting EGFR signal pathway |
Anti-HER2 antibody and small-molecule tyrosine kinase inhibitor therapy targeting EGFR signal pathway |
|
Japanese Journal of Cancer and Chemotherapy, 36, 7, 1067-1071 |
Japanese Journal of Cancer and Chemotherapy, 36, 7, 1067-1071 |
, 36, 7, 1067-1071 |
2009 |
有 |
日本語 |
|
公開 |
| M. Toi, H. Sasano, M.J. Ellis |
M. Toi, H. Sasano, M.J. Ellis |
|
Future prospects of neoadjuvant endocrine therapy in postmenopausal breast cancer |
Future prospects of neoadjuvant endocrine therapy in postmenopausal breast cancer |
|
Japanese Journal of Cancer and Chemotherapy, 36, 6, 1035-1042 |
Japanese Journal of Cancer and Chemotherapy, 36, 6, 1035-1042 |
, 36, 6, 1035-1042 |
2009 |
有 |
日本語 |
|
公開 |
| T. Sugie, Y. Tanaka, M. Toi |
T. Sugie, Y. Tanaka, M. Toi |
T. Sugie, Y. Tanaka, M. Toi |
New development in breast cancer therapy. III. Zoledronic acid and anti-tumor immunity in breast cancer |
New development in breast cancer therapy. III. Zoledronic acid and anti-tumor immunity in breast cancer |
New development in breast cancer therapy. III. Zoledronic acid and anti-tumor immunity in breast cancer |
Gan to kagaku ryoho. Cancer & chemotherapy, 36, 13, 2555-2559 |
Gan to kagaku ryoho. Cancer & chemotherapy, 36, 13, 2555-2559 |
Gan to kagaku ryoho. Cancer & chemotherapy, 36, 13, 2555-2559 |
2009 |
有 |
英語 |
|
公開 |
| Mariko Muta, Tomonori Yanagawa, Yoshimichi Sai, Shigehira Saji, Eiji Suzuki, Tomoyuki Aruga, Katsumasa Kuroi, Gaku Matsumoto, Masakazu Toi, Emi Nakashima |
Mariko Muta, Tomonori Yanagawa, Yoshimichi Sai, Shigehira Saji, Eiji Suzuki, Tomoyuki Aruga, Katsumasa Kuroi, Gaku Matsumoto, Masakazu Toi, Emi Nakashima |
Mariko Muta, Tomonori Yanagawa, Yoshimichi Sai, Shigehira Saji, Eiji Suzuki, Tomoyuki Aruga, Katsumasa Kuroi, Gaku Matsumoto, Masakazu Toi, Emi Nakashima |
Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells |
Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells |
Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells |
ONCOLOGY, 77, 3-4, 182-191 |
ONCOLOGY, 77, 3-4, 182-191 |
ONCOLOGY, 77, 3-4, 182-191 |
2009 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| 芳林 哲史, 石黒 洋, 戸井 雅和 |
芳林 哲史, 石黒 洋, 戸井 雅和 |
|
【補助化学療法】 乳がんに対する補助薬物療法 |
【補助化学療法】 乳がんに対する補助薬物療法 |
|
腫瘍内科, 2, 6, 500-509 |
腫瘍内科, 2, 6, 500-509 |
, 2, 6, 500-509 |
2008/12 |
|
|
|
公開 |
| Takayoshi Kiba, Takashi Inamoto, Tsutomu Nishimura, Masaya Ueno, Kazuhiro Yanagihara, Satoshi Teramukai, Hironori Kato, Masakazu Toi, Masanori Fukushima |
Takayoshi Kiba, Takashi Inamoto, Tsutomu Nishimura, Masaya Ueno, Kazuhiro Yanagihara, Satoshi Teramukai, Hironori Kato, Masakazu Toi, Masanori Fukushima |
Takayoshi Kiba, Takashi Inamoto, Tsutomu Nishimura, Masaya Ueno, Kazuhiro Yanagihara, Satoshi Teramukai, Hironori Kato, Masakazu Toi, Masanori Fukushima |
The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery |
The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery |
The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery |
BMC CANCER, 8 |
BMC CANCER, 8 |
BMC CANCER, 8 |
2008/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masahide Kondo, Shu Ling Hoshi, Hiroshi Ishiguro, Hiroshi Yoshibayashi, Masakazu Toi |
Masahide Kondo, Shu Ling Hoshi, Hiroshi Ishiguro, Hiroshi Yoshibayashi, Masakazu Toi |
Masahide Kondo, Shu Ling Hoshi, Hiroshi Ishiguro, Hiroshi Yoshibayashi, Masakazu Toi |
Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan |
Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan |
Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan |
BREAST CANCER RESEARCH AND TREATMENT, 112, 1, 175-187 |
BREAST CANCER RESEARCH AND TREATMENT, 112, 1, 175-187 |
BREAST CANCER RESEARCH AND TREATMENT, 112, 1, 175-187 |
2008/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| N. Honma, S. Saji, R. Kurabayashi, J. Aida, T. Arai, R. Horii, F. Akiyama, T. Iwase, N. Harada, M. Younes, M. Toi, K. Takubo, G. Sakamoto |
N. Honma, S. Saji, R. Kurabayashi, J. Aida, T. Arai, R. Horii, F. Akiyama, T. Iwase, N. Harada, M. Younes, M. Toi, K. Takubo, G. Sakamoto |
Naoko Honma, Shigehira Saji, Rie Kurabayashi, Junko Aida, Tomio Arai, Rie Horii, Futoshi Akiyama, Takuji Iwase, Nobuhiro Harada, Mamoun Younes, Masakazu Toi, Kaiyo Takubo, Goi Sakamoto |
Oestrogen receptor-β1 but not oestrogen receptor-βcx is of prognostic value in apocrine carcinoma of the breast |
Oestrogen receptor-β1 but not oestrogen receptor-βcx is of prognostic value in apocrine carcinoma of the breast |
Oestrogen receptor-beta 1 but not oestrogen receptor-beta cx is of prognostic value in apocrine carcinoma of the breast |
APMIS, 116, 10, 923-930 |
APMIS, 116, 10, 923-930 |
APMIS, 116, 10, 923-930 |
2008/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Nahomi Tokudome, Yoshinori Ito, Kiyohiko Hatake, Masakazu Toi, Muneaki Sano, Hiroji Iwata, Yasuyuki Sato, Toshiaki Saeki, Kenjiro Aogi, Shigemitsu Takashima |
Nahomi Tokudome, Yoshinori Ito, Kiyohiko Hatake, Masakazu Toi, Muneaki Sano, Hiroji Iwata, Yasuyuki Sato, Toshiaki Saeki, Kenjiro Aogi, Shigemitsu Takashima |
Nahomi Tokudome, Yoshinori Ito, Kiyohiko Hatake, Masakazu Toi, Muneaki Sano, Hiroji Iwata, Yasuyuki Sato, Toshiaki Saeki, Kenjiro Aogi, Shigemitsu Takashima |
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan |
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan |
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan |
ANTI-CANCER DRUGS, 19, 7, 753-759 |
ANTI-CANCER DRUGS, 19, 7, 753-759 |
ANTI-CANCER DRUGS, 19, 7, 753-759 |
2008/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masakazu Toi, Seigo Nakamura, Katsumasa Kuroi, Hiroji Iwata, Shinji Ohno, Norikazu Masuda, Mikihiro Kusama, Kosuke Yamazaki, Kazuhumi Hisamatsu, Yasuyuki Sato, Masahiro Kashiwaba, Hiroshi Kaise, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, Yuichi Takatsuka |
Masakazu Toi, Seigo Nakamura, Katsumasa Kuroi, Hiroji Iwata, Shinji Ohno, Norikazu Masuda, Mikihiro Kusama, Kosuke Yamazaki, Kazuhumi Hisamatsu, Yasuyuki Sato, Masahiro Kashiwaba, Hiroshi Kaise, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, Yuichi Takatsuka |
Masakazu Toi, Seigo Nakamura, Katsumasa Kuroi, Hiroji Iwata, Shinji Ohno, Norikazu Masuda, Mikihiro Kusama, Kosuke Yamazaki, Kazuhumi Hisamatsu, Yasuyuki Sato, Masahiro Kashiwaba, Hiroshi Kaise, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, Yuichi Takatsuka |
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival |
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival |
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival |
BREAST CANCER RESEARCH AND TREATMENT, 110, 3, 531-539 |
BREAST CANCER RESEARCH AND TREATMENT, 110, 3, 531-539 |
BREAST CANCER RESEARCH AND TREATMENT, 110, 3, 531-539 |
2008/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-Yung Loo, Chi-Kei Lam, Masakazu Toi |
Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-Yung Loo, Chi-Kei Lam, Masakazu Toi |
Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-Yung Loo, Chi-Kei Lam, Masakazu Toi |
Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer |
Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer |
Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer |
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 111, 1-2, 13-17 |
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 111, 1-2, 13-17 |
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 111, 1-2, 13-17 |
2008/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Hiroshi Yagata, Seigo Nakamura, Masakazu Toi, Hiroko Bando, Shinji Ohno, Akemi Kataoka |
Hiroshi Yagata, Seigo Nakamura, Masakazu Toi, Hiroko Bando, Shinji Ohno, Akemi Kataoka |
Hiroshi Yagata, Seigo Nakamura, Masakazu Toi, Hiroko Bando, Shinji Ohno, Akemi Kataoka |
Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional clinical trial in Japan |
Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional clinical trial in Japan |
Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional clinical trial in Japan |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 13, 3, 252-256 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 13, 3, 252-256 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 13, 3, 252-256 |
2008/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H. Ishiguro, T. Kitano, H. Yoshibayashi, M. Toi, T. Ueno, H. Yasuda, K. Yanagihara, C. L. Garbo, M. Fukushima |
H. Ishiguro, T. Kitano, H. Yoshibayashi, M. Toi, T. Ueno, H. Yasuda, K. Yanagihara, C. L. Garbo, M. Fukushima |
H. Ishiguro, T. Kitano, H. Yoshibayashi, M. Toi, T. Ueno, H. Yasuda, K. Yanagihara, C. L. Garbo, M. Fukushima |
Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim |
Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim |
Prolonged neutropenia after dose-dense chemotherapy with pegfilgrastim |
ANNALS OF ONCOLOGY, 19, 5, 1019- |
ANNALS OF ONCOLOGY, 19, 5, 1019- |
ANNALS OF ONCOLOGY, 19, 5, 1019- |
2008/05 |
有 |
英語 |
|
公開 |
| 山城 大泰, 石黒 洋, 戸井 雅和 |
山城 大泰, 石黒 洋, 戸井 雅和 |
|
【妊娠中に発見された悪性腫瘍の取り扱い】 妊娠中に発見される乳癌 |
【妊娠中に発見された悪性腫瘍の取り扱い】 妊娠中に発見される乳癌 |
|
産婦人科の実際, 57, 4, 669-675 |
産婦人科の実際, 57, 4, 669-675 |
, 57, 4, 669-675 |
2008/04 |
|
|
|
公開 |
| Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-Yung Loo, Masakazu Toi |
Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-Yung Loo, Masakazu Toi |
Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-Yung Loo, Masakazu Toi |
Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer |
Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer |
Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer |
CANCER LETTERS, 262, 2, 232-238 |
CANCER LETTERS, 262, 2, 232-238 |
CANCER LETTERS, 262, 2, 232-238 |
2008/04 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Takayuki Ueno, Goran Elmberger, Timothy E. Weaver, Masakazu Toi, Stig Linder |
Takayuki Ueno, Goran Elmberger, Timothy E. Weaver, Masakazu Toi, Stig Linder |
Takayuki Ueno, Goran Elmberger, Timothy E. Weaver, Masakazu Toi, Stig Linder |
The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity |
The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity |
The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity |
LABORATORY INVESTIGATION, 88, 3, 256-263 |
LABORATORY INVESTIGATION, 88, 3, 256-263 |
LABORATORY INVESTIGATION, 88, 3, 256-263 |
2008/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Hiroyasu Yamashiro, Masakazu Toi |
Hiroyasu Yamashiro, Masakazu Toi |
Hiroyasu Yamashiro, Masakazu Toi |
Update of evidence in chemotherapy for breast cancer |
Update of evidence in chemotherapy for breast cancer |
Update of evidence in chemotherapy for breast cancer |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 13, 1, 3-7 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 13, 1, 3-7 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 13, 1, 3-7 |
2008/02 |
有 |
英語 |
|
公開 |
| M. Takada, H. Ishiguro, M. Toi |
M. Takada, H. Ishiguro, M. Toi |
M. Takada, H. Ishiguro, M. Toi |
Treatment for breast cancer and endocrine neoplasm |
Treatment for breast cancer and endocrine neoplasm |
Treatment for breast cancer and endocrine neoplasm |
Gan to kagaku ryoho. Cancer & chemotherapy, 35, 13, 2344-2350 |
Gan to kagaku ryoho. Cancer & chemotherapy, 35, 13, 2344-2350 |
Gan to kagaku ryoho. Cancer & chemotherapy, 35, 13, 2344-2350 |
2008 |
有 |
英語 |
|
公開 |
| H. Yoshibayashi, H. Ishiguro, M. Takada, M. Takeuchi, H. Yamashiro, T. Ueno, H. Kato, K. Yoshikawa, S. Kanao, C. Yamauchi, Y. Mikami, M. Toi |
H. Yoshibayashi, H. Ishiguro, M. Takada, M. Takeuchi, H. Yamashiro, T. Ueno, H. Kato, K. Yoshikawa, S. Kanao, C. Yamauchi, Y. Mikami, M. Toi |
|
A case of primary breast cancer who responded remarkably to the neoadjuvant chemotherapy with the combination of docetaxel and cyclophosphamide |
A case of primary breast cancer who responded remarkably to the neoadjuvant chemotherapy with the combination of docetaxel and cyclophosphamide |
|
Gan to kagaku ryoho. Cancer & chemotherapy, 35, 6, 987-990 |
Gan to kagaku ryoho. Cancer & chemotherapy, 35, 6, 987-990 |
, 35, 6, 987-990 |
2008 |
有 |
日本語 |
|
公開 |
| M. Toi |
M. Toi |
M. Toi |
Novel targeting therapy concept for breast cancer treatment |
Novel targeting therapy concept for breast cancer treatment |
Novel targeting therapy concept for breast cancer treatment |
Folia Pharmacologica Japonica, 132, 3, 177-179 |
Folia Pharmacologica Japonica, 132, 3, 177-179 |
Folia Pharmacologica Japonica, 132, 3, 177-179 |
2008 |
有 |
英語 |
|
公開 |
| Shinzaburo Noguchi, Masakazu Toi |
Shinzaburo Noguchi, Masakazu Toi |
Shinzaburo Noguchi, Masakazu Toi |
Molecular target therapy: basics and clinical application |
Molecular target therapy: basics and clinical application |
Molecular target therapy: basics and clinical application |
BREAST CANCER, 15, 1, 47-48 |
BREAST CANCER, 15, 1, 47-48 |
BREAST CANCER, 15, 1, 47-48 |
2008/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masakazu Toi |
Masakazu Toi |
Masakazu Toi |
Long-term outcomes of aromatase inhibition for breast cancer |
Long-term outcomes of aromatase inhibition for breast cancer |
Long-term outcomes of aromatase inhibition for breast cancer |
LANCET ONCOLOGY, 9, 1, 8-10 |
LANCET ONCOLOGY, 9, 1, 8-10 |
LANCET ONCOLOGY, 9, 1, 8-10 |
2008/01 |
有 |
英語 |
|
公開 |
| Masakazu Toi, Tadashi Ikeda, Futoshi Akiyama, Masafumi Kurosumi, Hitoshi Tsuda, Goi Sakamoto, Osahiko Abe |
Masakazu Toi, Tadashi Ikeda, Futoshi Akiyama, Masafumi Kurosumi, Hitoshi Tsuda, Goi Sakamoto, Osahiko Abe |
Masakazu Toi, Tadashi Ikeda, Futoshi Akiyama, Masafumi Kurosumi, Hitoshi Tsuda, Goi Sakamoto, Osahiko Abe |
Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy |
Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy |
Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy |
INTERNATIONAL JOURNAL OF ONCOLOGY, 31, 4, 899-906 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 31, 4, 899-906 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 31, 4, 899-906 |
2007/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Md. Zahidunnabi Dewan, Hiroshi Terunuma, Masahiro Takada, Yuetsu Tanaka, Hiroyuki Abe, Tetsutaro Sata, Masakazu Toi, Naoki Yamamoto |
Md. Zahidunnabi Dewan, Hiroshi Terunuma, Masahiro Takada, Yuetsu Tanaka, Hiroyuki Abe, Tetsutaro Sata, Masakazu Toi, Naoki Yamamoto |
Md. Zahidunnabi Dewan, Hiroshi Terunuma, Masahiro Takada, Yuetsu Tanaka, Hiroyuki Abe, Tetsutaro Sata, Masakazu Toi, Naoki Yamamoto |
Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo |
Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo |
Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo |
BREAST CANCER RESEARCH AND TREATMENT, 104, 3, 267-275 |
BREAST CANCER RESEARCH AND TREATMENT, 104, 3, 267-275 |
BREAST CANCER RESEARCH AND TREATMENT, 104, 3, 267-275 |
2007/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Maria Hagg Olofsson, Takayuki Ueno, Yang Pan, Ren Xu, Feng Cai, Heiko van der Kuip, Thomas E. Muerdter, Maike Sonnenberg, Walter E. Aulitzk, Stephan Schwarz, Elina Andersson, Maria C. Shoshan, Aleksandra Mandic Havelka, Masakozu Toi, Stig Linder |
Maria Hagg Olofsson, Takayuki Ueno, Yang Pan, Ren Xu, Feng Cai, Heiko van der Kuip, Thomas E. Muerdter, Maike Sonnenberg, Walter E. Aulitzk, Stephan Schwarz, Elina Andersson, Maria C. Shoshan, Aleksandra Mandic Havelka, Masakozu Toi, Stig Linder |
Maria Hagg Olofsson, Takayuki Ueno, Yang Pan, Ren Xu, Feng Cai, Heiko van der Kuip, Thomas E. Muerdter, Maike Sonnenberg, Walter E. Aulitzk, Stephan Schwarz, Elina Andersson, Maria C. Shoshan, Aleksandra Mandic Havelka, Masakozu Toi, Stig Linder |
Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy |
Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy |
Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy |
CLINICAL CANCER RESEARCH, 13, 11, 3198-3206 |
CLINICAL CANCER RESEARCH, 13, 11, 3198-3206 |
CLINICAL CANCER RESEARCH, 13, 11, 3198-3206 |
2007/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Eiji Suzuki, Masakazu Toi |
Eiji Suzuki, Masakazu Toi |
Eiji Suzuki, Masakazu Toi |
Improving the efficacy of trastuzumab in breast cancer |
Improving the efficacy of trastuzumab in breast cancer |
Improving the efficacy of trastuzumab in breast cancer |
CANCER SCIENCE, 98, 6, 767-771 |
CANCER SCIENCE, 98, 6, 767-771 |
CANCER SCIENCE, 98, 6, 767-771 |
2007/06 |
有 |
英語 |
|
公開 |
| Eiji Suzuki, Rinpei Niwa, Shigehira Saji, Mariko Muta, Makiko Hirose, Shigeru Iida, Yukimasa Shiotsu, Mitsuo Satoh, Kenya Shitara, Masahide Kondo, Masakazu Toi |
Eiji Suzuki, Rinpei Niwa, Shigehira Saji, Mariko Muta, Makiko Hirose, Shigeru Iida, Yukimasa Shiotsu, Mitsuo Satoh, Kenya Shitara, Masahide Kondo, Masakazu Toi |
Eiji Suzuki, Rinpei Niwa, Shigehira Saji, Mariko Muta, Makiko Hirose, Shigeru Iida, Yukimasa Shiotsu, Mitsuo Satoh, Kenya Shitara, Masahide Kondo, Masakazu Toi |
A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients |
A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients |
A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients |
CLINICAL CANCER RESEARCH, 13, 6, 1875-1882 |
CLINICAL CANCER RESEARCH, 13, 6, 1875-1882 |
CLINICAL CANCER RESEARCH, 13, 6, 1875-1882 |
2007/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Tatsuro Yamaguchi, Hiroko Bando, Takeo Mori, Keiichi Takahashi, Hiroshi Matsumoto, Michiya Yasutome, Herbert A. Weich, Masakazu Toi |
Tatsuro Yamaguchi, Hiroko Bando, Takeo Mori, Keiichi Takahashi, Hiroshi Matsumoto, Michiya Yasutome, Herbert A. Weich, Masakazu Toi |
Tatsuro Yamaguchi, Hiroko Bando, Takeo Mori, Keiichi Takahashi, Hiroshi Matsumoto, Michiya Yasutome, Herbert A. Weich, Masakazu Toi |
Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis |
Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis |
Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis |
CANCER SCIENCE, 98, 3, 405-410 |
CANCER SCIENCE, 98, 3, 405-410 |
CANCER SCIENCE, 98, 3, 405-410 |
2007/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Toshiaki Saeki, Tadashi Nomizu, Masakazu Toi, Yoshinori Ito, Shinzaburo Noguchi, Tadashi Kobayashi, Taro Asaga, Hironobu Minami, Naohito Yamamoto, Kenjiro Aogi, Tadashi Ikeda, Yasuo Ohashi, Wakao Sato, Takashi Tsuruo |
Toshiaki Saeki, Tadashi Nomizu, Masakazu Toi, Yoshinori Ito, Shinzaburo Noguchi, Tadashi Kobayashi, Taro Asaga, Hironobu Minami, Naohito Yamamoto, Kenjiro Aogi, Tadashi Ikeda, Yasuo Ohashi, Wakao Sato, Takashi Tsuruo |
Toshiaki Saeki, Tadashi Nomizu, Masakazu Toi, Yoshinori Ito, Shinzaburo Noguchi, Tadashi Kobayashi, Taro Asaga, Hironobu Minami, Naohito Yamamoto, Kenjiro Aogi, Tadashi Ikeda, Yasuo Ohashi, Wakao Sato, Takashi Tsuruo |
Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer |
Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer |
Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer |
JOURNAL OF CLINICAL ONCOLOGY, 25, 4, 411-417 |
JOURNAL OF CLINICAL ONCOLOGY, 25, 4, 411-417 |
JOURNAL OF CLINICAL ONCOLOGY, 25, 4, 411-417 |
2007/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Tsutomu Oikawa, Chizuko Onozawa, Sachi Kuranuki, Yasuhiro Igarashi, Mayumi Sato, Hiromi Ashino, Mariko Shimamura, Masakazu Toi, Shinichi Kurakata |
Tsutomu Oikawa, Chizuko Onozawa, Sachi Kuranuki, Yasuhiro Igarashi, Mayumi Sato, Hiromi Ashino, Mariko Shimamura, Masakazu Toi, Shinichi Kurakata |
Tsutomu Oikawa, Chizuko Onozawa, Sachi Kuranuki, Yasuhiro Igarashi, Mayumi Sato, Hiromi Ashino, Mariko Shimamura, Masakazu Toi, Shinichi Kurakata |
Dipalmitoylation of radicicol results in improved efficacy against tumor growth and angiogenesis in vivo |
Dipalmitoylation of radicicol results in improved efficacy against tumor growth and angiogenesis in vivo |
Dipalmitoylation of radicicol results in improved efficacy against tumor growth and angiogenesis in vivo |
CANCER SCIENCE, 98, 2, 219-225 |
CANCER SCIENCE, 98, 2, 219-225 |
CANCER SCIENCE, 98, 2, 219-225 |
2007/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Shigehira Saji, Masakazu Toi, Satoshi Morita, Hiroji Iwata, Yoshinori Ito, Shinji Ohno, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto |
Shigehira Saji, Masakazu Toi, Satoshi Morita, Hiroji Iwata, Yoshinori Ito, Shinji Ohno, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto |
Shigehira Saji, Masakazu Toi, Satoshi Morita, Hiroji Iwata, Yoshinori Ito, Shinji Ohno, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto |
Dose-finding phase I and pharmacokinetic study of capecitabine (xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer |
Dose-finding phase I and pharmacokinetic study of capecitabine (xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer |
Dose-finding phase I and pharmacokinetic study of capecitabine (xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer |
ONCOLOGY, 72, 5-6, 330-337 |
ONCOLOGY, 72, 5-6, 330-337 |
ONCOLOGY, 72, 5-6, 330-337 |
2007 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Takada, M. Toi |
M. Takada, M. Toi |
|
Primary systemic chemotherapy for breast cancer |
Primary systemic chemotherapy for breast cancer |
|
Gan to kagaku ryoho. Cancer & chemotherapy, 34, 11, 1730-1734 |
Gan to kagaku ryoho. Cancer & chemotherapy, 34, 11, 1730-1734 |
, 34, 11, 1730-1734 |
2007 |
有 |
日本語 |
|
公開 |
| N. Masuda, M. Toi, Y. Takatsuka, S. Nakamura, H. Iwata, S. Ohno, K. Kuroi, M. Kusama, K. Hisamatsu, K. Yamazaki, S. Eisei, Y. Sato, H. Kaise, M. Kashiwaba, H. Iwase, M. Kurosumi, H. Tsuda, F. Akiyama |
N. Masuda, M. Toi, Y. Takatsuka, S. Nakamura, H. Iwata, S. Ohno, K. Kuroi, M. Kusama, K. Hisamatsu, K. Yamazaki, S. Eisei, Y. Sato, H. Kaise, M. Kashiwaba, H. Iwase, M. Kurosumi, H. Tsuda, F. Akiyama |
N. Masuda, M. Toi, Y. Takatsuka, S. Nakamura, H. Iwata, S. Ohno, K. Kuroi, M. Kusama, K. Hisamatsu, K. Yamazaki, S. Eisei, Y. Sato, H. Kaise, M. Kashiwaba, H. Iwase, M. Kurosumi, H. Tsuda, F. Akiyama |
Results of survey conducted on perioperative chemotherapy and supportive care in primary breast cancer (JBCRG01) |
Results of survey conducted on perioperative chemotherapy and supportive care in primary breast cancer (JBCRG01) |
Results of survey conducted on perioperative chemotherapy and supportive care in primary breast cancer (JBCRG01) |
Gan to kagaku ryoho. Cancer & chemotherapy, 34, 10, 1609-1615 |
Gan to kagaku ryoho. Cancer & chemotherapy, 34, 10, 1609-1615 |
Gan to kagaku ryoho. Cancer & chemotherapy, 34, 10, 1609-1615 |
2007 |
有 |
英語 |
|
公開 |
| Satoshi Morita, Masakazu Toi, Shigehira Saji, Hiroji Iwata, Shinji Ohno, Yoshinori Ito, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto |
Satoshi Morita, Masakazu Toi, Shigehira Saji, Hiroji Iwata, Shinji Ohno, Yoshinori Ito, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto |
Satoshi Morita, Masakazu Toi, Shigehira Saji, Hiroji Iwata, Shinji Ohno, Yoshinori Ito, Tadashi Kobayashi, Yasuo Hozumi, Junichi Sakamoto |
Practical application of the continual reassessment method to a phase I dose-finding trial in advanced breast cancer |
Practical application of the continual reassessment method to a phase I dose-finding trial in advanced breast cancer |
Practical application of the continual reassessment method to a phase I dose-finding trial in advanced breast cancer |
DRUG INFORMATION JOURNAL, 41, 6, 691-700 |
DRUG INFORMATION JOURNAL, 41, 6, 691-700 |
DRUG INFORMATION JOURNAL, 41, 6, 691-700 |
2007 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Gottfried E. Konecny |
Gottfried E. Konecny |
Gottfried E. Konecny |
Lapatinib - Viewpoint |
Lapatinib - Viewpoint |
Lapatinib - Viewpoint |
DRUGS, 67, 14, 2109-2110 |
DRUGS, 67, 14, 2109-2110 |
DRUGS, 67, 14, 2109-2110 |
2007 |
有 |
英語 |
|
公開 |
| H. Yamashiro, M. Toi |
H. Yamashiro, M. Toi |
|
Herceptin (trastuzumab) |
Herceptin (trastuzumab) |
|
Gan to kagaku ryoho. Cancer & chemotherapy, 34, 8, 1173-1176 |
Gan to kagaku ryoho. Cancer & chemotherapy, 34, 8, 1173-1176 |
, 34, 8, 1173-1176 |
2007 |
有 |
日本語 |
|
公開 |
| D. Kitagawa, M. Toi |
D. Kitagawa, M. Toi |
D. Kitagawa, M. Toi |
Current status and the perspective of treatment strategy for the patients with advanced or recurrent breast cancer |
Current status and the perspective of treatment strategy for the patients with advanced or recurrent breast cancer |
Current status and the perspective of treatment strategy for the patients with advanced or recurrent breast cancer |
Nippon rinsho. Japanese journal of clinical medicine, 65 Suppl 6, 396-401 |
Nippon rinsho. Japanese journal of clinical medicine, 65 Suppl 6, 396-401 |
Nippon rinsho. Japanese journal of clinical medicine, 65 Suppl 6, 396-401 |
2007 |
有 |
英語 |
|
公開 |
| Masakazu Toi |
Masakazu Toi |
Masakazu Toi |
What does DNA methylation surrogate? |
What does DNA methylation surrogate? |
What does DNA methylation surrogate? |
DIGESTION, 75, 1, 53-53 |
DIGESTION, 75, 1, 53-53 |
DIGESTION, 75, 1, 53-53 |
2007 |
有 |
英語 |
|
公開 |
| Md. Zahidunnabi Dewan, Hiroshi Terunuma, Masakazu Toi, Yuetsu Tanaka, Harutaka Katano, Xuewen Deng, Hiroyuki Abe, Tadashi Nakasone, Naoki Mori, Tetsutaro Sata, Naoki Yamamoto |
Md. Zahidunnabi Dewan, Hiroshi Terunuma, Masakazu Toi, Yuetsu Tanaka, Harutaka Katano, Xuewen Deng, Hiroyuki Abe, Tadashi Nakasone, Naoki Mori, Tetsutaro Sata, Naoki Yamamoto |
Md. Zahidunnabi Dewan, Hiroshi Terunuma, Masakazu Toi, Yuetsu Tanaka, Harutaka Katano, Xuewen Deng, Hiroyuki Abe, Tadashi Nakasone, Naoki Mori, Tetsutaro Sata, Naoki Yamamoto |
Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells |
Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells |
Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells |
CANCER SCIENCE, 97, 12, 1381-1387 |
CANCER SCIENCE, 97, 12, 1381-1387 |
CANCER SCIENCE, 97, 12, 1381-1387 |
2006/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Yukihiro Asami, Hideaki Kakeya, Gen Okada, Masakazu Toi, Hiroyuki Osada |
Yukihiro Asami, Hideaki Kakeya, Gen Okada, Masakazu Toi, Hiroyuki Osada |
Yukihiro Asami, Hideaki Kakeya, Gen Okada, Masakazu Toi, Hiroyuki Osada |
RK-95113, a new angiogenesis inhibitor produced by Aspergillus fumigatus |
RK-95113, a new angiogenesis inhibitor produced by Aspergillus fumigatus |
RK-95113, a new angiogenesis inhibitor produced by Aspergillus fumigatus |
JOURNAL OF ANTIBIOTICS, 59, 11, 724-728 |
JOURNAL OF ANTIBIOTICS, 59, 11, 724-728 |
JOURNAL OF ANTIBIOTICS, 59, 11, 724-728 |
2006/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T. Ueno, L.W.C. Chow, M. Toi |
T. Ueno, L.W.C. Chow, M. Toi |
T. Ueno, L. W. C. Chow, M. Toi |
Increases in circulating VEGF levels during COX-2 inhibitor treatment in breast cancer patients |
Increases in circulating VEGF levels during COX-2 inhibitor treatment in breast cancer patients |
Increases in circulating VEGF levels during COX-2 inhibitor treatment in breast cancer patients |
Biomedicine and Pharmacotherapy, 60, 6, 277-279 |
Biomedicine and Pharmacotherapy, 60, 6, 277-279 |
BIOMEDICINE & PHARMACOTHERAPY, 60, 6, 277-279 |
2006/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M.Z. Dewan, S. Ahmed, Y. Iwasaki, K. Ohba, M. Toi, N. Yamamoto |
M.Z. Dewan, S. Ahmed, Y. Iwasaki, K. Ohba, M. Toi, N. Yamamoto |
M. Z. Dewan, S. Ahmed, Y. Iwasaki, K. Ohba, M. Toi, N. Yamamoto |
Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer |
Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer |
Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer |
Biomedicine and Pharmacotherapy, 60, 6, 273-276 |
Biomedicine and Pharmacotherapy, 60, 6, 273-276 |
BIOMEDICINE & PHARMACOTHERAPY, 60, 6, 273-276 |
2006/07 |
有 |
英語 |
|
公開 |
| H Bando, HA Weich, S Horiguchi, N Funata, T Ogawa, M Toi |
H Bando, HA Weich, S Horiguchi, N Funata, T Ogawa, M Toi |
H Bando, HA Weich, S Horiguchi, N Funata, T Ogawa, M Toi |
The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: A study with 193 cases |
The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: A study with 193 cases |
The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: A study with 193 cases |
ONCOLOGY REPORTS, 15, 3, 653-659 |
ONCOLOGY REPORTS, 15, 3, 653-659 |
ONCOLOGY REPORTS, 15, 3, 653-659 |
2006/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Masahide Kondo, Masakazu Toi |
Masahide Kondo, Masakazu Toi |
Masahide Kondo, Masakazu Toi |
Cost-effective treatment options in first-line therapy for advanced breast cancer in Japan |
Cost-effective treatment options in first-line therapy for advanced breast cancer in Japan |
Cost-effective treatment options in first-line therapy for advanced breast cancer in Japan |
EXPERT REVIEW OF ANTICANCER THERAPY, 6, 2, 197-204 |
EXPERT REVIEW OF ANTICANCER THERAPY, 6, 2, 197-204 |
EXPERT REVIEW OF ANTICANCER THERAPY, 6, 2, 197-204 |
2006/02 |
有 |
英語 |
|
公開 |
| M. Toi, Y. Iino |
M. Toi, Y. Iino |
M. Toi, Y. Iino |
Who benefits from hormone therapy? |
Who benefits from hormone therapy? |
Who benefits from hormone therapy? |
Breast cancer (Tokyo, Japan), 13, 2, 117-122 |
Breast cancer (Tokyo, Japan), 13, 2, 117-122 |
Breast cancer (Tokyo, Japan), 13, 2, 117-122 |
2006 |
有 |
英語 |
|
公開 |
| E. Suzuki, M. Toi |
E. Suzuki, M. Toi |
E. Suzuki, M. Toi |
Neoadjuvant Chemotherapy in breast cancer |
Neoadjuvant Chemotherapy in breast cancer |
Neoadjuvant Chemotherapy in breast cancer |
Nippon rinsho. Japanese journal of clinical medicine, 64, 3, 536-539 |
Nippon rinsho. Japanese journal of clinical medicine, 64, 3, 536-539 |
Nippon rinsho. Japanese journal of clinical medicine, 64, 3, 536-539 |
2006 |
有 |
英語 |
|
公開 |
| K. Kuroi, M. Toi, H. Tsuda, M. Kurosumi, F. Akiyama |
K. Kuroi, M. Toi, H. Tsuda, M. Kurosumi, F. Akiyama |
K. Kuroi, M. Toi, H. Tsuda, M. Kurosumi, F. Akiyama |
Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer. |
Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer. |
Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer. |
Breast cancer (Tokyo, Japan), 13, 1, 38-48 |
Breast cancer (Tokyo, Japan), 13, 1, 38-48 |
Breast cancer (Tokyo, Japan), 13, 1, 38-48 |
2006 |
有 |
英語 |
|
公開 |
| T. Saeki, T. Kimura, M. Toi, T. Taguchi |
T. Saeki, T. Kimura, M. Toi, T. Taguchi |
T. Saeki, T. Kimura, M. Toi, T. Taguchi |
A pilot phase II study of capecitabine in advanced or recurrent breast cancer. |
A pilot phase II study of capecitabine in advanced or recurrent breast cancer. |
A pilot phase II study of capecitabine in advanced or recurrent breast cancer. |
Breast cancer (Tokyo, Japan), 13, 1, 49-57 |
Breast cancer (Tokyo, Japan), 13, 1, 49-57 |
Breast cancer (Tokyo, Japan), 13, 1, 49-57 |
2006 |
有 |
英語 |
|
公開 |
| T. Suzuki, M. Toi, S. Saji, K. Horiguchi, T. Aruga, E. Suzuki, S. Horiguchi, N. Funata, K. Karasawa, N. Kamata |
T. Suzuki, M. Toi, S. Saji, K. Horiguchi, T. Aruga, E. Suzuki, S. Horiguchi, N. Funata, K. Karasawa, N. Kamata |
T. Suzuki, M. Toi, S. Saji, K. Horiguchi, T. Aruga, E. Suzuki, S. Horiguchi, N. Funata, K. Karasawa, N. Kamata |
Early breast cancer |
Early breast cancer |
Early breast cancer |
International Journal of Clinical Oncology, 11, 2, 108-119 |
International Journal of Clinical Oncology, 11, 2, 108-119 |
International Journal of Clinical Oncology, 11, 2, 108-119 |
2006 |
有 |
英語 |
|
公開 |
| M Muta, G Matsumoto, E Nakashima, M Toi |
M Muta, G Matsumoto, E Nakashima, M Toi |
M Muta, G Matsumoto, E Nakashima, M Toi |
Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: Importance of monocyte chemoattractant protein-1 modulation |
Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: Importance of monocyte chemoattractant protein-1 modulation |
Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: Importance of monocyte chemoattractant protein-1 modulation |
CLINICAL CANCER RESEARCH, 12, 1, 264-272 |
CLINICAL CANCER RESEARCH, 12, 1, 264-272 |
CLINICAL CANCER RESEARCH, 12, 1, 264-272 |
2006/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| MZ Dewan, J Uchihara, K Terashima, M Honda, T Sata, M Ito, N Fujii, K Uozumi, K Tsukasaki, M Tomonaga, Y Kubuki, A Okayama, M Toi, N Mori, N Yamamoto |
MZ Dewan, J Uchihara, K Terashima, M Honda, T Sata, M Ito, N Fujii, K Uozumi, K Tsukasaki, M Tomonaga, Y Kubuki, A Okayama, M Toi, N Mori, N Yamamoto |
MZ Dewan, J Uchihara, K Terashima, M Honda, T Sata, M Ito, N Fujii, K Uozumi, K Tsukasaki, M Tomonaga, Y Kubuki, A Okayama, M Toi, N Mori, N Yamamoto |
Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir |
Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir |
Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir |
BLOOD, 107, 2, 716-724 |
BLOOD, 107, 2, 716-724 |
BLOOD, 107, 2, 716-724 |
2006/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| G. Matsumoto, M. Muta, K. Umezawa, T. Suzuki, K. Misumi, K. Tsuruta, A. Okamoto, M. Toi |
G. Matsumoto, M. Muta, K. Umezawa, T. Suzuki, K. Misumi, K. Tsuruta, A. Okamoto, M. Toi |
G Matsumoto, M Muta, K Umezawa, T Suzuki, K Misumi, K Tsuruta, A Okamoto, M Toi |
Enhancement of the caspase-independent apoptotic sensitivity of pancreatic cancer cells by DHMEQ, an NF-κB inhibitor |
Enhancement of the caspase-independent apoptotic sensitivity of pancreatic cancer cells by DHMEQ, an NF-κB inhibitor |
Enhancement of the caspase-independent apoptotic sensitivity of pancreatic cancer cells by DHMEQ, an NF-kappa B inhibitor |
International Journal of Oncology, 27, 5, 1247-1255 |
International Journal of Oncology, 27, 5, 1247-1255 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 27, 5, 1247-1255 |
2005/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Toi, K Horiguchi, H Bando, S Shigehira, LWC Chow |
M Toi, K Horiguchi, H Bando, S Shigehira, LWC Chow |
M Toi, K Horiguchi, H Bando, S Shigehira, LWC Chow |
Trastuzumab: updates and future issues |
Trastuzumab: updates and future issues |
Trastuzumab: updates and future issues |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 56, SUPPL. 7, S94-S99 |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 56, SUPPL. 7, S94-S99 |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 56, SUPPL. 7, S94-S99 |
2005/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| S. Saji, M. Hirose, M. Toi |
S. Saji, M. Hirose, M. Toi |
S Saji, M Hirose, M Toi |
Clinical significance of estrogen receptor β in breast cancer |
Clinical significance of estrogen receptor β in breast cancer |
Clinical significance of estrogen receptor beta in breast cancer |
Cancer Chemotherapy and Pharmacology, 56, SUPPL. 7, S21-S26 |
Cancer Chemotherapy and Pharmacology, 56, SUPPL. 7, S21-S26 |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 56, SUPPL. 7, S21-S26 |
2005/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| G Gasparini, R Longo, M Toi, N Ferrara |
G Gasparini, R Longo, M Toi, N Ferrara |
G Gasparini, R Longo, M Toi, N Ferrara |
Angiogenic inhibitors: a new therapeutic strategy in oncology |
Angiogenic inhibitors: a new therapeutic strategy in oncology |
Angiogenic inhibitors: a new therapeutic strategy in oncology |
NATURE CLINICAL PRACTICE ONCOLOGY, 2, 11, 562-577 |
NATURE CLINICAL PRACTICE ONCOLOGY, 2, 11, 562-577 |
NATURE CLINICAL PRACTICE ONCOLOGY, 2, 11, 562-577 |
2005/11 |
有 |
英語 |
|
公開 |
| LWC Chow, WTY Loo, M Toi |
LWC Chow, WTY Loo, M Toi |
LWC Chow, WTY Loo, M Toi |
Current directions for COX-2 inhibition in breast cancer |
Current directions for COX-2 inhibition in breast cancer |
Current directions for COX-2 inhibition in breast cancer |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S281-S284 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S281-S284 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S281-S284 |
2005/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Toi, H Bando, HA Weich |
M Toi, H Bando, HA Weich |
M Toi, H Bando, HA Weich |
Vascular endothelial growth factor and its relationships with endogenous inhibitors in a breast cancer microenvironment manipulated by hormonal therapy: a hypothetical consideration |
Vascular endothelial growth factor and its relationships with endogenous inhibitors in a breast cancer microenvironment manipulated by hormonal therapy: a hypothetical consideration |
Vascular endothelial growth factor and its relationships with endogenous inhibitors in a breast cancer microenvironment manipulated by hormonal therapy: a hypothetical consideration |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S344-S347 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S344-S347 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S344-S347 |
2005/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| LWC Chow, M Toi |
LWC Chow, M Toi |
LWC Chow, M Toi |
Translational research in oncology comes timely |
Translational research in oncology comes timely |
Translational research in oncology comes timely |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S263-S263 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S263-S263 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S263-S263 |
2005/10 |
有 |
英語 |
|
公開 |
| K Kuroi, M Toi, H Tsuda, M Kurosumi, F Akiyama |
K Kuroi, M Toi, H Tsuda, M Kurosumi, F Akiyama |
K Kuroi, M Toi, H Tsuda, M Kurosumi, F Akiyama |
Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer |
Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer |
Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S387-S392 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S387-S392 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S387-S392 |
2005/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| LWC Chow, CWL Cheng, JLN Wong, M Toi |
LWC Chow, CWL Cheng, JLN Wong, M Toi |
LWC Chow, CWL Cheng, JLN Wong, M Toi |
Serum lipid profiles in patients receiving endocrine treatment for breast cancer - the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) Trial |
Serum lipid profiles in patients receiving endocrine treatment for breast cancer - the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) Trial |
Serum lipid profiles in patients receiving endocrine treatment for breast cancer - the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) Trial |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S302-S305 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S302-S305 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S302-S305 |
2005/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T Ueno, M Toi, S Linder |
T Ueno, M Toi, S Linder |
T Ueno, M Toi, S Linder |
Detection of epithelial cell death in the body by cytokeratin 18 measurement |
Detection of epithelial cell death in the body by cytokeratin 18 measurement |
Detection of epithelial cell death in the body by cytokeratin 18 measurement |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S359-S362 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S359-S362 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S359-S362 |
2005/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| LWC Chow, WTY Loo, CCY Wai, ELH Lui, L Zhu, M Toi |
LWC Chow, WTY Loo, CCY Wai, ELH Lui, L Zhu, M Toi |
LWC Chow, WTY Loo, CCY Wai, ELH Lui, L Zhu, M Toi |
Study of COX-2, Ki67, and p53 expression to predict effectiveness of 5-flurouracil, epirubicin and cyclophosphamide with celecoxib treatment in breast cancer patients |
Study of COX-2, Ki67, and p53 expression to predict effectiveness of 5-flurouracil, epirubicin and cyclophosphamide with celecoxib treatment in breast cancer patients |
Study of COX-2, Ki67, and p53 expression to predict effectiveness of 5-flurouracil, epirubicin and cyclophosphamide with celecoxib treatment in breast cancer patients |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S298-S301 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S298-S301 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S298-S301 |
2005/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| MZ Dewan, H Terunuma, S Ahmed, K Ohba, M Takada, Y Tanaka, M Toi, N Yamamoto |
MZ Dewan, H Terunuma, S Ahmed, K Ohba, M Takada, Y Tanaka, M Toi, N Yamamoto |
MZ Dewan, H Terunuma, S Ahmed, K Ohba, M Takada, Y Tanaka, M Toi, N Yamamoto |
Natural killer cells in breast cancer cell growth and metastasis in SCID mice |
Natural killer cells in breast cancer cell growth and metastasis in SCID mice |
Natural killer cells in breast cancer cell growth and metastasis in SCID mice |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S375-S379 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S375-S379 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S375-S379 |
2005/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| S Ohno, M Toi, K Kuroi, S Nakamura, H Iwata, M Kusama, N Masuda, K Yamazaki, K Hisamatsu, Y Sato, Y Takatsuka, E Shin, H Kaise, M Kurozumi, H Tsuda, F Akiyama |
S Ohno, M Toi, K Kuroi, S Nakamura, H Iwata, M Kusama, N Masuda, K Yamazaki, K Hisamatsu, Y Sato, Y Takatsuka, E Shin, H Kaise, M Kurozumi, H Tsuda, F Akiyama |
S Ohno, M Toi, K Kuroi, S Nakamura, H Iwata, M Kusama, N Masuda, K Yamazaki, K Hisamatsu, Y Sato, Y Takatsuka, E Shin, H Kaise, M Kurozumi, H Tsuda, F Akiyama |
Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancer |
Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancer |
Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancer |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S323-S324 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S323-S324 |
BIOMEDICINE & PHARMACOTHERAPY, 59, SUPPL. 2, S323-S324 |
2005/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Toi, T Saeki, K Aogi, M Sano, K Hatake, T Asaga, Y Tokuda, S Mitsuyama, M Kimura, T Kobayashi, M Tamura, T Tabei, E Shin, R Nishimura, S Ohno, S Takashima |
M Toi, T Saeki, K Aogi, M Sano, K Hatake, T Asaga, Y Tokuda, S Mitsuyama, M Kimura, T Kobayashi, M Tamura, T Tabei, E Shin, R Nishimura, S Ohno, S Takashima |
M Toi, T Saeki, K Aogi, M Sano, K Hatake, T Asaga, Y Tokuda, S Mitsuyama, M Kimura, T Kobayashi, M Tamura, T Tabei, E Shin, R Nishimura, S Ohno, S Takashima |
Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes |
Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes |
Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 35, 6, 310-315 |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 35, 6, 310-315 |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 35, 6, 310-315 |
2005/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| S Saji, M Kawakami, S Hayashi, N Yoshida, M Hirose, SI Horiguchi, A Itoh, N Funata, SL Schreiber, M Yoshida, M Toi |
S Saji, M Kawakami, S Hayashi, N Yoshida, M Hirose, SI Horiguchi, A Itoh, N Funata, SL Schreiber, M Yoshida, M Toi |
S Saji, M Kawakami, S Hayashi, N Yoshida, M Hirose, SI Horiguchi, A Itoh, N Funata, SL Schreiber, M Yoshida, M Toi |
Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer |
Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer |
Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer |
ONCOGENE, 24, 28, 4531-4539 |
ONCOGENE, 24, 28, 4531-4539 |
ONCOGENE, 24, 28, 4531-4539 |
2005/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K Hiramatsu, K Takahashi, T Yamaguchi, H Matsumoto, H Miyamoto, S Tanaka, C Tanaka, Y Tamamori, M Imajo, M Kawaguchi, M Toi, T Mori, M Kawakita |
K Hiramatsu, K Takahashi, T Yamaguchi, H Matsumoto, H Miyamoto, S Tanaka, C Tanaka, Y Tamamori, M Imajo, M Kawaguchi, M Toi, T Mori, M Kawakita |
K Hiramatsu, K Takahashi, T Yamaguchi, H Matsumoto, H Miyamoto, S Tanaka, C Tanaka, Y Tamamori, M Imajo, M Kawaguchi, M Toi, T Mori, M Kawakita |
N-1,N-12-diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers |
N-1,N-12-diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers |
N-1,N-12-diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers |
CLINICAL CANCER RESEARCH, 11, 8, 2986-2990 |
CLINICAL CANCER RESEARCH, 11, 8, 2986-2990 |
CLINICAL CANCER RESEARCH, 11, 8, 2986-2990 |
2005/04 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| C. Nakanishi, M. Toi |
C. Nakanishi, M. Toi |
C Nakanishi, M Toi |
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs |
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs |
Nuclear factor-kappa B inhibitors as sensitizers to anticancer drugs |
Nature Reviews Cancer, 5, 4, 297-309 |
Nature Reviews Cancer, 5, 4, 297-309 |
NATURE REVIEWS CANCER, 5, 4, 297-309 |
2005/04 |
有 |
英語 |
|
公開 |
| M Yasuno, T Mori, M Koike, K Takahashi, M Toi, T Takizawa, S Shimizu, T Yamaguchi, H Matsumoto |
M Yasuno, T Mori, M Koike, K Takahashi, M Toi, T Takizawa, S Shimizu, T Yamaguchi, H Matsumoto |
M Yasuno, T Mori, M Koike, K Takahashi, M Toi, T Takizawa, S Shimizu, T Yamaguchi, H Matsumoto |
Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma |
Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma |
Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma |
ONCOLOGY REPORTS, 13, 3, 405-412 |
ONCOLOGY REPORTS, 13, 3, 405-412 |
ONCOLOGY REPORTS, 13, 3, 405-412 |
2005/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Toi, MA Rahman, H Bando, LWC Chow |
M Toi, MA Rahman, H Bando, LWC Chow |
M Toi, MA Rahman, H Bando, LWC Chow |
Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment |
Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment |
Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment |
LANCET ONCOLOGY, 6, 3, 158-166 |
LANCET ONCOLOGY, 6, 3, 158-166 |
LANCET ONCOLOGY, 6, 3, 158-166 |
2005/03 |
有 |
英語 |
|
公開 |
| G. Matsumoto, J.-I. Namekawa, M. Muta, T. Nakamura, H. Bando, K. Tohyama, M. Toi, K. Umezawa |
G. Matsumoto, J.-I. Namekawa, M. Muta, T. Nakamura, H. Bando, K. Tohyama, M. Toi, K. Umezawa |
G Matsumoto, J Namekawa, M Muta, T Nakamura, H Bando, K Tohyama, M Toi, K Umezawa |
Targeting of nuclear factor κB pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: Antitumor and antiangiogenic potential in vivo |
Targeting of nuclear factor κB pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: Antitumor and antiangiogenic potential in vivo |
Targeting of nuclear factor kappa B pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: Antitumor and antiangiogenic potential in vivo |
Clinical Cancer Research, 11, 3, 1287-1293 |
Clinical Cancer Research, 11, 3, 1287-1293 |
CLINICAL CANCER RESEARCH, 11, 3, 1287-1293 |
2005/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H Bando, HA Weich, M Brokelmann, S Horiguchi, N Funata, T Ogawa, M Toi |
H Bando, HA Weich, M Brokelmann, S Horiguchi, N Funata, T Ogawa, M Toi |
H Bando, HA Weich, M Brokelmann, S Horiguchi, N Funata, T Ogawa, M Toi |
Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer |
Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer |
Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer |
BRITISH JOURNAL OF CANCER, 92, 3, 553-561 |
BRITISH JOURNAL OF CANCER, 92, 3, 553-561 |
BRITISH JOURNAL OF CANCER, 92, 3, 553-561 |
2005/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| LWC Chow, M Toi |
LWC Chow, M Toi |
LWC Chow, M Toi |
Celecoxib anti-aromatase neoadjuvant (CAAN) Trial for locally advanced breast cancer |
Celecoxib anti-aromatase neoadjuvant (CAAN) Trial for locally advanced breast cancer |
Celecoxib anti-aromatase neoadjuvant (CAAN) Trial for locally advanced breast cancer |
BREAST CANCER RESEARCH AND TREATMENT, 94, 1-2, S240-S240 |
BREAST CANCER RESEARCH AND TREATMENT, 94, 1-2, S240-S240 |
BREAST CANCER RESEARCH AND TREATMENT, 94, 1-2, S240-S240 |
2005 |
有 |
英語 |
|
公開 |
| H. Bando, M. Toi |
H. Bando, M. Toi |
H. Bando, M. Toi |
VEGF (vascular endothelial growth factor) |
VEGF (vascular endothelial growth factor) |
VEGF (vascular endothelial growth factor) |
Nippon rinsho. Japanese journal of clinical medicine., 63 Suppl 8, 99-102 |
Nippon rinsho. Japanese journal of clinical medicine., 63 Suppl 8, 99-102 |
Nippon rinsho. Japanese journal of clinical medicine., 63 Suppl 8, 99-102 |
2005 |
有 |
英語 |
|
公開 |
| I. Okubo, M. Kondo, M. Toi, T. Ochiai, S. Miki |
I. Okubo, M. Kondo, M. Toi, T. Ochiai, S. Miki |
I. Okubo, M. Kondo, M. Toi, T. Ochiai, S. Miki |
Cost-effectiveness of letrozole versus tamoxifen as first-line hormonal therapy in treating postmenopausal women with advanced breast cancer in Japan. |
Cost-effectiveness of letrozole versus tamoxifen as first-line hormonal therapy in treating postmenopausal women with advanced breast cancer in Japan. |
Cost-effectiveness of letrozole versus tamoxifen as first-line hormonal therapy in treating postmenopausal women with advanced breast cancer in Japan. |
Gan to kagaku ryoho. Cancer & chemotherapy, 32, 3, 351-363 |
Gan to kagaku ryoho. Cancer & chemotherapy, 32, 3, 351-363 |
Gan to kagaku ryoho. Cancer & chemotherapy, 32, 3, 351-363 |
2005 |
有 |
英語 |
|
公開 |
| K.S. Albain, J. de, la, Garza Salazar, T. Pienkowski, M. Aapro, J. Bergh, M. Caleffi, R. Coleman, W. Eiermann, F. Içli, M. Pegram, M. Piccart, R. Snyder, M. Toi, G.N. Hortobagyi |
K.S. Albain, J. de, la, Garza Salazar, T. Pienkowski, M. Aapro, J. Bergh, M. Caleffi, R. Coleman, W. Eiermann, F. Içli, M. Pegram, M. Piccart, R. Snyder, M. Toi, G.N. Hortobagyi |
K.S. Albain, J. de, la, Garza Salazar, T. Pienkowski, M. Aapro, J. Bergh, M. Caleffi, R. Coleman, W. Eiermann, F. Içli, M. Pegram, M. Piccart, R. Snyder, M. Toi, G.N. Hortobagyi |
Reducing the global breast cancer burden: The importance of patterns of care research |
Reducing the global breast cancer burden: The importance of patterns of care research |
Reducing the global breast cancer burden: The importance of patterns of care research |
Clinical Breast Cancer, 6, 5, 412-420 |
Clinical Breast Cancer, 6, 5, 412-420 |
Clinical Breast Cancer, 6, 5, 412-420 |
2005 |
有 |
英語 |
|
公開 |
| H. Iwata, S. Nakamura, M. Toi, E. Shin, N. Masuda, S. Ohno, Y. Takatsuka, K. Hisamatsu, K. Yamazaki, M. Kusama, H. Kaise, Y. Sato, K. Kuroi, F. Akiyama, H. Tsuda, M. Kurosumi |
H. Iwata, S. Nakamura, M. Toi, E. Shin, N. Masuda, S. Ohno, Y. Takatsuka, K. Hisamatsu, K. Yamazaki, M. Kusama, H. Kaise, Y. Sato, K. Kuroi, F. Akiyama, H. Tsuda, M. Kurosumi |
H. Iwata, S. Nakamura, M. Toi, E. Shin, N. Masuda, S. Ohno, Y. Takatsuka, K. Hisamatsu, K. Yamazaki, M. Kusama, H. Kaise, Y. Sato, K. Kuroi, F. Akiyama, H. Tsuda, M. Kurosumi |
Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage Breast carcinoma |
Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage Breast carcinoma |
Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage Breast carcinoma |
Breast Cancer, 12, 2, 99-103 |
Breast Cancer, 12, 2, 99-103 |
Breast Cancer, 12, 2, 99-103 |
2005 |
有 |
英語 |
|
公開 |
| M. Toi, Y. Takebayashi, L.W. Chow |
M. Toi, Y. Takebayashi, L.W. Chow |
M. Toi, Y. Takebayashi, L.W. Chow |
Translational research in breast cancer |
Translational research in breast cancer |
Translational research in breast cancer |
Breast Cancer, 12, 2, 86-90 |
Breast Cancer, 12, 2, 86-90 |
Breast Cancer, 12, 2, 86-90 |
2005 |
有 |
英語 |
|
公開 |
| T. Saeki, S. Takashima, M. Terashima, A. Satoh, M. Toi, A. Osaki, T. Toge, S. Ohno, N. Nomura, Y. Fukuyama, W. Koizumi, T. Taguchi |
T. Saeki, S. Takashima, M. Terashima, A. Satoh, M. Toi, A. Osaki, T. Toge, S. Ohno, N. Nomura, Y. Fukuyama, W. Koizumi, T. Taguchi |
T. Saeki, S. Takashima, M. Terashima, A. Satoh, M. Toi, A. Osaki, T. Toge, S. Ohno, N. Nomura, Y. Fukuyama, W. Koizumi, T. Taguchi |
A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors |
A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors |
A Japanese phase I study of continuous oral capecitabine in patients with malignant solid tumors |
International Journal of Clinical Oncology, 10, 1, 51-57 |
International Journal of Clinical Oncology, 10, 1, 51-57 |
International Journal of Clinical Oncology, 10, 1, 51-57 |
2005 |
有 |
英語 |
|
公開 |
| M Toi, H Bando, LWC Chow |
M Toi, H Bando, LWC Chow |
M Toi, H Bando, LWC Chow |
Novel insights in clinical trials with preoperative systemic therapy for primary breast cancer |
Novel insights in clinical trials with preoperative systemic therapy for primary breast cancer |
Novel insights in clinical trials with preoperative systemic therapy for primary breast cancer |
BIOMEDICINE & PHARMACOTHERAPY, 58, 9, 531-535 |
BIOMEDICINE & PHARMACOTHERAPY, 58, 9, 531-535 |
BIOMEDICINE & PHARMACOTHERAPY, 58, 9, 531-535 |
2004/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Kuwano, Y Oda, H Izumi, SJ Yang, T Uchiumi, Y Iwamoto, M Toi, T Fujii, H Yamana, H Kinoshita, T Kamura, M Tsuneyoshi, K Yasumoto, K Kohno |
M Kuwano, Y Oda, H Izumi, SJ Yang, T Uchiumi, Y Iwamoto, M Toi, T Fujii, H Yamana, H Kinoshita, T Kamura, M Tsuneyoshi, K Yasumoto, K Kohno |
M Kuwano, Y Oda, H Izumi, SJ Yang, T Uchiumi, Y Iwamoto, M Toi, T Fujii, H Yamana, H Kinoshita, T Kamura, M Tsuneyoshi, K Yasumoto, K Kohno |
The role of nuclear Y-box binding protein 1 as a global marker in drug resistance |
The role of nuclear Y-box binding protein 1 as a global marker in drug resistance |
The role of nuclear Y-box binding protein 1 as a global marker in drug resistance |
MOLECULAR CANCER THERAPEUTICS, 3, 11, 1485-1492 |
MOLECULAR CANCER THERAPEUTICS, 3, 11, 1485-1492 |
MOLECULAR CANCER THERAPEUTICS, 3, 11, 1485-1492 |
2004/11 |
有 |
英語 |
|
公開 |
| T Tominaga, M Kimura, T Asaga, M Yoshida, H Awane, H Koyama, Y Takatsuka, S Mitsuyama, T Ikeda, M Ogita, H Aoyama, M Sano, R Abe, T Nish, T Wada, M Danno, M Toi, S Takashima |
T Tominaga, M Kimura, T Asaga, M Yoshida, H Awane, H Koyama, Y Takatsuka, S Mitsuyama, T Ikeda, M Ogita, H Aoyama, M Sano, R Abe, T Nish, T Wada, M Danno, M Toi, S Takashima |
T Tominaga, M Kimura, T Asaga, M Yoshida, H Awane, H Koyama, Y Takatsuka, S Mitsuyama, T Ikeda, M Ogita, H Aoyama, M Sano, R Abe, T Nish, T Wada, M Danno, M Toi, S Takashima |
1-hexylcarbamoyl-5-fluorouracil plus cyclophosphamide plus tamoxifen versus CMF plus tamoxifen in women with lymph node-positive breast cancer after primary surgery: A randomized controlled trial |
1-hexylcarbamoyl-5-fluorouracil plus cyclophosphamide plus tamoxifen versus CMF plus tamoxifen in women with lymph node-positive breast cancer after primary surgery: A randomized controlled trial |
1-hexylcarbamoyl-5-fluorouracil plus cyclophosphamide plus tamoxifen versus CMF plus tamoxifen in women with lymph node-positive breast cancer after primary surgery: A randomized controlled trial |
ONCOLOGY REPORTS, 12, 4, 797-803 |
ONCOLOGY REPORTS, 12, 4, 797-803 |
ONCOLOGY REPORTS, 12, 4, 797-803 |
2004/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Takada, A Kataoka, M Toi, H Bando, K Toyama, S Horiguchi, T Ueno, S Linder, S Saji, Y Hayashi, N Funata, J Kinoshita, S Murakami, S Ohono |
M Takada, A Kataoka, M Toi, H Bando, K Toyama, S Horiguchi, T Ueno, S Linder, S Saji, Y Hayashi, N Funata, J Kinoshita, S Murakami, S Ohono |
M Takada, A Kataoka, M Toi, H Bando, K Toyama, S Horiguchi, T Ueno, S Linder, S Saji, Y Hayashi, N Funata, J Kinoshita, S Murakami, S Ohono |
A close association between alteration in growth kinetics by neoadjuvant chemotherapy and survival outcome in primary breast cancer |
A close association between alteration in growth kinetics by neoadjuvant chemotherapy and survival outcome in primary breast cancer |
A close association between alteration in growth kinetics by neoadjuvant chemotherapy and survival outcome in primary breast cancer |
INTERNATIONAL JOURNAL OF ONCOLOGY, 25, 2, 397-405 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 25, 2, 397-405 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 25, 2, 397-405 |
2004/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| G Matsumoto, MA Rahman, M Muta, T Nakamura, H Bando, S Saji, K Tsuruta, A Okamoto, M Toi |
G Matsumoto, MA Rahman, M Muta, T Nakamura, H Bando, S Saji, K Tsuruta, A Okamoto, M Toi |
G Matsumoto, MA Rahman, M Muta, T Nakamura, H Bando, S Saji, K Tsuruta, A Okamoto, M Toi |
DFU, a selective COX-2 inhibitor, suppresses MCF-7 xenograft tumor growth in mice |
DFU, a selective COX-2 inhibitor, suppresses MCF-7 xenograft tumor growth in mice |
DFU, a selective COX-2 inhibitor, suppresses MCF-7 xenograft tumor growth in mice |
ONCOLOGY REPORTS, 12, 2, 281-285 |
ONCOLOGY REPORTS, 12, 2, 281-285 |
ONCOLOGY REPORTS, 12, 2, 281-285 |
2004/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Y Asami, H Kakeya, R Onose, YH Chang, M Toi, H Osada |
Y Asami, H Kakeya, R Onose, YH Chang, M Toi, H Osada |
Y Asami, H Kakeya, R Onose, YH Chang, M Toi, H Osada |
RK-805, an endothelial-cell-growth inhibitor produced by Neosartorya sp., and a docking model with methionine aminopeptidase-2 |
RK-805, an endothelial-cell-growth inhibitor produced by Neosartorya sp., and a docking model with methionine aminopeptidase-2 |
RK-805, an endothelial-cell-growth inhibitor produced by Neosartorya sp., and a docking model with methionine aminopeptidase-2 |
TETRAHEDRON, 60, 33, 7085-7091 |
TETRAHEDRON, 60, 33, 7085-7091 |
TETRAHEDRON, 60, 33, 7085-7091 |
2004/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H Bando, M Brokelmann, M Toi, K Alitalo, JP Sleeman, B Sipos, HJ Grone, HA Weich |
H Bando, M Brokelmann, M Toi, K Alitalo, JP Sleeman, B Sipos, HJ Grone, HA Weich |
H Bando, M Brokelmann, M Toi, K Alitalo, JP Sleeman, B Sipos, HJ Grone, HA Weich |
Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues |
Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues |
Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues |
INTERNATIONAL JOURNAL OF CANCER, 111, 2, 184-191 |
INTERNATIONAL JOURNAL OF CANCER, 111, 2, 184-191 |
INTERNATIONAL JOURNAL OF CANCER, 111, 2, 184-191 |
2004/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| L Zhu, LWC Chow, WTY Loo, XY Guan, M Toi |
L Zhu, LWC Chow, WTY Loo, XY Guan, M Toi |
L Zhu, LWC Chow, WTY Loo, XY Guan, M Toi |
Her2/neu expression predicts the response to antiaromatase neoadjuvant therapy in primary breast cancer: Subgroup analysis from celecoxib antiaromatase neoadjuvant trial |
Her2/neu expression predicts the response to antiaromatase neoadjuvant therapy in primary breast cancer: Subgroup analysis from celecoxib antiaromatase neoadjuvant trial |
Her2/neu expression predicts the response to antiaromatase neoadjuvant therapy in primary breast cancer: Subgroup analysis from celecoxib antiaromatase neoadjuvant trial |
CLINICAL CANCER RESEARCH, 10, 14, 4639-4644 |
CLINICAL CANCER RESEARCH, 10, 14, 4639-4644 |
CLINICAL CANCER RESEARCH, 10, 14, 4639-4644 |
2004/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Toi, H Bando, S Horiguchi, M Takada, A Kataoka, T Ueno, S Saji, M Muta, N Funata, S Ohno |
M Toi, H Bando, S Horiguchi, M Takada, A Kataoka, T Ueno, S Saji, M Muta, N Funata, S Ohno |
M Toi, H Bando, S Horiguchi, M Takada, A Kataoka, T Ueno, S Saji, M Muta, N Funata, S Ohno |
Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer |
Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer |
Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer |
BRITISH JOURNAL OF CANCER, 90, 12, 2338-2343 |
BRITISH JOURNAL OF CANCER, 90, 12, 2338-2343 |
BRITISH JOURNAL OF CANCER, 90, 12, 2338-2343 |
2004/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H Nakayama, H Enzan, E Miyazaki, N Kuroda, M Toi, M Hiroi, W Yasui |
H Nakayama, H Enzan, E Miyazaki, N Kuroda, M Toi, M Hiroi, W Yasui |
H Nakayama, H Enzan, E Miyazaki, N Kuroda, M Toi, M Hiroi, W Yasui |
Lack of vascular adventitial fibroblastic cells in tumour stroma of intestinal-type and solid-type gastric carcinomas |
Lack of vascular adventitial fibroblastic cells in tumour stroma of intestinal-type and solid-type gastric carcinomas |
Lack of vascular adventitial fibroblastic cells in tumour stroma of intestinal-type and solid-type gastric carcinomas |
JOURNAL OF CLINICAL PATHOLOGY, 57, 2, 183-185 |
JOURNAL OF CLINICAL PATHOLOGY, 57, 2, 183-185 |
JOURNAL OF CLINICAL PATHOLOGY, 57, 2, 183-185 |
2004/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| S Morita, M Toi, T Kobayashi, Y Ito, Y Hozumi, S Ohno, H Iwata, J Sakamoto |
S Morita, M Toi, T Kobayashi, Y Ito, Y Hozumi, S Ohno, H Iwata, J Sakamoto |
S Morita, M Toi, T Kobayashi, Y Ito, Y Hozumi, S Ohno, H Iwata, J Sakamoto |
Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer |
Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer |
Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 34, 2, 104-106 |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 34, 2, 104-106 |
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 34, 2, 104-106 |
2004/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| HA Weich, H Bando, M Brokelmann, P Baumann, M Toi, B Barleon, K Alitalo, B Sipos, J Sleeman |
HA Weich, H Bando, M Brokelmann, P Baumann, M Toi, B Barleon, K Alitalo, B Sipos, J Sleeman |
HA Weich, H Bando, M Brokelmann, P Baumann, M Toi, B Barleon, K Alitalo, B Sipos, J Sleeman |
Quantification of vascular endothelial growth factor-C (VEGF-C) by a novel ELISA |
Quantification of vascular endothelial growth factor-C (VEGF-C) by a novel ELISA |
Quantification of vascular endothelial growth factor-C (VEGF-C) by a novel ELISA |
JOURNAL OF IMMUNOLOGICAL METHODS, 285, 2, 145-155 |
JOURNAL OF IMMUNOLOGICAL METHODS, 285, 2, 145-155 |
JOURNAL OF IMMUNOLOGICAL METHODS, 285, 2, 145-155 |
2004/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H. Yamashiro, K. Toyama, H. Bando, S. Saji, M. Toi |
H. Yamashiro, K. Toyama, H. Bando, S. Saji, M. Toi |
H. Yamashiro, K. Toyama, H. Bando, S. Saji, M. Toi |
Trastuzumab treatment for breast cancer |
Trastuzumab treatment for breast cancer |
Trastuzumab treatment for breast cancer |
Nippon rinsho. Japanese journal of clinical medicine, 62, 7, 1305-1311 |
Nippon rinsho. Japanese journal of clinical medicine, 62, 7, 1305-1311 |
Nippon rinsho. Japanese journal of clinical medicine, 62, 7, 1305-1311 |
2004 |
有 |
英語 |
|
公開 |
| M. Kawakita, K. Hiramatsu, M. Sugimoto, K. Takahashi, M. Toi |
M. Kawakita, K. Hiramatsu, M. Sugimoto, K. Takahashi, M. Toi |
M. Kawakita, K. Hiramatsu, M. Sugimoto, K. Takahashi, M. Toi |
Clinical usefulness of urinary diacetylpolyamines as novel tumor markers |
Clinical usefulness of urinary diacetylpolyamines as novel tumor markers |
Clinical usefulness of urinary diacetylpolyamines as novel tumor markers |
Rinsho byori. The Japanese journal of clinical pathology, 52, 4, 321-327 |
Rinsho byori. The Japanese journal of clinical pathology, 52, 4, 321-327 |
Rinsho byori. The Japanese journal of clinical pathology, 52, 4, 321-327 |
2004 |
有 |
英語 |
|
公開 |
| M. Kawakami, S. Saji, M. Toi |
M. Kawakami, S. Saji, M. Toi |
M. Kawakami, S. Saji, M. Toi |
Controversies in endocrine therapy for breast cancer |
Controversies in endocrine therapy for breast cancer |
Controversies in endocrine therapy for breast cancer |
Gan to kagaku ryoho. Cancer & chemotherapy, 31, 2, 181-187 |
Gan to kagaku ryoho. Cancer & chemotherapy, 31, 2, 181-187 |
Gan to kagaku ryoho. Cancer & chemotherapy, 31, 2, 181-187 |
2004 |
有 |
英語 |
|
公開 |
| S. Saji, M. Hirose, M. Toi |
S. Saji, M. Hirose, M. Toi |
S. Saji, M. Hirose, M. Toi |
Novel sensitizing agents: Potential contribution of COX-2 inhibitor for endocrine therapy of breast cancer |
Novel sensitizing agents: Potential contribution of COX-2 inhibitor for endocrine therapy of breast cancer |
Novel sensitizing agents: Potential contribution of COX-2 inhibitor for endocrine therapy of breast cancer |
Breast Cancer, 11, 2, 129-133 |
Breast Cancer, 11, 2, 129-133 |
Breast Cancer, 11, 2, 129-133 |
2004 |
有 |
英語 |
|
公開 |
| M. Toi, M. Takada, H. Bando, K. Toyama, H. Yamashiro, S. Horiguchi, S. Saji |
M. Toi, M. Takada, H. Bando, K. Toyama, H. Yamashiro, S. Horiguchi, S. Saji |
M. Toi, M. Takada, H. Bando, K. Toyama, H. Yamashiro, S. Horiguchi, S. Saji |
Current status of antibody therapy for breast cancer |
Current status of antibody therapy for breast cancer |
Current status of antibody therapy for breast cancer |
Breast Cancer, 11, 1, 10-14 |
Breast Cancer, 11, 1, 10-14 |
Breast Cancer, 11, 1, 10-14 |
2004 |
有 |
英語 |
|
公開 |
| C Nakanishi, T Yamaguchi, T Iijima, S Saji, M Toi, T Mori, M Miyaki |
C Nakanishi, T Yamaguchi, T Iijima, S Saji, M Toi, T Mori, M Miyaki |
C Nakanishi, T Yamaguchi, T Iijima, S Saji, M Toi, T Mori, M Miyaki |
Germline mutation of the LKB1/STK11 gene with loss of the normal allele in an aggressive breast cancer of Peutz-Jeghers syndrome |
Germline mutation of the LKB1/STK11 gene with loss of the normal allele in an aggressive breast cancer of Peutz-Jeghers syndrome |
Germline mutation of the LKB1/STK11 gene with loss of the normal allele in an aggressive breast cancer of Peutz-Jeghers syndrome |
ONCOLOGY, 67, 5-6, 476-479 |
ONCOLOGY, 67, 5-6, 476-479 |
ONCOLOGY, 67, 5-6, 476-479 |
2004 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| MA Rahman, M Toi |
MA Rahman, M Toi |
MA Rahman, M Toi |
Anti-angiogenic therapy in breast cancer |
Anti-angiogenic therapy in breast cancer |
Anti-angiogenic therapy in breast cancer |
BIOMEDICINE & PHARMACOTHERAPY, 57, 10, 463-470 |
BIOMEDICINE & PHARMACOTHERAPY, 57, 10, 463-470 |
BIOMEDICINE & PHARMACOTHERAPY, 57, 10, 463-470 |
2003/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Muta, G Matsumoto, K Hiruma, E Nakashima, M Toi |
M Muta, G Matsumoto, K Hiruma, E Nakashima, M Toi |
M Muta, G Matsumoto, K Hiruma, E Nakashima, M Toi |
Study of cancer gene therapy using IL-12-secreting endothelial progenitor cells in a rat solid tumor model |
Study of cancer gene therapy using IL-12-secreting endothelial progenitor cells in a rat solid tumor model |
Study of cancer gene therapy using IL-12-secreting endothelial progenitor cells in a rat solid tumor model |
ONCOLOGY REPORTS, 10, 6, 1765-1769 |
ONCOLOGY REPORTS, 10, 6, 1765-1769 |
ONCOLOGY REPORTS, 10, 6, 1765-1769 |
2003/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H Bando, M Toi, K Kitada, M Koike |
H Bando, M Toi, K Kitada, M Koike |
H Bando, M Toi, K Kitada, M Koike |
Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231 |
Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231 |
Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231 |
BIOMEDICINE & PHARMACOTHERAPY, 57, 8, 333-340 |
BIOMEDICINE & PHARMACOTHERAPY, 57, 8, 333-340 |
BIOMEDICINE & PHARMACOTHERAPY, 57, 8, 333-340 |
2003/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K Kuroi, H Bando, S Saji, M Toi |
K Kuroi, H Bando, S Saji, M Toi |
K Kuroi, H Bando, S Saji, M Toi |
Protracted administration of weekly docetaxel in metastatic breast cancer |
Protracted administration of weekly docetaxel in metastatic breast cancer |
Protracted administration of weekly docetaxel in metastatic breast cancer |
ONCOLOGY REPORTS, 10, 5, 1479-1484 |
ONCOLOGY REPORTS, 10, 5, 1479-1484 |
ONCOLOGY REPORTS, 10, 5, 1479-1484 |
2003/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| G Matsumoto, S Nagai, M Muta, K Tsuruta, A Okamoto, M Toi |
G Matsumoto, S Nagai, M Muta, K Tsuruta, A Okamoto, M Toi |
G Matsumoto, S Nagai, M Muta, K Tsuruta, A Okamoto, M Toi |
Survival benefit of KRN7000 immune therapy in combination with TNP470 in hamster liver metastasis model of pancreatic cancer |
Survival benefit of KRN7000 immune therapy in combination with TNP470 in hamster liver metastasis model of pancreatic cancer |
Survival benefit of KRN7000 immune therapy in combination with TNP470 in hamster liver metastasis model of pancreatic cancer |
ONCOLOGY REPORTS, 10, 5, 1201-1206 |
ONCOLOGY REPORTS, 10, 5, 1201-1206 |
ONCOLOGY REPORTS, 10, 5, 1201-1206 |
2003/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Muta, G Matsumoto, K Hiruma, S Saji, E Nakashima, M Toi |
M Muta, G Matsumoto, K Hiruma, S Saji, E Nakashima, M Toi |
M Muta, G Matsumoto, K Hiruma, S Saji, E Nakashima, M Toi |
Impact of vasculogenesis on solid tumor growth in a rat model |
Impact of vasculogenesis on solid tumor growth in a rat model |
Impact of vasculogenesis on solid tumor growth in a rat model |
ONCOLOGY REPORTS, 10, 5, 1213-1218 |
ONCOLOGY REPORTS, 10, 5, 1213-1218 |
ONCOLOGY REPORTS, 10, 5, 1213-1218 |
2003/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| LWC Chow, JLN Wong, M Toi |
LWC Chow, JLN Wong, M Toi |
LWC Chow, JLN Wong, M Toi |
Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary report |
Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary report |
Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary report |
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 86, 3-5, 443-447 |
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 86, 3-5, 443-447 |
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 86, 3-5, 443-447 |
2003/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Y Yamamoto, JI Yamashita, M Toi, M Muta, S Nagai, N Hanai, A Furuya, Y Osawa, S Saji, M Ogawa |
Y Yamamoto, JI Yamashita, M Toi, M Muta, S Nagai, N Hanai, A Furuya, Y Osawa, S Saji, M Ogawa |
Y Yamamoto, JI Yamashita, M Toi, M Muta, S Nagai, N Hanai, A Furuya, Y Osawa, S Saji, M Ogawa |
Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues |
Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues |
Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues |
ONCOLOGY REPORTS, 10, 4, 791-796 |
ONCOLOGY REPORTS, 10, 4, 791-796 |
ONCOLOGY REPORTS, 10, 4, 791-796 |
2003/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K Biven, H Erdal, M Hagg, T Ueno, R Zhou, M Lynch, B Rowley, J Wood, C Zhang, M Toi, MC Shoshan, S Linder |
K Biven, H Erdal, M Hagg, T Ueno, R Zhou, M Lynch, B Rowley, J Wood, C Zhang, M Toi, MC Shoshan, S Linder |
K Biven, H Erdal, M Hagg, T Ueno, R Zhou, M Lynch, B Rowley, J Wood, C Zhang, M Toi, MC Shoshan, S Linder |
A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera |
A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera |
A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient sera |
APOPTOSIS, 8, 3, 263-268 |
APOPTOSIS, 8, 3, 263-268 |
APOPTOSIS, 8, 3, 263-268 |
2003/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T Ueno, M Toi, K Biven, H Bando, T Ogawa, S Linder |
T Ueno, M Toi, K Biven, H Bando, T Ogawa, S Linder |
T Ueno, M Toi, K Biven, H Bando, T Ogawa, S Linder |
Measurement of an apoptotic product in the sera of breast cancer patients |
Measurement of an apoptotic product in the sera of breast cancer patients |
Measurement of an apoptotic product in the sera of breast cancer patients |
EUROPEAN JOURNAL OF CANCER, 39, 6, 769-774 |
EUROPEAN JOURNAL OF CANCER, 39, 6, 769-774 |
EUROPEAN JOURNAL OF CANCER, 39, 6, 769-774 |
2003/04 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T Tominaga, H Koyama, T Toge, S Miura, K Sugimachi, S Yamaguchi, K Hirata, Y Monden, Y Nomura, M Toi, Kimijima, I, S Noguchi, H Sonoo, K Asaishi, T Ikeda, T Morimoto, J Ota, Y Ohashi, O Abe |
T Tominaga, H Koyama, T Toge, S Miura, K Sugimachi, S Yamaguchi, K Hirata, Y Monden, Y Nomura, M Toi, Kimijima, I, S Noguchi, H Sonoo, K Asaishi, T Ikeda, T Morimoto, J Ota, Y Ohashi, O Abe |
T Tominaga, H Koyama, T Toge, S Miura, K Sugimachi, S Yamaguchi, K Hirata, Y Monden, Y Nomura, M Toi, Kimijima, I, S Noguchi, H Sonoo, K Asaishi, T Ikeda, T Morimoto, J Ota, Y Ohashi, O Abe |
Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery |
Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery |
Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery |
JOURNAL OF CLINICAL ONCOLOGY, 21, 6, 991-998 |
JOURNAL OF CLINICAL ONCOLOGY, 21, 6, 991-998 |
JOURNAL OF CLINICAL ONCOLOGY, 21, 6, 991-998 |
2003/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H Saji, M Toi, S Saji, M Koike, K Kohno, M Kuwano |
H Saji, M Toi, S Saji, M Koike, K Kohno, M Kuwano |
H Saji, M Toi, S Saji, M Koike, K Kohno, M Kuwano |
Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma |
Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma |
Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma |
CANCER LETTERS, 190, 2, 191-197 |
CANCER LETTERS, 190, 2, 191-197 |
CANCER LETTERS, 190, 2, 191-197 |
2003/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| O Ogura, A Kanzaki, H Bando, T Ogura, M Toi, Y Takebayashi |
O Ogura, A Kanzaki, H Bando, T Ogura, M Toi, Y Takebayashi |
O Ogura, A Kanzaki, H Bando, T Ogura, M Toi, Y Takebayashi |
Expression of thymidylate synthase and thymidine phosphorylase in human breast carcinoma: implication for method to detect expression of these molecules in clinic |
Expression of thymidylate synthase and thymidine phosphorylase in human breast carcinoma: implication for method to detect expression of these molecules in clinic |
Expression of thymidylate synthase and thymidine phosphorylase in human breast carcinoma: implication for method to detect expression of these molecules in clinic |
CANCER LETTERS, 190, 1, 97-104 |
CANCER LETTERS, 190, 1, 97-104 |
CANCER LETTERS, 190, 1, 97-104 |
2003/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K. Kuroi, M. Toi |
K. Kuroi, M. Toi |
K. Kuroi, M. Toi |
Male breast cancer |
Male breast cancer |
Male breast cancer |
Gan to kagaku ryoho. Cancer & chemotherapy, 30, 5, 599-605 |
Gan to kagaku ryoho. Cancer & chemotherapy, 30, 5, 599-605 |
Gan to kagaku ryoho. Cancer & chemotherapy, 30, 5, 599-605 |
2003 |
有 |
英語 |
|
公開 |
| M. Toi, H. Bando, S. Saji |
M. Toi, H. Bando, S. Saji |
M. Toi, H. Bando, S. Saji |
Decision tree and paradigms of primary breast cancer: Changes elicited by preoperative therapy |
Decision tree and paradigms of primary breast cancer: Changes elicited by preoperative therapy |
Decision tree and paradigms of primary breast cancer: Changes elicited by preoperative therapy |
Medical Science Monitor, 9, 5, RA90-RA95 |
Medical Science Monitor, 9, 5, RA90-RA95 |
Medical Science Monitor, 9, 5, RA90-RA95 |
2003 |
有 |
英語 |
|
公開 |
| M. Toi, H. Bando, C. Ramachandran, S.J. Melnick, A. Imai, R.S. Fife, R.E. Carr, T. Oikawa, E.P. Lansky |
M. Toi, H. Bando, C. Ramachandran, S.J. Melnick, A. Imai, R.S. Fife, R.E. Carr, T. Oikawa, E.P. Lansky |
M. Toi, H. Bando, C. Ramachandran, S.J. Melnick, A. Imai, R.S. Fife, R.E. Carr, T. Oikawa, E.P. Lansky |
Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo |
Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo |
Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo |
Angiogenesis, 6, 2, 121-128 |
Angiogenesis, 6, 2, 121-128 |
Angiogenesis, 6, 2, 121-128 |
2003 |
有 |
英語 |
|
公開 |
| K. Kuroi, H. Bando, S. Saji, M. Toi |
K. Kuroi, H. Bando, S. Saji, M. Toi |
K. Kuroi, H. Bando, S. Saji, M. Toi |
Weekly schedule of docetaxel in breast cancer: Evaluation of response and toxicity |
Weekly schedule of docetaxel in breast cancer: Evaluation of response and toxicity |
Weekly schedule of docetaxel in breast cancer: Evaluation of response and toxicity |
Breast Cancer, 10, 1, 10-14 |
Breast Cancer, 10, 1, 10-14 |
Breast Cancer, 10, 1, 10-14 |
2003 |
有 |
英語 |
|
公開 |
| T Tominaga, Adachi, I, Y Sasaki, T Tabei, T Ikeda, Y Takatsuka, M Toi, T Suwa, Y Ohashi |
T Tominaga, Adachi, I, Y Sasaki, T Tabei, T Ikeda, Y Takatsuka, M Toi, T Suwa, Y Ohashi |
T Tominaga, Adachi, I, Y Sasaki, T Tabei, T Ikeda, Y Takatsuka, M Toi, T Suwa, Y Ohashi |
Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer |
Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer |
Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer |
ANNALS OF ONCOLOGY, 14, 1, 62-70 |
ANNALS OF ONCOLOGY, 14, 1, 62-70 |
ANNALS OF ONCOLOGY, 14, 1, 62-70 |
2003/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K Tsuruta, A Okamoto, M Toi, H Saji, T Takahashi |
K Tsuruta, A Okamoto, M Toi, H Saji, T Takahashi |
K Tsuruta, A Okamoto, M Toi, H Saji, T Takahashi |
Impact of selective Glisson transection on survival of hepatocellular carcinoma |
Impact of selective Glisson transection on survival of hepatocellular carcinoma |
Impact of selective Glisson transection on survival of hepatocellular carcinoma |
HEPATO-GASTROENTEROLOGY, 49, 48, 1607-1610 |
HEPATO-GASTROENTEROLOGY, 49, 48, 1607-1610 |
HEPATO-GASTROENTEROLOGY, 49, 48, 1607-1610 |
2002/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Y Kumagai, M Toi, H Inoue |
Y Kumagai, M Toi, H Inoue |
Y Kumagai, M Toi, H Inoue |
Dynamism of tumour vasculature in the early phase of cancer progression: outcomes from oesophageal cancer research |
Dynamism of tumour vasculature in the early phase of cancer progression: outcomes from oesophageal cancer research |
Dynamism of tumour vasculature in the early phase of cancer progression: outcomes from oesophageal cancer research |
LANCET ONCOLOGY, 3, 10, 604-610 |
LANCET ONCOLOGY, 3, 10, 604-610 |
LANCET ONCOLOGY, 3, 10, 604-610 |
2002/10 |
有 |
英語 |
|
公開 |
| S. Saji, Y. Omoto, C. Shimizu, M. Warner, Y. Hayashi, S.-I. Horiguchi, T. Watanabe, S.-I. Hayashi, J.-Å. Gustafsson, M. Toi |
S. Saji, Y. Omoto, C. Shimizu, M. Warner, Y. Hayashi, S.-I. Horiguchi, T. Watanabe, S.-I. Hayashi, J.-Å. Gustafsson, M. Toi |
S Saji, Y Omoto, C Shimizu, M Warner, Y Hayashi, S Horiguchi, T Watanabe, S Hayashi, JA Gustafsson, M Toi |
Expression of estrogen receptor (ER) βcx protein in ERα-positive breast cancer: Specific correlation with progesterone receptor |
Expression of estrogen receptor (ER) βcx protein in ERα-positive breast cancer: Specific correlation with progesterone receptor |
Expression of estrogen receptor (ER) beta cx protein in ER alpha-positive breast cancer: Specific correlation with progesterone receptor |
Cancer Research, 62, 17, 4849-4853 |
Cancer Research, 62, 17, 4849-4853 |
CANCER RESEARCH, 62, 17, 4849-4853 |
2002/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| G Asai, N Yamamoto, M Toi, E Shin, K Nishiyama, T Sekine, Y Nomura, S Takashima, M Kimura, T Tominaga |
G Asai, N Yamamoto, M Toi, E Shin, K Nishiyama, T Sekine, Y Nomura, S Takashima, M Kimura, T Tominaga |
G Asai, N Yamamoto, M Toi, E Shin, K Nishiyama, T Sekine, Y Nomura, S Takashima, M Kimura, T Tominaga |
Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer |
Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer |
Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 49, 6, 468-472 |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 49, 6, 468-472 |
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 49, 6, 468-472 |
2002/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H Bando, G Matsumoto, M Bando, M Muta, T Ogawa, N Funata, J Nishihira, M Koike, M Toi |
H Bando, G Matsumoto, M Bando, M Muta, T Ogawa, N Funata, J Nishihira, M Koike, M Toi |
H Bando, G Matsumoto, M Bando, M Muta, T Ogawa, N Funata, J Nishihira, M Koike, M Toi |
Expression of macrophage migration inhibitory factor in human breast cancer: Association with nodal spread |
Expression of macrophage migration inhibitory factor in human breast cancer: Association with nodal spread |
Expression of macrophage migration inhibitory factor in human breast cancer: Association with nodal spread |
JAPANESE JOURNAL OF CANCER RESEARCH, 93, 4, 389-396 |
JAPANESE JOURNAL OF CANCER RESEARCH, 93, 4, 389-396 |
JAPANESE JOURNAL OF CANCER RESEARCH, 93, 4, 389-396 |
2002/04 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T Tominaga, M Toi, O Abe, Y Ohashi, J Uchino, H Hayasaka, R Abe, M Izuo, K Enomoto, H Watanabe, M Yoshida, T Taguchi, H Koyama, T Senoo, T Toge, Y Monden, T Hattori, Y Nomura, K Sugimachi, K Hirata, H Nakazato, S Miura, T Morimoto, K Asaishi, Kimijima, I, J Ota, H Sonoo, S Yamaguchi |
T Tominaga, M Toi, O Abe, Y Ohashi, J Uchino, H Hayasaka, R Abe, M Izuo, K Enomoto, H Watanabe, M Yoshida, T Taguchi, H Koyama, T Senoo, T Toge, Y Monden, T Hattori, Y Nomura, K Sugimachi, K Hirata, H Nakazato, S Miura, T Morimoto, K Asaishi, Kimijima, I, J Ota, H Sonoo, S Yamaguchi |
T Tominaga, M Toi, O Abe, Y Ohashi, J Uchino, H Hayasaka, R Abe, M Izuo, K Enomoto, H Watanabe, M Yoshida, T Taguchi, H Koyama, T Senoo, T Toge, Y Monden, T Hattori, Y Nomura, K Sugimachi, K Hirata, H Nakazato, S Miura, T Morimoto, K Asaishi, Kimijima, I, J Ota, H Sonoo, S Yamaguchi |
The effect of adjuvant 5 '-deoxy-5-fluorouridine in early stage breast cancer patients: Results from a multicenter randomized controlled trial |
The effect of adjuvant 5 '-deoxy-5-fluorouridine in early stage breast cancer patients: Results from a multicenter randomized controlled trial |
The effect of adjuvant 5 '-deoxy-5-fluorouridine in early stage breast cancer patients: Results from a multicenter randomized controlled trial |
INTERNATIONAL JOURNAL OF ONCOLOGY, 20, 3, 517-525 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 20, 3, 517-525 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 20, 3, 517-525 |
2002/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Toi, H Bando, T Ogawa, M Muta, C Hornig, HA Weich |
M Toi, H Bando, T Ogawa, M Muta, C Hornig, HA Weich |
M Toi, H Bando, T Ogawa, M Muta, C Hornig, HA Weich |
Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer |
Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer |
Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer |
INTERNATIONAL JOURNAL OF CANCER, 98, 1, 14-18 |
INTERNATIONAL JOURNAL OF CANCER, 98, 1, 14-18 |
INTERNATIONAL JOURNAL OF CANCER, 98, 1, 14-18 |
2002/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| A Kanzaki, Y Takebayashi, H Bando, JF Eliason, S Watanabe, H Miyashita, M Fukumoto, M Toi, T Uchida |
A Kanzaki, Y Takebayashi, H Bando, JF Eliason, S Watanabe, H Miyashita, M Fukumoto, M Toi, T Uchida |
A Kanzaki, Y Takebayashi, H Bando, JF Eliason, S Watanabe, H Miyashita, M Fukumoto, M Toi, T Uchida |
Expression of uridine and thymidine phosphorylase genes in human breast carcinoma |
Expression of uridine and thymidine phosphorylase genes in human breast carcinoma |
Expression of uridine and thymidine phosphorylase genes in human breast carcinoma |
INTERNATIONAL JOURNAL OF CANCER, 97, 5, 631-635 |
INTERNATIONAL JOURNAL OF CANCER, 97, 5, 631-635 |
INTERNATIONAL JOURNAL OF CANCER, 97, 5, 631-635 |
2002/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| C. Nakanishi, M. Toi, S. Saji, H. Bando |
C. Nakanishi, M. Toi, S. Saji, H. Bando |
C. Nakanishi, M. Toi, S. Saji, H. Bando |
Current indications for mastectomy in patients with breast cancer |
Current indications for mastectomy in patients with breast cancer |
Current indications for mastectomy in patients with breast cancer |
Nippon Geka Gakkai zasshi, 103, 11, 821-824 |
Nippon Geka Gakkai zasshi, 103, 11, 821-824 |
Nippon Geka Gakkai zasshi, 103, 11, 821-824 |
2002 |
有 |
英語 |
|
公開 |
| T. Watanabe, M. Sano, M. Toi, T. Saeki, K. Kanda, S. Miura, H. Inaji, H. Sono, H. Saeki, R. Nishimura, Y. Fujita |
T. Watanabe, M. Sano, M. Toi, T. Saeki, K. Kanda, S. Miura, H. Inaji, H. Sono, H. Saeki, R. Nishimura, Y. Fujita |
T. Watanabe, M. Sano, M. Toi, T. Saeki, K. Kanda, S. Miura, H. Inaji, H. Sono, H. Saeki, R. Nishimura, Y. Fujita |
Late phase II study of exemestane in postmenopausal patients with breast cancer resistant to anti-estrogenic agents |
Late phase II study of exemestane in postmenopausal patients with breast cancer resistant to anti-estrogenic agents |
Late phase II study of exemestane in postmenopausal patients with breast cancer resistant to anti-estrogenic agents |
Japanese Journal of Cancer and Chemotherapy, 29, 7, 1211-1221 |
Japanese Journal of Cancer and Chemotherapy, 29, 7, 1211-1221 |
Japanese Journal of Cancer and Chemotherapy, 29, 7, 1211-1221 |
2002 |
有 |
英語 |
|
公開 |
| T. Tominaga, M. Toi, Y. Ohashi |
T. Tominaga, M. Toi, Y. Ohashi |
T. Tominaga, M. Toi, Y. Ohashi |
Erratum: Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients (Clinical Breast Cancer (2002) vol. 3 (55-64)) |
Erratum: Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients (Clinical Breast Cancer (2002) vol. 3 (55-64)) |
Erratum: Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients (Clinical Breast Cancer (2002) vol. 3 (55-64)) |
Clinical Breast Cancer, 3, 2, 159- |
Clinical Breast Cancer, 3, 2, 159- |
Clinical Breast Cancer, 3, 2, 159- |
2002 |
有 |
英語 |
|
公開 |
| M. Toi |
M. Toi |
M. Toi |
Proinflammation in human tumor microenvironment: Its status and implication [1] |
Proinflammation in human tumor microenvironment: Its status and implication [1] |
Proinflammation in human tumor microenvironment: Its status and implication [1] |
Medical Science Monitor, 8, 7, LE25-LE26 |
Medical Science Monitor, 8, 7, LE25-LE26 |
Medical Science Monitor, 8, 7, LE25-LE26 |
2002 |
有 |
英語 |
|
公開 |
| A Kanzaki, M Toi, N Neamati, H Miyashita, M Oubu, K Nakayama, H Bando, K Ogawa, M Mutoh, S Mori, K Terada, T Sugiyama, M Fukumoto, Y Takebayashi |
A Kanzaki, M Toi, N Neamati, H Miyashita, M Oubu, K Nakayama, H Bando, K Ogawa, M Mutoh, S Mori, K Terada, T Sugiyama, M Fukumoto, Y Takebayashi |
A Kanzaki, M Toi, N Neamati, H Miyashita, M Oubu, K Nakayama, H Bando, K Ogawa, M Mutoh, S Mori, K Terada, T Sugiyama, M Fukumoto, Y Takebayashi |
Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma |
Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma |
Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma |
JAPANESE JOURNAL OF CANCER RESEARCH, 93, 1, 70-77 |
JAPANESE JOURNAL OF CANCER RESEARCH, 93, 1, 70-77 |
JAPANESE JOURNAL OF CANCER RESEARCH, 93, 1, 70-77 |
2002/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| S. Saji, M. Toi |
S. Saji, M. Toi |
S. Saji, M. Toi |
Aromatase inhibitors and other novel agents in breast cancer treatment |
Aromatase inhibitors and other novel agents in breast cancer treatment |
Aromatase inhibitors and other novel agents in breast cancer treatment |
Expert Opinion on Emerging Drugs, 7, 2, 303-319 |
Expert Opinion on Emerging Drugs, 7, 2, 303-319 |
Expert Opinion on Emerging Drugs, 7, 2, 303-319 |
2002 |
有 |
英語 |
|
公開 |
| S. Saji, Y. Omoto, C. Shimizu, S.-I. Horiguchi, T. Watanabe, N. Funata, S.-I. Hayashi, J.-A. Gustafsson, M. Toi |
S. Saji, Y. Omoto, C. Shimizu, S.-I. Horiguchi, T. Watanabe, N. Funata, S.-I. Hayashi, J.-A. Gustafsson, M. Toi |
S. Saji, Y. Omoto, C. Shimizu, S.-I. Horiguchi, T. Watanabe, N. Funata, S.-I. Hayashi, J.-A. Gustafsson, M. Toi |
Clinical impact of assay of estrogen receptorβcx in breast cancer |
Clinical impact of assay of estrogen receptorβcx in breast cancer |
Clinical impact of assay of estrogen receptorβcx in breast cancer |
Breast Cancer, 9, 4, 303-307 |
Breast Cancer, 9, 4, 303-307 |
Breast Cancer, 9, 4, 303-307 |
2002 |
有 |
英語 |
|
公開 |
| N Kuroda, LM Guo, M Toi, K Naruse, E Miyazaki, Y Hayashi, C Yoshikawa, S Ashida, T Shuin, H Enzan |
N Kuroda, LM Guo, M Toi, K Naruse, E Miyazaki, Y Hayashi, C Yoshikawa, S Ashida, T Shuin, H Enzan |
N Kuroda, LM Guo, M Toi, K Naruse, E Miyazaki, Y Hayashi, C Yoshikawa, S Ashida, T Shuin, H Enzan |
Paxillin: Application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma |
Paxillin: Application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma |
Paxillin: Application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma |
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 9, 4, 315-318 |
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 9, 4, 315-318 |
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 9, 4, 315-318 |
2001/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Shitashige, M Toi, T Yano, M Shibata, Y Matsuo, F Shibasaki |
M Shitashige, M Toi, T Yano, M Shibata, Y Matsuo, F Shibasaki |
M Shitashige, M Toi, T Yano, M Shibata, Y Matsuo, F Shibasaki |
Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2 |
Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2 |
Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2 |
JOURNAL OF BIOCHEMISTRY, 130, 6, 741-748 |
JOURNAL OF BIOCHEMISTRY, 130, 6, 741-748 |
JOURNAL OF BIOCHEMISTRY, 130, 6, 741-748 |
2001/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Toi, T Matsumoto, H Bando |
M Toi, T Matsumoto, H Bando |
M Toi, T Matsumoto, H Bando |
Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications |
Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications |
Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications |
LANCET ONCOLOGY, 2, 11, 667-673 |
LANCET ONCOLOGY, 2, 11, 667-673 |
LANCET ONCOLOGY, 2, 11, 667-673 |
2001/11 |
有 |
英語 |
|
公開 |
| K Nakayama, A Kanzaki, Y Takebayashi, M Toi, H Bando, T Nabei, K Miyazaki, M Fukumoto |
K Nakayama, A Kanzaki, Y Takebayashi, M Toi, H Bando, T Nabei, K Miyazaki, M Fukumoto |
K Nakayama, A Kanzaki, Y Takebayashi, M Toi, H Bando, T Nabei, K Miyazaki, M Fukumoto |
Different features of angiogenesis between ovarian and breast carcinoma |
Different features of angiogenesis between ovarian and breast carcinoma |
Different features of angiogenesis between ovarian and breast carcinoma |
CANCER LETTERS, 170, 2, 161-167 |
CANCER LETTERS, 170, 2, 161-167 |
CANCER LETTERS, 170, 2, 161-167 |
2001/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H Saji, M Koike, T Yamori, S Saji, M Seiki, K Matsushima, M Toi |
H Saji, M Koike, T Yamori, S Saji, M Seiki, K Matsushima, M Toi |
H Saji, M Koike, T Yamori, S Saji, M Seiki, K Matsushima, M Toi |
Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma |
Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma |
Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma |
CANCER, 92, 5, 1085-1091 |
CANCER, 92, 5, 1085-1091 |
CANCER, 92, 5, 1085-1091 |
2001/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K Kuroi, C Tanaka, M Toi |
K Kuroi, C Tanaka, M Toi |
K Kuroi, C Tanaka, M Toi |
Clinical significance of plasma nucleosome levels in cancer patients |
Clinical significance of plasma nucleosome levels in cancer patients |
Clinical significance of plasma nucleosome levels in cancer patients |
INTERNATIONAL JOURNAL OF ONCOLOGY, 19, 1, 143-148 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 19, 1, 143-148 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 19, 1, 143-148 |
2001/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| A. Mandic, K. Viktorsson, M. Molin, G. Akusjärvi, H. Eguchi, S.-I. Hayashi, M. Toi, J. Hansson, S. Linder, M.C. Shoshan |
A. Mandic, K. Viktorsson, M. Molin, G. Akusjärvi, H. Eguchi, S.-I. Hayashi, M. Toi, J. Hansson, S. Linder, M.C. Shoshan |
A Mandic, K Viktorsson, M Molin, G Akusjarvi, H Eguchi, SI Hayashi, M Toi, J Hansson, S Linder, MC Shoshan |
Cisplatin induces the proapoptotic conformation of Bak in a ΔMEKK1-dependent manner |
Cisplatin induces the proapoptotic conformation of Bak in a ΔMEKK1-dependent manner |
Cisplatin induces the proapoptotic conformation of Bak in a Delta MEKK1-dependent manner |
Molecular and Cellular Biology, 21, 11, 3684-3691 |
Molecular and Cellular Biology, 21, 11, 3684-3691 |
MOLECULAR AND CELLULAR BIOLOGY, 21, 11, 3684-3691 |
2001/06 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| O Ohno, Y Shima, Y Ikeda, SI Kondo, K Kato, M Toi, K Umezawa |
O Ohno, Y Shima, Y Ikeda, SI Kondo, K Kato, M Toi, K Umezawa |
O Ohno, Y Shima, Y Ikeda, SI Kondo, K Kato, M Toi, K Umezawa |
Selective growth inhibition by sangivamycin of human umbilical vein endothelial cells |
Selective growth inhibition by sangivamycin of human umbilical vein endothelial cells |
Selective growth inhibition by sangivamycin of human umbilical vein endothelial cells |
INTERNATIONAL JOURNAL OF ONCOLOGY, 18, 5, 1009-1015 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 18, 5, 1009-1015 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 18, 5, 1009-1015 |
2001/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| A Kanzaki, M Toi, K Nakayama, H Bando, M Mutoh, T Uchida, M Fukumoto, Y Takebayashi |
A Kanzaki, M Toi, K Nakayama, H Bando, M Mutoh, T Uchida, M Fukumoto, Y Takebayashi |
A Kanzaki, M Toi, K Nakayama, H Bando, M Mutoh, T Uchida, M Fukumoto, Y Takebayashi |
Expression of multidrug resistance-related transporters in human breast carcinoma |
Expression of multidrug resistance-related transporters in human breast carcinoma |
Expression of multidrug resistance-related transporters in human breast carcinoma |
JAPANESE JOURNAL OF CANCER RESEARCH, 92, 4, 452-458 |
JAPANESE JOURNAL OF CANCER RESEARCH, 92, 4, 452-458 |
JAPANESE JOURNAL OF CANCER RESEARCH, 92, 4, 452-458 |
2001/04 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K Kuroi, C Tanaka, M Toi |
K Kuroi, C Tanaka, M Toi |
K Kuroi, C Tanaka, M Toi |
Circulating levels of endostatin in cancer patients |
Circulating levels of endostatin in cancer patients |
Circulating levels of endostatin in cancer patients |
ONCOLOGY REPORTS, 8, 2, 405-409 |
ONCOLOGY REPORTS, 8, 2, 405-409 |
ONCOLOGY REPORTS, 8, 2, 405-409 |
2001/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| N Tsuneyoshi, K Fukudome, S Horiguchi, XF Ye, M Matsuzaki, M Toi, K Suzuki, M Kimoto |
N Tsuneyoshi, K Fukudome, S Horiguchi, XF Ye, M Matsuzaki, M Toi, K Suzuki, M Kimoto |
N Tsuneyoshi, K Fukudome, S Horiguchi, XF Ye, M Matsuzaki, M Toi, K Suzuki, M Kimoto |
Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell lines |
Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell lines |
Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell lines |
THROMBOSIS AND HAEMOSTASIS, 85, 2, 356-361 |
THROMBOSIS AND HAEMOSTASIS, 85, 2, 356-361 |
THROMBOSIS AND HAEMOSTASIS, 85, 2, 356-361 |
2001/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| S Saji, N Okumura, H Eguchi, S Nakashima, A Suzuki, M Toi, Y Nozawa, S Saji, S Hayashi |
S Saji, N Okumura, H Eguchi, S Nakashima, A Suzuki, M Toi, Y Nozawa, S Saji, S Hayashi |
S Saji, N Okumura, H Eguchi, S Nakashima, A Suzuki, M Toi, Y Nozawa, S Saji, S Hayashi |
MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells |
MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells |
MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 281, 1, 259-265 |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 281, 1, 259-265 |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 281, 1, 259-265 |
2001/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H. Kodama, I. To, J. Ishiwata, Y. Shinohara, N. Katayanagi, K. Kubota, T. Murakami, K. Kuroi, K. Hayashi, M. Toi |
H. Kodama, I. To, J. Ishiwata, Y. Shinohara, N. Katayanagi, K. Kubota, T. Murakami, K. Kuroi, K. Hayashi, M. Toi |
H. Kodama, I. To, J. Ishiwata, Y. Shinohara, N. Katayanagi, K. Kubota, T. Murakami, K. Kuroi, K. Hayashi, M. Toi |
MEN2A incidentally detected by high level of CEA and family history |
MEN2A incidentally detected by high level of CEA and family history |
MEN2A incidentally detected by high level of CEA and family history |
[Zasshi] Journal. Nihon Naika Gakkai, 90, 4, 683-686 |
[Zasshi] Journal. Nihon Naika Gakkai, 90, 4, 683-686 |
[Zasshi] Journal. Nihon Naika Gakkai, 90, 4, 683-686 |
2001 |
有 |
英語 |
|
公開 |
| M. Toi, Y. Bando, S. Saji, T. Matsumoto |
M. Toi, Y. Bando, S. Saji, T. Matsumoto |
M. Toi, Y. Bando, S. Saji, T. Matsumoto |
Tumor angiogenesis and hypoxia |
Tumor angiogenesis and hypoxia |
Tumor angiogenesis and hypoxia |
Biotherapy, 15, 6, 663-668 |
Biotherapy, 15, 6, 663-668 |
Biotherapy, 15, 6, 663-668 |
2001 |
有 |
英語 |
|
公開 |
| K. Kuroi, H. Bando, S. Nagai, C. Tanaka, K. Hayashi, M. Toi |
K. Kuroi, H. Bando, S. Nagai, C. Tanaka, K. Hayashi, M. Toi |
K. Kuroi, H. Bando, S. Nagai, C. Tanaka, K. Hayashi, M. Toi |
Efficacy of weekly docetaxel therapy for advanced or recurrent breast cancer |
Efficacy of weekly docetaxel therapy for advanced or recurrent breast cancer |
Efficacy of weekly docetaxel therapy for advanced or recurrent breast cancer |
Japanese Journal of Cancer and Chemotherapy, 28, 6, 797-802 |
Japanese Journal of Cancer and Chemotherapy, 28, 6, 797-802 |
Japanese Journal of Cancer and Chemotherapy, 28, 6, 797-802 |
2001 |
有 |
英語 |
|
公開 |
| G. Matsumoto, S. Nagai, M. Toi, S. Ishiyama, K. Kuroi, K. Turuta, A. Okamoto, T. Takahashi |
G. Matsumoto, S. Nagai, M. Toi, S. Ishiyama, K. Kuroi, K. Turuta, A. Okamoto, T. Takahashi |
G. Matsumoto, S. Nagai, M. Toi, S. Ishiyama, K. Kuroi, K. Turuta, A. Okamoto, T. Takahashi |
KRN7000 inhibit hepatic metastasis of pancreatic cancer |
KRN7000 inhibit hepatic metastasis of pancreatic cancer |
KRN7000 inhibit hepatic metastasis of pancreatic cancer |
Nippon Geka Gakkai zasshi, 102, 5, 421- |
Nippon Geka Gakkai zasshi, 102, 5, 421- |
Nippon Geka Gakkai zasshi, 102, 5, 421- |
2001 |
有 |
英語 |
|
公開 |
| K Kuroi, M Toi |
K Kuroi, M Toi |
K Kuroi, M Toi |
Circulating angiogenesis regulators in cancer patients |
Circulating angiogenesis regulators in cancer patients |
Circulating angiogenesis regulators in cancer patients |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 16, 1, 5-26 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 16, 1, 5-26 |
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 16, 1, 5-26 |
2001/01 |
有 |
英語 |
|
公開 |
| S. Umemura, G. Sakamoto, H. Sasano, H. Tsuda, F. Akiyama, M. Kurosumi, Y. Tokuda, T. Watanabe, M. Toi, T. Hasegawa, R. Yoshiyuki Osamura |
S. Umemura, G. Sakamoto, H. Sasano, H. Tsuda, F. Akiyama, M. Kurosumi, Y. Tokuda, T. Watanabe, M. Toi, T. Hasegawa, R. Yoshiyuki Osamura |
S. Umemura, G. Sakamoto, H. Sasano, H. Tsuda, F. Akiyama, M. Kurosumi, Y. Tokuda, T. Watanabe, M. Toi, T. Hasegawa, R. Yoshiyuki Osamura |
Evaluation of HER2 status: For the treatment of metastatic breast cancers by humanized anti-HER2 monoclonal antibody (trastuzumab) (pathological committee for optimal use of trastuzumab) |
Evaluation of HER2 status: For the treatment of metastatic breast cancers by humanized anti-HER2 monoclonal antibody (trastuzumab) (pathological committee for optimal use of trastuzumab) |
Evaluation of HER2 status: For the treatment of metastatic breast cancers by humanized anti-HER2 monoclonal antibody (trastuzumab) (pathological committee for optimal use of trastuzumab) |
Breast Cancer, 8, 4, 316-320 |
Breast Cancer, 8, 4, 316-320 |
Breast Cancer, 8, 4, 316-320 |
2001 |
有 |
英語 |
|
公開 |
| M. Toi, H. Bando, S. Saji |
M. Toi, H. Bando, S. Saji |
M. Toi, H. Bando, S. Saji |
Aromatase and aromatase inhibitors |
Aromatase and aromatase inhibitors |
Aromatase and aromatase inhibitors |
Breast Cancer, 8, 4, 329-332 |
Breast Cancer, 8, 4, 329-332 |
Breast Cancer, 8, 4, 329-332 |
2001 |
有 |
英語 |
|
公開 |
| G Gasparini, M Toi, E Biganzoli, R Dittadi, M Fanelli, A Morabito, P Boracchi, M Gion |
G Gasparini, M Toi, E Biganzoli, R Dittadi, M Fanelli, A Morabito, P Boracchi, M Gion |
G Gasparini, M Toi, E Biganzoli, R Dittadi, M Fanelli, A Morabito, P Boracchi, M Gion |
Thrombospondin-l and-2 in node-negative breast cancer: Correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis |
Thrombospondin-l and-2 in node-negative breast cancer: Correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis |
Thrombospondin-l and-2 in node-negative breast cancer: Correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis |
ONCOLOGY, 60, 1, 72-80 |
ONCOLOGY, 60, 1, 72-80 |
ONCOLOGY, 60, 1, 72-80 |
2001 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K Hattori, M Muta, M Toi, H Iizasa, M Shinsei, T Terasaki, M Obinata, M Ueda, E Nakashima |
K Hattori, M Muta, M Toi, H Iizasa, M Shinsei, T Terasaki, M Obinata, M Ueda, E Nakashima |
K Hattori, M Muta, M Toi, H Iizasa, M Shinsei, T Terasaki, M Obinata, M Ueda, E Nakashima |
Establishment of bone marrow-derived endothelial cell lines from ts-SV40 T-antigen gene transgenic rats |
Establishment of bone marrow-derived endothelial cell lines from ts-SV40 T-antigen gene transgenic rats |
Establishment of bone marrow-derived endothelial cell lines from ts-SV40 T-antigen gene transgenic rats |
PHARMACEUTICAL RESEARCH, 18, 1, 9-15 |
PHARMACEUTICAL RESEARCH, 18, 1, 9-15 |
PHARMACEUTICAL RESEARCH, 18, 1, 9-15 |
2001/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Miyaki, T. Iijima, K. Hosono, R. Ishii, M. Yasuno, T. Mori, M. Toi, T. Hishima, N. Shitara, K. Tamura, J. Utsunomiya, N. Kobayashi, T. Kuroki, T. Iwama |
M. Miyaki, T. Iijima, K. Hosono, R. Ishii, M. Yasuno, T. Mori, M. Toi, T. Hishima, N. Shitara, K. Tamura, J. Utsunomiya, N. Kobayashi, T. Kuroki, T. Iwama |
M Miyaki, T Iijima, K Hosono, R Ishii, M Yasuno, T Mori, M Toi, T Hishima, N Shitara, K Tamura, J Utsunomiya, N Kobayashi, T Kuroki, T Iwama |
Somatic mutations of LKB1 and β-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome |
Somatic mutations of LKB1 and β-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome |
Somatic mutations of LKB1 and beta-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndrome |
Cancer Research, 60, 22, 6311-6313 |
Cancer Research, 60, 22, 6311-6313 |
CANCER RESEARCH, 60, 22, 6311-6313 |
2000/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Seki, M Toi, K Kobayashi, K Shitara, K Umezawa, BK Seon, M Kan, JS Rhim |
M Seki, M Toi, K Kobayashi, K Shitara, K Umezawa, BK Seon, M Kan, JS Rhim |
M Seki, M Toi, K Kobayashi, K Shitara, K Umezawa, BK Seon, M Kan, JS Rhim |
Differential behavior of VEGF receptor expression and response to TNP-470 in two immortalized human endothelial cell lines |
Differential behavior of VEGF receptor expression and response to TNP-470 in two immortalized human endothelial cell lines |
Differential behavior of VEGF receptor expression and response to TNP-470 in two immortalized human endothelial cell lines |
INTERNATIONAL JOURNAL OF ONCOLOGY, 17, 3, 525-533 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 17, 3, 525-533 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 17, 3, 525-533 |
2000/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Tozaki, M Toi, Y Miyamoto, K Fukuda |
M Tozaki, M Toi, Y Miyamoto, K Fukuda |
M Tozaki, M Toi, Y Miyamoto, K Fukuda |
Power Doppler sonography of breast masses: Correlation of Doppler spectral parameters with tumor angiogenesis and histologic growth pattern |
Power Doppler sonography of breast masses: Correlation of Doppler spectral parameters with tumor angiogenesis and histologic growth pattern |
Power Doppler sonography of breast masses: Correlation of Doppler spectral parameters with tumor angiogenesis and histologic growth pattern |
JOURNAL OF ULTRASOUND IN MEDICINE, 19, 9, 593-600 |
JOURNAL OF ULTRASOUND IN MEDICINE, 19, 9, 593-600 |
JOURNAL OF ULTRASOUND IN MEDICINE, 19, 9, 593-600 |
2000/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T Ueno, M Toi, H Saji, M Muta, H Bando, K Kuroi, M Koike, H Inadera, K Matsushima |
T Ueno, M Toi, H Saji, M Muta, H Bando, K Kuroi, M Koike, H Inadera, K Matsushima |
T Ueno, M Toi, H Saji, M Muta, H Bando, K Kuroi, M Koike, H Inadera, K Matsushima |
Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer |
Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer |
Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer |
CLINICAL CANCER RESEARCH, 6, 8, 3282-3289 |
CLINICAL CANCER RESEARCH, 6, 8, 3282-3289 |
CLINICAL CANCER RESEARCH, 6, 8, 3282-3289 |
2000/08 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K Mori, M Hasegawa, M Nishida, H Toma, M Fukuda, T Kubota, N Nagasue, H Yamana, KHY Chung, T Ikeda, K Takasaki, M Oka, M Kameyama, M Toi, H Fujii, M Kitamura, M Murai, H Sasaki, S Ozono, H Makuuchi, Y Shimada, Y Onishi, S Aoyagi, K Mizutani, M Ogawa, A Nakao, H Kinoshita, T Tono, H Imamoto, Y Nakashima, T Manabe |
K Mori, M Hasegawa, M Nishida, H Toma, M Fukuda, T Kubota, N Nagasue, H Yamana, KHY Chung, T Ikeda, K Takasaki, M Oka, M Kameyama, M Toi, H Fujii, M Kitamura, M Murai, H Sasaki, S Ozono, H Makuuchi, Y Shimada, Y Onishi, S Aoyagi, K Mizutani, M Ogawa, A Nakao, H Kinoshita, T Tono, H Imamoto, Y Nakashima, T Manabe |
K Mori, M Hasegawa, M Nishida, H Toma, M Fukuda, T Kubota, N Nagasue, H Yamana, KHY Chung, T Ikeda, K Takasaki, M Oka, M Kameyama, M Toi, H Fujii, M Kitamura, M Murai, H Sasaki, S Ozono, H Makuuchi, Y Shimada, Y Onishi, S Aoyagi, K Mizutani, M Ogawa, A Nakao, H Kinoshita, T Tono, H Imamoto, Y Nakashima, T Manabe |
Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues |
Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues |
Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues |
INTERNATIONAL JOURNAL OF ONCOLOGY, 17, 1, 33-38 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 17, 1, 33-38 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 17, 1, 33-38 |
2000/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T Ueno, M Toi, M Koike, S Nakamura, T Tominaga |
T Ueno, M Toi, M Koike, S Nakamura, T Tominaga |
T Ueno, M Toi, M Koike, S Nakamura, T Tominaga |
Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration |
Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration |
Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration |
BRITISH JOURNAL OF CANCER, 83, 2, 164-170 |
BRITISH JOURNAL OF CANCER, 83, 2, 164-170 |
BRITISH JOURNAL OF CANCER, 83, 2, 164-170 |
2000/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H Eguchi, K Suga, H Saji, M Toi, K Nakachi, SI Hayashi |
H Eguchi, K Suga, H Saji, M Toi, K Nakachi, SI Hayashi |
H Eguchi, K Suga, H Saji, M Toi, K Nakachi, SI Hayashi |
Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene |
Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene |
Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene |
CELL DEATH AND DIFFERENTIATION, 7, 5, 439-446 |
CELL DEATH AND DIFFERENTIATION, 7, 5, 439-446 |
CELL DEATH AND DIFFERENTIATION, 7, 5, 439-446 |
2000/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H Bando, M Toi |
H Bando, M Toi |
H Bando, M Toi |
Tumor angiogenesis, macrophages, and cytokines |
Tumor angiogenesis, macrophages, and cytokines |
Tumor angiogenesis, macrophages, and cytokines |
ANGIOGENESIS: FROM THE MOLECULAR TO INTEGRATIVE PHARMACOLOGY, 476, 267-284 |
ANGIOGENESIS: FROM THE MOLECULAR TO INTEGRATIVE PHARMACOLOGY, 476, 267-284 |
ANGIOGENESIS: FROM THE MOLECULAR TO INTEGRATIVE PHARMACOLOGY, 476, 267-284 |
2000 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Toi, G. Matsumoto |
M. Toi, G. Matsumoto |
M. Toi, G. Matsumoto |
Isolated tumor cells and micrometastasis--clinical behavior and therapeutic implications |
Isolated tumor cells and micrometastasis--clinical behavior and therapeutic implications |
Isolated tumor cells and micrometastasis--clinical behavior and therapeutic implications |
Japanese Journal of Cancer and Chemotherapy, 27, 9, 1315-1336 |
Japanese Journal of Cancer and Chemotherapy, 27, 9, 1315-1336 |
Japanese Journal of Cancer and Chemotherapy, 27, 9, 1315-1336 |
2000 |
有 |
英語 |
|
公開 |
| M. Toi, G. Matsumoto, H. Bando, K. Kuroi |
M. Toi, G. Matsumoto, H. Bando, K. Kuroi |
M. Toi, G. Matsumoto, H. Bando, K. Kuroi |
Antiangiogenesis therapy and hormone therapy--their resemblance and applications of prognostic and predictive factors |
Antiangiogenesis therapy and hormone therapy--their resemblance and applications of prognostic and predictive factors |
Antiangiogenesis therapy and hormone therapy--their resemblance and applications of prognostic and predictive factors |
Japanese Journal of Cancer and Chemotherapy, 27, 8, 1212-1216 |
Japanese Journal of Cancer and Chemotherapy, 27, 8, 1212-1216 |
Japanese Journal of Cancer and Chemotherapy, 27, 8, 1212-1216 |
2000 |
有 |
英語 |
|
公開 |
| K. Kuroi, M. Toi |
K. Kuroi, M. Toi |
K. Kuroi, M. Toi |
Angiogenesis as a prognostic factor of breast cancers |
Angiogenesis as a prognostic factor of breast cancers |
Angiogenesis as a prognostic factor of breast cancers |
Nippon rinsho. Japanese journal of clinical medicine, 58 Suppl, 435-441 |
Nippon rinsho. Japanese journal of clinical medicine, 58 Suppl, 435-441 |
Nippon rinsho. Japanese journal of clinical medicine, 58 Suppl, 435-441 |
2000 |
有 |
英語 |
|
公開 |
| C. Tanaka, M. Toi |
C. Tanaka, M. Toi |
C. Tanaka, M. Toi |
Capecitabine for treatment of advanced breast cancers |
Capecitabine for treatment of advanced breast cancers |
Capecitabine for treatment of advanced breast cancers |
Nippon rinsho. Japanese journal of clinical medicine, 58 Suppl, 279-283 |
Nippon rinsho. Japanese journal of clinical medicine, 58 Suppl, 279-283 |
Nippon rinsho. Japanese journal of clinical medicine, 58 Suppl, 279-283 |
2000 |
有 |
英語 |
|
公開 |
| M. Toi, H. Bando, K. Kuroi |
M. Toi, H. Bando, K. Kuroi |
M. Toi, H. Bando, K. Kuroi |
The predictive value of angiogenesis for adjuvant therapy in breast cancer |
The predictive value of angiogenesis for adjuvant therapy in breast cancer |
The predictive value of angiogenesis for adjuvant therapy in breast cancer |
Breast Cancer, 7, 4, 311-314 |
Breast Cancer, 7, 4, 311-314 |
Breast Cancer, 7, 4, 311-314 |
2000 |
有 |
英語 |
|
公開 |
| S. Nagai, M. Toi |
S. Nagai, M. Toi |
S. Nagai, M. Toi |
Interleukin-4 and breast cancer |
Interleukin-4 and breast cancer |
Interleukin-4 and breast cancer |
Breast Cancer, 7, 3, 181-186 |
Breast Cancer, 7, 3, 181-186 |
Breast Cancer, 7, 3, 181-186 |
2000 |
有 |
英語 |
|
公開 |
| J Kurebayashi, H Sonoo, H Inaji, R Nishimura, Y Iino, M Toi, S Kobayashi, T Saeki |
J Kurebayashi, H Sonoo, H Inaji, R Nishimura, Y Iino, M Toi, S Kobayashi, T Saeki |
J Kurebayashi, H Sonoo, H Inaji, R Nishimura, Y Iino, M Toi, S Kobayashi, T Saeki |
Endocrine therapies for patients with recurrent breast cancer: Predictive factors for responses to first- and second-line endocrine therapies |
Endocrine therapies for patients with recurrent breast cancer: Predictive factors for responses to first- and second-line endocrine therapies |
Endocrine therapies for patients with recurrent breast cancer: Predictive factors for responses to first- and second-line endocrine therapies |
ONCOLOGY, 59, SUPPL. 1, 31-37 |
ONCOLOGY, 59, SUPPL. 1, 31-37 |
ONCOLOGY, 59, SUPPL. 1, 31-37 |
2000 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Toi, M Gion, H Saji, M Asano, R Dittadi, S Gilberti, N Locopo, G Gasparini |
M Toi, M Gion, H Saji, M Asano, R Dittadi, S Gilberti, N Locopo, G Gasparini |
M Toi, M Gion, H Saji, M Asano, R Dittadi, S Gilberti, N Locopo, G Gasparini |
Endogenous interleukin-12: Relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma |
Endogenous interleukin-12: Relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma |
Endogenous interleukin-12: Relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma |
INTERNATIONAL JOURNAL OF ONCOLOGY, 15, 6, 1169-1175 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 15, 6, 1169-1175 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 15, 6, 1169-1175 |
1999/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T Ueno, M Toi, T Tominaga |
T Ueno, M Toi, T Tominaga |
T Ueno, M Toi, T Tominaga |
Circulating soluble Fas concentration in breast cancer patients |
Circulating soluble Fas concentration in breast cancer patients |
Circulating soluble Fas concentration in breast cancer patients |
CLINICAL CANCER RESEARCH, 5, 11, 3529-3533 |
CLINICAL CANCER RESEARCH, 5, 11, 3529-3533 |
CLINICAL CANCER RESEARCH, 5, 11, 3529-3533 |
1999/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| SI Kumeda, A Deguchi, M Toi, S Omura, K Umezawa |
SI Kumeda, A Deguchi, M Toi, S Omura, K Umezawa |
SI Kumeda, A Deguchi, M Toi, S Omura, K Umezawa |
Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells |
Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells |
Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells |
ANTICANCER RESEARCH, 19, 5B, 3961-3968 |
ANTICANCER RESEARCH, 19, 5B, 3961-3968 |
ANTICANCER RESEARCH, 19, 5B, 3961-3968 |
1999/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| S Ishigaki, M Toi, T Ueno, H Matsumoto, M Muta, M Koike, M Seiki |
S Ishigaki, M Toi, T Ueno, H Matsumoto, M Muta, M Koike, M Seiki |
S Ishigaki, M Toi, T Ueno, H Matsumoto, M Muta, M Koike, M Seiki |
Significance of membrane type 1 matrix metalloproteinase expression in breast cancer |
Significance of membrane type 1 matrix metalloproteinase expression in breast cancer |
Significance of membrane type 1 matrix metalloproteinase expression in breast cancer |
JAPANESE JOURNAL OF CANCER RESEARCH, 90, 5, 516-522 |
JAPANESE JOURNAL OF CANCER RESEARCH, 90, 5, 516-522 |
JAPANESE JOURNAL OF CANCER RESEARCH, 90, 5, 516-522 |
1999/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Toi, T Ueno, H Matsumoto, H Saji, N Funata, M Koike, T Tominaga |
M Toi, T Ueno, H Matsumoto, H Saji, N Funata, M Koike, T Tominaga |
M Toi, T Ueno, H Matsumoto, H Saji, N Funata, M Koike, T Tominaga |
Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer |
Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer |
Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer |
CLINICAL CANCER RESEARCH, 5, 5, 1131-1137 |
CLINICAL CANCER RESEARCH, 5, 5, 1131-1137 |
CLINICAL CANCER RESEARCH, 5, 5, 1131-1137 |
1999/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| G Gasparini, M Toi, R Miceli, PB Vermeulen, R Dittadi, E Biganzoli, A Morabito, M Fanelli, C Gatti, H Suzuki, T Tominaga, LY Dirix, M Gion |
G Gasparini, M Toi, R Miceli, PB Vermeulen, R Dittadi, E Biganzoli, A Morabito, M Fanelli, C Gatti, H Suzuki, T Tominaga, LY Dirix, M Gion |
G Gasparini, M Toi, R Miceli, PB Vermeulen, R Dittadi, E Biganzoli, A Morabito, M Fanelli, C Gatti, H Suzuki, T Tominaga, LY Dirix, M Gion |
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy |
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy |
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy |
CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 5, 2, 101-111 |
CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 5, 2, 101-111 |
CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 5, 2, 101-111 |
1999/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| S Saji, S Nakashima, S Hayashi, M Toi, S Saji, Y Nozawa |
S Saji, S Nakashima, S Hayashi, M Toi, S Saji, Y Nozawa |
S Saji, S Nakashima, S Hayashi, M Toi, S Saji, Y Nozawa |
Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol |
Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol |
Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol |
JAPANESE JOURNAL OF CANCER RESEARCH, 90, 2, 210-218 |
JAPANESE JOURNAL OF CANCER RESEARCH, 90, 2, 210-218 |
JAPANESE JOURNAL OF CANCER RESEARCH, 90, 2, 210-218 |
1999/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| S. Nagai, M. Toi, K. Kuroi, K. Hayashi, T. Tominaga |
S. Nagai, M. Toi, K. Kuroi, K. Hayashi, T. Tominaga |
S. Nagai, M. Toi, K. Kuroi, K. Hayashi, T. Tominaga |
Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline |
Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline |
Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline |
Gan to kagaku ryoho. Cancer & chemotherapy, 26, 13, 2037-2042 |
Gan to kagaku ryoho. Cancer & chemotherapy, 26, 13, 2037-2042 |
Gan to kagaku ryoho. Cancer & chemotherapy, 26, 13, 2037-2042 |
1999 |
有 |
英語 |
|
公開 |
| M. Toi, H. Saji |
M. Toi, H. Saji |
M. Toi, H. Saji |
Thymidine phosphorylase targeting treatment |
Thymidine phosphorylase targeting treatment |
Thymidine phosphorylase targeting treatment |
Biotherapy, 13, 2, 166-172 |
Biotherapy, 13, 2, 166-172 |
Biotherapy, 13, 2, 166-172 |
1999 |
有 |
英語 |
|
公開 |
| M. Toi, M. Seki |
M. Toi, M. Seki |
M. Toi, M. Seki |
Assessment of angiogenesis inhibitors using cultured endothelial cells |
Assessment of angiogenesis inhibitors using cultured endothelial cells |
Assessment of angiogenesis inhibitors using cultured endothelial cells |
Biotherapy, 13, 6, 675-678 |
Biotherapy, 13, 6, 675-678 |
Biotherapy, 13, 6, 675-678 |
1999 |
有 |
英語 |
|
公開 |
| H. Sonoo, J. Kurebayashi, Y. Lino, H. Inaji, T. Watanabe, M. Toi, S. Kobayashi, B. Sato, M. Yoshimoto |
H. Sonoo, J. Kurebayashi, Y. Lino, H. Inaji, T. Watanabe, M. Toi, S. Kobayashi, B. Sato, M. Yoshimoto |
H. Sonoo, J. Kurebayashi, Y. Lino, H. Inaji, T. Watanabe, M. Toi, S. Kobayashi, B. Sato, M. Yoshimoto |
Current status and controversial issues concerning endocrine therapy for patients with recurrent breast cancer in Japan |
Current status and controversial issues concerning endocrine therapy for patients with recurrent breast cancer in Japan |
Current status and controversial issues concerning endocrine therapy for patients with recurrent breast cancer in Japan |
Breast Cancer, 6, 4, 344-350 |
Breast Cancer, 6, 4, 344-350 |
Breast Cancer, 6, 4, 344-350 |
1999 |
有 |
英語 |
|
公開 |
| K. Kuroi, C. Tanaka, M. Toi |
K. Kuroi, C. Tanaka, M. Toi |
K. Kuroi, C. Tanaka, M. Toi |
Plasma nucleosome levels in node-negative breast cancer patients |
Plasma nucleosome levels in node-negative breast cancer patients |
Plasma nucleosome levels in node-negative breast cancer patients |
Breast Cancer, 6, 4, 361-364 |
Breast Cancer, 6, 4, 361-364 |
Breast Cancer, 6, 4, 361-364 |
1999 |
有 |
英語 |
|
公開 |
| M Kitamura, M Toi, K Arai, Y Iwasaki, H Suzuki, K Matsuo |
M Kitamura, M Toi, K Arai, Y Iwasaki, H Suzuki, K Matsuo |
M Kitamura, M Toi, K Arai, Y Iwasaki, H Suzuki, K Matsuo |
Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients |
Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients |
Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients |
ONCOLOGY REPORTS, 5, 6, 1419-1424 |
ONCOLOGY REPORTS, 5, 6, 1419-1424 |
ONCOLOGY REPORTS, 5, 6, 1419-1424 |
1998/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T Ueno, M Toi, T Taniguchi, T Tominaga |
T Ueno, M Toi, T Taniguchi, T Tominaga |
T Ueno, M Toi, T Taniguchi, T Tominaga |
Serum hepatocyte growth factor levels in breast cancer patients with distant metastases |
Serum hepatocyte growth factor levels in breast cancer patients with distant metastases |
Serum hepatocyte growth factor levels in breast cancer patients with distant metastases |
CANCER JOURNAL, 11, 3, 147-152 |
CANCER JOURNAL, 11, 3, 147-152 |
CANCER JOURNAL, 11, 3, 147-152 |
1998/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T Kurizaki, M Toi, T Tominaga |
T Kurizaki, M Toi, T Tominaga |
T Kurizaki, M Toi, T Tominaga |
Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma |
Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma |
Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma |
ONCOLOGY REPORTS, 5, 3, 673-677 |
ONCOLOGY REPORTS, 5, 3, 673-677 |
ONCOLOGY REPORTS, 5, 3, 673-677 |
1998/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| G Gasparini, M Toi, P Verderio, G Ranieri, S Dante, E Bonoldi, P Boracchi, M Fanelli, T Tominaga |
G Gasparini, M Toi, P Verderio, G Ranieri, S Dante, E Bonoldi, P Boracchi, M Fanelli, T Tominaga |
G Gasparini, M Toi, P Verderio, G Ranieri, S Dante, E Bonoldi, P Boracchi, M Fanelli, T Tominaga |
Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients |
Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients |
Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients |
INTERNATIONAL JOURNAL OF ONCOLOGY, 12, 5, 1117-1125 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 12, 5, 1117-1125 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 12, 5, 1117-1125 |
1998/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Toi, T Taniguchi, T Ueno, M Asano, N Funata, K Sekiguchi, H Iwanari, T Tominaga |
M Toi, T Taniguchi, T Ueno, M Asano, N Funata, K Sekiguchi, H Iwanari, T Tominaga |
M Toi, T Taniguchi, T Ueno, M Asano, N Funata, K Sekiguchi, H Iwanari, T Tominaga |
Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer |
Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer |
Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer |
CLINICAL CANCER RESEARCH, 4, 3, 659-664 |
CLINICAL CANCER RESEARCH, 4, 3, 659-664 |
CLINICAL CANCER RESEARCH, 4, 3, 659-664 |
1998/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| A Suzuki, M Toi, Y Yamamoto, S Saji, M Muta, T Tominaga |
A Suzuki, M Toi, Y Yamamoto, S Saji, M Muta, T Tominaga |
A Suzuki, M Toi, Y Yamamoto, S Saji, M Muta, T Tominaga |
Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma |
Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma |
Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma |
JAPANESE JOURNAL OF CANCER RESEARCH, 89, 2, 221-227 |
JAPANESE JOURNAL OF CANCER RESEARCH, 89, 2, 221-227 |
JAPANESE JOURNAL OF CANCER RESEARCH, 89, 2, 221-227 |
1998/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Toi |
M. Toi |
M. Toi |
Antiangiogenic therapy |
Antiangiogenic therapy |
Antiangiogenic therapy |
Gan to kagaku ryoho. Cancer & chemotherapy, 25, 13, 2003-2009 |
Gan to kagaku ryoho. Cancer & chemotherapy, 25, 13, 2003-2009 |
Gan to kagaku ryoho. Cancer & chemotherapy, 25, 13, 2003-2009 |
1998 |
有 |
英語 |
|
公開 |
| Y. Lino, M. Toi |
Y. Lino, M. Toi |
Y. Lino, M. Toi |
Chemoendocrine therapy: Basic science and clinical aspects |
Chemoendocrine therapy: Basic science and clinical aspects |
Chemoendocrine therapy: Basic science and clinical aspects |
Breast Cancer, 5, 4, 344-346 |
Breast Cancer, 5, 4, 344-346 |
Breast Cancer, 5, 4, 344-346 |
1998 |
有 |
英語 |
|
公開 |
| S. Umemura, K. Komaki, S. Noguchi, E. Shiba, M. Toi, I. Kimijima, H. Itoh, Y.R. Osamura |
S. Umemura, K. Komaki, S. Noguchi, E. Shiba, M. Toi, I. Kimijima, H. Itoh, Y.R. Osamura |
S. Umemura, K. Komaki, S. Noguchi, E. Shiba, M. Toi, I. Kimijima, H. Itoh, Y.R. Osamura |
Prognostic factors for node-negative breast cancers: Results of a study program by the Japanese breast cancer society |
Prognostic factors for node-negative breast cancers: Results of a study program by the Japanese breast cancer society |
Prognostic factors for node-negative breast cancers: Results of a study program by the Japanese breast cancer society |
Breast Cancer, 5, 3, 243-249 |
Breast Cancer, 5, 3, 243-249 |
Breast Cancer, 5, 3, 243-249 |
1998 |
有 |
英語 |
|
公開 |
| M Toi, S Ishigaki, T Tominaga |
M Toi, S Ishigaki, T Tominaga |
M Toi, S Ishigaki, T Tominaga |
Metalloproteinases and tissue inhibitors of metalloproteinases |
Metalloproteinases and tissue inhibitors of metalloproteinases |
Metalloproteinases and tissue inhibitors of metalloproteinases |
BREAST CANCER RESEARCH AND TREATMENT, 52, 1-3, 113-124 |
BREAST CANCER RESEARCH AND TREATMENT, 52, 1-3, 113-124 |
BREAST CANCER RESEARCH AND TREATMENT, 52, 1-3, 113-124 |
1998 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T Narita, N Kimura, C Mitsuoka, M Toi, M Sato, N Matsuura, K Matsumoto, T Nakamura, R Kannagi |
T Narita, N Kimura, C Mitsuoka, M Toi, M Sato, N Matsuura, K Matsumoto, T Nakamura, R Kannagi |
T Narita, N Kimura, C Mitsuoka, M Toi, M Sato, N Matsuura, K Matsumoto, T Nakamura, R Kannagi |
Biological and clinical significance of hepatocyte growth factor in breast cancer |
Biological and clinical significance of hepatocyte growth factor in breast cancer |
Biological and clinical significance of hepatocyte growth factor in breast cancer |
INTERNATIONAL JOURNAL OF ONCOLOGY, 11, 6, 1305-1310 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 11, 6, 1305-1310 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 11, 6, 1305-1310 |
1997/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T Narita, C Mitsuoka, N Kimura, M Toi, T Nakashio, K Sekiguchi, H Iwanari, R Kannagi |
T Narita, C Mitsuoka, N Kimura, M Toi, T Nakashio, K Sekiguchi, H Iwanari, R Kannagi |
T Narita, C Mitsuoka, N Kimura, M Toi, T Nakashio, K Sekiguchi, H Iwanari, R Kannagi |
Increased concentration of hepatocyte growth factor in the sera of patients with gastrointestinal cancer |
Increased concentration of hepatocyte growth factor in the sera of patients with gastrointestinal cancer |
Increased concentration of hepatocyte growth factor in the sera of patients with gastrointestinal cancer |
ONCOLOGY REPORTS, 4, 6, 1239-1241 |
ONCOLOGY REPORTS, 4, 6, 1239-1241 |
ONCOLOGY REPORTS, 4, 6, 1239-1241 |
1997/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| S Saji, M Toi, Y Yamamoto, T Tominaga |
S Saji, M Toi, Y Yamamoto, T Tominaga |
S Saji, M Toi, Y Yamamoto, T Tominaga |
The increase of apoptosis and the decrease of proliferation by angiogenesis inhibitor in rat mammary tumors |
The increase of apoptosis and the decrease of proliferation by angiogenesis inhibitor in rat mammary tumors |
The increase of apoptosis and the decrease of proliferation by angiogenesis inhibitor in rat mammary tumors |
ONCOLOGY REPORTS, 4, 1, 111-114 |
ONCOLOGY REPORTS, 4, 1, 111-114 |
ONCOLOGY REPORTS, 4, 1, 111-114 |
1997/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K Tsuruta, M Toi, M Kondo, A Okamoto |
K Tsuruta, M Toi, M Kondo, A Okamoto |
K Tsuruta, M Toi, M Kondo, A Okamoto |
Removal of primary tumor might alter the growth rate of metastatic tumor in hepatocellular carcinoma |
Removal of primary tumor might alter the growth rate of metastatic tumor in hepatocellular carcinoma |
Removal of primary tumor might alter the growth rate of metastatic tumor in hepatocellular carcinoma |
CANCER JOURNAL, 10, 1, 53-55 |
CANCER JOURNAL, 10, 1, 53-55 |
CANCER JOURNAL, 10, 1, 53-55 |
1997/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| N. Nagaya, M. Toi, S. Sunahara, F. Kurimoto, T. Tominaga |
N. Nagaya, M. Toi, S. Sunahara, F. Kurimoto, T. Tominaga |
N. Nagaya, M. Toi, S. Sunahara, F. Kurimoto, T. Tominaga |
Determination of intratumoral estrone (E<sub>1</sub>) and estradiol (E<sub>2</sub>) in primary breast cancer tissues by sensitive HPLC-RIA |
Determination of intratumoral estrone (E<sub>1</sub>) and estradiol (E<sub>2</sub>) in primary breast cancer tissues by sensitive HPLC-RIA |
Determination of intratumoral estrone (E<sub>1</sub>) and estradiol (E<sub>2</sub>) in primary breast cancer tissues by sensitive HPLC-RIA |
Japanese Journal of Cancer and Chemotherapy, 24, 3, 329-336 |
Japanese Journal of Cancer and Chemotherapy, 24, 3, 329-336 |
Japanese Journal of Cancer and Chemotherapy, 24, 3, 329-336 |
1997 |
有 |
英語 |
|
公開 |
| K. Abe, K. Suzuki, N. Kamata, Y. Yokoyama, T. Ushimi, T. Masumoto, M. Koike, M. Toi |
K. Abe, K. Suzuki, N. Kamata, Y. Yokoyama, T. Ushimi, T. Masumoto, M. Koike, M. Toi |
K. Abe, K. Suzuki, N. Kamata, Y. Yokoyama, T. Ushimi, T. Masumoto, M. Koike, M. Toi |
Case report ; pulmonary thromboembolism due to medroxyprogesterone acetate |
Case report ; pulmonary thromboembolism due to medroxyprogesterone acetate |
Case report ; pulmonary thromboembolism due to medroxyprogesterone acetate |
Japanese Journal of Clinical Radiology, 42, 6, 719-722 |
Japanese Journal of Clinical Radiology, 42, 6, 719-722 |
Japanese Journal of Clinical Radiology, 42, 6, 719-722 |
1997 |
有 |
英語 |
|
公開 |
| M. Toi, S. Saji, T. Tominaga |
M. Toi, S. Saji, T. Tominaga |
M. Toi, S. Saji, T. Tominaga |
Novel target of biotherapy: Angiogenesis |
Novel target of biotherapy: Angiogenesis |
Novel target of biotherapy: Angiogenesis |
Biotherapy, 11, 6, 738-742 |
Biotherapy, 11, 6, 738-742 |
Biotherapy, 11, 6, 738-742 |
1997 |
有 |
英語 |
|
公開 |
| M. Toi, M. Gion, E. Biganzoli, R. Dittadi, P. Boracchi, R. Miceli, S. Meli, K. Mori, T. Tominaga, G. Gasparini |
M. Toi, M. Gion, E. Biganzoli, R. Dittadi, P. Boracchi, R. Miceli, S. Meli, K. Mori, T. Tominaga, G. Gasparini |
M. Toi, M. Gion, E. Biganzoli, R. Dittadi, P. Boracchi, R. Miceli, S. Meli, K. Mori, T. Tominaga, G. Gasparini |
Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: Prognostic implications |
Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: Prognostic implications |
Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: Prognostic implications |
Angiogenesis, 1, 1, 71-83 |
Angiogenesis, 1, 1, 71-83 |
Angiogenesis, 1, 1, 71-83 |
1997 |
有 |
英語 |
|
公開 |
| M Toi, S Tanaka, M Bando, K Hayashi, T Tominaga |
M Toi, S Tanaka, M Bando, K Hayashi, T Tominaga |
M Toi, S Tanaka, M Bando, K Hayashi, T Tominaga |
Outcome of surgical resection for chest wall recurrence in breast cancer patients |
Outcome of surgical resection for chest wall recurrence in breast cancer patients |
Outcome of surgical resection for chest wall recurrence in breast cancer patients |
JOURNAL OF SURGICAL ONCOLOGY, 64, 1, 23-26 |
JOURNAL OF SURGICAL ONCOLOGY, 64, 1, 23-26 |
JOURNAL OF SURGICAL ONCOLOGY, 64, 1, 23-26 |
1997/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T Taniguchi, M Kitamura, K Arai, Y Iwasaki, Y Yamamoto, A Igari, M Toi |
T Taniguchi, M Kitamura, K Arai, Y Iwasaki, Y Yamamoto, A Igari, M Toi |
T Taniguchi, M Kitamura, K Arai, Y Iwasaki, Y Yamamoto, A Igari, M Toi |
Increase in the circulating level of hepatocyte growth factor in gastric cancer patients |
Increase in the circulating level of hepatocyte growth factor in gastric cancer patients |
Increase in the circulating level of hepatocyte growth factor in gastric cancer patients |
BRITISH JOURNAL OF CANCER, 75, 5, 673-677 |
BRITISH JOURNAL OF CANCER, 75, 5, 673-677 |
BRITISH JOURNAL OF CANCER, 75, 5, 673-677 |
1997 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| G Gasparini, M Toi, M Gion, P Verderio, R Dittadi, M Hanatani, Matsubara, I, O Vinante, E Bonoldi, P Boracchi, C Gatti, H Suzuki, T Tominaga |
G Gasparini, M Toi, M Gion, P Verderio, R Dittadi, M Hanatani, Matsubara, I, O Vinante, E Bonoldi, P Boracchi, C Gatti, H Suzuki, T Tominaga |
G Gasparini, M Toi, M Gion, P Verderio, R Dittadi, M Hanatani, Matsubara, I, O Vinante, E Bonoldi, P Boracchi, C Gatti, H Suzuki, T Tominaga |
Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma |
Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma |
Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma |
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 89, 2, 139-147 |
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 89, 2, 139-147 |
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 89, 2, 139-147 |
1997/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Toi, S. Saji, A. Suzuki, Y. Yamamoto, T. Tominaga |
M. Toi, S. Saji, A. Suzuki, Y. Yamamoto, T. Tominaga |
M. Toi, S. Saji, A. Suzuki, Y. Yamamoto, T. Tominaga |
MDM2 in breast cancer |
MDM2 in breast cancer |
MDM2 in breast cancer |
Breast Cancer, 4, 4, 264-268 |
Breast Cancer, 4, 4, 264-268 |
Breast Cancer, 4, 4, 264-268 |
1997 |
有 |
英語 |
|
公開 |
| PB Vermeulen, G Gasparini, SB Fox, M Toi, L Martin, P McCulloch, F Pezzella, G Viale, N Weidner, AL Harris, LY Dirix |
PB Vermeulen, G Gasparini, SB Fox, M Toi, L Martin, P McCulloch, F Pezzella, G Viale, N Weidner, AL Harris, LY Dirix |
PB Vermeulen, G Gasparini, SB Fox, M Toi, L Martin, P McCulloch, F Pezzella, G Viale, N Weidner, AL Harris, LY Dirix |
Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation |
Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation |
Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation |
EUROPEAN JOURNAL OF CANCER, 32A, 14, 2474-2484 |
EUROPEAN JOURNAL OF CANCER, 32A, 14, 2474-2484 |
EUROPEAN JOURNAL OF CANCER, 32A, 14, 2474-2484 |
1996/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Toi, T Taniguchi, Y Yamamoto, T Kurisaki, H Suzuki, T Tominaga |
M Toi, T Taniguchi, Y Yamamoto, T Kurisaki, H Suzuki, T Tominaga |
M Toi, T Taniguchi, Y Yamamoto, T Kurisaki, H Suzuki, T Tominaga |
Clinical significance of the determination of angiogenic factors |
Clinical significance of the determination of angiogenic factors |
Clinical significance of the determination of angiogenic factors |
EUROPEAN JOURNAL OF CANCER, 32A, 14, 2513-2519 |
EUROPEAN JOURNAL OF CANCER, 32A, 14, 2513-2519 |
EUROPEAN JOURNAL OF CANCER, 32A, 14, 2513-2519 |
1996/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K Inada, T Tominaga, M Toi, Y Yamamoto, M Abe, J Yamashita, M Ogawa |
K Inada, T Tominaga, M Toi, Y Yamamoto, M Abe, J Yamashita, M Ogawa |
K Inada, T Tominaga, M Toi, Y Yamamoto, M Abe, J Yamashita, M Ogawa |
Protective effect of leuprolide acetate on 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in rats |
Protective effect of leuprolide acetate on 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in rats |
Protective effect of leuprolide acetate on 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in rats |
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 22, 6, 583-587 |
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 22, 6, 583-587 |
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 22, 6, 583-587 |
1996/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Y Yamamoto, M Toi, T Tominaga |
Y Yamamoto, M Toi, T Tominaga |
Y Yamamoto, M Toi, T Tominaga |
Prediction of the effect of 5'-deoxy-5-fluorouridine by the status of angiogenic enzyme thymidine phosphorylase expression in recurrent breast cancer patients |
Prediction of the effect of 5'-deoxy-5-fluorouridine by the status of angiogenic enzyme thymidine phosphorylase expression in recurrent breast cancer patients |
Prediction of the effect of 5'-deoxy-5-fluorouridine by the status of angiogenic enzyme thymidine phosphorylase expression in recurrent breast cancer patients |
ONCOLOGY REPORTS, 3, 5, 863-865 |
ONCOLOGY REPORTS, 3, 5, 863-865 |
ONCOLOGY REPORTS, 3, 5, 863-865 |
1996/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K Inada, M Toi, Y Yamamoto, A Suzuki, T Kurisaki, H Suzuki, T Tominaga |
K Inada, M Toi, Y Yamamoto, A Suzuki, T Kurisaki, H Suzuki, T Tominaga |
K Inada, M Toi, Y Yamamoto, A Suzuki, T Kurisaki, H Suzuki, T Tominaga |
Immunocytochemical analysis of MDM2 protein expression and its relevance to tumor angiogenesis in primary breast cancer |
Immunocytochemical analysis of MDM2 protein expression and its relevance to tumor angiogenesis in primary breast cancer |
Immunocytochemical analysis of MDM2 protein expression and its relevance to tumor angiogenesis in primary breast cancer |
ONCOLOGY REPORTS, 3, 4, 667-671 |
ONCOLOGY REPORTS, 3, 4, 667-671 |
ONCOLOGY REPORTS, 3, 4, 667-671 |
1996/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Y Yamamoto, M Toi, S Kondo, T Matsumoto, H Suzuki, M Kitamura, K Tsuruta, T Taniguchi, A Okamoto, T Mori, M Yoshida, T Ikeda, T Tominaga |
Y Yamamoto, M Toi, S Kondo, T Matsumoto, H Suzuki, M Kitamura, K Tsuruta, T Taniguchi, A Okamoto, T Mori, M Yoshida, T Ikeda, T Tominaga |
Y Yamamoto, M Toi, S Kondo, T Matsumoto, H Suzuki, M Kitamura, K Tsuruta, T Taniguchi, A Okamoto, T Mori, M Yoshida, T Ikeda, T Tominaga |
Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients |
Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients |
Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients |
CLINICAL CANCER RESEARCH, 2, 5, 821-826 |
CLINICAL CANCER RESEARCH, 2, 5, 821-826 |
CLINICAL CANCER RESEARCH, 2, 5, 821-826 |
1996/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Toi, S Kondo, H Suzuki, Y Yamamoto, K Inada, T Imazawa, T Taniguchi, T Tominaga |
M Toi, S Kondo, H Suzuki, Y Yamamoto, K Inada, T Imazawa, T Taniguchi, T Tominaga |
M Toi, S Kondo, H Suzuki, Y Yamamoto, K Inada, T Imazawa, T Taniguchi, T Tominaga |
Quantitative analysis of vascular endothelial growth factor in primary breast cancer |
Quantitative analysis of vascular endothelial growth factor in primary breast cancer |
Quantitative analysis of vascular endothelial growth factor in primary breast cancer |
CANCER, 77, 6, 1101-1106 |
CANCER, 77, 6, 1101-1106 |
CANCER, 77, 6, 1101-1106 |
1996/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Kitamura, K Arai, Y Iwasaki, M Toi |
M Kitamura, K Arai, Y Iwasaki, M Toi |
M Kitamura, K Arai, Y Iwasaki, M Toi |
Antitumor effect of the angiogenesis inhibitor TNP-470 and its combination effect with 5-FU and PSK in colon 26 tumors |
Antitumor effect of the angiogenesis inhibitor TNP-470 and its combination effect with 5-FU and PSK in colon 26 tumors |
Antitumor effect of the angiogenesis inhibitor TNP-470 and its combination effect with 5-FU and PSK in colon 26 tumors |
ONCOLOGY REPORTS, 3, 1, 151-153 |
ONCOLOGY REPORTS, 3, 1, 151-153 |
ONCOLOGY REPORTS, 3, 1, 151-153 |
1996/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Toi, Y. Yamamoto, T. Taniguchi, S. Saji, K. Hayashi, T. Tominaga |
M. Toi, Y. Yamamoto, T. Taniguchi, S. Saji, K. Hayashi, T. Tominaga |
M. Toi, Y. Yamamoto, T. Taniguchi, S. Saji, K. Hayashi, T. Tominaga |
Regulation of endothelial growth factor expressions in breast cancer. |
Regulation of endothelial growth factor expressions in breast cancer. |
Regulation of endothelial growth factor expressions in breast cancer. |
Gan to kagaku ryoho. Cancer & chemotherapy, 23 Suppl 1, 75-79 |
Gan to kagaku ryoho. Cancer & chemotherapy, 23 Suppl 1, 75-79 |
Gan to kagaku ryoho. Cancer & chemotherapy, 23 Suppl 1, 75-79 |
1996 |
有 |
英語 |
|
公開 |
| S. Saji, M. Toi, T. Tominaga |
S. Saji, M. Toi, T. Tominaga |
S. Saji, M. Toi, T. Tominaga |
The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer |
The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer |
The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer |
Nippon Geka Gakkai zasshi, 97, 5, 368-374 |
Nippon Geka Gakkai zasshi, 97, 5, 368-374 |
Nippon Geka Gakkai zasshi, 97, 5, 368-374 |
1996 |
有 |
英語 |
|
公開 |
| M. Toi, T. Tominaga |
M. Toi, T. Tominaga |
M. Toi, T. Tominaga |
Breast cancer angiogenesis |
Breast cancer angiogenesis |
Breast cancer angiogenesis |
Japanese Journal of Cancer and Chemotherapy, 23, 6, 659-666 |
Japanese Journal of Cancer and Chemotherapy, 23, 6, 659-666 |
Japanese Journal of Cancer and Chemotherapy, 23, 6, 659-666 |
1996 |
有 |
英語 |
|
公開 |
| T. Tominaga, M. Toi, Y. Yamamoto |
T. Tominaga, M. Toi, Y. Yamamoto |
T. Tominaga, M. Toi, Y. Yamamoto |
Tumor angiogenesis as a key prognostic factor in breast cancer |
Tumor angiogenesis as a key prognostic factor in breast cancer |
Tumor angiogenesis as a key prognostic factor in breast cancer |
Biotherapy, 10, 7, 958-962 |
Biotherapy, 10, 7, 958-962 |
Biotherapy, 10, 7, 958-962 |
1996 |
有 |
英語 |
|
公開 |
| K Umezawa, T Taniguchi, M Toi, T Ohse, N Tsutsumi, T Yamamoto, T Koyano, M Ishizuka |
K Umezawa, T Taniguchi, M Toi, T Ohse, N Tsutsumi, T Yamamoto, T Koyano, M Ishizuka |
K Umezawa, T Taniguchi, M Toi, T Ohse, N Tsutsumi, T Yamamoto, T Koyano, M Ishizuka |
Growth inhibition of K-ras-expressing tumours by a new vinca alkaloid, conophylline, in nude mice |
Growth inhibition of K-ras-expressing tumours by a new vinca alkaloid, conophylline, in nude mice |
Growth inhibition of K-ras-expressing tumours by a new vinca alkaloid, conophylline, in nude mice |
DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 22, 2, 35-40 |
DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 22, 2, 35-40 |
DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 22, 2, 35-40 |
1996 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Toi |
M Toi |
M Toi |
Endothelial growth factors: A target for antiangiogenesis |
Endothelial growth factors: A target for antiangiogenesis |
Endothelial growth factors: A target for antiangiogenesis |
CANCER JOURNAL, 8, 6, 315-319 |
CANCER JOURNAL, 8, 6, 315-319 |
CANCER JOURNAL, 8, 6, 315-319 |
1995/11 |
有 |
英語 |
|
公開 |
| T Taniguchi, M Toi, K Inada, T Imazawa, Y Yamamoto, T Tominaga |
T Taniguchi, M Toi, K Inada, T Imazawa, Y Yamamoto, T Tominaga |
T Taniguchi, M Toi, K Inada, T Imazawa, Y Yamamoto, T Tominaga |
Serum concentrations of hepatocyte growth factor in breast cancer patients |
Serum concentrations of hepatocyte growth factor in breast cancer patients |
Serum concentrations of hepatocyte growth factor in breast cancer patients |
CLINICAL CANCER RESEARCH, 1, 9, 1031-1034 |
CLINICAL CANCER RESEARCH, 1, 9, 1031-1034 |
CLINICAL CANCER RESEARCH, 1, 9, 1031-1034 |
1995/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M Toi, K Inada, S Hoshina, H Suzuki, S Kondo, T Tominaga |
M Toi, K Inada, S Hoshina, H Suzuki, S Kondo, T Tominaga |
M Toi, K Inada, S Hoshina, H Suzuki, S Kondo, T Tominaga |
Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer |
Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer |
Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer |
CLINICAL CANCER RESEARCH, 1, 9, 961-964 |
CLINICAL CANCER RESEARCH, 1, 9, 961-964 |
CLINICAL CANCER RESEARCH, 1, 9, 961-964 |
1995/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| Y YAMAMOTO, M TOI, R YAMADA, T TOMINAGA |
Y YAMAMOTO, M TOI, R YAMADA, T TOMINAGA |
Y YAMAMOTO, M TOI, R YAMADA, T TOMINAGA |
COMBINATION EFFECT OF AN ANGIOGENESIS INHIBITOR AGM-1470 WITH 5'-DEOXY-5-FLUOROURIDINE, AND WITH HORMONAL DRUGS IN DMBA-INDUCED RAT MAMMARY-TUMORS |
COMBINATION EFFECT OF AN ANGIOGENESIS INHIBITOR AGM-1470 WITH 5'-DEOXY-5-FLUOROURIDINE, AND WITH HORMONAL DRUGS IN DMBA-INDUCED RAT MAMMARY-TUMORS |
COMBINATION EFFECT OF AN ANGIOGENESIS INHIBITOR AGM-1470 WITH 5'-DEOXY-5-FLUOROURIDINE, AND WITH HORMONAL DRUGS IN DMBA-INDUCED RAT MAMMARY-TUMORS |
ONCOLOGY REPORTS, 2, 5, 793-796 |
ONCOLOGY REPORTS, 2, 5, 793-796 |
ONCOLOGY REPORTS, 2, 5, 793-796 |
1995/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M TOI, S HOSHINA, T TANIGUCHI, Y YAMAMOTO, H ISHITSUKA, T TOMINAGA |
M TOI, S HOSHINA, T TANIGUCHI, Y YAMAMOTO, H ISHITSUKA, T TOMINAGA |
M TOI, S HOSHINA, T TANIGUCHI, Y YAMAMOTO, H ISHITSUKA, T TOMINAGA |
EXPRESSION OF PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE IN HUMAN BREAST-CANCER |
EXPRESSION OF PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE IN HUMAN BREAST-CANCER |
EXPRESSION OF PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR THYMIDINE PHOSPHORYLASE IN HUMAN BREAST-CANCER |
INTERNATIONAL JOURNAL OF CANCER, 64, 2, 79-82 |
INTERNATIONAL JOURNAL OF CANCER, 64, 2, 79-82 |
INTERNATIONAL JOURNAL OF CANCER, 64, 2, 79-82 |
1995/04 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Toi, T. Taniguchi, K. Hayashi, T. Tominaga |
M. Toi, T. Taniguchi, K. Hayashi, T. Tominaga |
M. Toi, T. Taniguchi, K. Hayashi, T. Tominaga |
The effect of combination treatment consisted of 5\\'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patients |
The effect of combination treatment consisted of 5\\'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patients |
The effect of combination treatment consisted of 5\\'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patients |
Japanese Journal of Cancer and Chemotherapy, 22, 6, 799-804 |
Japanese Journal of Cancer and Chemotherapy, 22, 6, 799-804 |
Japanese Journal of Cancer and Chemotherapy, 22, 6, 799-804 |
1995 |
有 |
英語 |
|
公開 |
| M TOI, K INADA, H SUZUKI, T TOMINAGA |
M TOI, K INADA, H SUZUKI, T TOMINAGA |
M TOI, K INADA, H SUZUKI, T TOMINAGA |
TUMOR ANGIOGENESIS IN BREAST-CANCER - ITS IMPORTANCE AS A PROGNOSTIC INDICATOR AND THE ASSOCIATION WITH VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION |
TUMOR ANGIOGENESIS IN BREAST-CANCER - ITS IMPORTANCE AS A PROGNOSTIC INDICATOR AND THE ASSOCIATION WITH VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION |
TUMOR ANGIOGENESIS IN BREAST-CANCER - ITS IMPORTANCE AS A PROGNOSTIC INDICATOR AND THE ASSOCIATION WITH VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION |
BREAST CANCER RESEARCH AND TREATMENT, 36, 2, 193-204 |
BREAST CANCER RESEARCH AND TREATMENT, 36, 2, 193-204 |
BREAST CANCER RESEARCH AND TREATMENT, 36, 2, 193-204 |
1995 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T TANIGUCHI, M TOI, T TOMINAGA |
T TANIGUCHI, M TOI, T TOMINAGA |
T TANIGUCHI, M TOI, T TOMINAGA |
INCREASE IN THE CIRCULATING LEVEL OF HEPATOCYTE GROWTH-FACTOR IN BREAST-CANCER PATIENTS WITH DISTANT METASTASES |
INCREASE IN THE CIRCULATING LEVEL OF HEPATOCYTE GROWTH-FACTOR IN BREAST-CANCER PATIENTS WITH DISTANT METASTASES |
INCREASE IN THE CIRCULATING LEVEL OF HEPATOCYTE GROWTH-FACTOR IN BREAST-CANCER PATIENTS WITH DISTANT METASTASES |
ONCOLOGY REPORTS, 1, 6, 1199-1201 |
ONCOLOGY REPORTS, 1, 6, 1199-1201 |
ONCOLOGY REPORTS, 1, 6, 1199-1201 |
1994/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M TOI, S HOSHINA, T TAKAYANAGI, T TOMINAGA |
M TOI, S HOSHINA, T TAKAYANAGI, T TOMINAGA |
M TOI, S HOSHINA, T TAKAYANAGI, T TOMINAGA |
ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION WITH TUMOR ANGIOGENESIS AND WITH EARLY RELAPSE IN PRIMARY BREAST-CANCER |
ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION WITH TUMOR ANGIOGENESIS AND WITH EARLY RELAPSE IN PRIMARY BREAST-CANCER |
ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION WITH TUMOR ANGIOGENESIS AND WITH EARLY RELAPSE IN PRIMARY BREAST-CANCER |
JAPANESE JOURNAL OF CANCER RESEARCH, 85, 10, 1045-1049 |
JAPANESE JOURNAL OF CANCER RESEARCH, 85, 10, 1045-1049 |
JAPANESE JOURNAL OF CANCER RESEARCH, 85, 10, 1045-1049 |
1994/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T TANIGUCHI, M TOI, T TOMINAGA |
T TANIGUCHI, M TOI, T TOMINAGA |
T TANIGUCHI, M TOI, T TOMINAGA |
RAPID INDUCTION OF HEPATOCYTE GROWTH-FACTOR BY HEPARIN |
RAPID INDUCTION OF HEPATOCYTE GROWTH-FACTOR BY HEPARIN |
RAPID INDUCTION OF HEPATOCYTE GROWTH-FACTOR BY HEPARIN |
LANCET, 344, 8920, 470-470 |
LANCET, 344, 8920, 470-470 |
LANCET, 344, 8920, 470-470 |
1994/08 |
有 |
英語 |
|
公開 |
| M TOI, T TAKAYANAGI, R SOUMA, T TOMINAGA |
M TOI, T TAKAYANAGI, R SOUMA, T TOMINAGA |
M TOI, T TAKAYANAGI, R SOUMA, T TOMINAGA |
INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR INDUCED CELL-GROWTH BY AN ANGIOGENESIS INHIBITOR AGM-1470 IN CAPILLARY ENDOTHELIAL-CELLS |
INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR INDUCED CELL-GROWTH BY AN ANGIOGENESIS INHIBITOR AGM-1470 IN CAPILLARY ENDOTHELIAL-CELLS |
INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR INDUCED CELL-GROWTH BY AN ANGIOGENESIS INHIBITOR AGM-1470 IN CAPILLARY ENDOTHELIAL-CELLS |
ONCOLOGY REPORTS, 1, 2, 423-426 |
ONCOLOGY REPORTS, 1, 2, 423-426 |
ONCOLOGY REPORTS, 1, 2, 423-426 |
1994/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M KITAMURA, K TAKAHASHI, T TOMINAGA, M TOI |
M KITAMURA, K TAKAHASHI, T TOMINAGA, M TOI |
M KITAMURA, K TAKAHASHI, T TOMINAGA, M TOI |
PREVENTIVE EFFECT OF WHOLE PEPTIDOGLYCAN (WPG) ON THE OCCURRENCE OF RAT MAMMARY-TUMORS INDUCED BY 7,12-DIMETHYLBENZ(A)ANTHRACENE (DMBA) |
PREVENTIVE EFFECT OF WHOLE PEPTIDOGLYCAN (WPG) ON THE OCCURRENCE OF RAT MAMMARY-TUMORS INDUCED BY 7,12-DIMETHYLBENZ(A)ANTHRACENE (DMBA) |
PREVENTIVE EFFECT OF WHOLE PEPTIDOGLYCAN (WPG) ON THE OCCURRENCE OF RAT MAMMARY-TUMORS INDUCED BY 7,12-DIMETHYLBENZ(A)ANTHRACENE (DMBA) |
ONCOLOGY REPORTS, 1, 2, 309-312 |
ONCOLOGY REPORTS, 1, 2, 309-312 |
ONCOLOGY REPORTS, 1, 2, 309-312 |
1994/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M. Toi, S. Hoshina, Y. Yamamoto, T. Ishii, K. Hayashi, T. Tominaga |
M. Toi, S. Hoshina, Y. Yamamoto, T. Ishii, K. Hayashi, T. Tominaga |
M. Toi, S. Hoshina, Y. Yamamoto, T. Ishii, K. Hayashi, T. Tominaga |
Tumor angiogenesis in breast cancer: significance of vessel density as a prognostic indicator |
Tumor angiogenesis in breast cancer: significance of vessel density as a prognostic indicator |
Tumor angiogenesis in breast cancer: significance of vessel density as a prognostic indicator |
Japanese Journal of Cancer and Chemotherapy, 21 Suppl 2, 178-182 |
Japanese Journal of Cancer and Chemotherapy, 21 Suppl 2, 178-182 |
Japanese Journal of Cancer and Chemotherapy, 21 Suppl 2, 178-182 |
1994 |
有 |
英語 |
|
公開 |
| K. Inada, M. Toi, T. Imazawa, S. Hoshina, K. Hayashi, T. Tominaga |
K. Inada, M. Toi, T. Imazawa, S. Hoshina, K. Hayashi, T. Tominaga |
K. Inada, M. Toi, T. Imazawa, S. Hoshina, K. Hayashi, T. Tominaga |
Significance of overexpression of p53 protein in human breast cancer |
Significance of overexpression of p53 protein in human breast cancer |
Significance of overexpression of p53 protein in human breast cancer |
Japanese Journal of Cancer and Chemotherapy, 21, 6, 817-821 |
Japanese Journal of Cancer and Chemotherapy, 21, 6, 817-821 |
Japanese Journal of Cancer and Chemotherapy, 21, 6, 817-821 |
1994 |
有 |
英語 |
|
公開 |
| M. Toi, K. Hayashi, T. Tominaga |
M. Toi, K. Hayashi, T. Tominaga |
M. Toi, K. Hayashi, T. Tominaga |
Feasibility of adjuvant high-dose CAF (cyclophosphamide, adriamycin, 5-FU) therapy for primary breast cancer patients |
Feasibility of adjuvant high-dose CAF (cyclophosphamide, adriamycin, 5-FU) therapy for primary breast cancer patients |
Feasibility of adjuvant high-dose CAF (cyclophosphamide, adriamycin, 5-FU) therapy for primary breast cancer patients |
Japanese Journal of Cancer and Chemotherapy, 21, 12, 2057-2060 |
Japanese Journal of Cancer and Chemotherapy, 21, 12, 2057-2060 |
Japanese Journal of Cancer and Chemotherapy, 21, 12, 2057-2060 |
1994 |
有 |
英語 |
|
公開 |
| M TOI, T TOMINAGA, A OSAKI, T TOGE |
M TOI, T TOMINAGA, A OSAKI, T TOGE |
M TOI, T TOMINAGA, A OSAKI, T TOGE |
ROLE OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN PRIMARY BREAST-CANCER - RESULTS OF A BIOCHEMICAL-STUDY AND AN IMMUNOCYTOCHEMICAL STUDY |
ROLE OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN PRIMARY BREAST-CANCER - RESULTS OF A BIOCHEMICAL-STUDY AND AN IMMUNOCYTOCHEMICAL STUDY |
ROLE OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN PRIMARY BREAST-CANCER - RESULTS OF A BIOCHEMICAL-STUDY AND AN IMMUNOCYTOCHEMICAL STUDY |
BREAST CANCER RESEARCH AND TREATMENT, 29, 1, 51-58 |
BREAST CANCER RESEARCH AND TREATMENT, 29, 1, 51-58 |
BREAST CANCER RESEARCH AND TREATMENT, 29, 1, 51-58 |
1994 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M TOI, AL HARRIS, R BICKNELL |
M TOI, AL HARRIS, R BICKNELL |
M TOI, AL HARRIS, R BICKNELL |
CDNA TRANSFECTION FOLLOWED BY THE ISOLATION OF A MCF-7 BREAST CELL-LINE RESISTANT TO TAMOXIFEN IN-VITRO AND IN-VIVO |
CDNA TRANSFECTION FOLLOWED BY THE ISOLATION OF A MCF-7 BREAST CELL-LINE RESISTANT TO TAMOXIFEN IN-VITRO AND IN-VIVO |
CDNA TRANSFECTION FOLLOWED BY THE ISOLATION OF A MCF-7 BREAST CELL-LINE RESISTANT TO TAMOXIFEN IN-VITRO AND IN-VIVO |
BRITISH JOURNAL OF CANCER, 68, 6, 1088-1096 |
BRITISH JOURNAL OF CANCER, 68, 6, 1088-1096 |
BRITISH JOURNAL OF CANCER, 68, 6, 1088-1096 |
1993/12 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T TOMINAGA, M TOI, T SHIRASAKA |
T TOMINAGA, M TOI, T SHIRASAKA |
T TOMINAGA, M TOI, T SHIRASAKA |
ENHANCED INHIBITION OF THYMIDYLATE SYNTHASE BY 5-FLUOROURACIL AND [6S]LEUCOVORIN COMBINATION THERAPY FOR BREAST-CANCER |
ENHANCED INHIBITION OF THYMIDYLATE SYNTHASE BY 5-FLUOROURACIL AND [6S]LEUCOVORIN COMBINATION THERAPY FOR BREAST-CANCER |
ENHANCED INHIBITION OF THYMIDYLATE SYNTHASE BY 5-FLUOROURACIL AND [6S]LEUCOVORIN COMBINATION THERAPY FOR BREAST-CANCER |
ANTICANCER RESEARCH, 13, 6B, 2425-2427 |
ANTICANCER RESEARCH, 13, 6B, 2425-2427 |
ANTICANCER RESEARCH, 13, 6B, 2425-2427 |
1993/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M TOI, Y YAMAMOTO, T IMAZAWA, T TAKAYANAGI, K AKUTSU, T TOMINAGA |
M TOI, Y YAMAMOTO, T IMAZAWA, T TAKAYANAGI, K AKUTSU, T TOMINAGA |
M TOI, Y YAMAMOTO, T IMAZAWA, T TAKAYANAGI, K AKUTSU, T TOMINAGA |
ANTITUMOR EFFECT OF THE ANGIOGENESIS INHIBITOR AGM-1470 AND ITS COMBINATION EFFECT WITH TAMOXIFEN IN DMBA INDUCED MAMMARY-TUMORS IN RATS |
ANTITUMOR EFFECT OF THE ANGIOGENESIS INHIBITOR AGM-1470 AND ITS COMBINATION EFFECT WITH TAMOXIFEN IN DMBA INDUCED MAMMARY-TUMORS IN RATS |
ANTITUMOR EFFECT OF THE ANGIOGENESIS INHIBITOR AGM-1470 AND ITS COMBINATION EFFECT WITH TAMOXIFEN IN DMBA INDUCED MAMMARY-TUMORS IN RATS |
INTERNATIONAL JOURNAL OF ONCOLOGY, 3, 3, 525-528 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 3, 3, 525-528 |
INTERNATIONAL JOURNAL OF ONCOLOGY, 3, 3, 525-528 |
1993/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M TOI, J KASHITANI, T TOMINAGA |
M TOI, J KASHITANI, T TOMINAGA |
M TOI, J KASHITANI, T TOMINAGA |
TUMOR ANGIOGENESIS IS AN INDEPENDENT PROGNOSTIC INDICATOR IN PRIMARY BREAST-CARCINOMA |
TUMOR ANGIOGENESIS IS AN INDEPENDENT PROGNOSTIC INDICATOR IN PRIMARY BREAST-CARCINOMA |
TUMOR ANGIOGENESIS IS AN INDEPENDENT PROGNOSTIC INDICATOR IN PRIMARY BREAST-CARCINOMA |
INTERNATIONAL JOURNAL OF CANCER, 55, 3, 371-374 |
INTERNATIONAL JOURNAL OF CANCER, 55, 3, 371-374 |
INTERNATIONAL JOURNAL OF CANCER, 55, 3, 371-374 |
1993/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T OIKAWA, H ITO, H ASHINO, M TOI, T TOMINAGA, MORITA, I, S MUROTA |
T OIKAWA, H ITO, H ASHINO, M TOI, T TOMINAGA, MORITA, I, S MUROTA |
T OIKAWA, H ITO, H ASHINO, M TOI, T TOMINAGA, MORITA, I, S MUROTA |
RADICICOL, A MICROBIAL CELL-DIFFERENTIATION MODULATOR, INHIBITS IN-VIVO ANGIOGENESIS |
RADICICOL, A MICROBIAL CELL-DIFFERENTIATION MODULATOR, INHIBITS IN-VIVO ANGIOGENESIS |
RADICICOL, A MICROBIAL CELL-DIFFERENTIATION MODULATOR, INHIBITS IN-VIVO ANGIOGENESIS |
EUROPEAN JOURNAL OF PHARMACOLOGY, 241, 2-3, 221-227 |
EUROPEAN JOURNAL OF PHARMACOLOGY, 241, 2-3, 221-227 |
EUROPEAN JOURNAL OF PHARMACOLOGY, 241, 2-3, 221-227 |
1993/09 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K KUROI, A OSAKI, H YAMADA, M TOI, T TOGE, Y TAKIMOTO, A KURAMOTO, K ARIHIRO, K INAI |
K KUROI, A OSAKI, H YAMADA, M TOI, T TOGE, Y TAKIMOTO, A KURAMOTO, K ARIHIRO, K INAI |
K KUROI, A OSAKI, H YAMADA, M TOI, T TOGE, Y TAKIMOTO, A KURAMOTO, K ARIHIRO, K INAI |
PRIMARY SQUAMOUS-CELL CARCINOMA OF THE BREAST AFTER CURED HODGKINS-DISEASE |
PRIMARY SQUAMOUS-CELL CARCINOMA OF THE BREAST AFTER CURED HODGKINS-DISEASE |
PRIMARY SQUAMOUS-CELL CARCINOMA OF THE BREAST AFTER CURED HODGKINS-DISEASE |
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 23, 1, 81-84 |
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 23, 1, 81-84 |
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 23, 1, 81-84 |
1993 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M TOI, T HATTORI, M AKAGI, K INOKUCHI, K ORITA, K SUGIMACHI, K DOHI, Y NOMURA, Y MONDEN, Y HAMADA, T MORIMOTO, N OGAWA |
M TOI, T HATTORI, M AKAGI, K INOKUCHI, K ORITA, K SUGIMACHI, K DOHI, Y NOMURA, Y MONDEN, Y HAMADA, T MORIMOTO, N OGAWA |
M TOI, T HATTORI, M AKAGI, K INOKUCHI, K ORITA, K SUGIMACHI, K DOHI, Y NOMURA, Y MONDEN, Y HAMADA, T MORIMOTO, N OGAWA |
RANDOMIZED ADJUVANT TRIAL TO EVALUATE THE ADDITION OF TAMOXIFEN AND PSK TO CHEMOTHERAPY IN PATIENTS WITH PRIMARY BREAST-CANCER - 5-YEAR RESULTS FROM THE NISHI-NIPPON GROUP OF THE ADJUVANT CHEMOENDOCRINE THERAPY FOR BREAST-CANCER ORGANIZATION |
RANDOMIZED ADJUVANT TRIAL TO EVALUATE THE ADDITION OF TAMOXIFEN AND PSK TO CHEMOTHERAPY IN PATIENTS WITH PRIMARY BREAST-CANCER - 5-YEAR RESULTS FROM THE NISHI-NIPPON GROUP OF THE ADJUVANT CHEMOENDOCRINE THERAPY FOR BREAST-CANCER ORGANIZATION |
RANDOMIZED ADJUVANT TRIAL TO EVALUATE THE ADDITION OF TAMOXIFEN AND PSK TO CHEMOTHERAPY IN PATIENTS WITH PRIMARY BREAST-CANCER - 5-YEAR RESULTS FROM THE NISHI-NIPPON GROUP OF THE ADJUVANT CHEMOENDOCRINE THERAPY FOR BREAST-CANCER ORGANIZATION |
CANCER, 70, 10, 2475-2483 |
CANCER, 70, 10, 2475-2483 |
CANCER, 70, 10, 2475-2483 |
1992/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| A OSAKI, M TOI, H YAMADA, H KAWAMI, K KUROI, T TOGE |
A OSAKI, M TOI, H YAMADA, H KAWAMI, K KUROI, T TOGE |
A OSAKI, M TOI, H YAMADA, H KAWAMI, K KUROI, T TOGE |
PROGNOSTIC-SIGNIFICANCE OF COEXPRESSION OF C-ERBB-2 ONCOPROTEIN AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN BREAST-CANCER PATIENTS |
PROGNOSTIC-SIGNIFICANCE OF COEXPRESSION OF C-ERBB-2 ONCOPROTEIN AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN BREAST-CANCER PATIENTS |
PROGNOSTIC-SIGNIFICANCE OF COEXPRESSION OF C-ERBB-2 ONCOPROTEIN AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN BREAST-CANCER PATIENTS |
AMERICAN JOURNAL OF SURGERY, 164, 4, 323-326 |
AMERICAN JOURNAL OF SURGERY, 164, 4, 323-326 |
AMERICAN JOURNAL OF SURGERY, 164, 4, 323-326 |
1992/10 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M TOI, R BICKNELL, AL HARRIS |
M TOI, R BICKNELL, AL HARRIS |
M TOI, R BICKNELL, AL HARRIS |
INHIBITION OF COLON AND BREAST-CARCINOMA CELL-GROWTH BY INTERLEUKIN-4 |
INHIBITION OF COLON AND BREAST-CARCINOMA CELL-GROWTH BY INTERLEUKIN-4 |
INHIBITION OF COLON AND BREAST-CARCINOMA CELL-GROWTH BY INTERLEUKIN-4 |
CANCER RESEARCH, 52, 2, 275-279 |
CANCER RESEARCH, 52, 2, 275-279 |
CANCER RESEARCH, 52, 2, 275-279 |
1992/01 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H MUKAIDA, M TOI, T HIRAI, Y YAMASHITA, T TOGE |
H MUKAIDA, M TOI, T HIRAI, Y YAMASHITA, T TOGE |
H MUKAIDA, M TOI, T HIRAI, Y YAMASHITA, T TOGE |
CLINICAL-SIGNIFICANCE OF THE EXPRESSION OF EPIDERMAL GROWTH-FACTOR AND ITS RECEPTOR IN ESOPHAGEAL CANCER |
CLINICAL-SIGNIFICANCE OF THE EXPRESSION OF EPIDERMAL GROWTH-FACTOR AND ITS RECEPTOR IN ESOPHAGEAL CANCER |
CLINICAL-SIGNIFICANCE OF THE EXPRESSION OF EPIDERMAL GROWTH-FACTOR AND ITS RECEPTOR IN ESOPHAGEAL CANCER |
CANCER, 68, 1, 142-148 |
CANCER, 68, 1, 142-148 |
CANCER, 68, 1, 142-148 |
1991/07 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M TOI, AL HARRIS, R BICKNELL |
M TOI, AL HARRIS, R BICKNELL |
M TOI, AL HARRIS, R BICKNELL |
INTERLEUKIN-4 IS A POTENT MITOGEN FOR CAPILLARY ENDOTHELIUM |
INTERLEUKIN-4 IS A POTENT MITOGEN FOR CAPILLARY ENDOTHELIUM |
INTERLEUKIN-4 IS A POTENT MITOGEN FOR CAPILLARY ENDOTHELIUM |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 174, 3, 1287-1293 |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 174, 3, 1287-1293 |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 174, 3, 1287-1293 |
1991/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| K. Umezaza, M. Toi |
K. Umezaza, M. Toi |
K. Umezaza, M. Toi |
Inhibitors of growth factor functions, possible antineoplastic agents |
Inhibitors of growth factor functions, possible antineoplastic agents |
Inhibitors of growth factor functions, possible antineoplastic agents |
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 36, 7, 1429-1435 |
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 36, 7, 1429-1435 |
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 36, 7, 1429-1435 |
1991 |
有 |
英語 |
|
公開 |
| K. Yoshinaka, M. Yagi, S. Ohtagaki, M. Toi, T. Toge |
K. Yoshinaka, M. Yagi, S. Ohtagaki, M. Toi, T. Toge |
K. Yoshinaka, M. Yagi, S. Ohtagaki, M. Toi, T. Toge |
5\\'-deoxy-5-fluorouridine (5\\'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer |
5\\'-deoxy-5-fluorouridine (5\\'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer |
5\\'-deoxy-5-fluorouridine (5\\'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer |
Japanese Journal of Cancer and Chemotherapy, 18, 1, 115-118 |
Japanese Journal of Cancer and Chemotherapy, 18, 1, 115-118 |
Japanese Journal of Cancer and Chemotherapy, 18, 1, 115-118 |
1991 |
有 |
英語 |
|
公開 |
| M TOI, A OSAKI, H YAMADA, T TOGE |
M TOI, A OSAKI, H YAMADA, T TOGE |
M TOI, A OSAKI, H YAMADA, T TOGE |
EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION AS A PROGNOSTIC INDICATOR IN BREAST-CANCER |
EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION AS A PROGNOSTIC INDICATOR IN BREAST-CANCER |
EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION AS A PROGNOSTIC INDICATOR IN BREAST-CANCER |
EUROPEAN JOURNAL OF CANCER, 27, 8, 977-980 |
EUROPEAN JOURNAL OF CANCER, 27, 8, 977-980 |
EUROPEAN JOURNAL OF CANCER, 27, 8, 977-980 |
1991 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M TOI, T NAKAMURA, H MUKAIDA, T WADA, A OSAKI, H YAMADA, T TOGE, M NIIMOTO, T HATTORI |
M TOI, T NAKAMURA, H MUKAIDA, T WADA, A OSAKI, H YAMADA, T TOGE, M NIIMOTO, T HATTORI |
M TOI, T NAKAMURA, H MUKAIDA, T WADA, A OSAKI, H YAMADA, T TOGE, M NIIMOTO, T HATTORI |
RELATIONSHIP BETWEEN EPIDERMAL GROWTH-FACTOR RECEPTOR STATUS AND VARIOUS PROGNOSTIC FACTORS IN HUMAN BREAST-CANCER |
RELATIONSHIP BETWEEN EPIDERMAL GROWTH-FACTOR RECEPTOR STATUS AND VARIOUS PROGNOSTIC FACTORS IN HUMAN BREAST-CANCER |
RELATIONSHIP BETWEEN EPIDERMAL GROWTH-FACTOR RECEPTOR STATUS AND VARIOUS PROGNOSTIC FACTORS IN HUMAN BREAST-CANCER |
CANCER, 65, 9, 1980-1984 |
CANCER, 65, 9, 1980-1984 |
CANCER, 65, 9, 1980-1984 |
1990/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M TOI, T WADA, H YAMADA, A OHSAKI, A YAMAMOTO, T NAKAMURA, M NIIMOTO, T HATTORI |
M TOI, T WADA, H YAMADA, A OHSAKI, A YAMAMOTO, T NAKAMURA, M NIIMOTO, T HATTORI |
M TOI, T WADA, H YAMADA, A OHSAKI, A YAMAMOTO, T NAKAMURA, M NIIMOTO, T HATTORI |
GROWTH FRACTIONS OF BREAST-CANCER IN RELATION TO EPIDERMAL GROWTH-FACTOR RECEPTOR AND ESTROGEN-RECEPTOR |
GROWTH FRACTIONS OF BREAST-CANCER IN RELATION TO EPIDERMAL GROWTH-FACTOR RECEPTOR AND ESTROGEN-RECEPTOR |
GROWTH FRACTIONS OF BREAST-CANCER IN RELATION TO EPIDERMAL GROWTH-FACTOR RECEPTOR AND ESTROGEN-RECEPTOR |
JAPANESE JOURNAL OF SURGERY, 20, 3, 327-330 |
JAPANESE JOURNAL OF SURGERY, 20, 3, 327-330 |
JAPANESE JOURNAL OF SURGERY, 20, 3, 327-330 |
1990/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| H MUKAIDA, T YAMAMOTO, T HIRAI, M TOI, T NAKAMURA, T WADA, Y YAMASHITA, K KAWANO, M NIIMOTO |
H MUKAIDA, T YAMAMOTO, T HIRAI, M TOI, T NAKAMURA, T WADA, Y YAMASHITA, K KAWANO, M NIIMOTO |
H MUKAIDA, T YAMAMOTO, T HIRAI, M TOI, T NAKAMURA, T WADA, Y YAMASHITA, K KAWANO, M NIIMOTO |
EXPRESSION OF HUMAN EPIDERMAL GROWTH-FACTOR AND ITS RECEPTOR IN ESOPHAGEAL CANCER |
EXPRESSION OF HUMAN EPIDERMAL GROWTH-FACTOR AND ITS RECEPTOR IN ESOPHAGEAL CANCER |
EXPRESSION OF HUMAN EPIDERMAL GROWTH-FACTOR AND ITS RECEPTOR IN ESOPHAGEAL CANCER |
JAPANESE JOURNAL OF SURGERY, 20, 3, 275-282 |
JAPANESE JOURNAL OF SURGERY, 20, 3, 275-282 |
JAPANESE JOURNAL OF SURGERY, 20, 3, 275-282 |
1990/05 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M NIIMOTO, T SAEKI, M TOI, M NISHIYAMA, T HIRAI, E YANAGAWA, T HATTORI |
M NIIMOTO, T SAEKI, M TOI, M NISHIYAMA, T HIRAI, E YANAGAWA, T HATTORI |
M NIIMOTO, T SAEKI, M TOI, M NISHIYAMA, T HIRAI, E YANAGAWA, T HATTORI |
PROSPECTIVE RANDOMIZED CONTROLLED-STUDY ON BESTATIN IN RESECTABLE GASTRIC-CANCER - 3RD REPORT |
PROSPECTIVE RANDOMIZED CONTROLLED-STUDY ON BESTATIN IN RESECTABLE GASTRIC-CANCER - 3RD REPORT |
PROSPECTIVE RANDOMIZED CONTROLLED-STUDY ON BESTATIN IN RESECTABLE GASTRIC-CANCER - 3RD REPORT |
JAPANESE JOURNAL OF SURGERY, 20, 2, 186-191 |
JAPANESE JOURNAL OF SURGERY, 20, 2, 186-191 |
JAPANESE JOURNAL OF SURGERY, 20, 2, 186-191 |
1990/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| E. Miyahara, M. Toi, T. Wada, H. Yamada, A. Osaki, E. Yanagawa, T. Toge |
E. Miyahara, M. Toi, T. Wada, H. Yamada, A. Osaki, E. Yanagawa, T. Toge |
E. Miyahara, M. Toi, T. Wada, H. Yamada, A. Osaki, E. Yanagawa, T. Toge |
The expression of NCC-ST-439, a tumor marker, in human breast cancer patients |
The expression of NCC-ST-439, a tumor marker, in human breast cancer patients |
The expression of NCC-ST-439, a tumor marker, in human breast cancer patients |
Gan no rinsho. Japan journal of cancer clinics, 36, 11, 2023-2026 |
Gan no rinsho. Japan journal of cancer clinics, 36, 11, 2023-2026 |
Gan no rinsho. Japan journal of cancer clinics, 36, 11, 2023-2026 |
1990 |
有 |
英語 |
|
公開 |
| S SUEHIRO, Y HAMADA, M TOI, T NAKAMURA, M NIIMOTO, T HATTORI |
S SUEHIRO, Y HAMADA, M TOI, T NAKAMURA, M NIIMOTO, T HATTORI |
S SUEHIRO, Y HAMADA, M TOI, T NAKAMURA, M NIIMOTO, T HATTORI |
NUCLEAR-DNA CONTENT IN BREAST-CARCINOMA WITH SPECIAL REFERENCE TO THE PARAMETERS OF MALIGNANT POTENTIALITY |
NUCLEAR-DNA CONTENT IN BREAST-CARCINOMA WITH SPECIAL REFERENCE TO THE PARAMETERS OF MALIGNANT POTENTIALITY |
NUCLEAR-DNA CONTENT IN BREAST-CARCINOMA WITH SPECIAL REFERENCE TO THE PARAMETERS OF MALIGNANT POTENTIALITY |
JAPANESE JOURNAL OF SURGERY, 20, 1, 115-118 |
JAPANESE JOURNAL OF SURGERY, 20, 1, 115-118 |
JAPANESE JOURNAL OF SURGERY, 20, 1, 115-118 |
1990/01 |
有 |
英語 |
|
公開 |
| M TOI, H MUKAIDA, T WADA, N HIRABAYASHI, T TOGE, T HORI, K UMEZAWA |
M TOI, H MUKAIDA, T WADA, N HIRABAYASHI, T TOGE, T HORI, K UMEZAWA |
M TOI, H MUKAIDA, T WADA, N HIRABAYASHI, T TOGE, T HORI, K UMEZAWA |
ANTINEOPLASTIC EFFECT OF ERBSTATIN ON HUMAN MAMMARY AND ESOPHAGEAL TUMORS IN ATHYMIC NUDE-MICE |
ANTINEOPLASTIC EFFECT OF ERBSTATIN ON HUMAN MAMMARY AND ESOPHAGEAL TUMORS IN ATHYMIC NUDE-MICE |
ANTINEOPLASTIC EFFECT OF ERBSTATIN ON HUMAN MAMMARY AND ESOPHAGEAL TUMORS IN ATHYMIC NUDE-MICE |
EUROPEAN JOURNAL OF CANCER, 26, 6, 722-724 |
EUROPEAN JOURNAL OF CANCER, 26, 6, 722-724 |
EUROPEAN JOURNAL OF CANCER, 26, 6, 722-724 |
1990 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M TOI, T NAKAMURA, T WADA, A YAMAMOTO, T TOGE, M NIIMOTO, T HATTORI |
M TOI, T NAKAMURA, T WADA, A YAMAMOTO, T TOGE, M NIIMOTO, T HATTORI |
M TOI, T NAKAMURA, T WADA, A YAMAMOTO, T TOGE, M NIIMOTO, T HATTORI |
THE DISCREPANCY BETWEEN IMMUNOCYTOCHEMICAL AND BIOCHEMICAL ASSAY OF ESTROGEN-RECEPTOR IN BREAST-CANCER PATIENTS TREATED BY ENDOCRINE THERAPY |
THE DISCREPANCY BETWEEN IMMUNOCYTOCHEMICAL AND BIOCHEMICAL ASSAY OF ESTROGEN-RECEPTOR IN BREAST-CANCER PATIENTS TREATED BY ENDOCRINE THERAPY |
THE DISCREPANCY BETWEEN IMMUNOCYTOCHEMICAL AND BIOCHEMICAL ASSAY OF ESTROGEN-RECEPTOR IN BREAST-CANCER PATIENTS TREATED BY ENDOCRINE THERAPY |
JAPANESE JOURNAL OF SURGERY, 19, 6, 768-772 |
JAPANESE JOURNAL OF SURGERY, 19, 6, 768-772 |
JAPANESE JOURNAL OF SURGERY, 19, 6, 768-772 |
1989/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M TOI, T NAKAMURA, T WADA, A YAMAMOTO, T TOGE, M NIIMOTO, T HATTORI |
M TOI, T NAKAMURA, T WADA, A YAMAMOTO, T TOGE, M NIIMOTO, T HATTORI |
M TOI, T NAKAMURA, T WADA, A YAMAMOTO, T TOGE, M NIIMOTO, T HATTORI |
THE ACCEPTABLE DELAY BETWEEN BIOPSY AND RADICAL-MASTECTOMY IN BREAST-CANCER PATIENTS |
THE ACCEPTABLE DELAY BETWEEN BIOPSY AND RADICAL-MASTECTOMY IN BREAST-CANCER PATIENTS |
THE ACCEPTABLE DELAY BETWEEN BIOPSY AND RADICAL-MASTECTOMY IN BREAST-CANCER PATIENTS |
JAPANESE JOURNAL OF SURGERY, 19, 6, 679-683 |
JAPANESE JOURNAL OF SURGERY, 19, 6, 679-683 |
JAPANESE JOURNAL OF SURGERY, 19, 6, 679-683 |
1989/11 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| S SUEHIRO, K INAI, S TOKUOKA, Y HAMADA, M TOI, M NIIMOTO, T HATTORI |
S SUEHIRO, K INAI, S TOKUOKA, Y HAMADA, M TOI, M NIIMOTO, T HATTORI |
S SUEHIRO, K INAI, S TOKUOKA, Y HAMADA, M TOI, M NIIMOTO, T HATTORI |
INVOLVEMENT OF THE NIPPLE IN EARLY CARCINOMA OF THE BREAST |
INVOLVEMENT OF THE NIPPLE IN EARLY CARCINOMA OF THE BREAST |
INVOLVEMENT OF THE NIPPLE IN EARLY CARCINOMA OF THE BREAST |
SURGERY GYNECOLOGY & OBSTETRICS, 168, 3, 244-248 |
SURGERY GYNECOLOGY & OBSTETRICS, 168, 3, 244-248 |
SURGERY GYNECOLOGY & OBSTETRICS, 168, 3, 244-248 |
1989/03 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| M TOI, Y HAMADA, T NAKAMURA, H MUKAIDA, S SUEHIRO, T WADA, T TOGE, M NIIMOTO, T HATTORI |
M TOI, Y HAMADA, T NAKAMURA, H MUKAIDA, S SUEHIRO, T WADA, T TOGE, M NIIMOTO, T HATTORI |
M TOI, Y HAMADA, T NAKAMURA, H MUKAIDA, S SUEHIRO, T WADA, T TOGE, M NIIMOTO, T HATTORI |
IMMUNOCYTOCHEMICAL AND BIOCHEMICAL-ANALYSIS OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN HUMAN-BREAST CANCER TISSUES - RELATIONSHIP TO ESTROGEN-RECEPTOR AND LYMPHATIC INVASION |
IMMUNOCYTOCHEMICAL AND BIOCHEMICAL-ANALYSIS OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN HUMAN-BREAST CANCER TISSUES - RELATIONSHIP TO ESTROGEN-RECEPTOR AND LYMPHATIC INVASION |
IMMUNOCYTOCHEMICAL AND BIOCHEMICAL-ANALYSIS OF EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN HUMAN-BREAST CANCER TISSUES - RELATIONSHIP TO ESTROGEN-RECEPTOR AND LYMPHATIC INVASION |
INTERNATIONAL JOURNAL OF CANCER, 43, 2, 220-225 |
INTERNATIONAL JOURNAL OF CANCER, 43, 2, 220-225 |
INTERNATIONAL JOURNAL OF CANCER, 43, 2, 220-225 |
1989/02 |
有 |
英語 |
研究論文(学術雑誌) |
公開 |
| T. Saeki, K. Jinushi, R. Kim, M. Toi, K. Saeki, K. Yoshinaka, E. Yanagawa, M. Niimoto, T. Hattori |
T. Saeki, K. Jinushi, R. Kim, M. Toi, K. Saeki, K. Yoshinaka, E. Yanagawa, M. Niimoto, T. Hattori |
T. Saeki, K. Jinushi, R. Kim, M. Toi, K. Saeki, K. Yoshinaka, E. Yanagawa, M. Niimoto, T. Hattori |
Combination chemotherapy of CPM-MTX-5-FU for non-resectable and recurrent cancer patients |
Combination chemotherapy of CPM-MTX-5-FU for non-resectable and recurrent cancer patients |
Combination chemotherapy of CPM-MTX-5-FU for non-resectable and recurrent cancer patients |
Japanese Journal of Cancer and Chemotherapy, 16, 4 I, 827-831 |
Japanese Journal of Cancer and Chemotherapy, 16, 4 I, 827-831 |
Japanese Journal of Cancer and Chemotherapy, 16, 4 I, 827-831 |
1989 |
有 |
英語 |
|
公開 |
| M TOI, Y HAMADA, Y SETO, M TANIMOTO, T NAKAMURA, T TOGE, M NIIMOTO, T HATTORI |
M TOI, Y HAMADA, Y SETO, M TANIMOTO, T NAKAMURA, T TOGE, M NIIMOTO, T HATTORI |
M TOI, Y HAMADA, Y SETO, M TANIMOTO, T NAKAMURA, T TOGE, M NIIMOTO, T HATTORI |
IMMUNOCYTOCHEMICAL STUDY ON THE VARIATION IN ESTROGEN-RECEPTORS OF PRIMARY AND NODAL METASTASES OF BREAST-CANCER |
IMMUNOCYTOCHEMICAL STUDY ON THE VARIATION IN ESTROGEN-RECEPTORS OF PRIMARY AND NODAL METASTASES OF BREAST-CANCER |
IMMUNOCYTOCHEMICAL STUDY ON THE VARIATION IN ESTROGEN-RECEPTORS OF PRIMARY AND NODAL METASTASES OF BREAST-CANCER |
JAPANESE JOURNAL OF SURGERY, 18, 2, 228-231 |
JAPANESE JOURNAL OF SURGERY, 18, 2, 228-231 |
JAPANESE JOURNAL OF SURGERY, 18, 2, 228-231 |
1988/03 |
有 |
英語 |
|
公開 |
| M. Toi |
M. Toi |
M. Toi |
Comparative study on estrogen receptor, epidermal growth factor and epidermal growth factor receptor using immunocytochemical and biochemical assays in breast cancer |
Comparative study on estrogen receptor, epidermal growth factor and epidermal growth factor receptor using immunocytochemical and biochemical assays in breast cancer |
Comparative study on estrogen receptor, epidermal growth factor and epidermal growth factor receptor using immunocytochemical and biochemical assays in breast cancer |
Nippon Geka Gakkai zasshi, 89, 5, 725-736 |
Nippon Geka Gakkai zasshi, 89, 5, 725-736 |
Nippon Geka Gakkai zasshi, 89, 5, 725-736 |
1988 |
有 |
英語 |
|
公開 |
| Y. Nomura, H. Tashiro, K. Hisamatsu, M. Toi |
Y. Nomura, H. Tashiro, K. Hisamatsu, M. Toi |
Y. Nomura, H. Tashiro, K. Hisamatsu, M. Toi |
Effects of high-dose medroxyprogesterone acetate for advanced breast cancer with special reference to prior endocrine therapy and hormone receptors |
Effects of high-dose medroxyprogesterone acetate for advanced breast cancer with special reference to prior endocrine therapy and hormone receptors |
Effects of high-dose medroxyprogesterone acetate for advanced breast cancer with special reference to prior endocrine therapy and hormone receptors |
Japanese Journal of Cancer and Chemotherapy, 15, 3, 513-518 |
Japanese Journal of Cancer and Chemotherapy, 15, 3, 513-518 |
Japanese Journal of Cancer and Chemotherapy, 15, 3, 513-518 |
1988 |
有 |
英語 |
|
公開 |
| K. Hisamatsu, T. Toge, E. Yanagawa, Y. Hamada, Y. Seto, H. Yamada, M. Toi, T. Hattori |
K. Hisamatsu, T. Toge, E. Yanagawa, Y. Hamada, Y. Seto, H. Yamada, M. Toi, T. Hattori |
K. Hisamatsu, T. Toge, E. Yanagawa, Y. Hamada, Y. Seto, H. Yamada, M. Toi, T. Hattori |
Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer patients |
Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer patients |
Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer patients |
Japanese Journal of Cancer and Chemotherapy, 13, 8, 2555-2561 |
Japanese Journal of Cancer and Chemotherapy, 13, 8, 2555-2561 |
Japanese Journal of Cancer and Chemotherapy, 13, 8, 2555-2561 |
1986 |
有 |
英語 |
|
公開 |
| M. Toi, Y. Hamada, Y. Seto, K. Hisamatsu, S. Suehiro, T. Toge, M. Niimoto, T. Hattori |
M. Toi, Y. Hamada, Y. Seto, K. Hisamatsu, S. Suehiro, T. Toge, M. Niimoto, T. Hattori |
M. Toi, Y. Hamada, Y. Seto, K. Hisamatsu, S. Suehiro, T. Toge, M. Niimoto, T. Hattori |
Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method |
Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method |
Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method |
Gan to kagaku ryoho. Cancer & chemotherapy, 13, 10, 3056-3062 |
Gan to kagaku ryoho. Cancer & chemotherapy, 13, 10, 3056-3062 |
Gan to kagaku ryoho. Cancer & chemotherapy, 13, 10, 3056-3062 |
1986 |
有 |
英語 |
|
公開 |
| M. Toi, T. Shiramizu, T. Yonemura, T. Ezaki, N. Oka, T. Yoshida, H. Tsurumaru |
M. Toi, T. Shiramizu, T. Yonemura, T. Ezaki, N. Oka, T. Yoshida, H. Tsurumaru |
M. Toi, T. Shiramizu, T. Yonemura, T. Ezaki, N. Oka, T. Yoshida, H. Tsurumaru |
Intraperitoneal cisplatin in peritoneal carcinomatosis patients |
Intraperitoneal cisplatin in peritoneal carcinomatosis patients |
Intraperitoneal cisplatin in peritoneal carcinomatosis patients |
Gan no rinsho. Japan journal of cancer clinics, 31, 5, 522-526 |
Gan no rinsho. Japan journal of cancer clinics, 31, 5, 522-526 |
Gan no rinsho. Japan journal of cancer clinics, 31, 5, 522-526 |
1985 |
有 |
英語 |
|
公開 |
| M. Toi, K. Matsuki, K. Nakagami, M. Hirono, M. Niimoto, T. Hattori |
M. Toi, K. Matsuki, K. Nakagami, M. Hirono, M. Niimoto, T. Hattori |
M. Toi, K. Matsuki, K. Nakagami, M. Hirono, M. Niimoto, T. Hattori |
A case of minute carcinoma associated with an atypical epithelial lesion of the stomach and histopathological analysis |
A case of minute carcinoma associated with an atypical epithelial lesion of the stomach and histopathological analysis |
A case of minute carcinoma associated with an atypical epithelial lesion of the stomach and histopathological analysis |
Gan no rinsho. Japan journal of cancer clinics, 30, 5, 519-523 |
Gan no rinsho. Japan journal of cancer clinics, 30, 5, 519-523 |
Gan no rinsho. Japan journal of cancer clinics, 30, 5, 519-523 |
1984 |
有 |
英語 |
|
公開 |
| Masahiro Takada, Hiroshi Ishiguro, Shigenori Nagai, Shoichiro Ohtani, Hidetaka Kawabata, Yasuhiro Yanagita, Yasuo Hozumi, Chikako Shimizu, Shintaro Takao, Nobuaki Sato, Yoshimasa Kosaka, Yasuaki Sagara, Hiroji Iwata, Shinji Ohno, Katsumasa Kuroi, Norikazu Masuda, Hiroyasu Yamashiro, Masahiro Sugimoto, Masahide Kondo, Yasuhiro Naito, Hironobu Sasano, Takashi Inamoto, Satoshi Morita, Masakazu Toi |
Masahiro Takada, Hiroshi Ishiguro, Shigenori Nagai, Shoichiro Ohtani, Hidetaka Kawabata, Yasuhiro Yanagita, Yasuo Hozumi, Chikako Shimizu, Shintaro Takao, Nobuaki Sato, Yoshimasa Kosaka, Yasuaki Sagara, Hiroji Iwata, Shinji Ohno, Katsumasa Kuroi, Norikazu Masuda, Hiroyasu Yamashiro, Masahiro Sugimoto, Masahide Kondo, Yasuhiro Naito, Hironobu Sasano, Takashi Inamoto, Satoshi Morita, Masakazu Toi |
Masahiro Takada, Hiroshi Ishiguro, Shigenori Nagai, Shoichiro Ohtani, Hidetaka Kawabata, Yasuhiro Yanagita, Yasuo Hozumi, Chikako Shimizu, Shintaro Takao, Nobuaki Sato, Yoshimasa Kosaka, Yasuaki Sagara, Hiroji Iwata, Shinji Ohno, Katsumasa Kuroi, Norikazu Masuda, Hiroyasu Yamashiro, Masahiro Sugimoto, Masahide Kondo, Yasuhiro Naito, Hironobu Sasano, Takashi Inamoto, Satoshi Morita, Masakazu Toi |
Predictive factors for pathologic complete response and disease-free survival after neoadjuvant chemotherapy with trastuzumab: a multicenter retrospective observational study in patients with HER2-positive primary breast cancer (JBCRG-C03 study) |
Predictive factors for pathologic complete response and disease-free survival after neoadjuvant chemotherapy with trastuzumab: a multicenter retrospective observational study in patients with HER2-positive primary breast cancer (JBCRG-C03 study) |
Predictive factors for pathologic complete response and disease-free survival after neoadjuvant chemotherapy with trastuzumab: a multicenter retrospective observational study in patients with HER2-positive primary breast cancer (JBCRG-C03 study) |
San Antonio Breast Cancer Symposium 2013 |
San Antonio Breast Cancer Symposium 2013 |
San Antonio Breast Cancer Symposium 2013 |
|
有 |
英語 |
|
公開 |
| 戸井 雅和 |
戸井 雅和 |
Matsumoto Y, Asao Y, Yoshikawa A, Sekiguchi H, Takada M, Furu M, Saito S, Kataoka M, Abe H, Yagi T, Togashi K, Toi M |
Label-free photoacoustic imaging of human palmar vessels: a structural morphological analysis. |
Label-free photoacoustic imaging of human palmar vessels: a structural morphological analysis. |
Label-free photoacoustic imaging of human palmar vessels: a structural morphological analysis. |
Sci Rep, 15;8(1), 786 |
Sci Rep, 15;8(1), 786 |
Sci Rep, 15;8(1), 786 |
|
有 |
|
|
公開 |
| 戸井 雅和 |
戸井 雅和 |
TOI Masakazu |
SALL4 - KHDRBS3 network enhances stemness by modulating CD44 splicing in basal-like breast cancer. |
SALL4 - KHDRBS3 network enhances stemness by modulating CD44 splicing in basal-like breast cancer. |
SALL4 - KHDRBS3 network enhances stemness by modulating CD44 splicing in basal-like breast cancer. |
Cancer Med, Feb;7(2), 454-462 |
Cancer Med, Feb;7(2), 454-462 |
Cancer Med, Feb;7(2), 454-462 |
|
有 |
|
|
公開 |
| 戸井 雅和 |
戸井 雅和 |
TOI Masakazu |
5-Chloro-2,4-dihydroxypyridine, CDHP, prevents lung metastasis of basal-like breast cancer cells by reducing nascent adhesion formation. |
5-Chloro-2,4-dihydroxypyridine, CDHP, prevents lung metastasis of basal-like breast cancer cells by reducing nascent adhesion formation. |
5-Chloro-2,4-dihydroxypyridine, CDHP, prevents lung metastasis of basal-like breast cancer cells by reducing nascent adhesion formation. |
Cancer Med, 7(2), 463-470 |
Cancer Med, 7(2), 463-470 |
Cancer Med, 7(2), 463-470 |
|
有 |
|
|
公開 |
| 戸井 雅和 |
戸井 雅和 |
Miyake KK, Nakamoto Y, Saji S, Sugie T, Kurihara K, Kanao S, Ikeda DM, Toi M, Togashi K |
Impact of physiological hormonal fluctuations on 18F-fluorodeoxyglucose uptake in breast cancer. |
Impact of physiological hormonal fluctuations on 18F-fluorodeoxyglucose uptake in breast cancer. |
Impact of physiological hormonal fluctuations on 18F-fluorodeoxyglucose uptake in breast cancer. |
Breast Cancer Res Treat, 169(3), 437-446 |
Breast Cancer Res Treat, 169(3), 437-446 |
, 169(3), 437-446 |
|
有 |
|
|
公開 |
| 戸井 雅和 |
戸井 雅和 |
TOI Masakazu |
Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1. |
Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1. |
Toi M, Shao Z, Hurvitz S, Tseng LM, Zhang Q, Shen K, Liu D, Feng J, Xu B, Wang X, Lee KS, Ng TY, Ridolfi A, Noel-Baron F, Ringeisen F, Jiang Z. |
Breast Cancer Res, 19(1), 2017 Apr 11;19(1):47. doi: 10. |
Breast Cancer Res, 19(1), 2017 Apr 11;19(1):47. doi: 10. |
Breast Cancer Res, 19(1), 2017 Apr 11;19(1):47. doi: 10. |
|
有 |
|
|
公開 |
| 戸井 雅和 |
戸井 雅和 |
Ueno T, Saji S, Sugimoto M, Masuda N, Kuroi K, Sato N, Takei H, Yamamoto Y, Ohno S, Yamashita H, Hisamatsu K, Aogi K, Iwata H, Imoto S, Sasano H, Toi M |
Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy. |
Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy. |
Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy. |
BMC Cancer, 16;16, 230-doi: 10 |
BMC Cancer, 16;16, 230-doi: 10 |
BMC Cancer, 16;16, 230-doi: 10 |
|
有 |
|
|
公開 |
| 戸井 雅和 |
戸井 雅和 |
André F, Hurvitz S, Fasolo A, Tseng LM, Jerusalem G, Wilks S, O'Regan R, Isaacs C, Toi M, Burris H, He W, Robinson D, Riester M, Taran T, Chen D, Slamon D |
Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3. |
Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3. |
Molecular Alterations and Everolimus Efficacy in Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Biomarker Analysis From BOLERO-1 and BOLERO-3. |
J Clin Oncol, 20;34, 18, 2115-2124 |
J Clin Oncol, 20;34, 18, 2115-2124 |
J Clin Oncol, 20;34, 18, 2115-2124 |
|
有 |
|
|
公開 |
| 戸井 雅和 |
戸井 雅和 |
Asao Y, Hashizume Y, Suita T, Nagae KI, Fukutani K, Sudo Y, Matsushita T, Kobayashi S, Tokiwa M, Yamaga I, Fakhrejahani E, Torii M, Kawashima M, Takada M, Kanao S, Kataoka M, Shiina T, Toi M |
Photoacoustic mammography capable of simultaneously acquiring photoacoustic and ultrasound images. |
Photoacoustic mammography capable of simultaneously acquiring photoacoustic and ultrasound images. |
Photoacoustic mammography capable of simultaneously acquiring photoacoustic and ultrasound images. |
J Biomed Opt, 1;21, 11, :116009. |
J Biomed Opt, 1;21, 11, :116009. |
J Biomed Opt, 1;21, 11, :116009. |
|
有 |
|
|
公開 |
| Cameron D, Brown J, Dent R, Jackisch C, Mackey J, Pivot X, Steger GG, Suter TM, Toi M, Parmar M, Laeufle R, Im YH, Romieu G, Harvey V, Lipatov O, Pienkowski T, Cottu P, Chan A, Im SA, Hall PS, Bubuteishvili-Pacaud L, Henschel V, Deurloo RJ, Pallaud C, Bell R |
Cameron D, Brown J, Dent R, Jackisch C, Mackey J, Pivot X, Steger GG, Suter TM, Toi M, Parmar M, Laeufle R, Im YH, Romieu G, Harvey V, Lipatov O, Pienkowski T, Cottu P, Chan A, Im SA, Hall PS, Bubuteishvili-Pacaud L, Henschel V, Deurloo RJ, Pallaud C, Bell R |
Cameron D, Brown J, Dent R, Jackisch C, Mackey J, Pivot X, Steger GG, Suter TM, Toi M, Parmar M, Laeufle R, Im YH, Romieu G, Harvey V, Lipatov O, Pienkowski T, Cottu P, Chan A, Im SA, Hall PS, Bubuteishvili-Pacaud L, Henschel V, Deurloo RJ, Pallaud C, Bell R |
Adjuvant bevacizumab- containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial |
Adjuvant bevacizumab- containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial |
Adjuvant bevacizumab- containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial |
Lancet Oncol. 2013 |
Lancet Oncol. 2013 |
Lancet Oncol. 2013 |
|
有 |
英語 |
|
公開 |
| Suzuki R, Saji S, Toi M |
Suzuki R, Saji S, Toi M |
Suzuki R, Saji S, Toi M |
Impact of body mass index on breast cancer in accordance with the life-stage of women. |
Impact of body mass index on breast cancer in accordance with the life-stage of women. |
Impact of body mass index on breast cancer in accordance with the life-stage of women. |
Front Oncol. 2012;2:123 |
Front Oncol. 2012;2:123 |
Front Oncol. 2012;2:123 |
|
有 |
英語 |
|
公開 |
HOME
教育研究活動データベースについて
利用方法について
